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Human cytokine responses during








Over one third of the human population is currently infected by one or more species of
parasitic helminth, but the immune responses elicited by these infections remain poorly
defined. Studies in helminth-exposed human populations and laboratory models suggest that
helminth infection elicits a range of different effector cell types and that protective immunity
and resistance to immune-mediated pathology depends on the balance between these
responses. The aim of this thesis was to investigate how cytokines, the molecular mediators
of the immune system, can be used to characterise human immune phenotype during natural
and experimental helminth infection. Cytokines associated with innate inflammatory
IL-6 and IL- -2 and IL-12p70), Th2 (IL-4, IL-5 and IL-13), Th17 (IL-17A,
IL-21 and IL-23) and regulatory (IL- immune phenotypes were analysed to
provide the most comprehensive analysis of cytokine responses in human helminth infection
conducted to-date. Using a multivariate statistical approach cytokines were analysed as
combined immune profiles to reflect their complex interactions in vivo.
In the first part of the study venous blood samples collected from a cross-sectional cohort of
284 Zimbabweans (age range: 3 -86 years) endemically-exposed to Schistosoma
haematobium were cultured with antigens from different -cycle
(cercariae, adult worms and eggs) and the anti-schistosome vaccine candidate antigen
glutathionine-S-transferase (GST). Cytokines responses were quantified in culture
supernatants via enzyme-linked immunosorbent assay (ELISA). These assays were repeated
6 weeks after clearance of infection by anti-helminthic treatment. Parasitological and
demographic characterisation of the cohort before, 6 weeks, 6 and 18 months after treatment
allowed cytokine responses to be related to epidemiological patterns of infection before
treatment and the risk of re-infection after treatment. The main findings of this study were:
Cytokine responses to the antigens of S. haematobium cercariae are more pro-
inflammatory than those elicited by adult worms and eggs prior to treatment,
reflecting the distinct proteomes and exposure patterns of the 3 life-cycle stages
Young children (5-10 years old) have a more regulatory and Th17-polarised cytokine
response to S. haematobium antigens than older children and adults. These responses
are significantly associated with schistosome infection intensity and may contribute
to the development of resistance to schistosomiasis with age and exposure to
infection
Anti-helminthic treatment leads to a shift in S. haematobium cercariae, egg and GST-
specific cytokine responses towards a more pro-inflammatory phenotype
The magnitude of change in S. haematobium-specific cytokine profiles after
treatment is dependent on schistosome infection intensity at the time of treatment
Individuals who remain un-infected up to 18 months after treatment to clear
schistosome infection have a more pro-inflammatory and IL-21-polarised response to
S. haematobium antigens 6 weeks after treatment than those who become re-infected,
suggesting that post-treatment cytokine profiles promote resistance to re-infection
The second part of the study assayed systemic, parasite and allergen-specific cytokine
responses in 45 adults with seasonally exacerbated allergy to grass pollen who were
experimentally exposed to Trichuris suis. Cytokine responses in infected individuals were
compared to those of 44 un-infected controls. This aspect of the study showed that:
Exposure to T. suis promotes systemic and parasite-specific Th2 and regulatory
cytokine responses, but does not alter cytokine responses to environmental allergens
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Parasitic helminths are evolutionarily ancient human pathogens (Cox 2002) and the causative
agents of highly prevalent and debilitating diseases world-wide (Hotez et al. 2008). Despite
their high prevalence there remains no effective vaccine against these infections and less
than 5% of those at risk of infection have access to anti-helminthic treatment (Gryseels et al.
2006; Hotez 2009). One of the major obstacles to eradicating human helminthiases and the
morbidity they cause is that the immune responses that these parasites elicit in humans are
ill-defined, particularly in endemically-exposed populations where hosts are repeatedly
exposed to infection throughout their lives. In this thesis I investigate how immune responses
to helminths can be better characterised in humans, focusing particularly on cytokine
responses which are the molecular mediators of the immune response.
Schistosoma spp. worms are amongst the most significant helminth species affecting global
health and over 650 million people are at risk of infection (Chitsulo et al. 2000). In chapters
3-6 I investigate how the schistosome-specific cytokine response is influenced by differences
in the parasite life-cycle and epidemiological patterns of infection in a schistosome-endemic
population and whether these responses are related to the development of immune-mediated
resistance before and after anti-helminthic treatment. This chapter provides an introduction
to the immunobiology and epidemiology of schistosomiasis and discusses the paradigms
from mathematical and laboratory models of infection that are yet to be tested in human
population studies.
One of the major features of parasitic helminths is their ability to modulate the host immune
response (Maizels et al. 1993; Maizels and Yazdanbakhsh 2003; Maizels et al. 2004). Whilst
this feature may contribute to their persistence during natural infections, recent interest has
developed into whether this feature could be exploited by using experimental helminth
infections to regulate immune-mediated diseases (Reddy and Fried 2007; Erb 2009). The
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conducted to-date and how these studies have contributed to our understanding of human
immune responses to helminth infections in previously un-exposed hosts.
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1.1 Parasitic helminth infections
The most prevalent human helminthiases are caused by nematode species including filarial
worms (Brugia malayi, Onchocerca volvulus, and Wuchereria bancrofti) and soil-
transmitted helminths (STH): Ascaris lumbricoides, Trichuris trichiura, hookworm
(Ancyclostoma duodenale and Necator americanus), Strongyloides spp. and Enterobius
vermicularis (Hotez et al. 2008). Of the trematodes, Schistosoma spp. are the most widely
distributed and cause the greatest burden to public health (Gryseels et al. 2006). There are
(Zhang et al. 2008).
Although parasitic helminths have a diverse phylogeny, they share a number of features that
have contributed to their success as parasites of humans. Firstly, they are large, multicellular
organisms ranging from millimetres to metres in length (Anderson and May 1992) and thus
the immune response directed against them differs markedly to that elicited by micro-
parasites (e.g. bacteria and viruses), which can be readily internalised by immune cells.
Parasitic helminths also tend to have complex life-cycles made up of several distinct stages
highly specialised to infect, inhabit and exit their human hosts respectively. Variation
between the life cycles of different helminth species, summarised in Table 1.1, reflects the
selective challenges posed by the different geographical environments and intra-host niches
that they exploit (Bourke et al. 2011) and is discussed in more detail for the human
schistosomes later in this chapter. This adaptation is also evident at a molecular level since
the large genomes of parasitic helminths correspond to a diverse range of expressed proteins
with which the host immune response can interact (Ghedin et al. 2007; Berriman et al. 2009;
Zhou et al. 2009; Mitreva et al. 2011). Identification of helminth homologues of human
proteins (Pastrana et al. 1998; Gomez-Escobar et al. 2000) and rapid evolution among
parasite secreted proteins (Hoekstra et al. 2000; Harcus et al. 2004) suggest that helminth
antigens exposed to (and interacting with) the host immune system have diversified in
response to the selective pressures associated with parasitism. Thus helminths are
evolutionarily adapted for long-term interactions with their hosts and tend to establish
chronic infections. The average life-span of mature parasites in their human host ranges from
1-10 years (see Table 1), although in rare cases individual parasites have been reported to
survive for up to 30 years (Christopherson 1924; Berberian et al. 1953; Harris et al. 1984).
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1.2 Human schistosomiasis
1.2.1 Global health burden
The 3 predominant Schistosoma species affecting humans are S. haematobium, S. japonicum
and S. mansoni which collectively account for over 200 million current infections(Fenwick
et al. 2003; W.H.O. 2006) and an estimated 15,000 deaths per year (Fenwick et al. 2003).
Infections are almost exclusively aggregated in areas of rural poverty, particularly in sub-
Saharan Africa (Platt and Brooks 1997; Gryseels et al. 2006) where co-infections with other
helminth species, Plasmodium parasites and human immunodeficiency virus (HIV) are
common (Raso et al. 2004; Brooker et al. 2006; Midzi et al. 2008b). S. intercalatum and S.
mekongi also cause human infections, but have a more restricted distribution (Gryseels et al.
2006). The global distribution of human schistosome infections is summarised in Figure 1.1.
In addition to the mortality that they cause, schistosome infections account for significant
chronic morbidities in infected individuals quantified globally as between 6 and 13.5 million
disability-adjusted life years (DALYs) per year (King et al. 2005). Unfortunately, the paucity
of data on the number of cases, particularly in young children (Stothard et al. 2011), and the
difficulty in identifying subtle and chronic morbidities due to infection (King 2007) mean
that these figures are almost certainly an under-estimate
1.2.2 Life-cycle
Schistosomes are dioecious trematode worms that have evolved a complex life-cycle
comprising 2 intra-host and 2 free-living stages, summarised in Figure 1.2. The global
distribution of schistosome infections (see Figure 1.1) is determined by the distribution of
intermediate snail host species in which schistosomes replicate asexually; aquatic Bulinus
spp. and Biomphalaria spp. for S. haematobium and S. mansoni respectively and amphibious
Oncomelania spp. for S. japonicum (Gryseels et al. 2006). The definitive human host is
exposed to 4 distinct life cycle stages of the parasite-infective larvae (cercariae), migratory
larvae (schistosomula), mature adult worms and transmission stage parasites (eggs).
Humans become infected via contact with fresh water containing cercariae released from
patently infected snails. In schistosome-endemic regions infection usually occurs during
Chapter 1 General Introduction
- 6 -
Figure 1.1. The global distribution of human schistosomiasis, reproduced from an article
by Gryseels et al, 2006 (originally adapted from Doumenge and Mott, 1984).
Figure 1.2. The life-cycle of Schistosoma spp. parasites. Adapted from online CDC
resource (www.dpd.cdc.gov/dpdx/Schistosomiasis.htm). Blue arrows indicate stages to
which the human host is exposed and red arrows indicate free-living aquatic stages and those
affecting the intermediate snail host.
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(Rudge et al.
2008) and occupational activities (e.g. fishing (Joseph et al. 2004a), car washing and sand
harvesting (Black et al. 2009)). Cercariae invade percutaneously using proteolytic enzymes
(Stirewalt and
Kruidenier 1961). During invasion cercariae mature into schistosomula, which are exposed
to a range of host tissues as they migrate from the skin via blood and lymphatic vessels to the
lungs and are then transported in the blood to the urogenital (S. haematobium) or hepatic (S.
japonicum and S. mansoni) veins. Adult schistosomes reside in these vessels and form long-
term male-female pairs to produce eggs. Unlike the larval stages, which survive for hours
(cercariae) or weeks (schistosomula) (Anderson and May 1992; Gryseels et al. 2006), adult
worms have an average intra-host life-span of several years (the most recent estimate for S.
mansoni is 3-10 years (Fulford et al. 1995) but estimates for Schistosoma spp. range from 6-
11 years (Table 1.1)) allowing parasites to establish chronic infections.
Egg-stage schistosomes are either transmitted to the environment via passage into the urinary
bladder (S. haematobium) or gastrointestinal (GI) tract (S. mansoni and S. japonicum). This
is an immune-mediated process in murine infections (Doenhoff 1997; Fallon and Dunne
1999) and evidence that immunosuppressed individuals have impaired excretion of S.
mansoni eggs suggests that this is also the case in human infections (Karanja et al. 1997).
Schistosome eggs are also the predominant cause of host morbidity in chronic
schistosomiasis since many become trapped in host tissues where they form fibrotic lesions
called granulomas (Henri et al. 2002; Dessein et al. 2004; Coutinho et al. 2007).
Accumulation of eggs occurs cumulatively and morbidity develops over many years (Dunne
and Pearce 1999). Eggs that are successfully transmitted to the environment in urine (S.
haematobium) or faeces (S. mansoni and S. japonicum) hatch in freshwater where they can
infect intermediate host snails to maintain the life-cycle.
1.2.3 Distinctions between schistosome species
In this thesis (chapter 3-6) I have focused on S. haematobium, the most prevalent
schistosome species in Africa (Chitsulo et al. 2000), but arguably the least studied. Unlike S.
mansoni and S. japonicum for which genome sequences were recently published (Berriman
et al. 2009; Zhou et al. 2009), the S. haematobium genome project is incomplete and its life
cycle is also more difficult to maintain in laboratory animals than the other 2 species. The
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mouse is a non-permissive host for S. haematobium (Moore and Meleney 1954; Cheever et
al. 1983) and the experimental host repertoire is generally more restricted and patterns of
infection more variable than those of experimental S. mansoni or S. japonicum (Meleney et
al. 1953; Moore and Meleney 1954). Thus, much of what is known about schistosome
immunobiology comes from S. mansoni (and to a lesser extent S. japonicum) infections in
laboratory mice. However, distinctions in the S. haematobium life-cycle mean that urogenital
schistosomiasis fundamentally differs from the intestinal forms of disease caused by S.
mansoni and S. japonicum. Given that S. haematobium adult worms reside in the veins of the
urogenital tract, deposition of S. haematobium eggs is associated with damage to these
tissues and haematuria is a common symptom regardless of age, sex, nutritional status and
environmental factors (Koukounari et al. 2007). If left un-treated S. haematobium infection
can lead to hydroureter, hydronephrosis and bladder fibrosis (Gryseels et al. 2006) and is
unique among the schistosome species in its link to the development of bladder carcinoma
(reviewed by (Mostafa et al. 1999)) and female infertility (Kjetland et al. 2010). Large-scale
human autopsy studies have also shown that S. haematobium eggs more often accumulate in
host tissues than in their excreta relative to S. mansoni infections (Cheever et al. 1977),
although the immunological relevance of these differences has not been investigated.
Murine infections also suggest that S. haematobium is more antigenically similar to the
bovine parasite S. bovis than to S. mansoni as the 2 species can elicit heterologous immune
responses to each other, but not to S. mansoni (Agnew et al. 1989a; Agnew et al. 1989b) and
S. haematobium 28kDa glutathionine-S-transferase (GST, an abundant schistosomal enzyme
and vaccine candidate antigen) shares greater sequence homology with S. bovis GST than S.
mansoni or S. japonicum GST (Trottein et al. 1992a). Thus, despite similarities in their life
cycle, epidemiology (chapter 1.2.4) and gene expression, the immune mechanisms identified
in experimental and human infections with S. mansoni and S. japonicum should be
extrapolated to S. haematobium with caution. Throughout this thesis I have referred to these
studies where relevant and in particular where there is no equivalent for S. haematobium.
1.2.4 Epidemiology
Within endemically-exposed populations, the highest schistosome burdens are aggregated in a
minority of individuals (Woolhouse 1994), an example of which is shown in Figure 1.3A.
Furthermore, individuals with the highest parasite numbers before anti-helminthic treatment also
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tend to accumulate high worm burdens after treatment (Bensted-Smith et al. 1987; Tingley et al.
1988; Etard et al. 1995), suggesting that certain individuals may: a) be genetically pre-disposed to
infection (reviewed by (Quinnell 2003)), although evidence from field studies of schistosomiasis
are mixed (Bethony et al. 2002; King et al. 2004), b) have greater exposure to infection due to
their water contact behaviour (Chandiwana and Woolhouse 1991) and/or c) may not have
developed protective immunological memory responses to schistosome antigens (Woolhouse and
Hagan 1999). It has been known since the 1930s that schistosome worm burdens vary with age in
endemic populations (Fisher 1934), suggesting that age-related changes also influence the risk of
infection.
Cross-sectional population surveys suggest that worm burdens increase incrementally from birth
with repeated exposure to infection ate childhood/adolescence and are
considerably lower (or absent) in adulthood (Fisher 1934; Anderson and May 1992; Agnew et al.
1996; Woolhouse 1998). Immune-mediated morbidities also tend to be aggregated in chronically
infected school-age children who have high intensity infections, but a shorter history of exposure
than adults (van der Werf et al. 2003; Garba et al. 2010). Thus, children tend to be considered
susceptible (both to infection and associated morbidity), whilst adults appear more resistant to
schistosomiasis. The basis of this age-infection pattern remains controversial since if exposure to
infection occurs throughout life the relative importance of physiological changes with age and
cumulative exposure to infection are difficult to extricate. Thus, on the one hand the cross-
sectional decline in infection intensity in older children and adolescents tends to coincide with
physiological, hormonal and behavioural changes at puberty that may alter susceptibility to
infection (Fulford et al. 1998). However, comparisons between populations have shown that the
age at which infection intensity begins to decline does not always occur at puberty and varies
according to parasite transmission intensity (reviewed by (Woolhouse 1998)). Importantly, the
age at which peak schistosome infection intensity occurs is at a younger age in populations with
high transmission intensity than in those with low infection intensity (Mutapi et al. 1997;
Woolhouse 1998)
mission,
accelerates the development of resistance to infection/re-infection and thus worm burdens decline
at an earlier age than in populations with limited exposure to infection (reviewed by Woolhouse in
1998). Variation in susceptibility/resistance between adults according to their history of exposure
to infection also contradicts the view that the distribution of infection is intrinsically linked to age.




Figure 1.3. Epidemiological patterns in the distribution of human S. haematobium infections
and parasite-specific immune responses. A) Frequency distribution of egg counts per 10ml
urine, B) distribution of infection intensity by age and C) age-related changes in adult worm-
specific serum IgA and IgG1 (quantified by ELISA) in 2 Zimbabwean villages with distinct
transmission intensities. Yellow bars (A), dashed line (B) and diamonds (C) represent mean
values of data collected from 133 participants from an area of low infection prevalence (33.8%).
Red bars (A), solid line (B) and squares (C) represent mean values of data collected from 147
participants from an area of high infection prevalence (62.7%). Figures are reproduced from
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This was first demonstrated in a study of Sudanese canal workers hyper-exposed to S. mansoni
infection, which showed that those who had been occupationally exposed for over 10 years were
more resistant to infection than newly recruited workers (Satti et al. 1996). More recently a direct
comparison between two male cohorts occupationally exposed to S. mansoni, found that failure to
cure infection following anti-helminthic treatment was less common in men with a long history of
previous exposure to infection than in men who had been exposed more recently (Black et al.
2010).
1.3 Studying schistosome immunoepidemiology
Immunoepidemiology is the study of the patterns and relationships between infection and markers
of the immune response at a population level and provides an important means of identifying
correlates of resistance and susceptibility to disease (Hellriegel 2001). Identification of
measurable changes in immune biomarkers (e.g. switching from IgG4 to IgE, IgA to IgG1 (Figure
1.3C) and IL-10 to IL-5 (Hagan et al. 1991; Mutapi et al. 1997; Mutapi et al. 2007b)) at the age of
peak infection intensity provide the best evidence that the host immune response may drive the
decline in worm burdens post-peak. In addition to age-related immunological changes within
populations, comparison between populations reveals that isotype-specific antibody responses
(Mutapi et al. 1997). However, what is notably
lacking from existing studies is a link between immunoepidemiological patterns of individual
immune response that they reflect. The latter may provide a better indicator of how protective
immunity develops and which antigens are driving it in the context of considerable host
heterogeneity and I have investigated this possibility in the immunoepidemiological study of S.
haematobium described in chapters 3-6. Immunoepidemiological studies rely on collection of
peripheral samples (e.g. venous blood, stool, urine) and thus the estimates of infection and
immune responses come from indirect quantification. The disadvantage of using peripheral
samples to assess immune responses is that they may not reflect tissue-specific levels of
immunological analytes (Remick et al. 2000), however since adult schistosomes reside in the
vasculature and chronic infection leads to systemic antigen exposure (Polman et al. 1998; van
Lieshout et al. 1998) peripheral samples remain an effective indicator of immune variations.
Furthermore, the major advantage of an immunoepidemiological approach over animal models of
infection is that it allows immune responses to be characterised in their natural contexts,
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incorporating host and parasite heterogeneity that are necessarily absent in the laboratory (Druilhe
et al. 2002; Bourke et al. 2011).
1.3.1 Quantifying infection
Schistosomiasis is diagnosed and host infection intensity can be quantified by counting eggs
present in the excreta. Microscopic examination of eggs in stool (S. mansoni, S. japonicum
and STH) (Katz et al. 1972) or in filtered urine (S. haematobium)(Mott 1983) are the
recommended methods of quantifying helminth infection intensity during human field
studies since they are suitable for expedient processing of large numbers of samples in sites
where specialist equipment and reliable electricity supplies are un-available (Montresor et al.
1998). In general egg counts are considered an indicator of adult worm burden, however
accumulation of ectopic eggs (Cheever et al. 1977), temporal variations in egg production
rates (van Etten et al. 1997; Hotez et al. 2008), reduced egg production per worm in high
intensity infections (Cheever et al. 1977) and reduction in adult worm fecundity over time
(Agnew et al. 1996) may all affect the correlation between egg output and adult worm
numbers. Concerns have been raised that microscopy-based parasitological methods may
lack the sensitivity to detect low intensity helminth infections (Kongs et al. 2001; Tarafder et
al. 2010), however, analysis of repeat samples and repeat smears from each stool sample has
been shown to significantly increase the sensitivity of detection via microscopy (Ebrahim et
al. 1997).
Schistosome antigens can also be quantified in blood or urine via enzyme-linked
immunosorbent assay (ELISA) or urine dipsticks (Nibbeling et al. 1997; Hassan et al. 1998;
Kahama et al. 1998; Polman et al. 2000; Ugbomoiko et al. 2009; Standley et al. 2010;
Stothard et al. 2011). Circulating antigens tend to reflect results obtained via microscopic
egg counts (Polman et al. 2001; Hotez et al. 2008) although the strength of correlation
between the 2 measures vary between studies (Agnew et al. 1996; Kahama et al. 1998;
Hotez et al. 2008; Standley et al. 2010) and the efficacy of the antigen detection method is
dependent on the choice of antigen (Kahama et al. 1998) and whether antigens are assessed
in urine or serum samples (Hotez et al. 2008).
Another method is to use immunological indicators of parasite exposure (e.g. parasite-
specific antibodies), which has proven particularly effective for identifying early exposure in
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young children (Mutapi et al. 2011c; Stothard et al. 2011). However, in older people who
have been exposed to but subsequently cleared schistosome infection these methods may be
a less sensitive indicator of patent infections.
1.3.2 Quantifying immune responses
ELISA is a widely used means of measuring analytes in biological samples and has also been
used extensively in chapters 3-6 of this thesis. Nearly all immunoepidemiological field
studies conducted to date have used ELISA to quantify a range of immune biomarkers
including cytokines, antibodies and cellular proteins. Total and antigen-specific antibody
titres and non-specific circulating cytokine responses can be directly quantified in serum or
plasma (Hagan et al. 1991; Fitzsimmons et al. 2004; Milner et al. 2010). However, since
cytokines can be secreted in response to a range of stimuli and often act locally, systemic
cytokines cannot be directly related to parasite-specific immune responses and may be
present at very low or un-detectable levels.
Re-stimulation of whole blood (Scott et al. 2000; Scott et al. 2001; Joseph et al. 2004a;
Mutapi et al. 2007b) or purified cell populations (Grogan et al. 1996a; van den Biggelaar et
al. 2002; Silveira et al. 2004) prior to quantification is a useful means of assaying cytokine
responses directly elicited by antigens of interest and also leads to much higher cytokine
concentrations than in serum or plasma, allowing them to be more readily detected (Remick
et al. 2000). Purification of cell populations from whole blood samples has the advantage of
allowing the cellular source of assayed cytokines to be identified; however an important
caveat is that these cells are not activated in isolation from other cell types in vivo. Assaying
antigen-specific whole blood cytokine responses provides an effective
alternative/complement to these studies since the physiological composition of cell types
present in the vasculature is preserved and less sample processing is required, reducing the
risk of artificially activating cells (Remick et al. 2000). Whole blood culture is also better
suited to processing large numbers of samples during field studies since lower sample
volumes are required than for cell purification and access to the equipment and reagents
required for cell purification may be limited (Remick et al. 2000).
Cryopreserved cells can be further purified after collection and their phenotypes defined
according to surface marker and intracellular cytokine expression assessed using flow
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cytometry (Watanabe et al. 2007; Silveira-Lemos et al. 2008; Nausch et al. 2011).
Alternatively purified cells can be used for functional assays in vitro, including assessment
of proliferative responses to antigen stimulation (Grogan et al. 1996a; Medhat et al. 1998)
and in vitro granuloma formation (IVGF) (El Ridi et al. 1997).
1.4 Schistosome antigens
Immunological changes during infection are closely linked to progression of the parasites
through their life-cycle (Pearce and MacDonald 2002). This is clearly traceable in murine
models where infected animals are exposed to each life-cycle stage sequentially. In
schistosome endemic human populations however simultaneous exposure to adult worms
and eggs during infection occurs in the context of repeated challenge with cercariae, which
can make the association between parasite life-cycle stages and the host immune response
more difficult to discern. In general human field studies have assessed immune responses to
life cycle stage-specific crude homogenate preparations; cercarial antigen preparation (CAP),
schistosomula antigen preparation (SAP), whole (adult) worm homogenate (WWH) and
schistosome egg antigen (SEA). These preparations comprise stage-specific cocktails of
parasite molecules including surface-exposed antigens, secreted molecules and those that are
not exposed to the immune system by live parasites (e.g. cytosolic antigens) (Curwen et al.
2004). The advantage of using parasite antigens in their native (crude) form rather than
recombinant antigens is that these preparations reflect the diverse range of parasite
molecules present during infection, where parasite metabolism, death and the presence of
cross-reactive antigens can influence the immune responses directed against each life-cycle
stage. These preparations also incorporate post-translational modifications that may
influence immune responses but are absent from recombinant antigens. Surprisingly, despite
their wide use in immunoepidemiological studies, the immune responses to the different life-
cycle stage-specific preparations has been compared in relatively few studies and early
comparisons have never been up-dated to include markers associated with recently
discovered cell types (chapter 1.5).
1.4.1 Cercariae
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Cercarial antigens comprise a range of unique glucose and fucose carbohydrates found in the
cercarial coating (glycocalyx) and tail (Nanduri et al. 1991; Xu et al. 1994) and the contents
of the acetabular glands, which are actively secreted during invasion and enriched with
glycans (Jang-Lee et al. 2007) proteases (e.g. cercarial elastases (Salter et al. 2002; Curwen
et al. 2006)) and toxin-like molecules (Curwen et al. 2006). Notably the glycocalyx, tail and
acetabular gland contents are lost during penetration and absent from later stages of the
parasite (Samuelson and Caulfield 1985). Carbohydrate antigens derived from these
structures are highly immunogenic in mice (Samuelson and Caulfield 1985; Hussein et al.
1997) and in vitro stimulation with cercarial secretions have also been found to elicit a pro-
inflammatory cytokine response in whole blood and peripheral blood mononuclear cells
(PBMC) collected from an S. mansoni and S. haematobium co-endemic human population in
Senegal (Dr. Joseph Turner, Liverpool School of Tropical Medicine, U.K., personal
communication).
Pro-inflammatory responses of innate effector cells to cercarial antigens in the skin, which
are well documented in murine schistosomiasis (Jenkins et al. 2005a; Paveley et al. 2009),
may mediate the acute ur
individuals who make only seasonal or one-off contacts with schistosome-infested water
(Colebunders et al. 1995; Moore and Doherty 2005; Lambertucci 2010)
rarely reported in endemic communities, which may reflect under-reporting (Appleton
1984), the relatively low severity of the condition (Lambertucci 2010) or development of
tolerance to cercariae due to repeated exposure, as has been reported in repeatedly-infected
mice (Cook et al. 2011). In the absence of repeat exposure, for example in tourists visiting
endemic regions, elevated proliferative and cytokine responses to schistosome antigens can
persist for years after initial exposure (Soonawala et al. 2011).
1.4.2 Schistosomula
Cercariae become classified as schistosomula after they enter the vasculature and thus this
stage is associated with both migration and maturation of the parasite. Schistosomula
tegument antigens are particularly immunogenic (more so than whole schistosomula antigen
preparations) when cultured with PBMCs isolated from humans endemically-exposed to S.
mansoni (Gazzinelli et al. 1983). However, whole schistosomula preparations and secreted
vesicles have also been shown to elicit PBMC proliferation in vitro (Vieira et al. 1987).
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Although schistosomula are of interest as an intermediate stage, they have not been
investigated in this thesis since studies in S. mansoni suggest that over 80% of SAP
constituents overlaps with WWH, whilst CAP and SEA express a more distinct protein
repertoire (Curwen et al. 2004).
1.4.3 Adult worms
Despite their large size and prolonged exposure to circulating immune cells, there is little
evidence for immune-mediated attrition of adult parasites during experimental infections
(Meleney et al. 1953; Agnew et al. 1993). This may be due to direct modulation of systemic
immune responses by adult parasites, which has been shown to occur in the absence of eggs
in laboratory animals (Mangan et al. 2004; Smith et al. 2004; Mangan et al. 2006), or via
sequestration of immunogenic antigens beneath their thick surface tegument (van Hellemond
et al. 2006).
Separation of adult worm homogenates by 2-dimensional electrophoresis and proteomic
analysis of their constituents has shown that the most abundant soluble proteins are cytosolic
and therefore may not be exposed to immune recognition in live adult worms (Curwen et al.
2004). Consistent with these observations, Western blot screening of adult worm antigens
with serum from humans endemically-exposed to S. haematobium infection suggest that not
all adult worm antigens are constitutively exposed to the immune system during infection
since the range and intensity of antigens recognised increases after treatment-induced killing
of adult worms (Mutapi et al. 2005). The antigens that are exposed to immune-recognition
prior to adult worm death are likely to be those present on the tegument surface or
excreted/secreted, which is a restricted repertoire relative to the adult worm proteome as a
whole (Curwen et al. 2004; van Hellemond et al. 2006). Adult worm tegumental extracts
induce relatively poor in vitro proliferative responses when cultured with PBMC from
endemically-exposed humans (Gazzinelli et al. 1983) and are less reactive with anti-sera
from infected animals (Beisler et al. 1984) than whole worm antigen preparations. Together
these observations suggest that tegumental antigens are not highly immunogenic per se, but
-
worm constituents. This would be consistent with the hypothesis that release of antigens
from dead or dying adult worms provides an important immune stimulus for protective
immunity (Woolhouse and Hagan 1999) as has been shown in early animal models where
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live adult worms do not activate the surrounding host tissues, but dead worms are rapidly
cleared by infiltrating immune cells (Meleney et al. 1953).
Interestingly both the range and intensity of adult S. haematobium antigens recognised by
human serum antibodies increases with age and infection intensity (Mutapi et al. 2008) and
this is also the case for post-treatment antibody responses to S. mansoni antigens isolated
from the adult worm tegument (Roberts et al. 1987). Thus, the duration and intensity of
exposure to infection, rather than infection status alone appear to be key determinants of
responsiveness to both tegumental and cytosolic adult worm antigens.
1.4.4 Eggs
Transition from the acute to chronic stage of schistosome infection can be clearly defined in
murine models as the onset of oviposition (5-6 weeks post-infection) (Pearce and
MacDonald 2002), which coincides with a large increase in circulating parasite antigens
relative to the pre-patent stage of infection (Lei et al. 2009). Egg antigens are also clearly
detectable in the urine (Nibbeling et al. 1998; Polman et al. 2000) and sera (Hassan et al.
1998; Polman et al. 2000) of infected humans. Thus, schistosome eggs are an abundant
source of systemic antigen during infection. Furthermore, whilst ectopic eggs trapped in host
in urine after clearance of infection (Nibbeling et al. 1998) suggests that they continue to be
a source of antigens for host immune cells.
Egg antigens are potent inducers of CD4+ T helper (Th) 2-type responses in vivo (described
in chapter 1.5.3) and instigate a shift away from the pro-inflammatory responses that
predominate during acute murine infections (Grzych et al. 1991; Pearce et al. 1991). Specific
constituent antigens of homogenised eggs can also elicit Th2-type responses in human
basophils, dendritic cells (DCs) and T cell cultures (Schramm et al. 2003; Everts et al. 2009).
Egg glycans such as Lacto-N-fucopentanose III (LNFPIII) (Okano et al. 2001; Thomas et al.
2003) and Omega 1 (Schramm et al. 2003; Everts et al. 2009; Steinfelder et al. 2009) appear
to be particularly important in this respect. Furthermore, crude egg but not adult worm
antigens can directly induce IVGF by PBMCs collected from schistosome-exposed children
(El Ridi et al. 1997), suggesting that the granulomatous response generated during infection
is directly mediated by eggs.
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1.4.5 Cross reactive antigens
In addition to the stage-specific expression of certain schistosome antigens cercariae,
schistosomula, adult worm and egg stage parasites also share a range of antigens (Curwen et
al. 2004; Jolly et al. 2007). Consistent with progression from one life-cycle stage to another,
the soluble proteomes of adjacent stages are the most similar to each other (Curwen et al.
2004) and this may also be the case for the immune responses directed against them. The
latter hypothesis is supported by a study which used rabbit anti-serum to show that antigens
exposed on the adult worm tegument, but not in the gut, elicited antibodies that cross-react
with egg antigens, but less so with cercarial antigens (Beisler et al. 1984).
Schistosome antigens also cross-react between species (Agnew et al. 1989a; Agnew et al.
1989b; Dean et al. 1996) and with antigens from other parasites, including Plasmodium spp.
(Naus et al. 2003; Mutapi et al. 2007a) and STH (Correa-Oliveira et al. 1988; deNoya et al.
1996). Co-infection studies in humans suggest that schistosome immunopathogenesis may be
influenced by the presence of other pathogens (Ganley-Leal et al. 2006; Geiger 2008;
Wilson et al. 2008; Diallo et al. 2010), although whether these effects are due to antigen
cross-reactivity is subject to debate (Reilly et al. 2008; Diallo et al. 2010).
1.5 Immune responses to schistosomes
Innate immune responses provide a first line of defence from pathogens. Cellular effectors of
the innate immune system are non-clonal and interact with pathogens and their antigens
directly via expression of pathogen recognition receptors (PRRs), including Toll-like
receptors (TLRs) and cytoplasmic NOD-like receptors (NLRs) (reviewed by Akira and
colleagues (Akira et al. 2006)). Innate cells also process and present antigen to activate T
cells, however, since helminths are too large to be internalised by phagocytic cells,
presentation of their antigens is limited to their excreted/secreted molecules or those released
when they die. Upon exposure to antigen CD4+ T cells are activated to selectively
differentiate into alternative functional lineages: Th1, Th2, Th17 and T regulatory (Treg), as
se,
with the immune response characterised by Th2-associated effectors including production of
Chapter 1 General Introduction
- 19 -
Figure 1.4. Summary of the major CD4+ T cell differentiation pathways following
activation in the periphery. Cytokines and transcription factors involved in T cell
polarisation are shown in boxes and within cells respectively. Effector cell types and
cytokines associated with each CD4+ T cell phenotype are given adjacent to relevant cells.
Th0 murine transcription factor, the human orthologue is RORC2.
Figure reproduced from article by Bourke et al, 2011 (originally adapted from Deenick and
Tangyne, 2007 and Diaz and Allen, 2007) with permission from the licensed content
publisher.
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interleukins (IL-)4, 5, 9, 10 and 13 (refer to reviews (Pearce and MacDonald 2002; Caldas et
al. 2008)), secretion of Immunoglobulin (Ig)E and IgG4 isotypes by plasma cells (Hagan et
al. 1991) and activation of downstream effector cells such as eosinophils (reviewed by
(Klion and Nutman 2004)). These responses markedly differ from the Th1-type immune
responses thought to typify infections with intracellular pathogens (the Th1-Th2 paradigm is
reviewed and discussed elsewhere (Mosmann and Coffman 1989; Mosmann and Sad 1996;
Allen and Maizels 1997)).
Whilst human field studies initially focused on the dichotomy between Th1 and Th2 cells
and their associated effectors, cellular and cytokine responses rarely segregate according to
these delineations (Contigli et al. 1999; Mduluza et al. 2001; Joseph et al. 2004a; Mutapi et
al. 2007b; Milner et al. 2010). In particular, chronic schistosomiasis is characterised by
immune hypo-responsiveness to parasite specific (Grogan et al. 1998b; Montenegro et al.
1999a; Silveira-Lemos et al. 2008) and non-parasite antigens (reviewed by Yazdanbakhsh et
al. 2002), suggesting that both Th1 and Th2-type effector immune responses are modified by
relentless exposure to parasite antigens, allowing infections to be tolerated for many years
(Yazdanbakhsh and Sacks 2010). Regulatory mechanisms promoted during infection include
secretion of suppressive cytokines, such as IL-
populations, particularly Tregs (identified in human (Watanabe et al. 2007; Nausch et al.
2011) and murine (Stanworth and Smith 1973; Hesse et al. 2004; Wilson et al. 2005; Mo et
al. 2007; Dittrich et al. 2008) schistosomiasis). Studies have also identified a range of
surface-expressed and secreted molecules in a number of helminths species that can directly
inhibit immune activation (reviewed extensively by Maizels and colleagues (Maizels et al.
1993; Maizels et al. 2001; Maizels and Yazdanbakhsh 2003; Maizels 2009; Maizels et al.
2009)), suggesting that parasites may actively perpetuate host hypo-responsiveness in the
chronic stage of infection in order to facilitate intra-host survival.
The discovery of new cell populations including Treg and Th17 and the more recent
description of IL-5 and IL- , which differentiate from Th2
cells in an IL- -4 dependent manner respectively, has also prompted a re-
evaluation of the classical Th1-Th2 paradigm (Dardalhon et al. 2008; Kurowska-Stolarska et
al. 2008; Veldhoen et al. 2008). Furthermore, the CD4+ T cell axis can be regulated both by
effector cytokines derived from CD4+ T cell populations themselves and innate and adaptive
non-T cell populations (Hesse et al. 2004), including regulatory macrophages (Jenkins and
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Allen 2010). Although the latter has been identified in murine schistosomiasis (Smith et al.
2004; Pesce et al. 2009), observations that human PBMC proliferation in response to
schistosome antigens is enhanced by removing adherent/phagocytic cells (Todd, 1979),
suggest that circulating non-lymphocytes may also play a regulatory role during human
infection. Thus, immunoepidemiological studies that exclude non-T cells (e.g. via cell
purification and cell-specific culture) during analysis may miss the important contribution of
innate effector cells to anti-parasite responses.
1.5.1 Cytokine responses in helminth infection
Cytokines are soluble mediators of cellular immune responses and are secreted by all known
cell types of the innate and acquired immune system. In most cases they act locally via
autocrine or paracrine signalling however, where a cytokine producing cell is present in the
circulation or a cytokine has a long half-life, these molecules can also have endocrine
functions (Turnbull and Rivier 1999). Identification of cytokines has been instrumental in
characterising cellular function and phenotype. This has been particularly effective for CD4+
T cell phenotypes (Mosmann et al. 1986; Cua et al. 2003; Veldhoen et al. 2008; Eyerich et
al. 2009) as discussed above, however cytokine profiles have also been used to characterise
subsets of other cell types, including macrophages (Pesce et al. 2009; Huang et al. 2010),
DCs (Thomas et al. 2003) and B cells (Mangan et al. 2004). Extensive characterisation of
different cytokines in humans and animal models has also made it possible to use cytokines
as biomarkers of specific immune polarisations (Diaz and Allen 2007; Allen and Maizels
2011). Thus, although most immunoepidemiological field studies to-date have relied on
analysis of individual cytokine responses, there has been a shift in murine studies towards
characterising the type of immune responses elicited by helminth parasites rather than their
individual constituents (Allen and Maizels 2011), which I hope to investigate further in this
thesis.
1.5.1.1 Innate inflammatory cytokines
All known TLRs signal via MyD88, an intracellular signal transducer that activates secretion
of systemic IL-6 by whole blood cells (Hayashi et al. 2001). In humans serum levels of IL-6
(Damas et al. 1992) and IL-6, IL-8 a
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secreted by PBMCs in response to viruses and their antigens (Schindler et al. 1990). Levels
of these 3 pro- inflammatory cytokines are positively correlated when human PBMCs are
cultured with agonistic antigens (e.g. endotoxin and phytohaemagluttanin (PHA)) (Schindler
et al. 1990) .
produced by macrophages rather than lymphocytes (Carswell et al. 1975). In h
induces secretion of both IL-6 and IL-8 and these 3 cytokines are co-produced by activated
human macrophages and DCs (Huang et al. 2010).
IL-6 functions range from a well characterised role in inducing the acute-phase protein
response in the liver (Barton 1996) , activating human T cell proliferation (Tosato and Pike
1988) and enhancing antibody production by activated human B cells (Tosato et al. 1988).
IL-6 is also essential for negative feedback regulation of -
induced inflammation (Schindler et al. 1990).
The principal role of IL-8 is as a chemoattractant of neutrophils, accumulation of which is a
common feature of inflamed tissues (refer to reviews by Curfs and Oppenheim (Curfs et al.
1997; Oppenheim 2001)).
Despite the overwhelming focus on innate inflammatory cytokine responses in bacterial and
viral infections, their role during human schistosomiasis is becoming increasingly apparent.
Activation of innate inflammatory cytokines (and IL-10) by S. haematobium egg antigens
-
6, IL-8 and IL-10 production in vitro independent of bacterial endotoxin-specific
concentrations of these cytokines (van der Kleij et al. 2002a). However, PBMC TLR4-
agonist and endotoxin-specific concentrations of -6 and IL-8 are lower in S.
haematobium-infected children than in un-infected children (van der Kleij et al. 2004),
suggesting innate inflammatory cytokine responses to mitogenic stimuli are limited during
chronic infection. Both -6 are also readily produced by in vitro culture of
human whole blood with S. mansoni SEA (and WWH to a lesser extent), however low
parasite-specific IL- concentrations are associated with development of severe
liver pathology (Wilson et al. 2008), suggesting that IL-6 feedback regulation and synergy
with anti-inflammatory responses may be required to limit immunopathology. Innate
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inflammatory cytokine responses to cercariae are yet to be characterised in human
schistosomiasis, but are the focus of on-going studies (Dr. Joseph Turner, Liverpool School
of Tropical Medicine, U.K., personal communication).
1.5.1.2 Th1-type cytokines
production is one of the main phenotypic features of human and murine Th1 cells
(Mosmann et al. 1986; Del Prete et al. 1991). is mainly produced by T cells (CD4+,
-inflammatory stimuli and is
often up-regulated in the context of innate inflammatory cytokines (reviewed by Curfs et al,
1997). ligation to its receptor on human mononuclear phagocytes promotes their
activation via up-regulating surface receptors, anti-pathogen functions and cellular
proliferation (Nathan et al. 1984; Celada and Schreiber 1985) and is a more effective
activator of human macrophages than other pro-inflammatory cytokines (Nathan et al. 1984).
Despite being predominantly secreted by macrophages and B cells, IL-12 is also considered
a Th1-type cytokine since it directly induces T cells to secrete (Trinchieri 2003). The
cross-talk between STAT4/T bet (intracellular markers of the Th1 phenotype), which are up-
regulated by IL-
Th2 phenotype) , which are up-regulated by IL-4 signalling, appears to be instrumental in
determining CD4+ T cell polarisation (Szabo et al. 2000; Fields et al. 2002; Usui et al.
2003). However, whilst the broad association of IL- -
holds true, the mechanisms of Th1 differentiation in human CD4+ T cells is less well defined
than in the murine system (Rao and Avni 2000; Moingeon 2002). It has been shown that, of
the 2 sub-units that make up IL-12 (p40 and p70), only p70 is specific for IL-12 since p40 is
shared with IL-23 (p19 and p40) (see below) (Wilson and Maizels 2004), although not all
studies make this distinction in their assays.
IL-2 is secreted by activated T cells and promotes cell growth and proliferation of T cells, B
cells and NK cells (Curfs et al. 1997; Oppenheim 2001). Although IL-2 alone can promote
Th2 proliferation, it up-regulates secretion of pro-
combination these cytokines promote a Th1-type environment (Mosmann and Coffman
1989; Oppenheim 2001). Initial characterisation of Th1 cells in humans confirmed that cells
stabl -2 mRNA lacked expression of IL-4 and IL-5 and vice versa
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(Del Prete et al. 1991) -2 proteins are also co-expressed by human Th1
(Cousins et al. 2002).
-2 and IL-12, as well as IL-10, limit egg-
induced granuloma formation (Wynn et al. 1994; Wynn and Cheever 1995; Wynn et al.
1995a; Wynn et al. 1995b), although IL-12 has also been shown to exacerbate
granulomatous pathology in the absence of (Wynn et al. 1995b). In human S.
haematobium and S. mansoni infections, parasite-specific is consistently higher in un-
infected than in infected individuals prior to treatment (Mduluza et al. 2003; Silveira et al.
2004; Wilson et al. 2008) and appear to be actively down-regulated during infection (Grogan
et al. 1998a; Montenegro et al. 1999a).
1.5.1.3 Th2-type cytokines
Polarisation of CD4+ T cells towards a Th2 phenotype was initially characterised in humans
by the production of IL-4 and IL-5 (Del Prete et al. 1991), and IL-13 and IL-10 are also
associated with Th2 responses in mice and humans (reviewed by Mosmann and Sad
(Mosmann and Sad 1996)). IL-4 in particular appears to be a Th2-specific growth factor and
an IL-2 alternative for the Th2 lineage in mice (Howard et al. 1982). IL-4 is produced by
activated T cells, DCs, mast cells and basophils and can also activate these cells via the IL-4
receptor. Multiple functions have been attributed to IL-4 including induction of B cell
proliferation, inhibition of Th1 polarisation and macrophage activation (Mosmann and Sad
1996; Curfs et al. 1997; Rao and Avni 2000) and regulation of pro-inflammatory cytokine
production by circulating monocytes (Cluitmans et al. 1994; Chen and Manning 1996).
The predominant function of human IL-5 is to activate and attract eosinophils and basophils
and this cytokine does not appear to affect B cell or T cell function directly (Sanderson
1992).
The functions of IL-4 and IL-13 show considerable overlap since they share a common
receptor sub-unit (IL- -13 lacks the ability to directly induce Th2
polarisation since the full IL-13 receptor is not expressed by T cells (de Waal Malefyt et al.
1993). Both IL-4 and IL-13 inhibit pro-inflammatory cytokine secretion by human
monocytes (de Waal Malefyt et al. 1993; Minty et al. 1993)
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Jenkins and Allen (Jenkins and Allen 2010)). IL-4 and IL-13 are also elevated during local
allergic responses in human mucosal tissues (Ghaffar et al. 1997), consistent with their role
in activating goblet cell hyperplasia and mucus secretion, which are known to facilitate
clearance of murine GI nematode infections (Finkelman et al. 2004).
IL-10 is a well characterised immunosuppressive cytokine and its direct inhibition of both
Th1 and Th2 effector cytokine expression during schistosome infections has been
demonstrated using IL-10 blocking antibodies in PBMC and human whole blood cultures
stimulated with S. mansoni and S. haematobium antigens (Corrêa-Oliveira et al. 1998;
Grogan et al. 1998a; Montenegro et al. 1999a; Mutapi et al. 2007b). In infected individuals
of all ages parasite-specific IL-10 concentrations are higher than in their un-infected
counterparts (van den Biggelaar et al. 2000; Silveira et al. 2004; Mutapi et al. 2007b; Caldas
et al. 2008) or individuals who have not been exposed to infection (McManus et al. 1999),
suggesting that IL-10 is a marker of infection and key regulator of immunopathogenesis
during chronic infection. The negative association of IL-10 with exposure to S. haematobium
and S. japonicum (McManus et al. 1999; Scott et al. 2001) and lower S. haematobium-
specific IL-10 relative to effector cytokine responses in older, parasite-resistant individuals
in endemic populations (Mutapi et al. 2007b) suggest that IL-10 responses are also
influenced by age and exposure history.
Interestingly, although IL-10 is considered to be a Th2 cytokine, expression appears to be
much lower in human CD4+ T cells expressing Th2 effector cytokines (particularly IL-5) or
IL-2 (Cousins et al. 2002). Conversely, in Th2-polarising culture conditions, IL-4, IL-5 and
IL-13 tend to be co-expressed by human CD4+ T cells (Cousins et al. 2002), which may
reflect their genetic co-localisation within a Th2 gene cluster on chromosome 5 (van
Leeuwen et al. 1989; Dolganov et al. 1996). This locus has been implicated in genetic
predisposition to re-infection post-treatment in a pedigree analysis of S. mansoni-exposed
individuals (Marquet et al. 1996). However, studies have also shown that IL-4 and IL-5
responses can dissociate in human nematode (Sartono et al. 1997) and trematode (Grogan et
al. 1996a; Scott et al. 2000) infections, demonstrating that Th2-associated cytokines are not
always co-expressed.
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Since its discovery in mice in 2005 (Schmitz et al. 2005), a range of studies have supported a
role for IL-33 in human Th2-type responses both as a chemoattractant for Th2 cells
(Mannino et al. 1998) and also as a mediator of eosinophil, basophil and mast cell function
(Herrstrom et al. 1997; Pecaric-Petkovic et al. 2009). Along with other epithelial cell-
derived cytokines, IL-33 has also been linked to immune responses during Th2-mediated
allergy (reviewed by (Smits et al. 2010)). Murine infections with Trichuris muris are
associated with an increased expression of IL-33 mRNA in the caecum (Humphreys et al.
2008) however (at the time of writing) no studies have investigated expression of this
cytokine in any human helminthiases.
1.5.1.4 Th17-type cytokines
The identification of the Th17 lineage and its role in chronic inflammatory diseases has led
to growing interest in the function of Th17 cells in other contexts. In murine and human T
cells IL-17 production is a definitive marker of Th17 cells (Wilson et al. 2007; Volpe et al.
2008). IL-17 secreted by activated T cells is a potent chemoattractant for neutrophils and IL-
17 has been shown to perpetuate tissue inflammation in mice (Liang et al. 2007; Hammerich
et al. 2011). In addition IL-23 and IL-21 appear to perpetuate IL-17 secretion by CD4+ T
cells (Hoeve et al. 2006) and, unlike murine Th17 differentiation which is driven by a
-6, IL-23 appears to be the principal cytokine promoting Th17
differentiation in humans (Hoeve et al. 2006; Wilson et al. 2007). Activated dendritic cells
and macrophages are major sources of IL-23 (Oppmann et al. 2000; Verreck et al. 2004)
and, in addition to promoting Th17 differentiation, IL-23 also up-regulates expression
by human T cells in vitro (Hoeve et al. 2006).
Despite promoting IL-17 secretion, the association of IL-21 with Th17-type responses is less
clear-cut than for IL-23 and IL-17. In mice IL-21 is preferentially produced by Th2 relative
to Th1 cells (Wurster et al. 2002). IL-21 and also appear to regulate each other since
IL-21 is transcriptionally repressed by T-bet, a Th1-associated transcription factor (Mehta et
al. 2005). However, whilst IL-21 can inhibit secretion at an early stage of T cell
priming (Wurster et al. 2002), it can also up-regulate expression of Th1-associated markers
on activated peripheral T cells (Strengell et al. 2002). Furthermore, expression of IL-21 and
IL-21 receptor during both Th1 and Th2-polarised responses (Pesce et al. 2006) and the
distinct genetic locus of IL-21 relative to Th2-type cytokines (Mehta et al. 2005) suggests
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that it is not restricted to a single CD4+ T cell lineage, at least in mice. Clearly further
investigation of the Th17 phenotype is required to test the relevance of these experimental
observations in humans. In particular, it remains to be seen whether associations between IL-
21 and Th17 responses in humans (but not in mice) reflect fundamental differences in human
and murine immunology or simply a lack of study.
There is growing evidence that Th17 cells may contribute to pathological immune responses
in murine schistosomiasis. Recent studies of murine S. mansoni infection suggest that IL-
23p19 promotes hepatic pathology in response to injected SEA via up-regulating IL-17
expression in granulomas (Rutitzky et al. 2008). A recent pilot study in human filariasis also
found that IL-17, IL-21 and IL-23 mRNA expression by PBMCs after stimulation with
Brugia malayi antigens was elevated in individuals with lymphedema relative to their
asymptomatic counterparts (Babu et al. 2009). Only one study has measured Th17-type
cytokine responses in human schistosomiasis and showed that the prevalence of detectable
parasite non-specific IL-17 and IL-23, but not IL-21 in plasma, was greater in S.
haematobium egg-positive relative to egg-negative participants (Milner et al. 2010).
1.6 Protective immunity
Since schistosome infections affect multiple host tissues and their antigens circulate
systemically, protective immunity must comprise both effector mechanisms to clear infection
and regulatory mechanisms to limit immune-mediated pathologies (Allen and Maizels 2011).
Thus protective immunity can be classified via several overlapping mechanisms ; a)
complete elimination of parasites (sterile immunity), b) tolerance of patent infection but
resistance to de novo infection (non-
c) responses that reduce egg production or viability (anti-fecundity or anti-transmission
immunity) and d) reduction of immunopathology (tolerance). I will refer to the former 3
- -pathology
that sterile immunity is rarely generated. However, epidemiological patterns of infection (see
chapter 1.2.4) indicate that non-sterile immunity, though slow to develop, does occur with
cumulative exposure (Woolhouse 1998; Yazdanbakhsh and Sacks 2010). Conversely, since
the majority of schistosome infections do not result in mortality, it seems likely that hosts
develop a degree of tolerance to low-level infections in order to limit tissue damage (Dessein
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et al. 2004) (Yazdanbakhsh and Sacks 2010) and thus even infected individuals do not lack
immune-mediated protection.
Immunological correlates of anti-parasite and anti-pathology immunity identified to-date are
summarised below, however the molecular mediators of these processes for endemically-
exposed hosts have not been conclusively defined. Furthermore, as highlighted in recent
reviews (Diaz and Allen 2007; Jenkins and Allen 2010; Allen and Maizels 2011), the
balance between pleiotropic and redundant cytokines and their associated cellular effectors is
dynamic and a single molecule is unlikely to confer protective immunity in isolation or at all
stages of a life-time spent exposed to parasite challenge.
1.6.1 Anti-parasite immunity
In humans, resistance to high intensity schistosome infections is typically attributed to
elevated titres of parasite-specific IgE whilst IgG4 is considered a marker of infection and
susceptibility both before and after treatment (Hagan et al. 1991; Rihet et al. 1991; Viana et
al. 1995; Grogan et al. 1996b; Al-Sherbiny et al. 2003; Acosta et al. 2004; de Moira et al.
2010). For S. haematobium, circulating IgE responses can be induced by adult worm or egg
antigens (Hagan et al. 1991) . The association between IgE and anti-parasite immunity may
reflect the ability of IgE to bind to high affinity receptors on eosinophils facilitating
antibody-dependent cell-mediated cytotoxicity (ADCC) (David et al. 1980; Gounni et al.
1994; Ganley-Leal et al. 2006)
and eosinophil counts are associated with resistance to re-infection with S. mansoni (Ganley-
Leal et al. 2006). Incubation of human eosinophils with schistosomula leads to direct killing
of larval parasites (Butterworth et al. 1974; Butterworth et al. 1975; Hagan et al. 1985) and
eosinophil granules are toxic to schistosomula in vitro (David et al. 1980; Ackerman et al.
1985), although a variety of antibody isotypes may mediate this process (Khalife et al. 1989;
Dunne et al. 1993). In addition to IgE a number of other antibody isotypes have been
associated with resistance to schistosome infection (e.g. IgG1 (Mutapi et al. 1997) and IgA
(Acosta et al. 2004)), the schistosome antigen-specificity of IgE from endemically-exposed
individuals overlaps with that of IgA, IgG1 and IgG4 (Mutapi et al. 2011a)(and potentially
others) and IgE responses often correlate with other antibody isotypes during infection
(Viana et al. 1995), which may more accurately reflect variation in infection intensity,
exposure and treatment history than IgE titres (Webster et al. 1997a). Importantly, as noted
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for cytokine responses (Mutapi et al. 2007b), reciprocal relationships between different
isotypes rather than levels of individual antibodies appear to be important determinants of
resistance/susceptibility to infection (e.g. the ratio between IgE and IgG4 (Hagan et al. 1991;
Demeure et al. 1993) and IgG1 and IgA (Mutapi et al. 1997)).
Effector immune responses elicited by adult parasites but targeting cercariae have been
proposed as a mechanism for limiting accrual of parasites in the context of on-going
infection (concomitant immunity). This was originally shown in experimental S. mansoni
infections of rhesus monkeys, where implantation of adult parasites induced resistance to
cercarial invasion but prior-exposure to irradiated cercariae, which do not reach maturity, did
not (Smithers and Terry 1967). That these mechanisms do not target adult parasites may be
due to the reduced susceptibility of parasites to ADCC-mediated killing as they mature,
although this has only been shown in murine studies in vitro (Moser et al. 1980; Ahmed et
al. 1997). Paradoxically anti-larval immunity may not be elicited by larval parasites due to
short-term exposure of larval peptides during invasion (Fitzsimmons et al. 2007), relatively
responses in the skin are biased towards immunogenic carbohydrate antigens that cannot
elicit memory T cell responses (Woolhouse and Hagan 1999). In human helminth infections
the stimulus and target of anti-parasite immunity are difficult to distinguish since resistance
to high worm burdens can only be assessed via egg output and circulating antigen levels.
However, development of concomitant immunity to infection is corroborated by the
predictions of mathematical models of infection (Woolhouse 1994) and empirical evidence
for the development of immune-mediated resistance to the larvae of tissue-dwelling
nematodes in endemically-exposed populations (e.g. PBMC-mediated resistance to L3
invasion in Onchocerca volvulus infection in Cameroon (MacDonald et al. 2002) and
peripheral antibody-dependent immunity to W. bancrofti larvae with age in Papua New
Guinea (Day et al. 1991a; Day et al. 1991b)).
Both eosinophilia and IgE responses in human schistosomiasis are linked to Th2-type
cytokine responses and particularly IL-5 (Dutra et al. 2002; Ganley-Leal et al. 2006; Walter
et al. 2006; Silveira-Lemos et al. 2008). A variety of immunoepidemiological studies have
implicated Th2-type cytokines in anti-S. haematobium immunity, including higher adult
worm-specific PBMC IL-4 and IL-5 in individuals resistant to re-infection (Medhat et al.
1998) and increased IL-5 responses to WWH with age in un-treated populations (Mutapi et
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al. 2007b). However, the latter study found that reciprocal changes in IL-10, levels of which
peak in young children who are most susceptible to infection and can suppress adult worm-
specific IL-5 responses in vitro, may be a more important determinant of resistance to S.
haematobium infection than levels of individual effector cytokines (Mutapi et al. 2007b).
The importance of effector: regulatory immune responses in the development of resistance to
infection with age is supported by age-related changes in the relationship between circulating
effector T cells (Teff):Treg ratios and infection intensity in S. haematobium-exposed cross-
sectional populations (Nausch et al. 2011) and observations that high levels of IL-10 are
associated with an increased the risk of re-infection after treatment of chronically-exposed
children (van den Biggelaar et al. 2002). A number of studies have also suggested that S.
haematobium and S. mansoni-specific Th1-type cytokines are associated with resistance to
infection (Mduluza et al. 2003; Silveira et al. 2004; Wilson et al. 2008) and re-infection
post-treatment (Grogan et al. 1998b; El Ridi et al. 2001), suggesting that protective
immunity in humans may constitute a mixed rather than Th2-polarised effector phenotype.
Evidence for a reduction in egg counts in the absence of adult worm clearance during natural
S. haematobium infections comes from observations that egg counts, but not circulating
antigen levels, decline with age (Agnew et al. 1996). This effect was not observed in S.
mansoni-infected populations (Agnew et al. 1996). However, since egg excretion can also be
reduced by sequestration of eggs in tissues (Cheever et al. 1977) and
immunocompromisation (Karanja et al. 1997) it is unclear whether these observations reflect
a genuine reduction in fecundity or species-specific variations in egg transmission with time
post-infection. Due to the association between parasite eggs and morbidity in chronic
schistosomiasis, anti-pathology immunity may also be achieved by reducing adult worm
fecundity.
1.6.2 Anti-pathology immunity
Schistosome morbidity is characterised by immune hyper-reactivity to parasite antigens,
particularly those of eggs. For example in human S. haematobium infections both SEA-
specific T - -10 are higher in subjects
with urinary tract morbidity than in those without morbidity (Wamachi et al. 2004). High
levels of parasite-specific IL-5 after treatment are also a risk factor for subsequent
development of microhaematuria (van den Biggelaar et al. 2002). Elevated eosinophil
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activation markers and expression of SEA and WWH-specific , IL-4 and IL-5 are also
associated with periportal fibrosis in chronic S. mansoni infections (Silveira-Lemos et al.
2008). These observations suggest that, despite their association with anti-parasite immunity,
effector cytokine responses are suppressed as a counter-balance to acute reactivity to parasite
antigens. This may be particularly the case in young children where regulatory responses,
including Tregs (Nausch et al. 2011) and parasite-specific IL-10 (Silveira et al. 2004), are
positively correlated with infection intensity.
In addition to Treg and IL-10-mediated immunoregulation, activation of multiple cell types
in response to systemic antigen may induce cross-regulation between effector cells. For
example in chronic S. mansoni infections, Th2-mediated damage may be limited by Th1-
type (Henri et al. 2002; Dessein et al. 2004)
IL-6 (Booth et al. 2004; Wilson et al. 2008). Conversely, Th2-type responses appear to
mitigate pro-inflammatory pathologies since liver damage and mortality are associated with
an absence of Th2-associated biomarkers (Dunne et al. 2006; Wilson et al. 2008). Most
recently T bet and -dependent processes have been shown to reduce egg-specific Th17-
(Rutitzky et al. 2008;
Rutitzky et al. 2009), although the relevance of this for human anti-pathology immunity is
yet to be tested.
1.7 Control of schistosomiasis
The World Health Organisation (W.H.O.) currently advocates 3 main interventions to
control parasitic helminthiases: 1) chemotherapy to reduce morbidity due to high worm
burdens, particularly in children, 2) improved sanitation as a means to reduce parasite
transmission and 3) health education to encourage populations to modify their water contact
behaviours and thus reduce both transmission and the risk of re-infection post-treatment
(Montresor et al. 2002). There is no effective vaccine for schistosomiasis, although this
remains an attractive prospect for long-term control of infections, particularly where
behavioural modifications are un-realistic (e.g. in very young children and communities
without access to sanitation) and access to chemotherapy is sporadic (Chitsulo et al. 2000).
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1.7.1 Mass drug administration
Mass anti-schistosome treatment of all community members regardless of age, sex or
infection status is recommended where infection prevalence is 50% or over as assessed by
treatment of school-age children is recommended if infection prevalence is between 20 and
50% (moderate prevalence) and treatment of infected individuals or those with visible
haematuria is recommended for communities where prevalence is below 20% (Montresor et
al. 1998; W.H.O. 2006). The recommended treatment for schistosome infections is a single
40mg/kg body weight dose of the anti-schistosomal drug praziquantel or 2 doses of 15-
30mg/kg of oxamniquine, which is effective only against S. mansoni (Montresor et al. 1998;
Montresor et al. 2002). This summary will focus on praziquantel, which remains the most
effective and widely used anti-schistosomal drug (Danso-Appiah et al. 2008).
Mass treatment with praziquantel is highly effective at clearing infection with studies
reporting cure rates (i.e. no detectable infection) of over 80% 6 weeks after treatment
(Tchuem Tchuente et al. 2004; Midzi et al. 2008a). Much lower cure rates have been
reported where post-treatment parasitological assessments were made within 6 weeks of
treatment (Saathoff et al. 2004; Tchuem Tchuente et al. 2004; Sissoko et al. 2009) although
this appears to be due to a lag in excretion of eggs from tissues rather than a delayed effect
against adult worms (Tchuem Tchuente et al. 2004; Guidi et al. 2010). Delayed excretion of
eggs relative to adult worms after treatment is also consistent with post-treatment studies of
S. mansoni where levels of adult worm antigen in urine decrease rapidly (within 1 week), but
egg antigens were still detectable in urine 6 weeks after successful clearance of infection
(Nibbeling et al. 1998). Importantly, even in studies reporting low rates of complete cure, the
overall reduction in S. haematobium egg counts within treated cohorts were found to be
consistently high (over 80%) and treatment-related side-effects mild or absent (Saathoff et
al. 2004; Tchuem Tchuente et al. 2004; Midzi et al. 2008a; Sissoko et al. 2009). Although
concerns have been raised that mass anti-helminthic treatment programs may promote drug
resistance (Redman et al. 1996), longitudinal treatment-re-infection studies provide no
evidence for reduced praziquantel efficacy against schistosome infections after repeated
doses (Gryseels et al. 2001; Black et al. 2009). Longitudinal follow-up studies in S. mansoni
affected populations also suggest that the severity of liver fibrosis is reduced in the majority
of treated individuals (Martins-Leite et al. 2008; Rahoud et al. 2010). Furthermore, although
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children aged under 5 years are currently excluded from mass treatment programmes due to
concerns about side-effects and the disputed assumption that this age group does not harbour
sufficient levels of infection to cause significant morbidity, preliminary studies provide
evidence of both exposure to infection and morbidity in this age group(Opara et al. 2007;
Mutapi et al. 2011c; Stothard et al. 2011). A recent safety-efficacy trial conducted in parallel
with the study described in chapters 2-6 has also proven that children aged under 5 are
tolerant of praziquantel treatment (Mutapi et al. 2011c).
In areas where schistosomiasis and STH are co-endemic, praziquantel is often co-
administered with albendazole. In contrast to praziquantel, albendazole has only limited
solubility and its activity is restricted to parasites in the GI tract (Marriner et al. 1986; Urbani
and Albonico 2003). No synergy between albendazole and praziquantel activity has been
observed in the clearance of schistosome or STH infections (Sirivichayakul et al. 2001;
Pengsaa et al. 2004) and no increase in adverse side-effects has been reported for combined
treatment (Olds et al. 1999).
1.7.2 Praziquantel mode of action
Praziquantel appears to act via paralysing adult parasites and disrupting their tegument,
which has been visualised in vitro via electron microscopy (Becker et al. 1980). However,
only one study to-date has conclusively identified a molecular target of praziquantel, the S.
mansoni myosin light chain, which is abundantly expressed by adult worms and
schistosomules and to a lesser extent by cercariae (Gnanasekar et al. 2009). Murine studies
suggest that the schistosomicidal activity of praziquantel relies on activation of the host
immune response (Brindley and Sher 1987; Doenhoff et al. 1987), which may be promoted
by treatment-induced exposure of antigens on the adult worm surface (Harnett and Kusel
1986; Redman et al. 1996), including GST (Dupre et al. 1999).
Although the principal in vivo target of praziquantel appears to be adult worms and it has
been shown that immature S. mansoni parasites are less susceptible to praziquantel-mediated
damage in murine infection models (Andrews 1985; Sabah et al. 1986; Shaw 1990),
immature worms are still damaged even at sub-curative doses and even adult worms vary in
their susceptibility (Shaw 1990). In vitro studies also show that praziquantel can reduce
cercarial tail shedding, egg hatch rates and miracidial motility in laboratory S. mansoni
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isolates (Liang et al. 2001). Furthermore, whilst researchers hypothesise that eggs and larval
stages may be sequestered from circulating praziquantel relative to adult S. mansoni in the
hepatic veins (Sabah et al. 1986; Picquet et al. 1998), intra-dermal and intra-muscular
injection of the drug reduces migration of S. mansoni cercariae and schistosomula in mice
(Flisser et al. 1989).
Since orally administered praziquantel is absorbed into the bloodstream within 2 hours and
approximately 70% is excreted in urine 24 hours later (Njomo et al. 2010), it is unclear
whether its active components can access parasites in human tissues. However, orally-
administered doses cause a rapid release of S. mansoni egg enzymes (Xu et al. 1988) and a
reduction of tissue egg viability in murine schistosome infections (Giboda and Smith 1994).
Treatment has been also been shown to reduce the viability of S. haematobium eggs excreted
up to 7 weeks (Guidi et al. 2010) and increase S. haematobium egg-specific serum antibody
titres relative to pre-treatment levels up to 18 and 36 weeks (Mutapi et al. 1998b) after
successful treatment in human populations.
1.7.3 Effects of praziquantel on the immune response
Praziquantel treatment is known to alter human immune responses (Barsoum et al. 1982;
Butterworth et al. 1985; Colley et al. 1986; Roberts et al. 1987; Medhat et al. 1998; Mutapi
et al. 1998b; Mutapi et al. 2002; van den Biggelaar et al. 2002; Fitzsimmons et al. 2004;
Joseph et al. 2004b; Mutapi et al. 2005; Reimert et al. 2006) and these effects may be due to
activation by the release/exposure of parasite antigens (discussed above) and/or a rebound in
effector immune responses due to the removal of immunosuppression mediated by live
parasites. The latter is supported by the observation that the proportion of Teff:Tregs
increases 8-14 months after treatment of S. mansoni relative to pre-treatment levels
(Watanabe et al. 2007) and increased antibody responses to host anti-nuclear antigen (a
marker of immune reactivity) 6 months after clearance of S. haematobium infection (Mutapi
et al. 2011b). A boost in immune responses following treatment has been demonstrated as
early as 24 hours after treatment of S. mansoni in humans, where plasma levels of eotaxin,
IL-5 and IL-10 are elevated leading to eosinophilia at 3 weeks post-treatment (Reimert et al.
2006). PBMC proliferative responses to schistosome antigens are also enhanced by treatment
(Barsoum et al. 1982; Colley et al. 1986; Feldmeier et al. 1988) and serum titres of S.
mansoni and S. haematobium adult worm-specific antibodies (van den Biggelaar et al. 2002;
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Walter et al. 2006) and S. haematobium egg-specific antibodies (Mutapi et al. 1998b) are
also boosted by clearance of infection.
Treatment also induces changes in cellular cytokine responses, although there is considerable
variation between studies both in methodology and findings. In an S. mansoni-exposed
population, Th2 cytokine responses in plasma were elevated within 21 days of treatment
(Fitzsimmons et al. 2004) and adult worm, but not egg-specific, Th2-type whole blood
cytokine levels were increased 7 weeks after treatment relative to pre-treatment levels
(Joseph et al. 2004b). However, Th1 and Th2-type whole blood cytokines responses to both
SEA and WWH were found to be elevated post-treatment in a separate S. mansoni-exposed
cohort, although cultures were conducted for considerably longer (Tweyongyere et al. 2009).
Studies investigating whole blood cytokine responses to S. haematobium antigens suggest
that Th2-type responses are differentially affected by treatment (Scott et al. 2000) a
phenomenon that has also been observed in CD4+ T cell cytokine responses to S.
haematobium antigens (Grogan et al. 1996a). PBMC cytokine studies after S. haematobium
treatment broadly support the findings of S. mansoni studies that levels of Th2-type
cytokines increase after treatment (van den Biggelaar et al. 2002; Mduluza et al. 2009),
although it is noteworthy that the former study compares responses between an un-treated
and treated cohort rather than the responses of the same individuals before and after
treatment and reports only cytokine responses elicited by adult worm antigens. Importantly,
no studies have investigated whether other cellular phenotypes or the balance between them
are influenced by praziquantel treatment.
The protective efficacy of treatment-induced changes to the host immune response remains a
subject of debate, particularly since even repeatedly treated cohorts remain susceptible to re-
infection (van den Biggelaar et al. 2002; Guidi et al. 2010) and there is a resurgence of
schistosome-associated pathologies at a population level after treatment has stopped
(Wagatsuma et al. 1999; van den Biggelaar et al. 2002). However, longitudinal treatment-re-
infection surveys indicate that whilst some individuals are re-infected rapidly others remain
free from infection for prolonged periods and a number of studies have identified an
association between post-treatment immune responses, particularly parasite-specific
antibody titres (Hagan et al. 1991; Mutapi et al. 1999; Caldas et al. 2000) and cellular
proliferative responses (Colley et al. 1986), and a reduced risk of re-infection. To date the
results of studies investigating the association between cytokine responses and the risk of re-
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infection have been inconsistent. For example, a study of adolescent boys found an
association between adult worm-specific PBMC IL-4 and IL-5 and resistance to S.
haematobium re-infection in Egypt (Medhat et al. 1998), whilst in a cohort of 5-14 year olds
in Gabon adult worm-specific PBMC IL-10 was associated with an increased risk of S.
haematobium re-infection and IL-5 was not associated with resistance to re-infection (van
den Biggelaar et al. 2002). Variation in host age (9-35 years) and exposure have also
confounded identification of a significant association between S. mansoni-specific cytokine
responses and subsequent re-infection (Roberts et al. 1993). These inconsistencies may
reflect variation in age ranges, gender and water contact activities between the study cohorts,
but may also be due to the limited range of cytokines (6 or less) investigated and analysis of
these responses one at a time, rather than as constituent parts of an immune profile. Thus a




Since studies in the late 1970s found that up to 70-80% resistance to cercarial challenge
could be induced in mice by pre-exposure to a single dose of radiation-attenuated (RA)
cercariae (Minard et al. 1978; Murrell et al. 1979), significant efforts have been made to
identify immunogenic parasite antigens that can induce equivalent efficacy. These have
included isolation of sero-reactive molecules from RA cercariae (Richter and Harn 1993),
probing the schistosomulum surface with monoclonal antibodies (Pierce et al. 1987) and
selecting molecules according to recognition by serum antibodies from children endemically
exposed to schistosomes but resistant to re-infection after treatment (Dessein et al. 1988). In
1998 a meeting in Egypt led to the identification of the major vaccine candidate antigens
capable of inducing protective immunity in animal models of S. mansoni, which were
glutathionine-S-transferase 28kDa (GST), Paramyosin (Sm97), Irv5, Triose-phosphate
isomerase (TPI), Sm23 and Sm14 ((Bergquist and Colley 1998). Independent laboratory
trials of these vaccine candidate antigens in animal models were conducted, but the results
have never been published (Wilson and Coulson 2006). Subsequent correlate studies of the
immune responses elicited by the same antigens (and others) in endemically exposed humans
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showed that a range of antibody and cytokine responses associated with both resistance and
susceptibility could be elicited, however only those elicited by GST and Sm37-SG3PDH were
consistently associated with protective immunity both before and after clearance of infection
by praziquantel (Al-Sherbiny et al. 2003). Notably however, whilst the latter study noted
variation according to host age, the effects of this variation on the protective immune
responses identified were not reported or accounted for in statistical analyses (Al-Sherbiny et
al. 2003). Thus the comparison of resistant (mainly adults) with susceptible (mainly young
children) groups does not account for variation in their exposure, an essential consideration
(discussed in 1.2.4).
1.8.2 Glutathionine-S-transferase
schistosomiasis (Capron et al. 2002). In S. mansoni GST is expressed on the tegument and
sub-tegument of adult worms (Taylor et al. 1988) and schistosomula (Balloul et al. 1985). Its
enzymic activity is also required for synthesis of prostaglandin D2 (PGD2), a molecule
k (Angeli et al. 2001) and promote
immunoregulatory cytokine responses at the site of infection (Ramaswamy et al. 2000). A
variety of GST preparations have been shown to induce a degree of resistance to S. mansoni
infection in mice (Boulanger et al. 1991; Xu et al. 1991; Lebens et al. 2003), rats (Grezel et
al. 1993) and S. matthei in cattle (Grzych et al. 1998). However, evidence for a reduction in
pathology and parasite fecundity in S. haematobium infected primates after GST vaccination
(Boulanger et al. 1995; Boulanger et al. 1999) has led to a focus on an ShGST-based vaccine
rather than its S. mansoni counterpart (Bergquist and Colley 1998; Bergquist et al. 2002; Al-
Sherbiny et al. 2003). It is hypothesised that reducing immunopathology via inducing anti-
fecundity immune responses may be more achievable than induction of sterile immunity in
endemically-exposed human populations. The ShGST-induced anti-fecundity effect appears
to be primarily antibody mediated since vaccination induces strong IgA and IgG responses in
mice (Lane et al. 1998) and humans (Remoué et al. 2000; Capron et al. 2002). In S. mansoni
models IgA and IgE-mediated cell cytotoxicity (Grezel et al. 1993) and passive transfer of
SmGST-specific neutralising antibodies (Xu et al. 1993) can lead to a reduction in egg
viability, although the same experiments have not been reported for ShGST.
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ShGST remains the only purified schistosome antigen to be used in a Phase II clinical trial
and Phase III trials of GST vaccination in combination with praziquantel are on-going (NIH
2009), however much of the raw data obtained from these studies has never been published
outside of review articles (Capron et al. 2002; Wilson and Coulson 2006). The most recent
correlate studies in humans endemically exposed to S. haematobium showed gender
distinctions in GST-specific serum antibodies (Remoué et al. 2000; Remoué et al. 2001) and
PBMC cytokine production (Remoué et al. 2001), but published data was not analysed in the
context of resistance to re-infection or reduced excretion of eggs. Furthermore, although
initial studies in mice suggest that ShGST vaccination elicits poor T cell effector responses
(Lane et al. 1998) no studies to-date have investigated the relationship between GST-specific
cytokine responses and immune-mediated protection in human schistosomiasis.
In addition to its proposed importance as a vaccine candidate, GST is also an abundantly
expressed schistosome antigen with isoforms expressed by larval, adult and egg-stage S.
mansoni (Balloul et al. 1985; Curwen et al. 2004) and adult S. haematobium (Mutapi et al.
2005). Thus, there are several advantages to investigating GST-specific immune responses in
conjunction with those directed against crude antigen preparations: a) the large amount of
potentially non-protective target antigens in crude parasite preparations may obscure changes
in immune responses directed against individual antigens that may promote protective
immune responses, such as GST, b) reactivity of serum antibody responses to GST isoforms
vary with age and infection intensity in S. haematobium-exposed populations and thus may
(Agnew et al. 1996; Mutapi et al. 2008) and c) exposure to
GST is known to change after treatment in humans (Mutapi et al. 2005). Thus, purified GST
may be a useful indicator of S. haematobium-specific immune responses in humans both
before and after treatment.
1.9 Helminth therapy
In contrast to the concerted efforts to control natural helminth infections in endemic areas,
recent interest has developed in how artificial helminth infection may be exploited as an
immunotherapy in non-endemic areas. Schistosoma spp. parasites are not alone in their
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ability to regulate human immune responses and hypo-responsiveness to parasite and
bystander antigens is also a common feature of human nematode infections (Yazdanbakhsh
et al. 2002; Jackson et al. 2009). Both the immunoregulatory capacity of parasitic helminths
and the geographical segregation of helminth-endemic regions from those where allergy and
autoimmune conditions are common has led to speculation that helminthiases reduce the risk
of immune-mediated disease (Yazdanbakhsh et al. 2002). This hypothesis stems from earlier
observations that that exposure to bacterial infections during early life is negatively
correlated with atopy (Matricardi et al. 2000) and atopy is more common in urban than in
rural populations (Yemaneberhan et al. 1997; Riedler et al. 2000; von Ehrenstein et al.
2000). A potentially unifying explanation for these observations comes from the
antigens due to improved sanitation and healthcare in affluent urbanised populations also
deprives these populations of helminth-mediated immunomodulation of the immune
response to non-pathogenic antigens (e.g. allergens and auto-antigens).
The phenomenon that parasitic helminths can reduce immune-reactivity to allergens was
first identified in S. haematobium-infected school-children (van den Biggelaar et al. 2000).
Since then a wealth of studies have investigated the association between immune-mediated
disease and helminth infections in humans and recent meta-analyses confirm a consistent
association between Ascaris lumbricoides, Trichuris trichuria, hookworm and schistosome
infections and a reduced risk of skin sensitisation to allergens (Feary et al. 2011) and
hookworm infections and a reduced risk of developing asthma (Leonardi-Bee et al. 2006).
1.9.2 Experimental helminth infections
Recent clinical trials have attempted to evaluate whether experimental helminth infection can
ameliorate symptoms of human disease (summarised in Table 1.2). These studies have
mainly focused on 2 helminth species, the human hookworm Necator americanus and the
porcine nematode Trichuris suis, although there are also cases of individuals suffering
from severe immune-mediated diseases voluntarily infecting themselves (e.g. T. trichiura
(Broadhurst et al. 2010)). These GI species have been favoured over tissue-dwelling
helminths such as schistosomes since they have a relatively lower pathogenic potential and
more restricted locale within the host. T. suis has the added benefit of being incapable of
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establishing long-term infections in humans and is readily eliminated after a few weeks of
infection (Summers et al. 2005c).
Natural T. suis infection occurs in pigs via ingestion of eggs, after which larval worms hatch
in the gut lumen without migrating through host tissues. The Th2 response elicited by T. suis
in the porcine host is well characterised and comprises increasing numbers of parasite-
specific IL-4-secreting cells with time post-infection (Steenhard et al. 2007), mucosal goblet
cell hyperplasia (Kringel et al. 2006), elevation of blood eosinophils (Kringel et al. 2006;
Steenhard et al. 2007), mast cells (Kringel et al. 2006) and basophils (Kringel and Roepstorff
2006). Although chronic human infections with T. trichiura are characterised by a mixed
profile of parasite-specific cytokines ( , , IL-4, IL-9, IL-10 and IL-13) and
antibody isotypes (IgG1, IgG4, IgA, and IgE) (Faulkner et al. 2002), the immune responses
elicited by T. suis infection in helminth-naïve human hosts are less well characterised
(discussed below).
The hookworm life-cycle differs from that of T. suis as infection occurs via percutaneous
penetration by infective-stage free-living larvae (L3). Following infection, hookworm larvae
migrate through the lungs and into the GI tract, where adult parasites feed on host blood,
mate and produce eggs, which are transmitted to the environment in host faeces Although
heavy infestations can lead to anaemia and stunted growth (Hotez et al. 2004), chronic
hookworm infections are usually asymptomatic and are particularly associated with a
reduced risk of asthma and atopy (Leonardi-Bee et al. 2006; Feary et al. 2011) . Hookworms
induce a mixed Th1/Th2-type cytokine response during natural human infections, but
cytokine production during experimental infections appear to be more Th2 polarised
(McSorley and Loukas 2010).
1.9.3 Diseases targeted in clinical trials
1.9.3.1 Inflammatory bowel diseases
Inflammatory bowel disease (IBD) is a collective term for pathologies caused by hyperactive
Necatoramericanus Trichurissuis
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colitis, the former of which develops from Th1 and Th17-type responses, whilst the latter is
more often associated with Th2-type responses (Brand 2009). American trials of
experimental T. suis
demonstrated clinical efficacy in the absence of adverse side effects (Summers et al. 2003;
Summers et al. 2005a; Summers et al. 2005b). Although a single dose of T. suis ova (TSO)
was found to alleviate symptoms in initial trials (Summers et al. 2003), this effect was short-
lived and subsequent larger-scale randomised double-blinded placebo-controlled trials were
conducted using repeated doses (Summers et al. 2005a; Summers et al. 2005b).
Whilst strongly contested (Summers et al. 2005c) , concern that repeated doses of TSO may
incur a risk of chronic infection and do not induce lasting reductions in IBD symptoms
prompted interest in experimental N. americanus infections, which have been shown to
reduce Crohn's disease activity index for up to 45 weeks after a single dose of infective larvae
(Croese et al. 2006). However, the latter study was conducted in only a small number of
patients and clinical improvements appeared to be delayed by infection-induced eosinophilia
(Croese et al. 2006).
1.9.3.2 Allergic airway diseases
Allergic airway diseases are attractive targets for helminth therapy since current therapies
rely on prolonged treatment regimens and pose a risk of adverse side-effects (Varney et al.
1991). Allergic rhinitis, which was the target of TSO therapy in the clinical trial described in
chapter 7, is amongst the most common allergic airway diseases and affects approximately
20% of Western Europeans (Varney 1991). Symptoms include sneezing, blocked nose,
red/itchy and watery eyes. Where rhinitis results from allergy to pollen, these symptoms are
seasonally exacerbated and are particularly debilitating when environmental pollen counts
are high. Successful therapies for sensitivity to aero-allergen have been shown to depend on
modification of local immune responses in the nasal mucosa (Wachholz et al. 2002; Senti et
al. 2008). Therapeutic GI nematode infections would therefore be required to alter systemic
immune responses in order to influence symptoms at sites distal to the gut, as has been
observed in helminth-infected mouse models of allergic airway diseases (Wilson et al. 2005;
Mangan et al. 2006).
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To date neither hookworm nor TSO therapy has shown significant clinical benefit to allergic
airway disease or asthma relative to placebo-treated controls (Feary et al. 2009; Bager et al.
2010a; Feary et al. 2010). Furthermore, both have been associated with a higher incidence of
adverse side-effects (Bager et al. 2010a; Feary et al. 2010), which had not been reported in
previous TSO treatment studies. Importantly, the immunological basis for these clinical
observations has not been explored.
1.9.3.3 Multiple sclerosis
A small number of studies have investigated the efficacy of helminth therapy in multiple
sclerosis (MS) (Fleming et al. 2009; Fleming et al. 2011), a relapsing-remitting autoimmune
disease affecting the central nervous system and perpetuated by pro-inflammatory Th1 and
Th17 cells (Juszczak and Glabinski 2009). Repeated doses of TSO were orally administered
at 2 week intervals over a 3 month period and, of the 5 enrolled participants, all but one had
a reduced number of new MS lesions assessed by Magnetic Resonance Imaging (MRI),
although this reduction did not affect neurological symptoms (Fleming et al. 2011).
1.9.4 Immune responses during experimental helminth infection
Of the studies investigating immune responses during experimental helminth infection all
report a treatment-induced increase in eosinophil counts relative to pre-treatment levels
(Wright and Bickle 2005; Croese et al. 2006; Blount et al. 2009; Feary et al. 2009; Bager et
al. 2010a; Daveson et al. 2011; Fleming et al. 2011). As would be expected, treatment is also
associated with an increase in parasite-specific antibodies, reflecting exposure to helminth
antigens in previously helminth naïve individuals (Blount et al. 2009; Bager et al. 2010a;
Fleming et al. 2011).
All trials of N. americanus have reported adverse side-effects during experimental infection
(Croese et al. 2006; Feary et al. 2009; Feary et al. 2010; Daveson et al. 2011) which may be
attributable to duodenal eosinophilia and allergic reactivity to larvae in the skin.
Experimental N. americanus infections in individuals with allergic rhinitis has also been
shown to elevate PBMC IL-5 and IL-13 responses to Staphyloccocal enterotoxin (peaking
within the first 4 weeks of administration of a single dose of 10 larval parasites) relative to
placebo-treated controls, although this difference was not statistically significant and had
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declined to levels equivalent to placebo-treated participants by week 10 (Blount et al. 2009).
Interestingly TNF levels in the same individuals were marginally lower (week 4-12 post
infection) and IL-10 marginally higher (week 8-12 post infection) than PBMC from placebo-
treated participants after enterotoxin stimulation, though these differences were also not
statistically significant (Blount et al. 2009).Changes in cytokine responses did not
correspond to changes in the total number of circulating T cells, IL-4+ T cells,
CD4+CD25+Foxp3+ Tregs or total IgE titres (Blount et al. 2009), but suggest that even
light, single dose infection with a gastrointestinal helminth can influence the host cytokine
environment within weeks of exposure without exacerbating allergen-specific IgE responses
(Blount et al. 2009). Th2-type cytokine responses (IL-5 and IL-13) to somatic hookworm
antigens have also been shown to increase transiently in an individual who self-infected with
N. americanus larvae and this increase recurred upon a second percutaneous dose of
parasites (Wright and Bickle 2005). Investigation of these immunological effects in larger
cohorts and over a longer exposure period are warranted to investigate the influence of such
immunological changes on allergic disease and the applicability of anecdotal observations.
Only 2 studies to date have investigated cytokine responses during experimental human
Trichuris spp. infections involving only 5 individuals. For T. suis ova treated participants,
serum cytokine levels varied considerably between individuals, but a sustained increase in
IL-4 and IL-5 and an initial increase in IL-10 and IL-13 (in 4 out of 5 individuals), but not
I and IL-2, was observed in most participants relative to pre-treatment levels (Fleming et
al. 2011). These changes in serum cytokines did not correspond to variations in the
frequency of circulating CD4+CD25+Foxp3+ Treg or monocytes expressing markers of
alternative activation (CD14+CD124+CD23+) (Fleming et al. 2011). Importantly, unlike
hookworm infections which have a lung migratory stage to which transient changes in
cytokine responses have been previously attributed (Blount et al. 2009), T. suis remains in
the gut lumen and does not migrate through host tissues. Experimental T. trichiura infection
lead to an increase in a mixed profile of Th2 (IL-4), Th1 ( ) and Th17 (IL-17) associated
cytokines and IL-22 in a single individual who repeatedly self-infected over several years
(Broadhurst et al. 2010). Gut biopsy analyses showed that infection lead to reduced
expression of pro-inflammatory genes in colitic tissue and, whilst IL-17+ CD4+ T cells were
prominent during active disease, infiltration by IL-22+ CD4+ T cells were associated with
clinical improvements during infection (Broadhurst et al. 2010). No corresponding change
was observed in the Foxp3+ Treg population during colitis relapse or remission (Broadhurst
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et al. 2010). Although conducted in only a single individual and somewhat confounded by
self-administered doses of anti-inflammatory drugs, the latter study presents the first insight
into human immune responses to experimental infection in local tissues. Larger scale studies
are required to investigate the reproducibility of these promising observations.
Since helminth therapy is proposed to act via modulating the host immune response to
allergens and auto-antigens it is noteworthy that despite marked changes in parasite-specific
immune responses, experimental T. suis infection was not found to alter allergen-specific
antibody responses during the clinical trial in allergic rhinitis sufferers described in chapter 7
(Bager et al. 2010a). Similarly, experimental hookworm infection failed to alter the number
of + T cells responding to dietary gluten allergens in patients with Coeliac disease
(Daveson et al. 2011). Both studies found no clinical efficacy relative to placebo controls.
However, the absence of data on parasite-specific cytokines mean that the clinical read-outs
of these trials cannot be related to changes in immune polarisation, which is proposed as the
major cause of hypo-responsiveness during chronic helminth infections (Figueiredo et al.
2010).
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1.10 Thesis outline
This thesis will address some of the key gaps in our current understanding of the
immunobiology of human helminth infection, particularly in relation to cytokine responses.
The specific aims of each aspect of the study, design and implementation of the collaborative
projects of which it is a part and the methods shared between subsequent chapters are
outlined in chapter 2.
In chapter 3 I directly compare the innate inflammatory, Th1, Th2 and Th17-type cytokine
profile elicited by S. haematobium cercariae, adult worm and egg-stage antigens in a
population endemically-exposed to infection. This is the first systematic analysis of how this
comprehensive range of different cytokine responses may differ according to parasite life-
cycle stage.
In chapter 4 I investigate the complex relationship between host age, current infection levels
and S. haematobium-specific cytokine responses and how this relationship may contribute to
epidemiological patterns of natural schistosome infection. This study is also the first to
investigate human S. haematobium GST-specific cytokine profiles in the context of variation
in host age and infection intensity.
The focus of chapter 5 is how praziquantel treatment alters S. haematobium-specific cytokine
responses, including analysis of changes in individual cytokine responses and how combined
cytokine responses shift relative to pre-treatment patterns.
Chapter 6 provides a further investigation of how praziquantel treatment influences the S.
haematobium-specific cytokine environment by first determining how pre-treatment
infection intensity affects the magnitude of change in cytokine responses after treatment and
going on to show that post-treatment cytokine profiles may influence the risk of subsequent
re-infection.
Whilst chapters 3-6 investigate helminth-specific cytokine responses during natural exposure
to infection in an endemic setting, chapter 7 characterises systemic and parasite-specific
cytokine responses during experimental Trichuris suis infection in a cohort of helminth-
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naïve allergic rhinitis sufferers. Importantly this study is the first to investigate how
experimental helminth infection affects allergen-specific cytokine responses, a key target for
allergy immunotherapies.
Chapter 8 provides a general discussion of my findings, how these relate to the existing
literature and proposals for future research in the field.
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Chapter 2
Aims, study design and methods
2.1 Introduction
This study comprises 2 distinct projects, the first being part of a large-scale
immunoepidemiological survey of Schistosoma haematobium infection in an endemically-
exposed community in Zimbabwe and the second being conducted as part of a clinical trial
of experimental Trichuris suis infection as an immunotherapy for grass pollen allergy
(allergic rhinitis) in a cohort of Danish volunteers. The unifying theme of both studies is the
characterisation of how helminth parasites affect host cytokine responses in the context of
variation in the host, parasite and their shared environment.
To date studies of helminth-specific cytokine responses in both animal models and humans
with Th1 and Th2-type responses (reviewed by Allen and colleagues (Allen and Maizels
1997; Diaz and Allen 2007; Allen and Maizels 2011)), as a means of identifying immune
phenotype. However, analyses of cytokine responses assayed in field studies of helminth
immunobiology in humans have tended to focus on cytokines as individual responses, rather
Importantly
effector immune responses are perpetuated by multiple co-incident cytokines derived from a
variety of cell types and thus individual cytokine dynamics never occur in isolation. Whilst
there is clearly an argument for selection of cytokines according to a priori hypotheses,
effective cytokine multiplex assays, current statistical tools and our increased understanding
preclude hypothesis-driven analysis. Furthermore, inconsistencies in assay protocols and
heterogeneity in human populations have inevitably led to variation in the findings of
different studies supporting a cohesive approach to within-study cytokine analysis in
addition to between-study comparisons (reviewed by(Bourke et al. 2011)).
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The purpose of the current study is to characterise how cytokine profiles, in addition to
levels of individual cytokines, relate to helminth immunobiology during both natural and
experimental infections. This approach warranted both assessment of a broader range of
cytokines than that assayed by previous studies and use of multivariate statistical methods
adapted from population ecology (McCune and Grace 2002) and psychometrics (Rummel
1970) that allowed cytokine responses to be analysed in combination.
This chapter describes the specific aims and study design of each aspect of the study and
their shared practical and statistical methods. For the S. haematobium study, which addressed
different research questions using data collected from the same population (chapter 3-6), the
participant selection criteria and epidemiological features of the study cohort are also
outlined.
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2.2 Study aims
As part of the immunoepidemiological survey of S. haematobium infection, the specific aims
of my study were to:
Compare the cytokine environment elicited by S. haematobium cercariae, adult
worm and egg antigens in peripheral whole blood samples collected from a cohort
endemically exposed to infection (chapter 3)
Determine the relationship between S. haematobium infection intensity, age and S.
haematobium-specific whole blood cytokine responses and how these relationships
may correspond to epidemiological patterns of infection (chapter 4)
Characterise changes in S. haematobium-specific whole blood cytokine responses 6
weeks after anti-helminthic treatment (chapter 5)
Relate treatment-induced changes in S. haematobium-specific cytokine responses to
infection levels prior to treatment and the risk of re-infection within 18 months of
treatment (chapter 6)
Characterise the pre and post-treatment whole blood cytokine responses elicited by
the S. haematobium vaccine candidate antigen glutathionine-S-transferase 28kDa
(GST) (chapter 4, 5 and 6)
Within the clinical trial of experimental T. suis infection in patients with grass pollen allergy,
my specific aims were to:
Characterise changes in the systemic cytokine environment over the course of the
grass pollen season in plasma samples from T. suis and placebo-treated patients
(chapter 7)
Investigate the effects of T. suis infection on allergen and parasite-specific peripheral
blood mononuclear cell (PBMC) cytokine responses (chapter 7)
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2.3 Immunoepidemiological survey of S. haematobium-specific cytokine
responses in an endemically-exposed population
The following study design and methods are shared between chapters 3-6.
2.3.1 Study design
This aspect of the study is part of a 3 year longitudinal treatment-re-infection survey of S.
haematobium immunoepidemiology being conducted by researchers at the University of
Edinburgh, University of Zimbabwe (UZ) and the National Institute of Health Research
(NIHR), Harare. The project was made up of both a cross-sectional survey of schistosome
infection and immune responses prior to treatment and a longitudinal follow-up survey of re-
infection levels and immune responses in a sub-set of participants 6 weeks, 6 months and 18
months after praziquantel treatment. The focus of the current study is the S. haematobium-
specific cytokine response elicited in peripheral whole blood samples collected before and 6
weeks after treatment.
The cross-sectional survey involved mass, school-based recruitment of school children
(Figure 2.1A) and members of the local community over a 3 week period. School-based
recruitment facilitated efficient recruitment and follow-up of compliant participants and
dissemination of information about the study to the local community. A population census
was conducted during the recruitment phase. All compliant participants provided stool and
urine samples for parasitological analysis (Figure 2.1B and C) and a sample of venous blood
was collected for immunological assays (Figure 2.1D). Samples were transported from the
study sites for processing in the diagnostics laboratory of the local hospital on the day of
collection. Samples for subsequent immunological analysis were frozen and transported to
the University of Edinburgh.
After collection of cross-sectional samples, all compliant individuals were treated with a
single standard dose of praziquantel (40mg/kg body weight) and albendazole (400mg) as





Figure 2.1. Photographs from immunoepidemiological field survey of Magaya
community, Zimbabwe. A) Recruitment of participants at Magaya primary school, B)
Collection of stool and urine samples for parasitological analysis, C) Filtration of urine
samples to quantify S. haematobium infection intensity (egg counts/10ml), D) Collection of
serological samples and E) Praziquantel treatment (40mg/kg).
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recommended by the W.H.O. (Montresor et al. 1998) (Figure 2.1E). Both praziquantel and
albendazole were administered irrespective of infection status in accordance with ethical
permissions obtained for the study (see 2.3.2). Repeat doses of anti-helminthic were
provided to individuals found to be persistently excreting schistosome or soil-transmitted
helminth (STH) eggs, but these individuals were not included in post-treatment analyses.
Follow-up samples were collected 6 weeks, 6 months and 18 months post-treatment as part
of an on-going survey of re-infection post-treatment within the population.
2.3.2 Study site and participants
The study was conducted in Murehwa district in Northern Zimbabwe. The study area
experiences a dry season from May to October with low precipitation, low humidity and high
average temperatures and a rainy season from November to April when temperatures are
cooler. The local climate means that transmission of Plasmodium spp. parasites is seasonal,
and this has been confirmed by collation of district level data on the number of malaria cases
in children collected over a 10 year period (Mabaso et al. 2005). Country-wide Plasmodium
spp. infections peak during the rainy season from February to May (Taylor and Mutambu
1986; Mabaso et al. 2005) and the predominant species is Plasmodium falciparum, however
infection prevalence is low, particularly in high-altitude areas such as our study site (Taylor
and Mutambu 1986). The pre-treatment survey of Magaya community was initiated in
September 2008 and the 6 weeks post-treatment follow-up survey was conducted in late
October of the same year.
Samples were collected from 5 schools in 3 distinct locations within Murehwa district;
Magaya primary and secondary schools, Chipinda primary and secondary schools and
Chitate primary school. These schools were selected from a pre-survey of schools in the area
for the presence of S. haematobium infection and the relatively low prevalence of S. mansoni
and STH infections. The schools are non-residential and enrolled students travel from a
range of local villages and homesteads. All 5 schools are located in the rural surrounds of
Murehwa, the largest town in the district. Adult members of the local community, including
school teachers, parents, relatives and friends of children enrolled at the schools, were
informed about the study and invited to participate through community meetings held in
during the pre-survey period and were enrolled at school sites. The cohort recruited from
Magaya community is the main focus of my study (Chapter 3, 4, 5 and 6) as it was found to
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have the highest prevalence of S. haematobium infection of the 3 communities. In total,
demographic data was collected from 675 members of Magaya community prior to
treatment, of which 423 were primary school children, 158 were secondary school children,
94 were community members who did not attend school. Of these participants, 35 family
groups (mean family group size identified: 2.5 members, range: 2-5 members) were
identified amounting to a total of 88 participants. 13 recruited adult community members
were directly related (father, mother or grandparent) to school-aged children in the cohort.
Although familial groups were identified, only a minority of recruited adults were directly
related to school-age recruits, indicating that school-based recruitment did not bias the adult
cohort that enrolled in the study.
The schools and a subset of water contact si
surveyed and mapped using hand-held global positioning systems (GPS) by my colleagues
Kate Mitchell and Laura Appleby. Water contact sites ranged from dammed pools, rivers,
some of which are seasonal, and wells. The majority of study participants relied on natural
water sources for at least some of their domestic activities (assessed by questionnaire,
Appendix 1). On average study participants made 2 contacts per day with water sources that
posed a potential risk of schistosome infection (i.e. stagnant or slow-moving freshwater
sources) (Mitchell and Appleby, un-published data). S. haematobium intermediate host snails
(Bulinus spp.) were also found at water contact sites identified by the GPS mapping survey.
Although it would have been desirable to conduct an observational water contact survey, as
has been conducted previously (Chandiwana and Woolhouse 1991), the extensive range and
distribution of water contact sites meant that this approach was not practically feasible. A
GPS map of the study area produced by Kate Mitchell and Laura Appleby is shown in Figure
2.2.
2.3.4 Ethical considerations
Ethical approval to conduct the study was granted by the Medical Research Council of
Zimbabwe (MCRZ) and institutional approval was granted by the Institute Review Board of
the University of Zimbabwe (UZIRB). Permission to recruit participants at the study sites
was provided by the Provincial Medical Director.
Only compliant participants were included in the study and all recruited participants were
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Figure 2.2. Map of the field study area. The map was generated from GPS co-ordinate
data collected on-foot and co-ordinates were overlaid onto a satellite image of the area
obtained from GoogleEarth (Mitchell and Appleby, un-published data). Markers indicate
school sites where samples were collected (red markers), village centres and participant
homesteads (white circles), rivers (blue lines), roads (black lines) and local
clinics/hospitals (red crosses). Water contact sites were distributed throughout the area.
Scale is in miles (mi) and map co-ordinates are: 17o39o o52o
East. Elevation: 4489ft.
3.6 miles
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free to withdraw at any time. All participants were given a full explanation of the study aims,
approach and procedures in the local language (Shona) after which they were invited to
participate in the study. Enrolment involved provision of informed written consent, which
r to sample collection. A parent or
guardian provided consent for children aged less than 18 years at recruitment. Each
participant was allocated a unique case number and all pre and post-treatment samples and
data collected from an individual was identified by case number. Collection of blood
samples and administration of praziquantel and albendazole was carried out by nursing staff
from Murehwa District Hospital and local clinics.
2.3.5 Methods
2.3.5.1 Population survey
All participants completed a questionnaire (Appendix 1)to assess name, age, date of birth,
sex, relatives within the cohort, place of residence, residential history, typical water contact
behaviour (on day of survey and over the preceding week), prior knowledge of schistosome
infection and treatment history for schistosomiasis (treatment status, type of treatment, date
and location of treatment). Questionnaires were prepared in English, but administered to all
participants by a native Shona speaker to avoid language, accent or literacy barriers
(Mduluza et al. 2007). A parent or guardian of children under 5 years of age completed
specially-prepared questionnaires on their behalf and a post-treatment follow-up
questionnaire to assess any side-effects of treatment (Mutapi et al. 2011c). To ensure the
accuracy of age and gender data, information from pre-treatment questionnaires was used in
concert with school registers and surveys conducted at follow-up visits.
2.3.5.2 Diagnosis & quantification of infection
S. haematobium, S. mansoni, STH, Plasmodium spp. and HIV infection were diagnosed and
quantified in collected samples by experienced technical staff from the NIHR.
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2.3.5.2.1 S. haematobium
Individuals provided urine samples (between 2 and 6 samples on consecutive days) and were
classified as positive for S. haematobium infection if eggs were detected in any of the
samples that they provided. Eggs were identified on the day of sample collection by filtration
of 10ml urine through a nitrocellulose filter (Figure 1B), which was then examined under a
(Mott 1983). Arithmetic mean egg counts were
used in all analyses and participants who provided fewer than 2 urine samples for
quantification of S. haematobium infection were excluded from the study.
2.3.5.2.2 S. mansoni and Soil-transmitted helminths (STH)
S. mansoni and STH infection were assessed using the Kato-Katz technique (Katz et al.
1972). Stool samples were first sieved to remove large particles and a minimum of 2 slides
per sample were prepared using standard 41.7mg templates. Samples were stained with
glycerol-malachite green, which stains stool components but cannot penetrate live helminth
eggs making them easier to identify. Eggs were counted under a light microscope and all
slides were analysed on the day of collection. As recommended by previous studies a
minimum of 2 stool samples with 2 smears per stool were analysed to ensure sensitivity of
egg detection (Ebrahim et al. 1997).
2.3.5.2.3 Plasmodium spp.
Thick and thin blood smear slides were prepared for each participant from freshly collected
venous blood, dried at room temperature and fixed with methanol. Malaria infection was
detected by microscopic analysis of thick smear blood slides and, if an individual was found
to be positive, infection was quantified by counting infected red blood cells on a
corresponding thin-smear blood slide. In addition, Paracheck Pf® kits (Orchid, Catalogue#
30302100), a malaria rapid diagnostic test specific for the histidine rich protein 2 of P.
falciparum, confirmed malaria positive/negative cases.
2.3.5.2.4 Human Immunodeficiency Virus (HIV)
HIV infection was diagnosed using DoubleCheckGold HIV 1&2 Whole Blood test
(Orgenics, Catalogue# 70633020), an immunochromatographic assay for HIV-1 and HIV-2-
specific antibody using 2-3 drops of fresh whole blood. The test detects circulating
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antibodies specific for the immunodominant epitopes of HIV-1 and 2 envelope and gag
proteins. All positive cases were confirmed by subsequent enzyme-linked immunosorbent
assay (ELISA) analysis detecting sero-reactivity to HIV proteins at the NIHR.
2.3.5.3 Serology
Each individual provided up to 50ml of whole blood (depending on body weight), which was
collected via venous puncture into 5 separate collection tubes. 3x 10ml samples were
collected into heparinised tubes for isolation of PBMCs and plasma samples. 10ml were
collected into a silicon-coated tube without anti-coagulant for isolation of sera. 10ml were
collected into a K2EDTA-treated collection tube, which was subsequently used for whole
blood re-stimulation cultures (5ml), HIV diagnosis (2-3drops), preparation of differential cell
count slides (200µl), inclusion in a whole blood sample archive (500µl) and plasma (1ml) for
subsequent assays of cytokine production. K2EDTA was chosen for sample collection for
whole blood culture because it is known to prevent coagulation of blood cells and also yield
viable cells for re-stimulation and cytokine analysis (Mayringer et al. 2000; Remick et al.
2000). All tubes were inverted after sample collection to ensure mixing of the anti-coagulant
with the blood, transported from the field site in chilled containers and processed at the
diagnostics laboratory at Murehwa District Hospital.
2.3.5.4 Whole blood re-stimulation culture
2.3.5.4.1 Antigens
Crude homogenates of S. haematobium cercariae (cercarial antigen preparation (CAP)), adult
worms (whole worm homogenate (WWH)) and eggs (soluble egg antigen (SEA)) were
obtained from the Schistosome Biological Supply Centre at the Theodor Bilharz Institute,
Giza, Egypt. The centre routinely produces schistosome antigens from an Egyptian strain of
S. haematobium using established protocols similar to those for preparation of S. mansoni
antigens (Jassim et al. 1987). Freeze-dried antigen preparations were reconstituted in 500µl
double-distilled water and protein content was quantified by Bradford assay. All antigens
were stored at -20 C in concentrations >1mg/ml. Identically prepared antigens from this
parasite strain have been used in previous studies by our research group (Mutapi et al. 2008;
Reilly et al. 2008; Milner et al. 2010; Imai et al. 2011).
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Recombinant glutathionine-S-transferase 28kDa (GST) of a Senegalese strain of S.
haematobium was provided by Professor Francois Trottein of the Centre of Immunology and
Parasite Biology at the Institut Pasteur de Lille, France. The protein was cloned and purified
according to previously published protocols (Trottein et al. 1992b). In brief, the GST was
sub-cloned into a pET-24d(+) vector and expressed in E. coli BL21(DE3) cells. The
expression product was purified on a sepharose column, dialysed and concentrated to yield
an endotoxin-free recombinant protein (Prof. Francois Trottein, Institut Pasteur de Lille,
France, personal communication).
Escherichia. coli Maltose-binding protein (MBP) and phytohaemagglutinin (PHA), an
activator of T cell proliferation, were used to confirm the viability of cultured cells and their
capacity to produce cytokine in response to non-schistosome antigens. MBP was obtained
from New England Biolabs and PHA was obtained from Sigma Aldrich.
To determine whether crude antigens and GST were contaminated by endotoxin,
preparations of all antigens were cultured overnight with murine bone marrow-derived
dendritic cells (BMDC), which are highly sensitive to endotoxin. Parallel cultures were
conducted with and without polymixin B (an endotoxin-neutralising antibiotic) according to
a previously published protocol (Jenkins et al. 2005a). Inflammatory cytokine secretion was
assayed by ELISA and indicated no significant -6, IL-
12p40 or IL-12p70 in the endotoxin blocked and un-blocked cultures. Cytokine responses to
titrated endotoxin verified the efficacy of polymixin B treatment. From these assays it can be
concluded that, if endotoxin is present in the preparations, it not in sufficient quantities to
elicit significant levels of inflammatory cytokines from endotoxin-responsive cells in vitro. I
used this method rather than a quantitative assay of endotoxin (e.g. Limulus ameobocyte
assay) because quantitative assays do not provide information on the effect that the level of
endotoxin has on in vitro cytokine responses, which are the focus of my study.
2.3.5.4.2 Culture conditions
Whole blood cultures were carried out in the diagnostics laboratory of Murehwa District
Hospital for a sub-set of samples collected from Magaya community using established
culture protocols (Remick et al. 2000; Joseph et al. 2004a; Walter et al. 2006; Mutapi et al.
2007b). All antigens were diluted in culture medium (RPMI supplemented with 5U/ml
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penicillin, 50µg/ml streptomycin and 1%v/v L-glutamine) to a give a final culture
concentration of 10µg/ml (CAP, SEA, WWH and PHA) or 2µg/ml (GST and MBP) after
addition of diluted blood (see below). Antigens were plated in duplicate at 500µl/well in 48
well culture plates. 500µl/well of culture media without antigen acted as an un-stimulated
control. The same culture protocol has been used in previous studies (Scott et al. 2000;
Joseph et al. 2004a; Joseph et al. 2004b; Mutapi et al. 2007b).
On arrival at the laboratory 5ml of whole blood from the K2EDTA-treated collection tube
was diluted to 1:3 in 10ml culture medium. 500µl/well of diluted blood was added to
antigen-coated wells to give a final dilution of blood of 1:6 and a final culture volume/well
of 1ml. Duplicate cultures for each antigen-stimulation were prepared in adjacent wells and
all antigen stimulations and control cultures were conducted on the same plate for each
individual to ensure identical culture conditions. Where less than 5ml of blood was collected
(e.g. due to participant discomfort during sampling) blood was diluted 1:3 in a lower volume
and the maximum number of duplicate cultures possible were conducted prioritising SEA,
WWH, GST, un-stimulated and agonist control cultures since a limited amount of CAP was
available. For this reason, the number of participant whole blood samples stimulated with
CAP during the pre-treatment cross-sectional survey (n = 80) was less than for the other
antigens (n = 259).
Plates were cultured for 48 hours at 37 C. Whilst a range of culture durations have been used
in previous studies of schistosomiasis, and some studies have used separate timepoints for
different cytokines (Joseph et al. 2004a) a single 48 hour timepoint was chosen for this study
according to protocols optimised for assaying production of multiple cytokines (Scott et al.
2000; Joseph et al. 2004a). To maintain a constant carbon dioxide concentration, all plates
were cultured using the OXOID AnaerogenTM Compact anaerobic atmosphere generation
system (OXOID, Product code: AN0010 & AN0020). This involved culturing plates in
sealed pouches with a sachet of ascorbic acid and activated carbon that reacts with oxygen
inside the pouch to reduce atmospheric oxygen to less than 1% and generate stable levels of
CO2 within 30 minutes of activation.
After 48 hours culture supernatants were harvested into individual microtubes and frozen at -
20 C. After transport to the University of Edinburgh, samples were stored at -80°C and
processed within 18 months of collection.
Chapter 2 Aims, study design and methods
- 62 -
2.3.5.5 Immunological assays
2.3.5.5.1 Choice of cytokine assays
I chose to assay a panel of 13 cytokines (IFN -2, IL-4, IL-5, IL-6, IL-10, IL-
12p70, IL-13, IL-17A, IL-21 and IL-23) associated with established cellular phenotypes
from pathway immunology (Diaz and Allen 2007) as a means of comparing stage-specific
variations both within and between these immunological paradigms. The large panel of
cytokines was chosen to avoid reliance on the Th1/Th2 dichotomy in isolation (Allen and
Maizels 1997) and to address the paucity of data on cytokines associated with innate and
Th17-type responses in human helminth studies. For interpretation of the cytokine assays I
have used innate and CD4+ T cell-based terminology despite the range of cytokine-
producing cell types present in whole blood because this terminology is frequently used to
describe cytokine responses in studies of human helminthiases and studies of murine and
human immunology suggest that these immunological groupings can be used to broadly
categorise host immune phenotypes in infection (Diaz and Allen 2007).
To avoid biasing my interpretations according to individual empirical studies, review articles
or murine cytokine literature, I conducted a literature search of recent studies on human
cytokine responses and the immune phenotype with which they are most frequently
associated. The search was not restricted to studies of helminth infection. The keywords:
were entered into the online PubMed database (http://www.ncbi.nlm.nih.gov/pubmed/) and
the top 50 hits arising from each combination of keywords were reviewed. The top 100 hits
he abundance of literature identified
as using these terms (n > 64,000). Articles were included in subsequent assessment if they
-2, IL-4, IL-5,
IL-6, IL-8, IL-10, IL-12 (all subtypes), IL-13, IL-17 (all subtypes), IL-21 and/or IL-23
activity or production in human cell culture, cell lines, tissues or peripheral blood samples, 3)
responses and 4) presented original empirical data (i.e. review papers were excluded).
Articles identifying cytokine mRNA, gene sequencing data or intracellular cytokine
expression alone were excluded since all cytokines assayed in the present study were
detected in cell-free supernatants. 127 of 250 articles reviewed met the inclusion criteria.
-6 and IL- -2


























Figure 2.3. Cytokine responses grouped according to their associations with different
cellular immune phenotypes. Results of a literature review of empirical human cytokine
studies (127 articles) to determine appropriate groupings for assayed cytokines. Keywords
into the PubMed online database and the frequency with which a particular cytokine was
associated with each phenotype (Th1, Th2, Th17 or innate inflammatory) used to determine
its appropriate group. Each circle represents a cellular phenotype and cytokines are included
in the phenotype with which they were most frequently associated. Cytokines which were
associated with other phenotypes at a lower frequency are given in overlapping areas of the
diagram. * -inflamm
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and IL- -4, IL-5, IL-10 and IL- -17A, IL-21 and IL-23 as
(cytokines are also grouped in this way in chapter 1.5.1). The phenotypic groupings of
cytokines identified from the literature review are summarised in Figure 2.3. It is of note that
many papers also described IL- - (Coelho dos Santos
et al. 2010; Dorresteijn et al. 2010; O'Leary et al. 2010; Osakwe et al. 2010; van der Does et
al. 2010) and IL-10 was more often described in these terms than as a Th2-type cytokine.
Furthermore, TNF , IL-6, IL- - -
(Corrigan and Rowe 2010; Fedele et al. 2010; Gruaz et al. 2010; Huang et al.
2010; Marr et al. 2010) and IL-2 as mediating expansion of T cells of a variety of lineages
(Pahwa et al. 2010; Rivino et al. 2010), reflecting that the functions of these cytokines are
associated with, but not restricted to these phenotypic groups.
2.3.5.5.2 Optimising ELISA protocol
A cytokine sandwich ELISA technique was used to assay all 13 cytokines from 48 hour
whole blood cultures conducted in the field. The ELISA method used was adapted from
commercial protocols provided by BD Biosciences, R&D Systems and eBiosciences. To
determine optimal assay conditions several preliminary assays were conducted. Firstly,
ELISAs were conducted on all recombinant cytokine standard proteins titrated in doubling
dilutions from the maximum concentration recommended by the manufacturers to identify
the optimum top standard concentration for standard curve generation. ELISA capture and
detection antibodies were also titrated to determine respective working concentrations for
maximum sensitivity to sample analytes and minimal non-specific binding of detection
reagents. Preliminary assays of field samples indicated that dilutin
-2, IL-4, IL-5, IL-10, IL-12p70, IL-13, IL-17A, IL-21 and IL-23) and 1:4 (IL-6 and
IL-8) was the most appropriate means of capturing the range of cytokine concentrations
produced in the whole blood cultures. ELISAs were also conducted using coating buffers,
blocking buffers, wash buffers and tetramethylbenzidine dihydrochloride (TMB) substrate
reagents provided commercially and equivalent reagents prepared in-house. No notable
differences were observed between assays.
During preliminary assays IL-33 was also included in the cytokine panel, however the IL-33
assay used (R&D, Catalogue number: DY3625) was found to be both highly sensitive to
variation in ELISA reagents and unsuitable for long-term storage at -80 C at the time. In the
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absence of alternative human IL-33 ELISA reagents suitable for large-scale analyses, IL-33
was subsequently omitted from the cytokine assay panel. For the remaining 13 cytokine
assays commercial capture and detection antibodies and recombinant standards were used in
conjunction with in-house prepared buffers and detection reagents. Antibodies were stored at
4 C and standards aliquoted and stored at -80 C for the duration of the study, according to
2.3.5.5.3 Pre and Post-treatment cytokine ELISA
-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-13, IL17A, IL-21 and
IL23p19, were assayed in supernatants harvested from 48 hour cultures of whole blood from
each individual. All cytokines were assayed for each individual in a single set of assays
conducted over 3 days. Supernatants were defrosted overnight at 4 C prior to use. Full
details of the specific recombinant standard proteins, capture and detection antibodies used
for each cytokine ELISA are given in Table 2.1.
96 well maxisorp ELISA plates (NUNC, Catalogue#DIS-971-010P) were coated with
50µl/well capture antibody diluted in heat-sterilised phosphate-buffered saline (PBS) at
1µg/ml (IFN -2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-13, IL-17A and IL-21) and
-23). Plates were stored overnight at 4 C.
The following day plates were washed 3 times in ELISA wash buffer (PBS, 0.05% Tween
20) before incubation for 2 hours at room temperature with 200µl/well blocking buffer
(PBS/2% bovine serum albumen (BSA)). Protease-free BSA was supplied by Alpha
Diagnostic International (Catalogue#80400).
After blocking, 11 doubling dilutions of 50µl/well recombinant standard cytokine were
prepared in PBS/2%BSA in duplicate across the plate with a starting concentration of 1ng/ml
(IL-17A), 2ng/ml (IL-23p19 and IL-4), 5ng/ml (IFN -5, IL-6, IL-8 and IL-10),
10ng/ml (IL-13), 20ng/ml (IL-2 and IL-12p70) and 40ng/ml (IL-21). 50µl/well of PBS/2%
BSA without antigen was added to a twelfth set of duplicate wells to act as a 0ng/ml standard
(blank). Supernatant samples were dilu -2, IL-4, IL-5, IL-10, IL-
12p70, IL-13, IL-17A, IL-21 and IL-23p19) or 1:4 (IL-6 and IL-8) in PBS/2% BSA on assay
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Table 2.1 Cytokine sandwich ELISA reagents. Details of the capture and biotinylated-detection
antibodies and recombinant cytokine standard proteins used for both pre and post-treatment assays.
The catalogue number, clones and antibody isotype for each product is given according to the product
references available at the time of the study. Reagents supplied by: *BDBiosciences, #Insight
Biosciences and +eBiosciences.
Analyte Reagent Description Isotype Clone Catalogue#
Capture* Purified mouse anti- NIB42 551221
Standard* - - 554616
Detection* Biotin mouse anti- 4S.B3 554550
Capture* Purified mouse anti- IgG1 MAb1 551220
Standard* - - 554618
Detection* Biotin mouse anti-human MAb11 554511
IL-2
Capture* Purified mouse anti-human IL-2 5344.111 555051
Standard* Recombinant human IL-2 - - 554603
Detection* Biotin mouse anti-human IL-2 B33-2 555040
IL-4
Capture* Purified mouse anti-human IL-4 8D4-8 556917
Standard* Recombinant human IL-4 - - 554605
Detection* Biotin rat anti-human IL-4 IgG1 MP4-25D2 554483
IL-5
Capture* Purified rat anti-human IL-5 IgG2a JES1-39D10 554487
Standard* Recombinant human IL-5 - - 554606
Detection* Biotin rat anti-human IL-5 IgG2a JES1-5A10 554491
IL-6
Capture* Purified rat anti-human IL-6 IgG1 MQ2-13A5 554543
Standard* Recombinant human IL-6 - - 550071
Detection* Biotin rat anti-human IL-6 IgG2a MQ2-39C3 554546
IL-8
Capture* Purified mouse anti-human IL-8 G265-5 554716
Standard* Recombinant human IL-8 - - 554609
Detection* Biotin mouse anti-human IL-8 IgG2b G265-8 554718
IL-10
Capture*
Purified rat anti-human and viral IL-
10
IgG1 JES3-9D7 554497
Standard* Recombinant human IL-10 - - 554611
Detection*




Capture* Purified rat anti-human IL-12p70 20C2 555065






Capture* Purified rat anti-human IL-13 IgG1 JES10.5A2 554570
Standard# Recombinant human IL-13 - - 10-1025-C
Detection* Biotin mouse anti-human IL-13 B69-2 555054
IL-17A
Capture+ Purified mouse anti-human IL-17A eBio64CAP17 14-7178
Standard+ Recombinant human IL-17A - - 14-8179
Detection+ Biotin mouse anti-human IL-17A eBio64DEC17 13-7179
IL-21
Capture* Purified mouse anti-human IL-21 JI48-1134 558503
Standard# Recombinant human IL-21 - - 10-1666-C
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plates in duplicate wells to a final volume of 50µl/well. Plates were incubated overnight at
4 C.
Plates were washed 3 times before addition of 50ul/well detection antibody at 0.5µg/ml
(IFN -2, IL-5, IL-6, IL-8, IL-12p70 and IL-23) or 1µg/ml (IL-4, IL-10, IL-13, IL-
17A and IL-21) in PBS/2% BSA. Assays were incubated for 2 hours at 37 C, after which
they were washed 4 times. 50µ streptavidin-horseradish peroxidase (HRP)
(GEHealthcare, Catalogue#RPN4401) diluted at 1:6000 in PBS/2% BSA was added and
plates were incubated for 2 hours at 37 C.
Excess horseradish peroxidase (HRP)-conjugated streptavidin was removed by washing
plates 4 times. The reaction was developed in 50µl/well TMB-based streptavidin-HRP
substrate solution, which generates a colourless to blue colour change proportional to the
concentration of cytokine in the well. The Tetramethylbenzidine dihydrochloride
monohydrate (TMB) substrate solution was prepared fresh for each assay by dissolving
0.024g TMB (Sigma, Catalogue#T8768) in 5ml 1:1 acetic acid and double distilled H2O and
adding it to 145ml of phosphate-citric acid buffer prepared from a 10x stock (25.5g citric
acid and 45.7g Na2HPO4 in 500ml ultra pure H2O, adjusted to pH 5). 120µl H2O2 was added
directly before use. Assays were developed for 1.5min (IL-8) or 5min (IFN -2,
IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13, IL-17A, IL-21 and IL-23) in the dark to reduce the
effect of light on the colour-change reaction. The reaction was stopped by adding 50µl/well
25% hydrochloric acid.
Optical densities of each well were read at a wavelength of 450nm using a microplate reader
(Emax precision microplate reader, Molecular devices) and mean cytokine concentrations
were interpolated from the 12-point recombinant cytokine standard curve using SoftmaxPro
spectrophotometer software. All sample cytokine concentrations were multiplied by the
appropriate dilution factor.
2.3.6 Cohort selection
After sample collection, cytokine assays and analysis of parasitology and demographic data,
the eligibility of each participant for inclusion in each aspect of the study was assessed.
Chapter 2 Aims, study design and methods
- 68 -
A total of 284 participants provided a whole blood sample at recruitment and of this initial
cohort, 129 provided post-treatment follow-up samples at 6 weeks and 53 provided follow-
up samples at 18 months post-treatment. Chapters 3, 4, 5 and 6 are based on data collected
from relevant sub-cohorts of these individuals. Selection of each cohort was dependent on
the research questions being addressed and detailed inclusion/exclusion criteria are described
in relevant chapters. An overview of these criteria is given in Figure 2.4.
Since only a limited amount of CAP was available for the study, samples from 80
individuals were randomly selected for culture with CAP. Random allocation was ensured by
use of anonymous identification numbers during assays and analysis of demographic and
parasitology data only after initial selection of individuals for this aspect of the study.
Selection of sub-cohorts was based on 4 groups of criteria (shown in Figure 4): a)
parasitology, b) treatment history, c) residential history and d) cytokine data. Firstly
participants were automatically excluded from all aspects of the study if they provided
insufficient parasitology data for reliable diagnosis of infections and quantification of
schistosomiasis haematobium and mansoni (minimum of 2 urine and 2 stool samples).
Furthermore, participants were excluded if they were diagnosed positive for S. mansoni,
STH or Plasmodium spp. infection since immune responses to the antigens of these parasites
are known to cross-react with those of S. haematobium (chapter 1.4.5). S. mansoni
prevalence was low in the study cohort and few participants were excluded due to S.
mansoni co-infection (Figure 2.4). No participants tested positive for STH eggs in stool or
Plasmodium spp. infection during the study. These findings are consistent with the low
prevalence of S. mansoni (Midzi et al. 2008b; Midzi et al. 2010) and sporadic focal
distribution of STH (Chandiwana 1989) in Zimbabwe. The absence of malaria-positive cases
is most likely due to sampling during the dry season when malaria transmission is low in the
study area (Taylor and Mutambu 1986; Mabaso et al. 2005). HIV infection is also thought to
influence schistosome immunobiology (Karanja et al. 1997; Ganley-Leal et al. 2006) and,
where there were insufficient cases to account for HIV status in statistical analyses, HIV
positive cases were also excluded.
The second group of exclusion/inclusion criteria was based on praziquantel treatment. For
assessment of pre-treatment cytokine responses to S. haematobium antigens (chapters 3 and
4) participants were excluded if they had previously received treatment for schistosomiasis
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(assessed by questionnaire). Exclusion on the basis of prior treatment was considered
important since studies suggest that treatment can alter acquired immune responses elicited
by parasite antigens (chapter 1.7.3). Selection of an area of Zimbabwe that has not been
included in national mass anti-helminthic treatment programmes meant that few participants
were excluded on the basis of prior treatment. For assessment of post-treatment cytokine
responses (chapters 5 and 6) participants who had not received treatment after initial
sampling or who had received treatment for schistosomiasis prior to recruitment were
excluded.
The third group of exclusion/inclusion criteria was based on residential history. This was
considered particularly important for assessment of the relationship between cytokine
responses, infection intensity, age and exposure history (chapter 4), since age is only
reflective of duration of endemic exposure to S. haematobium infection if a participant is a
life-long resident of an endemic area. Furthermore, the cytokine responses of individuals
with short-term or recent exposure to schistosome infection are known to differ from those
of endemically-exposed individuals (Caldas et al. 2008). Heterogeneity in the duration of
residence in the study site (from 30 years to 6 months) meant that variation due to residential
history was not suitable for inclusion in statistical analyses.
Finally, cases were excluded if they provided an insufficient volume of blood to conduct
cultures with all antigens or insufficient supernatant was harvested to conduct all 13 cytokine
ELISAs. This was essential to avoid biasing interpretation of cytokine profiles, particularly
for analyses based on the combination of each ine responses.
2.3.7 Determination of population age-infection profiles
Population estimates of S. haematobium infection intensity and prevalence were obtained
from analysis of the 284 individuals who provided whole blood samples for the pre-
treatment cross-sectional study. As is common in schistosome-endemic regions, infection
intensity varied with age (Anderson and May 1992) as shown in Figure 2.5A. This
distribution was convex in nature, with 11-12 year old children having the highest mean
infection intensity when compared to other age groups within the population. 3 distinct age
groups were identified from exploratory analysis reflecting age groups where infection levels
are expected to increase with age (3-10 years), have reached a peak intensity (11-12 years) or
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decline with age (13-86 years) according to this pattern (Figure 2.5B). The demographic and
infection characteristics of these 3 groups are summarised in Table 1. These age groups are
used throughout the study to relate cytokine responses to age and pre-treatment S.
haematobium infection dynamics within Magaya community as a whole.
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Figure 2.5. S. haematobium infection intensity by age in Magaya community (n = 284).
A) Mean infection intensity is highest in 11-12 year olds and lowest in adults (aged 19+).
B) The population-level distribution of infection is reflected in 3 age groups (3-10, 11-12 and
13+ years). Mean infection intensity (eggs/10ml urine) was compared between age groups
(3-4, 5-6, 7-8, 9-10, 11-12, 13-14, 15-16, 17-18 and 19+ years (A) and 3-10, 11-12 and 13+
years (B)) by univariate analysis of variance with log10(x+1)-transformed infection intensity
as the dependent variable and age group as the explanatory variable. *p<0.05, **p<0.01,
***p<0.001.
Age group (years)
3 - 10 11 - 12 13 +
n 109 60 111
Mean age (S.E.M.) 7.4 (0.1) 11.5(0.07) 27.4 (1.7)
Number of males: females 52:57 31:29 45:66
Mean infection intensity (S.E.M) 24.0 (6.6) 68.7 (18.3) 12.6 (4.3)
Infection range (eggs/10ml urine) 0-481 0-692 0-403
Infection prevalence (%) 55.0 71.7 38.7
Table 2.2. Summary of demographic and S. haematobium infection characteristics of
participants recruited from Magaya community (n = 284).
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2.4 Cytokine responses of helminth-naïve participants experimentally exposed
to Trichuris suis infection
The following study design and methods provide an overview of the clinical trial from which
the samples analysed in chapter 7 were obtained (Bager et al. 2010a). Specific methods used
for cytokine assays are provided in chapter 7.
2.4.1 Study design
This aspect of the study is part of a phase II randomised double-blind, placebo controlled
clinical trial of T. suis ova (TSO) as an immunotherapy for allergic rhinitis (Registration
number: R000001298, Trial ID: UMIN000001070). The trial was designed and implemented
by Dr. Peter Bager and colleagues at the Serum Statens Institute, Copenhagen, Denmark,
who provided plasma and PBMC supernatant samples collected during the study for
cytokine analyses. The broader aim of the trial was to assess the efficacy of experimental T.
suis infection on clinical symptoms of allergic rhinitis in a voluntary cohort of Danish
individuals and these results have been recently published (Bager et al. 2010a).
Participants were recruited and randomly assigned to T. suis or placebo treatment groups and
received 8 doses of 2500 TSO suspended in sulphate stabilised 0.015moles/L H2SO4 or the
H2SO4 alone (placebo) in double-blinded preparations at 21 day intervals. Blood samples
were collected at recruitment, during the peak grass pollen season and 21 days after the last
treatment was administered. The grass pollen season was defined as the period from the first
of 3 consecutive days where pollen counts reached (or exceeded) 10 pollen/m3 (28th May
2008) until the first of 3 consecutive days after the start of the season where pollen counts
were below 10 pollen/m3 (27th July 2008). The design for the study is summarised in Figure
2.6. Although the date of sample collection during the grass pollen season varied between
day 42 and 126 after initial treatment (Figure 2.6), 77% of the cohort received 3-5 doses
prior to collection of grass pollen season serology (Bager et al. 2010b).
All participants were required to keep a patient diary throughout the study and report
occurrence of asthma, diarrhoea, flatulence, pruritus ani, and any spontaneous reports of
adverse events. Diarrhoeal episodes and gastric discomfort were assessed by daily
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Figure 2.6. Study Design for phase II double-blind, placebo controlled clinical trial of T.
suis ova as an immunotherapy for allergic rhinitis. Volunteers were randomly assigned to
either TSO or placebo treatment groups and received 8 doses (indicated by arrows) of either
2500 TSO or placebo at 21 day intervals. Plasma and PBMC samples were collected at 3
timepoints (baseline, grass pollen season and end). The interval during which samples were
collected for each timepoint is indicated by red boxes and the start and end of the grass
pollen season are shown by dashed lines. d number of days after ingestion of first treatment
dose.
d0 d21 d42 d84d63 d105 d147d126
Time (days)
d168
Baseline Grass Pollen Season End
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questionnaire. Data on self-reported GI symptoms (diarrhoea and discomfort) experienced
between baseline and the peak grass pollen season and between the peak grass pollen season
and the final timepoint were pooled into a single binary index (i.e. 0 no gastrointestinal
symptoms reported, 1 GI symptom/s reported at any time after initial treatment). Daily,
self-reported assessment of allergic rhinitis symptoms on a scale from 0 to 3 (0 no
symptoms, 1 mild, 2 moderate and 3
perceived improvement in symptoms compared to the grass pollen season of the previous
year were used to assess the clinical efficacy of the treatment regime.
Preliminary results of the trial indicated that, although eosinophil counts and parasite-
specific antibody titres were significantly elevated in the TSO-treated group relative to
placebo controls, infection had no significant effect on clinical allergy (Bager et al. 2010a).
The impetus for the current study was that sub-clinical changes in systemic, allergen and
parasite-specific cytokine responses may yield insights into the immunobiology of
experimental T. suis infection and identify a means of enhancing the clinical efficacy of the
treatment regime.
2.4.2 Ethical considerations
Ethical permission to conduct the trial was obtained from the Danish Ethics Committee via
independent review (number: H-KF-2006-4100). All volunteers provided written consent at
recruitment and all aspects of the study accorded with the Declaration of Helsinki and Good
Clinical Practice (GCP) (Bager et al. 2010a). Volunteers were free to drop-out of the study at
any point and treatment was made available for GI and allergic symptoms if required. To
ensure the safety of all participants, health assessment was monitored during visits and via
telephone.
2.4.3 Study participants
Allergic rhinitis sufferes were recruited in Copenhagen, Denmark. All individuals suffered
from seasonally exacerbated symptoms as a result of allergy to airborne pollen antigens
(confirmed by skin prick test), levels of which peak in the Danish grass pollen season. 100
adult volunteers (age range: 19-63 years) provided a plasma sample and PBMCs were
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Venous whole blood samples were collected in anti-coagulant treated tubes for isolation of
plasma by centrifugation and purification of PBMCs during the clinical trial conducted by
Bager and colleagues (Bager et al. 2010a).
To complement these samples, raw data on eosinophil and lymphocyte counts, serum
histamine levels, antigen-specific and total antibody titres over the course of the study were
provided by Dr. Bager and colleagues. Eosinophil numbers were quantified by the
Copenhagen G. P. Laboratory using differential cell counts slides. Total histamine (an
indicator of basophil numbers) was assessed by lysis of whole blood cells with perchloric
acid followed by spectroflurometric analysis using the glass microfiber protocol (RefLab
ApS, Copenhagen, Denmark). Serum levels of grass pollen allergen-specific IgE, IgG and
IgG4 and T. suis E/S-specific IgA, IgE, IgG and IgG4 were measured by ImmunoCAP (ISO
13485, Phadia AB, Uppsala, Sweden). These markers were chosen because peripheral blood
eosinophilia and basophilia are characteristic of T. suis infection in pigs (Kringel and
Roepstorff 2006) and IgA, IgE and IgG subclasses are prevalent in natural human
trichiuriasis (Faulkner et al. 2002). IgE and IgG4 are associated with both allergic reactivity
and helminth infection in humans (Yazdanbakhsh et al. 2002). This data has been
independently analysed and published, confirming that antibody titres, cell counts, histamine
levels and GI symptoms did not differ between the 2 treatment groups prior to treatment
(Bager et al. 2010a). This was also the case when these parameters were compared by
treatment group in the cohort included in cytokine analyses in the current study (Appendix
2).
2.4.4.2 Peripheral blood mononuclear cell (PBMC) re-stimulation cultures
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PBMCs isolated from whole blood samples were cultured for 6 days with birch pollen
allergen extract (t3, 15 µg/ml), timothy grass pollen allergen extract (g6, 15 µg/ml) or adult
T. suis excretory-secretory products (E/S, 50 µg/ml) or left un-stimulated for control
purposes. PBMCs were re-stimulated for a further 24 hours with PMA (25ng/ml) and
ionomycin (1µg/ml) to enhance production of intracellular cytokines, after which cultures
were centrifuged (5min, 500G) and the supernatants were harvested. All PBMC cultures
were conducted by Bager and colleagues during the clinical trial(Bager et al. 2010a) and
frozen culture supernatants were transported to the University of Edinburgh on dry ice for
the cytokine analyses described in chapter 7.
2.4.4.3 Cytokine assays
-4, IL-5, IL-10 and IL-13 were measured in plasma and PBMC culture
supernatants and total (heat-
supernatants. This panel of cytokines was chosen to characterise responses associated with
exacerbated allergy and T. suis infection. The Th2-type cytokines IL-4 and IL-13, Th1-type
-regulated in
natural human T. trichiura infection (Faulkner et al. 2002). IL-4 and IL-13 are also
mediators of the allergen-induced late-nasal response in allergic rhinitis (Ghaffar et al.
1997). IL-5 was included in the panel as it is associated both with resistance to re-infection
with T. trichiura (Jackson et al. 2004a) and exacerbation of Th2-mediated allergic pathology
(Fallon and Mangan 2007). The immunomodulatory cytokines IL-
been shown to play an important role in dampening immune activation in natural human
helminth infections (Doetze et al. 2000; Figueiredo et al. 2010).
-4, IL-5, IL-10 and IL-13 were quantified via cytometric bead array (CBA).
CBA uses a combination of cytokine-specific antibody conjugated capture beads and
cytokine-specific phycoerythrin (PE)-conjugated detection antibody to quantify cytokines in
biological samples. This method differs from ELISA because the unique size and emission
wavelength of 2-fluorescence markers (Red and Near Infra-red) of each cytokine-specific
capture bead population allows multiple cytokines to be assayed simultaneously in a single
sample and quantified independently using flow cytometry. The sensitivity of CBA is
equivalent to that of a sandwich ELISA (BDBiosciences 2009), but the requirement for
lower volumes of sample meant that this method was ideal for maximising the number of
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cytokines that could be assayed in the sample aliquots obtained from the clinical trial. For
full details of the CBA protocol used, see chapter 7.
TGF -stimulated PBMC culture supernatant
rather than the inactive latent form and details of the method used are provided in chapter 7.
2.5 Statistical methods
In the current study I have used multivariate statistical methods to characterise cytokine
profiles and immune phenotype rather than focusing on individual cytokines in isolation.
Detailed methods are described in relevant chapters; however an overview of my statistical
approach is described here.
2.5.1 Parasitology data
It is well established from epidemiological surveys of schistosome infection that egg counts
are highly heterogeneous within human populations and tend to be aggregated in a minority
of individuals (reviewed by (Mutapi and Roddam 2002)). Thus arithmetic mean schistosome
infection intensities were log10(x+1) transformed to meet the assumptions of parametric
tests where possible (Sokal and Rohlf 1995c). For all parametric analyses of schistosome
infection intensity the distribution of residuals from statistical models and group variances
were compared for both un-transformed and transformed data to check that the assumption
of normality and equality of variance were met and that the data transformation was
appropriate for the analysis.
2.5.2 Cytokine data
Assaying multiple cytokines presents an analytical challenge for a number of reasons: 1)
antigen-specific cytokine responses measured in the same individual are not independent
since measured concentrations are influenced by spontaneously secreted levels of non-
specific cytokines, which vary between individuals, 2) cytokine responses to the same
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antigen within a single sample are not independent of one another as they both mediate and
are influenced by cellular interactions, 3) concentrations are not directly comparable between
different types of cytokines due to their distinct bioactivities (determined by cellular
expression of cytokine receptors, presence of cytokine receptor antagonists and
immunoregulatory molecules), 4) different cytokine responses vary greatly in their secretion
patterns with some found to be produced at almost ubiquitously high concentrations (e.g. IL-
6 and IL-8) and others consistently produced in low or negligible amounts (e.g. IL-4 and IL-
17A) and 5) multiple comparisons between cytokine responses must be accounted for in
analyses to avoid type I error (Holm 1979; Rice 1989).
To address these issues I have used a number of procedures throughout the study. Firstly, I
have subtracted levels of non-specific cytokines (measured in parallel un-stimulated
cultures) from those measured in antigen-specific cultures to ensure that responses to
different antigens can be compared as independent variables (Mutapi and Roddam 2002).
This approach has been used for analysis of antigen-specific cytokine in a number of
previous human field studies (Remoué et al. 2001; Mutapi et al. 2007b; Wilson et al. 2008).
So that non-specific cytokine dynamics are not ignored I have also analysed responses in un-
stimulated cultures where relevant.
To facilitate combined analysis of multiple cytokine responses in the context of their inter-
dependency, aggregated secretion patterns within populations and the quantitative
differences between types I have used data reduction (factor analysis) and ordination
methods (non-metric multi-dimensional scaling (NMS)) adapted for use in heterogeneous
data sets with variables measured on a range of different scales (Sokal and Rohlf 1995a;
McCune and Grace 2002). These methods (described below) provide an ideal means of
identifying patterns of cytokine responses because they group cytokine variables according
to their co-variance with each other(factor analysis) (Sokal and Rohlf 1995a) and relative
dissimilarities between participants (NMS) (McCune and Grace 2002) rather than by their
absolute quantities. Reducing cytokines into a smaller number of variables via factor analysis
and a combined cytokine NMS have the added benefit of reducing the number of
comparisons made and thus reduce the risk of false positive results. These methods are used
routinely in psychometric (Kruskal 1964; Harris 1967) and population ecology (McCune and
Grace 2002) analyses respectively.
Chapter 2 Aims, study design and methods
- 80 -
To account for multiple comparisons made in statistical tests I have used the sequential
Bonferroni adjustment of the significance level (p<0.05) for each set of comparisons made
(Holm 1979; Rice 1989). The sequential rather than standard adjustment was chosen because
it imposes less risk of false negative results but retains statistical power to reject false
positive results (Rice 1989). This method involves ranking the p-values of all comparisons
made (smallest to largest) and adjusting the chosen significance level (0.05) for each
comparison by dividing by its rank (Rice 1989). The Bonferroni adjustment is conducted for
all tests where more than 5 comparisons are made using a statistical test and adjustments are
- (i.e. where test statistics are reported in the same table, the Bonferroni
adjustment is made across all tabulated p-values). In all cases raw p-values for tests are
reported and discussed as an indicator of an observed trend and those significant after
adjustment are highlighted.
To meet the assumption of linearity for parametric tests I have used statistical
transformations of cytokine data where possible. In most cases the square-root(x+1)
transformation was found to most effectively render aggregated cytokine concentrations
suitable for parametric analysis (Sokal and Rohlf 1995c; Mutapi and Roddam 2002; Osborne
2002). Addition of a constant (i.e. 1) prior to square-root transformation also allowed
individuals negative for one or more cytokine to be included in analyses (Osborne 2002). For
all statistical models the distribution of residuals obtained from analysis of both un-
transformed and transformed data was checked for normality and the variance of groups was
compared to check that the assumption of equality of variance was met. Where transformed
data did not meet the assumptions of parametric tests I have used appropriate non-parametric
alternatives to analyse un-transformed data.
2.5.3 Factor analysis
I have used factor analysis to reduce multiple cytokines responses into a smaller number of
variables reflecting the groups of cytokine responses that show similar secretion patterns
between individuals (chapters 3, 4, 5 and 6). The variables extracted by this analysis, called
principal components (PCs), can be considered analogous to distinct phenotypic immune
-specific cytokine milieu. These
phenotypes were interpreted for each PC according to the innate inflammatory, Th1, Th2,
Th17, pro-inflammatory and regulatory cytokine groupings identified via the literature
Chapter 2 Aims, study design and methods
- 81 -
review described in chapter 2.3.5.5. PC regression factor scores for each participant were
subsequently analysed in statistical models.
Square-root(x+1) transformed cytokine data was used for factor analysis throughout the
study as exploratory analysis indicated that transformation improved the fit of the data to
subsequent statistical models (assessed by comparing the R2 values of each model) without
altering the groupings of the cytokine variables relative to un-transformed data. Monotonic
transformation of raw data in this way is also recommended prior to factor analysis to reduce
the weight of outliers, which might bias interpretation of the extracted PCs (Rummel 1970).
The factor analysis procedure is described in detail elsewhere (Sokal and Rohlf 1995a).
Briefly, the cytokine responses of the study cohort are grouped according to their linear
correlations into a smaller number of un-correlated variables (PCs). Each PC accounts for a
proportion of variation in the cytokine responses between the cohort as a whole with PC1
accounting for the most variation and subsequent PCs accounting for sequentially lower
amounts of the remaining variation. Only PCs which accounted for a greater than average
proportion of variance in the original cytokine data (eigenvalue >1) were included in
subsequent analyses (Kaiser 1960). The cytokines constituting each PC can be identified by
their factor loading, which is the correlation coefficient between that cytokine response and
the new variable (PC). PCs reflect the patterns of cytokine responses with which they are
positively correlated and the opposite pattern to cytokines with which they are negatively
correlated. Where 2 cytokine responses load onto the same PC with different directions of
correlation, their secretion patterns are considered to be reciprocal. Only PCs that correlated
with at least 2 of the original cytokine variables with a factor loading of greater than 0.5 or
less than -0.5 were included in subsequent analyses. These cut-off values were chosen
because they equate to at least 25% of the variance in a factor positively/negatively
correlating with the extracted PC. The result is that each participant is assigned a regression
factor loading of the PC) for each PC (cytokine profile). All factor analyses were conducted
in SPSS software.
I have used 2 main types of factor analysis to group cytokine variables according to immune
phenotype. Firstly, where the purpose was to subsequently compare the cytokine profiles
elicited by different antigens in the same individuals (chapters 3.3.2 and 5.4.1), each
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participant was included separately for each antigen stimulation (CAP, WWH and SEA-
specific responses). Thus part of the variation explained by the extracted PCs was due to
differences between antigens, allowing their comparison. Secondly, where the purpose was
to relate cytokine profiles to variation between different groups of individuals (chapter 4 and
6), each participant was included once but cytokine responses to different antigens were
included as separate variables for that individual. Thus the extracted PCs would allow
antigen-specific responses of each individual to be collectively related to other variables.
Only cytokine responses to crude parasite antigen preparations (S. haematobium CAP,
WWH and SEA) were considered suitable for inclusion in the same factor analysis because
each contains a physiologically-relevant mixture of antigens (i.e. derived from whole
parasites), some of which will be expressed by more than one of the 3 life-cycle
stages(Curwen et al. 2004). S. haematobium GST-specific cytokines were analysed
separately because they reflect responses to a single recombinant antigen and because
stimulation was conducted using the antigen at concentrations in excess of that expected to
be present in a natural infection.
2.5.4 Non-metric multi-dimensional scaling
NMS is an ordination technique that allow
responses to be identified according their similarity/dissimilarity to other participants and
their own cytokine profiles at different timepoints. NMS also produces a comprehensive
visual representation of these variations via ordination plots allowing patterns of cytokine
responses between individuals to be qualitatively characterised by how close together
(similar) or far apart (dissimilar) they are. Unlike factor analysis, which assumes that
variables are linearly related, NMS does not assume linear relationships between participants
or cytokine responses (McCune and Grace 2002), making it more suitable for comparison of
different timepoints. In particular I have used NMS to investigate how cytokine responses
change with time: pre and 6 weeks post-treatment for the S. haematobium study (chapter 5)
and baseline, grass pollen season and end timepoints for the T. suis study (chapter 7).
Prior to NMS cytokine concentrations were square-root(x+1)-transformed to reduce the
weight of outliers on the ordination solutions without affecting relative ranks of each
participant (Rummel 1970), as has been effectively used previously (Moore-Kucera and
Dick 2008; Walker 2008; Turcotte et al. 2009).
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Full details of the NMS procedure are described elsewhere (McCune and Grace 2002).
Firstly, the Sorensen distance (a measure of how similar/dissimilar one participant is from
another) was calculated for each participant according to the rank of each of their cytokine
responses relative to those of other participants (McCune and Grace 2002). Sorensen
distance was chosen for NMS because it is sensitive to patterns in heterogeneous data sets
and assigns less weight to outlier values than alternative distance measures (McCune and
Grace 2002). Sorensen values were then used to position each participant relative to all other
participants at all timepoints on 2 dimensional axes (i.e. each participant is plotted at all
timepoints are plotted reflect cytokine responses that account for the greatest variation within
the data set as a whole. Axes values are arbitrary since NMS ordination plots characterise
patterns of cytokine responses spatially rather than quantitatively. All NMS analyses were
conducted in PC-ORD software.
Since NMS is an iterative process, the final ordination plot achieved can vary (particularly if
patterns of cytokine responses are weak) and depends upon the starting configuration of the
analysis. Thus 2-dimensional NMS ordination was initiated with random starting
configurations and repeated a minimum of 5 times with different starting configurations to
ensure that the final solution reliably reproduced patterns of participant cytokine responses.
Final ordination plots were obtained after 100 runs with the cytokine data and a maximum of
500 iterations with a stability criterion of 0.000001, an adaptation of the default software
settings selected to increase the accuracy of the final solution (recommended by (McCune
and Grace 2002)) and verified by comparison of final stress values using a range of different
settings. Ordination solutions were considered to reliably represent patterns of cytokine
responses if a final stress value (a measure of the difference between the rank of a
tion
(McCune and Grace 2002)) of less than 20 was achieved. Monte-Carlo randomisation tests
were also conducted to ensure that spatial patterns identified in the cytokine data were
stronger than those that would result from the same data if it were randomly assorted
(McCune and Grace 2002). 20 runs of randomly assorted data were used to select initial
assessment of the NMS parameters (McCune and Grace 2002).
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To identify how ordination patterns related to variation in the original cytokine data the
proportion of variance represented by each axis (i.e. the coefficient of determination (r2)
between the original cytokine matrices and the ordination space generated by NMS) was
calculated to identify how much variation between participants was accounted for by each
axis. Clusters of participant cytokine responses relative to these axes were identified
were then calculated to identify the cytokines responsible for the observed variation between
participants. In the latter case only cytokines with an r2>0.5 were considered to contribute to
contribute to the axes.
2.5.5 Multiple-response permutation procedure (MRPP)
MRPP is a non-parametric alternative to multivariate ANOVA and is more suitable for
multivariate analysis of heterogeneous data, such as Sorensen distance values used for NMS
(McCune and Grace 2002). MRPP was conducted using PC-ORD software.
MRPP is a step-wise process, described in detail in (McCune and Grace 2002). Firstly, the
sum of Sorensen distances between participant cytokine responses is calculated for each
group (e.g. treatment, timepoint or antigen stimulation) (see 2.5.4) to give the weighted mean
within- Mean within-group differences reflect the total variation between
participant cytokine responses in each group. A test statistic (T) is then calculated by
dividing the differe
(no difference) divided by the expected standard deviation. Thus larger values of T indicate a
greater difference between the groups being compared and the significance of this difference
can be determined by its associated p-value. Finally, homogeneity in cytokine profiles within
groups is quantified via the chance corrected within-group agreement statistic (A = 1-
- -group difference
identified by MRPP. When participants within a group exhibit the same cytokine profile and
groups differ considerably the value of A is closer to 1 (if all participants cytokine profiles
were identical after treatment, A = 1 (McCune and Grace 2002)). This can be visualised on
an NMS ordination plot as participants in different groups forming distinct clusters with little
overlap. Alternatively if cytokine profiles are highly heterogeneous and show little structure
according to treatment, A is closer to 0 (if heterogeneity within the pre and post-treatment
groups is equal to that expected by chance, A = 0 (McCune and Grace 2002)). On an NMS
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ordination plot this visualised as indistinct clusters and overlap between participants in the
different groups. Given the size of our study cohort, an A <0.1 was considered as a small and
A> 0.3 was considered a large effect size (McCune and Grace 2002).
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Chapter 3
Life-cycle stage-specific cytokine responses to
Schistosoma haematobium in a naturally exposed
human population
3.1 Introduction
Given their distinct exposure patterns, intra-host behaviour, proteomes (Curwen et al. 2004)
and gene expression patterns (Jolly et al. 2007; Fitzpatrick et al. 2009) it seems likely that
cercariae, adult worm and egg-stage schistosomes also differ in their immunobiology. Crude
antigen preparations of these 3 life-cycle stages are known to elicit distinct antibody
responses (Viana et al. 1995) and a number of studies suggest that there are also differences
in the cytokine responses that they elicit (see chapter 1.5.1). However, investigations
conducted to-date provide an incomplete picture of the human cytokine responses to the
different life-cycle stages of S. haematobium due to 3 main limitations:1) a bias towards Th1
and Th2-associated cytokine responses and an absence of data on schistosome-specific
Th17-associated cytokines, despite evidence that this lineage may influence the development
of human helminth-associated disease (Babu et al. 2009; Milner et al. 2010), 2) a
predominant focus on schistosome eggs and adult worms, but few recent studies of
cercariae-specific cytokine responses and 3) analysis of individual parasite-specific cytokine
responses without accounting for the multivariate interactions between them. The latter is
particularly limiting when a small panel of cytokines are assayed and interpreted in terms of
specific CD4+ T cell phenotypes since human peripheral immune responses are less clearly
defined than those of murine models (from which many immunological paradigms are
translated) and even cytokines associated with the same phenotype can dissociate in response
to schistosome antigens (Grogan et al. 1996a; Scott et al. 2000).
The aim of this chapter is to provide a systematic analysis of schistosome-specific cytokine
responses in whole blood samples collected from endemically-exposed humans. To address
the limitations of previous cytokine studies I have assayed responses to cercariae, adult
worm and egg antigens and quantified cytokines associated with both innate and acquired
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cellular immune responses, including Th1, Th2 and for the first time in human
schistosomiasis haematobium, Th17-type cytokines. Thus it was possible to test the
hypothesis that cercariae, adult worm and egg stage parasites elicit not only distinct amounts
of individual cytokines, but also elicit distinct profiles of cytokines reflecting differences in
the way that they polarise cellular immune responses. The results of this chapter provide an
indicator of how exposure to different S. haematobium life cycle stages may influence the
immune environment of their host.
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3.2 Hypotheses
Schistosome antigens elicit cytokines associated with Th17-type responses in
addition to innate inflammatory, Th1 and Th2-type cytokines
S. haematobium cercariae, adult worm and egg antigens differ both in the levels of
individual whole blood cytokines and the cytokine profiles that they elicit in vitro
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3.3 Materials and Methods
3.3.1 Study participants
Of the initial cross-sectional cohort recruited from Magaya community only those who met
the following inclusion criteria are included in the current chapter: 1) provided adequate
samples for parasitology, to enable reliable detection of S. haematobium infections and co-
infections, 2) were negative for all co-infections assayed (S. mansoni, soil-transmitted
helminths (STH), malaria and human immunodeficiency virus (HIV)), which are known to
influence immune responses to schistosome antigens (chapter 1.4.5 and 2.3.6) and 3) had
never received treatment for schistosomiasis, which is known to alter naturally acquired
immune responses to schistosome antigens (chapter 1.7.3). Since the study aimed to directly
compare cytokine responses to cercariae, adult worm and egg antigens, participants were
also excluded if their blood sample had not been cultured with all three antigen preparations.
56 individuals (both infected and un-infected) met the above selection criteria and their
demographic and infection characteristics are summarised in Table 3.1.
Males (n = 26) Females ( n = 30) Total (n = 56)
Mean (S.EM.) Range Mean (S.E.M.) Range Mean (S.E.M.) Range
Age (years) 9.35 (0.266) 8 12 22.41 (3.93) 8 - 84 16.24 (2.24) 8 - 84
Infection intensity 53.82 (28.36) 0 693 10.01 (5.639) 0 - 158 30.35 (13.69) 0 - 693
Prevalence (%) 53.85 36.67 44.64
Table 3.1. Characteristics of the study cohort for comparison of life-cycle stage-specific
cytokine responses to S. haematobium. Infection intensity was quantified as mean S.
haematobium egg counts/10ml urine. S.E.M. Standard error of the mean.
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3.3.2 Immunological assays
All individuals provided a whole blood sample which was stimulated for 48 hours at 37 C
with 10µg/ml crude preparations of S. haematobium cercariae (CAP), adult worms (WWH)
and eggs (SEA) in parallel cultures. Cultures stimulated with 2µg/ml maltose binding protein
(MBP) indicated the ability of cultured whole blood cells to respond to non-schistosome
antigens. Whole blood cultured with media alone (un-stimulated) acted as negative controls
for levels of spontaneous cytokine. Cytokines associated with innate inflammatory (TNF ,
IL-6 and IL-8), Th1 (IFN , IL-2 and IL-12p70), Th2 (IL-4, IL-5, IL-10 and IL-13) and Th17
(IL-17A, IL-21 and IL-23p19)-type responses were assayed in culture supernatants by
enzyme-linked immunosorbent assay (ELISA) and a mean concentration (ng/ml) was
obtained from duplicate ELISA wells. The association of individual cytokine responses with
cellular immune phenotypes was determined by a review of current literature on human
cytokine responses (summarised in chapter 2.3.5.5). The magnitude of cytokine responses to
MBP and in un-stimulated cultures are shown in Figure 3.1, which demonstrates that all
selected participants produced one or more of the assayed cytokines in response to MBP
stimulation and that pro-inflammatory cytokine responses to MBP were above background
levels (un-stimulated cultures).
3.3.3 Statistical Analyses
Antigen-specific cytokine responses were obtained by subtracting cytokine concentrations
present in un-stimulated cultures from those present in antigen-stimulated cultures so that
CAP, WWH and SEA-specific cytokine responses could be analysed as independent
variables. Antigen-specific cytokine responses were compared between exactly the same
individuals to control for potential variation according to age, sex, genetic factors, infection
intensity, residential or exposure history. Comparisons were made using data on all 13
cytokines to all 3 antigens.
Exploratory analysis indicated that the distribution of cytokine concentrations was highly
skewed and the variance in the cytokine responses to the 3 antigen preparations was non-
homogenous even after statistical transformations. Therefore, to test the hypothesis that
individual
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cytokine responses differ according to S. haematobium life-cycle stage, the non-parametric
paired Wilcoxon signed-rank test was used to compare ranks of un-transformed supernatant
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Figure 3.1 Levels of cytokines present in whole blood cultures stimulated with
Maltose-binding protein (MBP) and those cultured with media alone (un-
stimulated). Raw concentrations of innate inflammatory-(A), Th1-(B), Th2-(C) and
Th17(D)-type cytokines assayed in whole blood supernatants (n = 56) and median
values are indicated. Results of Wilcoxon comparisons are shown. ***p<0.001.
Chapter 3 Schistosome life-cycle stage-specific responses
- 94 -
cytokine levels (Wilcoxon 1945).
To characterise the cytokine profile elicited by the different parasite life-cycle stages, all 13
square-root(x+1)-transformed CAP, WWH and SEA-specific cytokines were reduced into
groups by factor analysis (Sokal and Rohlf 1995c).
all 3 antigens was included in the same analysis so that variation within each of the extracted
principal components (PCs) included variation in the cytokine profiles due to antigen
stimulation. The factor analysis procedure is described in detail in chapter 2. 5.3. Only PCs
accounting for a greater than average proportion of variation in cytokine responses (Kaiser
1960) and loaded with 2 or more of the original cytokine variables with factor loadings
greater than 0.5 or less than -0.5 were included in subsequent analyses.
To investigate whether cytokine profiles differed between cercariae, adult worm and egg-
stage antigens analysis of variance (ANOVA) of the PC regression factor scores for each
cytokine profile was used. Regression factor scores for all PCs were entered as dependent
variables and antigen (CAP, WWH and SEA) was included as the explanatory variable.
Exploratory analysis indicated that the residuals of all PC regression factor scores from
ANOVA models were normally distributed and the variance in CAP, WWH and SEA-
specific scores were equal and thus the data met the assumptions of parametric testing. Post-
hoc pair-
difference test (Sokal and Rohlf 1995b).
For all statistical tests cytokine profiles were considered to differ significantly according to
antigen stimulation if p<0.05.To provide an indicator of the effect of multiple comparisons
on the significance of the difference between antigen stimulations the significance level was
adjusted for all tests using the sequential Bonferroni method (Holm 1979; Rice 1989) (see
2.5.2 for full details). Raw p-values are reported and their significance after Bonferroni
correction indicated where relevant.
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3.4 Results
3.4.1 Individual cytokine responses to S. haematobium cercariae, adult worm
and egg antigens
To test the hypothesis that S. haematobium life-cycle stage antigens elicit different levels of
individual cytokine responses within the cohort concentrations of each of the 13 cytokines
assayed were compared by antigen stimulation (CAP, WWH and SEA). The highest mean
concentrations of different cytokines are clearly segregated according to both antigen
stimulation and the cellular immune phenotype with which the cytokines are associated.
WWH did not elicit higher mean concentrations of any cytokine than either CAP or SEA
within the cohort. A summary of the relative mean concentrations of each cytokine elicited
by each antigen is given in Table 3.2.
Antigen
Cytokine CAP WWH SEA













Table 3.2. Summary of differences between mean whole blood cytokine concentrations
elicited by S. haematobium cercariae (CAP), adult worm (WWH) and egg (SEA)-
specific antigen preparations. Colours indicate whether mean cytokine concentrations were
highest (red), intermediate (orange) or lowest (yellow) relative to parallel cultures conducted
in the same individuals using the other 2 crude homogenate antigens.
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CAP- -6, IL-12p70 and IL-23 responses were significantly greater
than those produced in response to either SEA or WWH. IL-8 and IL-10 were significantly
greater in CAP-stimulated cultures than in WWH-stimulated cultures, but the difference in
IL-10 was not significant after Bonferroni correction. SEA-stimulated cultures had higher
IL-6 (not significant after Bonferroni correction) and IL-8 than WWH-stimulated cultures.
IL-2, IL-4, IL-17A and IL-21 were significantly higher in SEA relative to CAP-stimulated
cultures although these differences were not significant after Bonferroni correction for
multiple comparisons. Of the cytokines assayed, IL-17A was detectable in few participants
and median levels in response to CAP, WWH and SEA
concentrations present in un-stimulated cultures. Collectively these patterns indicate that
cercarial antigens elicit higher levels of pro-inflammatory effector cytokines than adult
worms or eggs. In contrast, eggs elicit higher levels of a distinct sub-set of cytokines than
CAP, suggesting that the 2 life-cycle stages polarise the immune-response differently.
Un-transformed life cycle stage-specific cytokine responses of the cohort are plotted for each
individual cytokine and plots are grouped as innate inflammatory (Figure 3.2), Th1-type
(Figure 3.3), Th2-type (Figure 3.4) or Th17-type (Figure 3.5) cytokines. Z values and the
associated significance levels obtained from paired Wilcoxon signed-rank test comparisons
of individual cytokine responses to each of the stage-specific antigen preparations are given
in Table 3.3.
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Figure 3.2. Innate inflammatory-type cytokine responses differ between S.
haematobium cercariae, adult worm and egg stage antigens. Graphs show un-transformed
mean concentrations (ng/ml) produced by whole blood cells in response to stimulation with
cercariae (CAP), adult worm (WWH) or egg (SEA) antigens. Median values are indicated by
black lines. Ranked cytokine concentrations were compared between antigens via paired
Wilcoxon signed rank test. *p<0.05, ***p<0.001
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Figure 3.3. Th1-type cytokine responses differ between S. haematobium cercariae, adult
worm and egg stage antigens. Graphs show un-transformed mean concentrations (ng/ml)
produced by whole blood cells in response to stimulation with cercariae (CAP), adult worm
(WWH) or egg (SEA) antigens. Median values are indicated by black lines. Ranked cytokine
concentrations were compared between antigens via paired Wilcoxon signed rank test.
*p<0.05, **p<0.01, ***p<0.001
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Figure 3.4. Th2-type cytokine responses differ between S. haematobium cercariae, adult
worm and egg stage antigens. Graphs show un-transformed mean concentrations (ng/ml)
produced by whole blood cells in response to stimulation with cercariae (CAP), adult worm
(WWH) or egg (SEA) antigens. Median values are indicated by black lines. Ranked cytokine
concentrations were compared between antigens via paired Wilcoxon signed rank
test.*p<0.05, **p<0.01
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Figure 3.5. Th17-type cytokine responses differ between S. haematobium cercariae,
adult worm and egg stage antigens. Graphs show un-transformed mean concentrations
(ng/ml) produced by whole blood cells in response to stimulation with cercariae (CAP), adult
worm (WWH) or egg (SEA) antigens. Median values are indicated by black lines. Ranked
cytokine concentrations were compared between antigens via paired Wilcoxon signed rank
test. *p<0.05, **p<0.01, ***p<0.001
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3.4.2 Phenotypic cytokine responses to S. haematobium cercariae, adult worm
and egg antigens
Since whole blood cytokine responses occur in the context of multiple and potentially
interacting cell types it was important to investigate the phenotypic characteristics of
cytokine responses to the different parasite antigens in addition to differences between
individual cytokines. To investigate the hypothesis that the S. haematobium cercariae, adult
worm and egg antigens differ in the cytokine profiles that they elicit, cytokines were grouped
according to their patterns of co-variance using factor analysis. Factor analysis extracted 4
significant principal components from the 13 individual cytokine responses assayed in CAP,
WWH and SEA-stimulated cultures reflecting the distinct patterns of these responses in
vitro. Factor loadings for each PC and the cellular phenotype/s with which each is putatively
associated are summarised in Table 3.4.
PC1, accounting for the largest percentage of variance in the data (28.8%), is loaded with
-6 and IL- -
12p70), Th2 (IL-10) and Th17-type (IL-23) effector responses, corresponding to a mixed
inflammatory cytokine profile. PC2 is positively loaded with IL-17A, the characteristic
cytokine of Th17-type responses, and IL-2, a T cell derived cytokine which promotes
cellular proliferation (chapter 1.5.1). PC3 is loaded with IL-4, IL-5 and IL-10, which are
associated with Th2-type immune responses. PC4 is loaded with a combination of Th2-type
(IL-13) and Th17-type (IL-21) cytokines.
CAP stimulation resulted in higher PC1 (inflammatory) responses in whole blood cultures
relative to all other antigens. Mean factor scores for SEA-suggest that egg antigens induce a
moreTh17 (PC2 and PC4) and Th2 (PC3 and PC4)-type cytokine response than CAP.
However, these trends were not statistically significant. Mean regression factor scores for
each antigen are plotted in Figure 3.6 and results of ANOVA comparison of ANOVA of PC
regression factor scores between the 3 antigens are given in Table 3.5.
Chapter 3 Schistosome life-cycle stage-specific responses
- 103 -
Principal Components
1 2 3 4
Inflammatory Th17 Th2 Th2/Th17
Phenotype Cytokine
0.8 -0.1 -0.1 0.1
IL-6 0.7 0.2 -0.2 0.1
IL-8 0.6 -0.1 -0.2 -0.2
0.8 -0.1 0.2 0.0
IL-2 0.1 0.9 -0.2 -0.1
IL-12p70 0.8 -0.2 -0.1 0.1
IL-4 0.2 0.3 0.7 0.2
IL-5 0.3 0.4 0.6 -0.1
IL-10 0.5 0.0 0.5 -0.1
IL-13 -0.2 0.0 0.2 0.6
IL-17A 0.1 0.9 -0.3 0.0
IL-21 0.0 0.1 -0.2 0.8
IL-23p19 0.8 -0.1 -0.1 0.1
% of total variance 28.8 16.0 11.1 8.9
Table 3.4. S. haematobium-specific whole blood cytokine responses group according to
distinct immune phenotypes. Table shows PCs 1-4 extracted by regression factor analysis
and the factor loadings for each of the square-root(x+1)-transformed S. haematobium
cercariae, adult worm and egg-specific cytokine variables. Cytokines with factor loadings
-0.5 for an extracted PC are highlighted in bold. The cellular immune phenotype
with which the cytokines are associated is given for each PC. The percentage of total
variance in the dataset accounted for by each component is given below the relevant column.
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Figure 3.6. S. haematobium life cycle stage-specific antigens elicit distinct cytokine
profiles. Bar charts shows mean regression factor scores for extracted principal components
partitioned by S. haematobium antigen (CAP (black), WWH (grey) and SEA (white)).
Regression factor loadings were compared between antigens using ANOVA. ***p<0.001.
Error bars: standard error of the mean. CAP cercarial antigen preparation, WWH whole
worm homogenate and SEA - soluble egg antigen
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Principal Component Phenotype F p Post-hoc comparison
1 Inflammatory 8.97 <0.001 CAP>WWH & SEA
2 Th17 0.55 0.580
3 Th2 1.23 0.295
4 Th2/Th17 2.11 0.125
Table 3.5. S. haematobium life cycle stage-specific antigens elicit distinct whole blood
cytokine phenotypes. Principal component regression factor scores were compared by
antigen (CAP, WWH and SEA) using ANOVA (degrees of freedom: 1, 55). Table gives F-
statistic and the associated p-value for each extracted component. Significant pair-wise
differences between antigen stimulations identified by post-
difference test are shown. Significant results (p<0.05) are highlighted in bold. CAP
cercarial antigen preparation, WWH whole worm homogenate and SEA - soluble egg
antigen
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3.5 Discussion
The development of immune responses to schistosome infections is driven by exposure to
cercariae, adult worms and egg antigens, which often occur simultaneously in schistosome
endemic regions. To-date a number of studies have shown that immune responses to crude
antigens prepared from these life-cycle stages are different and used analysis of individual
cytokines to infer changes in the immune phenotype as a whole. However, no human studies
have directly compared both individual cytokine responses and the cytokine profiles elicited
by all 3 schistosome life cycle stages and few have extended cytokine analysis beyond a
restricted sub-set of commonly assayed Th1 and Th2 cytokines. Thus, I hypothesised that
human whole blood cytokine responses would differ when stimulated in vitro with cercariae,
adult worm and egg antigens and that Th17 and innate inflammatory-type responses would
also vary in response to these 3 life-cycle stages.
The results of this study unequivocally show that S. haematobium antigens elicit detectable
levels of Th17-type cytokines in whole blood from individuals endemically exposed to
infection. IL-17A was present at low but detectable concentrations and parasite-specific IL-
21 and IL-23 were readily detectable above background levels present in un-stimulated
cultures in most individuals. This extends the observation of a previous study also conducted
in a Zimbabwean population, which showed that systemic IL-17A, IL-21 and IL-23 were
detectable in plasma samples from an S. haematobium-endemic cohort (Milner et al. 2010),
although in the latter case these observations could not be directly related to parasite
antigens. As predicted, Th17-type cytokines were co-produced with a range of other
cytokines associated with innate inflammatory, Th1 and Th2-type responses. Interestingly
however IL-17A, IL-21 and IL-23 showed distinct patterns of expression in response to the
S. haematobium antigens, with IL-23 highest in response to CAP, but IL-17A and IL-21
highest in response to SEA. These distinct patterns suggest that IL-17A, IL-21 and IL-23
responses did not follow the expected shared patterns of expression despite their collective
association with the Th17 lineage (chapter 1.5.1.4 and 2.3.5.5.1). Although recent human
cytokine literature groups these responses together (chapter 2.3.5.5.1), it is important to note
that IL-21 was initially characterised as a Th2-type cytokine in mice (Pesce et al. 2006;
Fröhlich et al. 2007) and IL-23 is also known to perpetuate pro-inflammatory/Th1-type
cytokine expression by human T cells (Hoeve et al. 2006). Thus, whether IL-21 and IL-23
are definitive markers of Th17-type immune responses remains controversial. It is
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particularly interesting that IL-21 and IL-13 grouped into a single cytokine profile (PC4)
suggesting that S. haematobium-specific IL-21 is co-expressed with Th2-type cytokine
responses to a greater extent than with Th17-associated IL-17A and IL-23. Both IL-21 and
IL-13 appear to play a role in alternative activation of macrophages during experimental
schistosomiasis in mice (Pesce et al. 2006), although this association has not been
investigated in human studies to date.
Direct comparison of the cytokine profiles elicited by the antigens of the 3 life-cycle stages
indicated that CAP elicited higher levels of pro-inflammatory effector cytokines than whole
homogenised adult worm or egg preparations. CAP elicited the highest concentration of
- -12p70, which perpetuate
Th1 differentiation and macrophage activation, and IL-23p19, which promotes development
of human Th17 cells (chapter 1.5.1). Consistent with the higher levels of pro-inflammatory
cytokines by cercariae, CAP also elicited a more pro-inflammatory cytokine profile (PC1)
than the other 2 life-cycle stages. Collectively these results suggest that schistosome life-
cycle stages affect host immune polarisation differently. There are several potential reasons
for the greater cercariae-specific inflammatory responses relative to adult worms or eggs: 1)
cercariae express unique antigens that stimulate inflammatory and effector responses, 2) all
members of the cohort are primed to respond to cercarial antigens due to repeated exposure,
whilst only those who are S. haematobium infected are constitutively exposed to egg and
adult worm antigens and/or 3) immune responses to adult worm and egg antigens are limited
during infection by parasite or host mediated regulatory mechanisms.
The first hypothesis stems from observations that cercariae shed a number of structures,
including the acetabular glands, glycocalyx and tail, after penetration of the host (Hansell et
al. 2008). Thus cercarial homogenates contain a range of antigens (Xu et al. 1994; Curwen et
al. 2004; Hansell et al. 2008) that are absent in SEA and WWH. Whilst the reconstituted
homogenised cercarial preparations (CAP) used in the current study lack the enzyme activity
associated with the secretions of live parasites (Curwen et al. 2006; Hansell et al. 2008),
CAP does contain the carbohydrate antigens (Xu et al. 1994) shown to be primarily
responsible for parasite-specific IL-6 and IL-12p40 production in murine studies (Jenkins et
al. 2005a). Cercarial secreted carbohydrate antigens have also been implicated in the
-8, IL-10 and IL-12p40 secretion by human whole blood collected
from a Senegalese cohort endemically exposed to both S. mansoni and S. haematobium (Dr.
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Joseph Turner, Liverpool School of Tropical Medicine, U.K., personal communication). It
has been previously suggested that somatic antigens shared with adult worm and egg stage
parasites (Beisler et al. 1984; Jolly et al. 2007) found within crude cercarial preparations
ve to secreted antigens (Jenkins et al.
2005a) and prevent discrimination between life-cycle stage-specific immune responses
(Curwen et al. 2004). However, the marked difference between the CAP-specific whole
blood cytokine profile and those elicited by WWH and SEA suggests that responses to cross-
reactive antigens are not immunodominant in vitro. In addition, the relative abundance of
CAP-specific pro-inflammatory cytokines, particularly those associated with innate
inflammation, compared to SEA and WWH-stimulated cultures would be consistent with a
more prominent innate effector response to cercariae in human peripheral blood. Although
the cell types and numbers expressing these cytokines were not characterised in the current
study, work in the murine model of infection has identified antigen presenting cells (APCs),
particularly dendritic cells (DCs) and macrophages, as a key source of cercariae-specific
inflammatory cytokines in vivo (Jenkins et al. 2005a; Jenkins and Mountford 2005; Paveley
et al. 2009). Circulating eosinophils present in human whole blood have also been shown to
be a source of adult and egg-stage schistosome- in vitro (Silveira-Lemos et al.
2008) and cercarial penetration of human skin biopsies leads to an up-regulation of
macrophage activation markers (Hansell et al. 2008). However, the contribution of
circulating innate cell types to the cercariae-specific cytokine response has never been
investigated. Thus, an important extension of the current study would be to characterise
relative proportions of different cell populations in PBMCs isolated from the same
individuals and investigate whether they are related to the profile of whole blood cytokines
produced. The latter is an area of on-going study as part of the larger
immunoepidemiological field study of Magaya community.
An alternative hypothesis for the less inflammatory cytokine responses elicited by SEA and
WWH relative to CAP is that exposure to adult worm and egg antigens are limited relative to
cercariae. Exposure to adult worms and eggs may be restricted to cohort members that were
patently infected (44.64%) or had experienced fecund infections prior to sampling, whilst all
cohort members are at risk of repeated exposure to cercariae during daily water contact
activities. In particular young children within the cohort may be naïve to adult worm and
egg-specific antigens due to their short history of exposure to infection and this hypothesis is
explored in more detail in chapter 4. Evidence for the greater and more constitutive exposure
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to cercariae than to adult worms comes from previous observations that cercariae-specific
antibodies are present at higher titres than those specific for adult worm antigens (Viana et
al. 1995) and that larvae-specific IgE titres do not decline after removal of adult
schistosomes by chemotherapy (Butterworth et al. 1985). Even in infected individuals
exposure to adult worm antigens may be limited by sequestration of antigens by live
parasites, for example serum antibody responses to many adult worm antigens are only
elicited after worms have been killed by praziquantel treatment (Mutapi et al. 2003). Thus
the proportion of individuals with effector and memory cells primed to secrete cytokines in
response to cercarial antigens may exceed those specific for the other life cycle stages.
Consistent with the cytokine data presented here, which suggests that immune responses to
adult worm antigens are lower or equivalent to those elicited by cercariae and egg-specific
antigens, it has been shown that serum antibody responses (IgA, IgM, IgE and IgG1-4) to S.
mansoni cercariae and egg stage antigens are greater than those to adult worm antigens in an
un-treated endemic cohort with a similar age range to the current study (3 88 years)(Caldas
et al. 2000). Equivalent studies of S. haematobium cercariae, adult worm and egg-specific
antibody responses have not been conducted.
The lower inflammatory responses elicited by WWH and SEA relative to CAP may also
result from parasite or host-mediated immunoregulation of cells that recognise these
antigens. Chronic schistosomiasis is associated with cellular hypo-responsiveness specific to
egg and adult worms (Grogan et al. 1998b; Maizels et al. 2009) and genomic studies indicate
that adult schistosomes express a large number of unique genes with potential
immunoregulatory functions, whilst cercariae express genes mainly associated with motility
and invasion (Jolly et al. 2007). Cytokine responses to egg antigens may also be specifically
regulated in infected individuals to limit immunopathology resulting from transmission of
eggs to the environment (Wilson et al. 2008). However, studies in a variety of tissue-
dwelling helminth species suggest that tolerance of patent helminth infection does not inhibit
immune responses to de novo challenge by larval stage parasites (Smithers and Terry 1967;
Day et al. 1991a; Day et al. 1991b; MacDonald et al. 2002). From the data in this chapter it
is not possible to infer whether the less pro-inflammatory cytokine profiles elicited by WWH
and SEA are due to direct immunoregulation. However, since the same individuals readily
produced pro-inflammatory cytokines in parallel MBP-stimulated cultures (data not shown)
the low cytokine response to SEA and WWH were not due to non-specific hypo-
responsiveness or poor cell viability. Furthermore the marked pro-inflammatory cytokine
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profile elicited by cercarial antigens occurred in the context of higher IL-10, as has been
observed by others ((Dr. Joseph Turner, Liverpool School of Tropical Medicine, U.K.,
personal communication), suggesting that CAP-specific IL-10 did not preclude development
of a pro-inflammatory cytokine profile. Neutralising antibody studies have shown that adult
worm-specific IL-10 inhibits both Th1 and Th2 effector cytokine production during in vitro
culture of human cells (Grogan et al. 1998a; Mutapi et al. 2007b), and it would be interesting
to conduct similar studies for CAP and SEA-stimulated cultures to investigate whether the
regulatory role of IL-10 differs according to life-cycle stage. It is conceivable that cercariae
regulate immune responsiveness at the site of infection in the skin (perhaps via the elevated
IL-10 responses that their antigens elicit alongside pro-inflammatory responses (Hogg et al.
2003b)), but that these mechanisms do not inhibit the cercariae-specific cytokine responses
of circulating cells. It should be noted however that infiltrating cells responsible for site-
specific regulation of cytokine responses (Cook et al. 2011) and active immunomodulatory
secretions present in live cercarial challenge in murine models (reviewed by (Jenkins et al.
2005b)) are absent from the in vitro cultures conducted in this study.
In contrast to CAP, SEA is known to contain specific molecules capable of inducing Th2-
type responses, including IL-4 production by human basophils (Schramm et al. 2003) and
DCs (Everts et al. 2009) in purified cell-specific culture. A switch from a Th1 to a Th2-type
immune response is also attributed to the onset of egg production in murine schistosomiasis
(Pearce et al. 1991). Consistent with these observations, SEA elicited more IL-4 than CAP.
SEA also had higher mean scores for PC3 (IL-4 and IL-5) and PC4 (IL-13 and IL-21) than
CAP, although these differences were not statistically significant. It is also of interest that
SEA stimulated cultures had significantly higher IL-17A and IL-21 and a more Th17-type
cytokine profile (PC2 (IL-17A and IL-2) and PC4) than CAP, although the latter was not
statistically significant. The lack of statistically significant difference between PC2 responses
to the 3 life-cycle stages may be partly due to the low number of participants who produced
IL-17A at levels detectable above those present in un-stimulated cultures. Th17 cells are
relatively uncharacterised in human helminth infections, however their role in chronic
autoimmune inflammation and liver disease suggests that they may also contribute to
immunopathology in chronic helminthiases (Juszczak and Glabinski 2009; Hammerich et al.
2011). The observation that crude cercariae and egg antigen preparations elicit dichotomous
cytokine responses (innate inflammatory/Th1-type and Th2/Th17-type respectively (see
Table 3.2, Figure 3.2, Figure 3.4) is consistent with expression of distinct antigens by these
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life cycle stages and may also reflect differences in exposure patterns during human infection
(discussed above).
Despite a number of studies comparing egg and adult worm-specific cytokine responses,
there is no consensus in the literature as to their relative immunogenicity in endemically
exposed humans. Evidence from whole blood culture studies of human cohorts including
both infected and un-infected individuals is conflicting, with some showing that SEA elicits
(Joseph et al. 2004a), IL-4, IL-5 and IL-13 (Joseph et al. 2004a; Wilson et al.
2008) and others showing that SEA elicits higher IL-10 (Joseph et al. 2004a), IL-6 and
TNF (Wilson et al. 2008) relative to WWH in vitro. These inconsistencies may reflect
differences between study populations, protocols or simply the omission of specific cytokine
assays, which the current study circumvents by covering a comprehensive cytokine panel.
The results of this study show that SEA-specific Th1, Th2 and Th17-type cytokine responses
do not differ from those elicited by WWH, which may reflect the presence of antigens shared
between these parasite life cycle stages as indicated by genetic and serological screens
(Beisler et al. 1984; Jolly et al. 2007). Unlike cercariae, eggs and adult worms are
concurrently exposed in venous blood during infection, which may also lead to similarities in
the phenotypes and subsets of cells responding to these life cycle stages. It is also possible
that SEA and WWH-specific cytokine responses differ below the ELISA detection limit
used, although prior optimisation of the standard concentrations for each assay suggests that
this is unlikely.
Interestingly, although concerted efforts were made to standardise whole blood culture
conditions relative to those of previous studies in S. mansoni, the results of the current study
contradict observations that WWH elicits higher levels of Th2-type cytokines than SEA
(Joseph et al. 2004a; Joseph et al. 2004b). However, my findings are consistent with S.
haematobium studies showing that SEA and WWH-specific IL-4 and IL-5 do not differ in
the majority of individuals, regardless of whether cultures were conducted for 24, 48 or 72
hours (Scott et al. 2000). This may reflect fundamental differences between S. haematobium
and S. mansoni immunobiology (chapter 1.2.3). However, since infection intensities of up to
8,100 eggs/gram of faeces and an infection prevalence of 94% were reported in the S.
mansoni study (Joseph et al. 2004a), significantly greater than that observed for S.
haematobium in Magaya community, these differences may also reflect distinct exposure
patterns within the 2 communities. For example, it seems intuitive that exposure to adult
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worm antigens and therefore WWH-specific immune responses would be higher in
individuals with high worm burdens and this is evident from studies comparing WWH-
specific antibody responses in areas with high and low intensity transmission (Mutapi et al.
1997). Thus exposure to parasite antigens may be an important determinant of cytokine
polarisation, which I will explore further in chapter 4.
Of the innate inflammatory cytokines measured SEA-stimulated cultures secreted higher IL-
6 and IL-8 than WWH, this may reflect the greater immunogenicity of schistosome eggs
and/or greater exposure of egg antigens to innate effector cells in vivo. Previous studies have
shown that antigens derived from schistosome eggs can elicit innate inflammatory cytokine
production by PBMCs via TLR2 ligation (van der Kleij et al. 2004) and, consistent with our
study, -6 are also readily produced by in vitro culture of human whole blood
with S. mansoni SEA to a greater extent than WWH (Wilson et al. 2008). Although the
functional relevance of these differences is unclear, egg-specific inflammatory cytokine
responses may contribute to egg-mediated immunopathology as proposed for S. mansoni
(Wilson et al. 2008).
3.6 Conclusions
The findings of this study show for the first time that S. haematobium antigens elicit Th17-
type cytokines when cultured with whole blood samples from an endemically-exposed
community. This is an important step forward for immunoepidemiological field studies of
schistosomiasis, where cytokine assays have been biased towards those associated with the
Th1 and Th2 lineages.
Direct comparison of whole blood cultures stimulated with crude antigen preparations of S.
haematobium cercariae, adult worms and eggs also showed that peripheral whole blood
cytokine responses differ between the life-cycle stages. These findings are consistent with
previous studies showing variation in host responses according to parasite life history (El
Ridi et al. 1997; Malaquias et al. 1997; Webster et al. 1997b; Montenegro et al. 1999b;
Acosta et al. 2004), but extend these studies since none investigated immune responses to all
3 life-cycle stages. Furthermore, the current study shows that parasite life-cycle stage affects
both the magnitude of individual cytokine responses and the phenotypic characteristics of the
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whole blood cytokine profile. In particular, the high levels of pro-inflammatory cytokines
elicited by cercarial antigens was in contrast to the low levels of cytokines elicited by adult
worms and the predominantly Th2 and Th17 profile of cytokines elevated in response to egg
antigens.
The results of this chapter suggest that assaying a broader repertoire of parasite-specific
responses provides a greater insight into the complex host-parasite interactions that may
shape the immune environment during natural infection. The stage-specific secretion of
innate inflammatory and Th17-type cytokines are particularly desirable candidates for
further investigation. For example, given the involvement of Th17 in chronic inflammatory
diseases in the liver and central nervous system (Juszczak and Glabinski 2009; Hammerich
et al. 2011) and observations that Th17-type cytokines are associated with morbidity in
lymphatic filariasis (Babu et al. 2009), it is possible that these responses may also drive
immunopathogenic responses to cercariae and eggs in human schistosomiasis.
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Chapter 4
The interaction between age, infection intensity and
Schistosoma haematobium-specific cytokine responses in an
endemically-exposed community
4.1 Introduction
The convex relationship between age and schistosome infection intensity in endemic
populations suggests that the development of resistance to infection is shaped by changes in
age-related factors (Fisher 1934). However, whether this resistance results from development
of anti-parasite immunity in response to prolonged exposure to schistosome infection or
physiological/behavioural changes with age (or a combination of the two) remains
controversial (Fulford et al. 1998; Woolhouse 1998). A direct role for the immune response
in development of resistance to infection is difficult to discern since parasite-specific
immune responses and infection intensity have reciprocal effects and both are influenced by
age. This is particularly challenging for permanent residents of schistosome-endemic areas
since these individuals are repeatedly exposed to infection throughout their lives and thus
age can be considered a proxy of exposure history (Woolhouse 1992, 1994, 1998).
The aim of this chapter is to investigate how the relationship between parasite-specific
cytokine responses and schistosome infection intensity is affected by host age in people with
life-long exposure to S. haematobium in an area of stable, endemic transmission. Firstly I
investigate if and how cytokine responses vary with age as an indicator of how age-related
factors contribute to the development of distinct schistosome-specific cytokine profiles.
Secondly I characterise how correlations between infection intensity and schistosome-
specific cytokine responses change with age. The latter is of particular interest since these
changes may contribute to the age-related switch from a susceptible phenotype in young
children, in whom infection intensity is increasing with age, to a resistant phenotype in
adults, in whom infection intensity has declined relative to peak intensities in adolescence
(chapter 2.3.7). My study builds upon previous immunoepidemiological surveys showing
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that variations in cytokine responses coincide with epidemiological patterns of schistosome
infection (Scott et al. 2001; Joseph et al. 2004a; Mutapi et al. 2007b; Milner et al. 2010) and
extends them by including previously un-characterised cytokines reflecting recent advances
in T cell immunology (Diaz and Allen 2007; Allen and Maizels 2011).
I have focused on cytokine responses to adult worm and egg-stage antigens, to which
infected hosts are simultaneously exposed, and to the purified schistosome antigen and
vaccine candidate glutathionine-S-transferase (GST). Despite promising results from GST-
based vaccine trials in animals (chapter 1.8.2), there is conflicting evidence for the
contribution of GST-specific antibody response to resistance to S. mansoni infection
(Correa-Oliveira et al. 1989; Grzych et al. 1993) and only a single published study to-date
has investigated the cytokine responses of endemically-exposed humans to S. haematobium
GST (Remoué et al. 2001). Thus, the findings of this chapter are of relevance both to
understanding how parasite-specific cytokine responses develop in an endemic setting and
assessing whether GST-specific cytokines contribute to naturally acquired resistance to high
intensity infections.
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4.2 Hypotheses
S. haematobium adult worm and egg-specific and GST-specific whole blood
cytokine profiles vary with age
Variation in infection intensity is related to parasite-specific cytokine profiles
The relationship between infection intensity and schistosome-specific cytokine
responses differs according to participant age
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4.3 Materials and Methods
4.3.1 Study participants
Participants were selected from the cross-sectional cohort of individuals recruited from
Magaya community according to the following criteria: 1) provided adequate urine samples
for an accurate quantification of S. haematobium infection intensity (minimum of 2 samples
collected on consecutive days), 2) tested negative for S. mansoni, soil-transmitted helminth
(STH) and malaria infection, which may influence immune responses to S. haematobium
antigens (see chapter 1.4.5 and 2.3.6), 3) had not received prior treatment for
schistosomiasis, which may artificially increase exposure to parasite antigens and thus affect
age and exposure related patterns of cytokine responses (see chapter 1.7.3) and 4) were long-
term permanent residents of the area. In the latter case questionnaire-based assessment of
residential history (Appendix 1) allowed individuals who had recently moved to the area
from urban and schistosome non-endemic areas or those who were visitors to the study site
to be excluded. It was considered important to exclude individuals on this basis so that host
age could be used as a proxy for duration of exposure to schistosome infection in the area
the rate at which resistance to high intensity infections (Hagan 1992; Woolhouse 1998) and
parasite-specific immune responses (Mutapi et al. 1997) develop. Exclusion of recent
immigrants to Magaya did not significantly affect the mean age or male: female ratio of the
selected cohort relative to that of the cross-sectional cohort of Magaya community as a
whole (chapter 2.3.7).
198 individuals met the above selection criteria and are included in the current study. Of
these 15 tested positive for HIV infection. Potential variations in schistosome-specific
cytokine responses due to HIV infection were accounted for in all statistical analyses.
4.3.2 Immunological assays
As described in chapter 2.3.5.5 and outlined in chapter 3, all participants provided a whole
blood sample which was stimulated for 48 hours at 37 C with 10µg/ml crude preparations of
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S. haematobium adult worms (WWH) and eggs (SEA) in parallel cultures. Purified GST was
used at a concentration of 2µg/ml. Culture conditions for crude and purified antigen
stimulations were identical in all other respects and were conducted using the same diluted
whole blood sample stock for each individual. Cultures stimulated with MBP (2µg/ml) acted
as a positive control, confirming that cultured cells were viable and capable of producing
cytokines in response to antigen stimulus (mean MBP-specific cytokine responses reported
in Appendix 2). Un-stimulated cultures acted as negative controls for levels of spontaneous
cytokine production (mean cytokine concentrations present in un-stimulated cultures
reported in Appendix 2).
Cytokines associated with innate inflammatory (TNF -6 and IL- -2 and
IL-12p70), Th2 (IL-4, IL-5, IL-10 and IL-13) and Th17 (IL-17A, IL-21 and IL-23p19)
responses were assayed in culture supernatants by ELISA and a mean concentration (ng/ml)
obtained from duplicate ELISA wells.
4.3.3 Statistical Analyses
Epidemiological patterns of S. haematobium infection intensity and prevalence were
characterised within all members of Magaya community who provided blood samples (n =
284) and used to identify the age range in which infection intensity was increasing (age 5-10
years, n = 109), peaking (age 11-12 years, n = 60) and declining (age 13-84 years, n = 111).
Categorising age allowed the non-linear relationship between infection intensity and age to
be incorporated into ANOVA models (Mutapi and Roddam 2002) and has been effectively
used in previous studies of human schistosomiasis (Mutapi et al. 2008; Milner et al. 2010).
The selection of these age groups is described in detail in chapter 2.3.7.
To verify that the age-infection intensity dynamics of the selected cohort reflected those of
all recruits from Magaya community log10(x+1) transformed S. haematobium egg
counts/10ml urine (infection intensity) were compared between the 3 age groups via
univariate ANOVA with age group as the explanatory variable. Analysis was conducted on
log10(x+1)-transformed data since raw egg counts exhibited a strong negative binomial
distribution and unequal variance between age groups (Mutapi and Roddam 2002).
Exploratory analysis to check that transformed data met the assumptions of parametric tests
indicated that the residuals of log10(x+1)-transformed infection intensity data from ANOVA
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models were normally distributed and the variances of the 3 age groups were equal. Gender-
specific variations in water contact behaviour described in previous studies (Chandiwana and
Woolhouse 1991; de Moira et al. 2010) and the effect of HIV status were accounted for by
including sex and HIV status prior to age group in the sequential sum of squares ANOVA
(Mutapi and Roddam 2002). To verify that variations in the mean infection intensity of the 3
age groups were not due to age-dependent variations in the frequency of water contacts, un-
transformed mean daily frequencies of contact with local water sources (assessed by a water
contact survey in a sub-set of individuals included in the cohort (n = 76)) were also
compared between the 3 age groups by ANOVA.
To characterise distinct cytokine profiles within antigen-stimulated whole blood culture
supernatants, square root(x+1) transformed WWH and SEA-specific whole blood cytokine
responses were grouped by factor analysis into a smaller number of principal components
(PCs) (Sokal and Rohlf 1995c). All WWH and SEA-specific cytokine responses were
included as separate factors in a single factor analysis since adult worms and eggs are present
simultaneously during infection. Thus the extracted principal components (PCs) reflect both
the antigen specificity (WWH and/or SEA) and groups of cytokines (cytokine profiles) that
account for variation between participants. Extracted PCs were included in subsequent
analyses only if they: 1) accounted for a greater than average proportion of variance in the
original cytokine data (eigenvalue >1) (Kaiser 1960) and 2) correlated with at least 2 of the
original cytokine variables with a factor loading of greater than 0.5 or less than -0.5. The
cytokine profile of each PC was determined according to the putative association of cytokine
responses with innate inflammatory, Th1, Th2, Th17, pro-inflammatory and regulatory
immune phenotypes (chapter 2.3.5.5.1). A separate factor analysis was conducted for GST-
specific cytokine responses. Full details of the factor analysis procedure are given in chapter
2.5.3.
To address the hypothesis that the parasite-specific cytokine profiles identified by factor
analysis were influenced by age ANOVA was used. PC regression factor scores were the
dependent variables and sex (male, female), HIV status (positive, negative), log10(x+1)-
transformed infection intensity (covariate), age group (5-10, 11-12 and 13+ years) and the
infection intensity-age group interaction were included as explanatory variables. Sequential
sums of squares were used for the analysis to allow for the fact that infection prevalence was
higher in males than in females (as has been observed in previous studies of schistosome
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infection in Zimbabwe (Mutapi et al. 2007b)), the potential for HIV infection to affect
exposure to schistosome antigens (Karanja et al. 1997) and to account for variation in the
cytokine profiles due to infection intensity prior to comparing cytokine responses between
the 3 age groups. The infection intensity-age group interaction term was included to assess
whether differences between age groups were dependent on the intensity of infection within
these groups. PC regression factor scores and the residuals of ANOVA of PC factor scores
met the assumptions of parametric tests. Post-hoc pair-wise comparisons between the
difference test. The test involves calculating the square-root of the residual mean squares
from the ANOVA for the 2 groups being compared and dividing the difference between the
2 square roots by the standard error of that difference to give a t-ratio (T) and its associated
p-value (Sokal and Rohlf 1995b), which are reported where relevant.
To address the hypothesis that variation in infection intensity was related to parasite-specific
cytokine profiles, I used a univariate ANOVA with log10(x+1)-transformed infection
intensity as the dependent variable and sex, HIV status, age group and cytokine profile
(principal component regression factor scores) as explanatory variables. Variation due to all
other explanatory variables was accounted for prior to age group by using sequential sums of
squares. The interaction between age group and each principal component was also included
to test the hypothesis that the relationship between infection intensity and cytokine responses
was age-dependent. Exploratory analysis indicated that the transformed infection intensity
data and residuals of ANOVA met parametric assumptions. Preliminary analysis also
indicated that the effect of each cytokine profile was influenced by the order in which it was
entered into the model, indicating that their independent effects on infection intensity are
more appropriately characterised in separate univariate ANOVA rather than a single
MANOVA (Mutapi and Roddam 2002). Post- -tailed correlation analysis was
used to identify the direction of the relationship between residual factor scores for each
cytokine profile from the ANOVA and residuals of infection intensity (after accounting for
sex, HIV status and age).
The sequential Bonferroni-adjusted significance level is reported in addition to raw p-values
for all tests (main effects, interactions and post-hoc tests) to provide an indicator of the
significance of the relationship after accounting for multiple comparisons (Holm 1979; Rice
1989).
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4.4 Results
4.4.1 Infection intensity and prevalence
The cross-sectional distribution of infection and prevalence by age provides an indicator of
how levels of infection may change across the life-span of an individual, permanent resident
of Magaya community. It is also important to identify other potential reasons for variation in
infection levels, including sex (since hormones and certain water contact behaviours may be
gender-specific) and HIV status (which may increase susceptibility to infection). S.
haematobium infection intensities within the cohort were significantly higher in males than
females (F1, 190: 12.23, p = 0.001) and differed significantly between the age groups (F2, 190:
10.30, p < 0.001), consistent with the age-infection distribution in all recruits from Magaya
community (see chapter 2.3.7). Children aged 11-12 years had higher mean infection
intensities than younger children (5-10 years, T: 3.53, p = 0.001) and older children and
adults (13+ years, T: 4.54, p<0.001). Infection intensity was not significantly affected by
HIV status (F1, 190: 0.846, p = 0.359). The distribution of S. haematobium infection intensity
by age group is shown in Figure 4.1 and the demographic and infection characteristics of the
study cohort are summarised in Table 4.1.
Of the individuals who provided details of their daily water contact activities (n = 76), mean
daily water contacts did not significantly differ according to age group (F2,72: 2.862, p =
0.064) and the effect of age group on infection intensity was significant after accounting for
mean daily water contacts in these individuals (F2,71: 4.856, p = 0.011). Together these
observations indicate that the convex age-infection distribution does not result from age-
dependent variation in water contact behaviour alone.
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Figure 4.1. Pre-treatment S. haematobium infection distribution by age group. Bar chart
indicates the mean log10(x+1)-transformed infection intensity of each age group and the
black line indicates percentage prevalence of infection for each age group. Error bars:
standard error of the mean. Mean infection intensity was compared between age groups by
univariate ANOVA. ** p <0.01, ***p<0.001.
Age group (years)
5 - 10 11 12 13+
n 83 33 82
Mean age 7.4 11.6 28.3
Number of males: females 43:40 18:15 33:49
HIV +ve 4 2 9
Mean infection intensity*(S.E.M.) 25.23 (8.37) 89.14 (29.38) 7.20 (1.94)
Infection range* 0 - 481 0 692 0 - 107
Infection prevalence (%) 50.6 72.7 40.2
Table 4.1. Demographic and S. haematobium infection characteristics of each age
group. *Infection intensity quantified as arithmetic mean egg counts/10ml urine. S.E.M.
standard error of the mean.
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4.4.2 Adult worm and egg-specific cytokine profiles
Since adult worm and egg antigens are simultaneously exposed to circulating blood cells
during infection I sought to characterise the cytokine profiles elicited by these antigens in
vitro. Factor analysis of all SEA and WWH-specific cytokines extracted 6 principal
components reflecting inflammatory (PC1: - -12p70 and IL-23),
regulatory/Th17 (PC2: IL-10 and IL-21), Th2/Th17 (PC3: IL-13 and IL-21), IL-4/IL-13
(PC4) , Th2/regulatory (PC5: IL-5 and IL-10) and Th17 (PC6: IL-17A)-type cytokine
profiles. IL-4 was positively loaded and IL-13 was negatively loaded onto PC4 meaning that
individuals with high PC4 factor scores have a more IL-4 polarised response and relatively
less prominent IL-13 response. In most cases cytokines specific for both adult worm and egg
antigens had the same association (positive/negative) and similar values for factor loadings
onto each extracted principal component and were grouped together, supporting the
similarities between WWH and SEA-specific cytokine profiles identified in chapter 3. The
only exceptions were -5, for which egg, but not adult worm-specific responses
grouped with inflammatory cytokine responses (PC1) and Th2/regulatory (PC6) responses
respectively. The factor analysis and extracted components are summarised in Table 4.2. The
mean and standard error of the mean for individual SEA and WWH-specific cytokine
responses within the cohort (n = 198) is given in Appendix 2.
Chapter 4 Age, infection intensity and schistosome-specific cytokine profiles
- 125 -
Table 4.2. Whole blood cytokine profiles grouped by factor analysis of all adult worm
and egg-specific cytokine responses. Table shows PCs1-6 extracted by regression factor
analysis and the factor loadings for each of the square-root(x+1)-transformed whole worm
homogenate (WWH) and soluble egg antigen (SEA)-specific cytokine variables. Cytokines
with factor loadings -0.5 for an extracted PC are highlighted in bold. The cellular
immune phenotype with which the cytokines are associated is given for each PC. The
percentage of total variance in the dataset accounted for by each PC is given below
the relevant column.
Principal Components











TNF SEA 0.5 -0.2 0.0 0.4 0.4 -0.3
WWH 0.2 0.1 -0.2 -0.1 -0.1 0.2
IL-6 SEA 0.5 0.1 -0.2 0.1 0.1 -0.3
WWH 0.5 0.4 -0.3 -0.1 0.0 0.1
IL-8 SEA 0.2 0.2 0.1 0.0 -0.3 -0.4
WWH 0.4 0.3 0.3 -0.1 -0.4 -0.3
SEA 0.7 -0.1 0.2 0.0 0.2 0.1
WWH 0.6 0.0 0.1 -0.2 -0.1 0.3
IL-2 SEA -0.1 -0.1 0.0 0.0 0.0 0.1
WWH 0.0 0.0 0.2 -0.2 -0.1 0.0
IL-12p70 SEA 0.8 -0.1 0.0 -0.1 0.0 0.2
WWH 0.6 -0.1 0.0 -0.2 -0.1 0.2
IL-4 SEA 0.0 0.0 0.3 0.5 0.0 0.4
WWH 0.1 0.0 0.2 0.5 0.0 0.4
IL-5 SEA 0.0 -0.3 -0.1 0.2 0.5 -0.2
WWH 0.0 -0.3 -0.1 0.1 0.4 -0.1
IL-10 SEA 0.1 0.7 -0.4 -0.1 0.5 0.0
WWH 0.0 0.6 -0.3 -0.1 0.5 0.1
IL-13 SEA -0.1 -0.1 0.5 -0.6 0.4 0.0
WWH -0.1 -0.1 0.6 -0.6 0.3 0.0
IL-17A SEA 0.2 0.0 0.1 0.0 0.2 0.5
WWH 0.0 0.0 0.2 0.1 0.2 0.5
IL-21 SEA 0.0 0.5 0.6 0.3 0.0 -0.2
WWH 0.0 0.6 0.5 0.3 0.1 -0.1
IL-23p19 SEA 0.6 -0.2 0.0 0.2 0.2 -0.4
WWH 0.6 0.1 -0.1 -0.1 -0.3 0.0
% of total variance 14.2 8.0 7.4 7.3 6.7 6.5
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4.4.3 Variation in adult worm and egg-specific cytokine profiles by age group
Having identified the major patterns of adult worm and egg-specific cytokine responses I
investigated the hypothesis that these the cytokine profiles extracted by factor analysis varied
according to age group after accounting for variation due to sex, HIV status and infection
intensity. Although mean factor scores for adult worm and egg-specific inflammatory
responses (PC1) were highest in 11-12 year olds and scores for Th2/Th17 (PC3), IL-4/ IL-13
(PC4) and Th2/regulatory (PC5) responses were lowest in 11-12 year olds, age group was
only a significant explanatory variable for regulatory/Th17 (PC2) and Th17 (PC6)-type
responses. Pair-wise comparisons confirmed that 5-10 year olds had higher scores for
regulatory/Th17-type responses than 11-12 (T: 2.41, p = 0.017) and 13+ year olds (T: 3.32, p
= 0.001). Th17-type responses (PC6) were significantly lower in 13+ year olds than 5-10 (T:
3.31, p = 0.001) or 11-12 year olds (T: 3.43, p = 0.001). In addition, regulatory/Th17-type
responses to adult worm and egg antigens were significantly influenced both by current
infection intensity and by the interaction between age group and infection intensity,
indicating that the effects of age and infection on the schistosome-specific cytokine
environment are inter-dependent. Mean scores are plotted by age group for each of the
cytokine profile in Figure 4.2 and results of statistical analyses are summarised in Table 4.3.
















































Figure 4.2. Adult worm and egg-specific cytokine profiles differ between age groups.
Bar charts represent the variation in mean adult worm and egg-specific principal component
regression factor scores for each age group after accounting for variation due to sex, HIV
status and infection intensity in ANOVA. Error bars: standard error of the mean, *p<0.05,
**p<0.01.
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4.4.4 Relationship between infection intensity and adult worm and egg-
specific cytokine profiles
Since the effect of age and infection intensity on schistosome-specific cytokine profiles were
inter-dependent I hypothesised that the relationship between infection levels and
schistosome-specific cytokine profiles would vary with age. Whilst the latter may be inferred
from the results described in 4.4.3, it has been previously suggested that age alone is
sufficient to explain the distribution of infection intensity (chapter 1.2.4) and thus it was
important to account for the effects of age group prior to those of participant cytokine
profiles in the analysis.
Consistent with the significant association between cytokine profiles and infection intensity
(4.4.3) variation in infection intensity within the cohort was related to variation in parasite-
specific whole blood cytokine responses after accounting for the effects of sex, HIV status
and age group (Table 4.4). Post-hoc Pearson 2-tailed correlation analysis confirmed a
significant positive relationship between infection intensity and regulatory/Th17-type
responses (PC2) suggesting that individuals with high intensity infections have a more
regulatory/Th17-polarised cytokine profile than un-infected individuals or those with light
infections. Infection intensity was negatively correlated with Th17-type responses (PC6).
The relationship between adult worm and egg-specific cytokine profiles and infection
intensity are shown in Figure 4.3 and the direction and significance of the correlation
between the 2 variables is indicated for each plot.
In addition to the effects of age group and regulatory/Th17-type cytokine responses,
infection intensity was also influenced by the interaction between these two variables (not
significant after Bonferroni correction). Whilst there was a significant positive correlation
between mean S. haematobium egg counts and regulatory/Th17 factor scores in the youngest
age group (5-10 years), there was no correlation in either of the two older age groups. The
correlation between infection intensity and regulatory/Th17 factor scores within the different
age groups is shown in Figure 4.4. Infection intensity was not significantly influenced by the
interaction between age group and any of the other adult worm and egg-specific principal
components.
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Figure 4.3. Correlations between infection intensity and adult worm and egg-specific
whole blood cytokine profiles. Residual variance in log10(x+1)-transformed infection
intensity after accounting for sex, HIV status and age group is plotted against residual
variance in participant factor scores for each cytokine profile (PC) identified by factor
s are indicated for each
plot and significant correlations are highlighted in bold and underlined. Black lines: best fit
values from linear regression. ve IL-13 - IL-13 is negatively associated with PC4 and
therefore higher PC4 factor scores correspond to a lesser change in IL-13 responses.
Chapter 4 Age, infection intensity and schistosome-specific cytokine profiles
- 131 -
Figure 4.4. Schistosome infection intensity is influenced by the interaction between an
adult worm and egg-specific regulatory/Th17-polarised cytokine profile and age group.
Residual variance in log10(x+1)-transformed infection intensity after accounting for sex and
HIV status is plotted against residual variance in regulatory/Th17 (PC2) factor scores for
indicated for each plot and significant correlations are highlighted in bold and underlined.
Black lines: best fit values from linear regression.
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Sex(1, 190) 12.229 0.001 males > females
HIV status(1, 190) 0.846 0.359
Age group(2, 190) 10.304 <0.001
11-12 > 5-10 years
11-12 > 13+ years
WWH & SEA-specific cytokine profiles:
PC1 (Inflammatory)(1, 190) 2.750 0.067
PC1*Age group(2, 190) 0.36 0.7
PC2 (Regulatory/Th17)(1, 190) 7.350 0.001 +ve correlation
PC2*Age group(2, 190) 5.44 0.005
PC3 (Th2/Th17)(1, 190) 0.240 0.787
PC3*Age group(2, 190) 1.25 0.3
PC4 (IL-4/IL-13)(1, 190) 1.276 0.282
PC4*Age group(2, 190) 0.736 0.481
PC5 (Th2/Regulatory) (1, 190) 1.520 0.220
PC5*Age group(2, 190) 0.086 0.918
PC6 (Th17)(1, 190) 8.060 <0.001 -ve correlation
PC6*Age group(2, 190) 0.263 0.769
Table 4.4. Variation in infection intensity is associated with adult worm and egg-
specific cytokine profiles. Results of ANOVA of log10(x+1)-transformed mean S.
haematobium egg counts/10ml for each cytokine profile (PC) using sequential sums of
squares to account for variation due to sex, HIV status and age group. The effects of each PC
was analysed in separate ANOVA. Significant results (p<0.05) are highlighted in bold and
those significant at the sequential Bonferroni-adjusted significance level are shaded grey.
+ve positive, -ve negative
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4.4.5 GST-specific cytokine profiles
The major cytokine profiles elicited by GST in vitro were identified by factor analysis,
which extracted 5 PCs. As for adult worm and egg-specific cytokine profiles, GST-specific
inflammatory (IL- -12p70 and IL-23) and regulatory/Th17 (IL-10 and IL-21)-type
responses were grouped into distinct PCs (PC1 and PC3 respectively). PCs reflecting a
combination of IL-2, IL-8 and IL-13 responses (PC2), Th2/Th17 (PC4) and Th2 (PC5)-type
cytokine profiles were also extracted. GST-specific cytokine profiles identified by the factor
analysis are summarised in Table 4.5. . The mean and standard error of the mean for
individual GST-specific cytokine responses within the cohort is given in Appendix 2.
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Principal Components
1 2 3 4 5








GST 0.4 0.1 0 0 0
IL-6 GST 0.7 0.1 0.2 0.1 -0.4
IL-8 GST 0.4 0.5 0.2 0 -0.4
GST 0.8 -0.3 -0.1 -0.1 0.3
IL-2 GST 0.1 0.7 0.2 0.2 0.2
IL-12p70 GST 0.8 -0.3 -0.1 -0.1 0.2
IL-4 GST 0 -0.2 -0.1 0.7 0.1
IL-5 GST -0.1 -0.1 0 0.2 0.5
IL-10 GST -0.1 -0.3 0.8 0.2 0.1
IL-13 GST 0 0.6 0.1 0.1 0.5
IL-17A GST 0 -0.1 -0.2 0.7 -0.2
IL-21 GST -0.1 -0.3 0.8 0 0
IL-23p19 GST 0.7 0 0 0 0.1
% of total variance 20.5 11.9 10.6 9.4 8.6
Table 4.5. Whole blood cytokine profiles grouped by factor analysis of all GST-specific
cytokine responses. Table shows PCs 1-5 extracted by factor analysis and the factor
loadings for each of the square-root(x+1)-transformed S. haematobium GST-specific
cytokines. Cytokines with loadings -0.5 are highlighted in bold for each PC. The
immune phenotype with which cytokines are associated is given for each PC. The percentage
of total cytokine variance accounted for by each PC is given below each column.
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4.4.6 Variation in GST-specific cytokine profiles by age group
As an abundant constituent of the schistosome proteome I hypothesised that GST-specific
cytokine profiles, like those elicited by WWH and SEA, would vary with age and this was
confirmed by comparison of the mean regression factor scores for the GST-specific cytokine
profiles between the 3 age groups. GST-specific inflammatory cytokine responses were
highest in 11-12 year olds relative to 5-10 (T: 3.16, p = 0.002) and 13+ year olds (T: 3.31, p
= 0.001). As observed for adult worm and egg-specific cytokine responses, GST-specific
regulatory/Th17 responses were highest in the youngest age group, but only significantly
differed between 5-10 and 11-12 year olds (T:2.41, p = 0.017). None of the other GST-
specific cytokine profiles (PC2, PC4 and PC5) significantly differed according to age group.
GST-specific cytokine profiles were not significantly influenced by the interaction between
age group and infection intensity. Factor scores for GST-specific cytokine profiles are
plotted by age group in Figure 4.5 and statistical analyses are summarised in Table 4.6.
4.4.7 Variation in infection intensity according to GST-specific cytokine
profiles
Since GST is proposed as an anti-schistosome vaccine I investigated whether infection
intensity was related to the GST-specific cytokine profiles after accounting for the effects of
age group. Infection intensity was not significantly related to variation in GST-specific
cytokine profiles or the interaction between GST-specific cytokine profiles and age group
(Figure 4.6). ANOVA results are summarised in Table 4.7.




































Figure 4.5. GST-specific cytokine profiles differ between age groups. Bar charts
represent the residual variation in mean GST-specific PC regression factor scores for each
age group after accounting for variation due to sex, HIV status and infection intensity. Error
bars: standard error of the mean, *p<0.05, ** p<0.01.
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Figure 4.6. Pre-treatment infection intensity is not significantly correlated with GST-
specific whole blood cytokine profiles. Residual variance in log10(x+1)-transformed
infection intensity after accounting for sex, HIV status and age group is plotted against
residual variance in participant factor scores for each PC extracted from pre-treatment GST-
specific cytokine responses. The Pearson
indicated for each plot and significant correlations are highlighted in bold and underlined.
Black lines: best fit values from linear regression.
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Sex(1, 190) 12.173 0.001 males > females
HIV status(1, 190) 0.842 0.360
Age group(2, 190) 10.258 <0.001
11-12 > 5-10
years
11-12 > 13+ years
GST-specific cytokine profiles:
PC1 (Inflammatory) (1, 190) 0.004 0.950
PC1*Age group(2, 190) 0.995 0.372
PC2 (Inflammatory/Th2) (1, 190) 0.095 0.758
PC2*Age group(2, 190) 0.037 0.964
PC3 (Regulatory/Th17) (1, 190) 2.607 0.108
PC3*Age group(2, 190) 1.317 0.270
PC4 (Th2/Th17) (1, 190) 1.970 0.162
PC4*Age group(2, 190) 1.207 0.301
PC5 (Th2) (1, 190) 0.748 0.388
PC5*Age group(2, 190) 1.060 0.349
Table 4.7. Variation in infection intensity is not associated with GST-specific cytokine
profiles. Results of ANOVA of log10(x+1)-transformed mean S. haematobium egg
counts/10ml compared according to factor scores of each cytokine profile (PC) after
accounting for variation due to sex, HIV status and age group. The effects of each PC was
analysed in separate ANOVA. Significant results (p<0.05) are highlighted in bold. None of
the relationships identified were significant after Bonferroni correction for multiple
comparisons.
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4.5 Discussion
Schistosome infection intensity and the immune responses to parasite antigens are inter-
dependent and both are influenced by age-related factors. Physiological changes with age.
(Grogan et al. 1996b),
immunological effects of pubertal hormones (Fulford et al. 1998), immunosensescence in
adulthood (Comin et al. 2008) and variation in water contact behaviour (Chandiwana and
Woolhouse 1991; Chandiwana et al. 1991), appear to influence immune responses to
schistosomes. However, in light of studies demonstrating that age-related exposure to
schistosome infection rather than age alone may promote the development of parasite-
specific immune responses (Mutapi et al. 1997), I sought to investigate whether parasite-
specific cytokine responses could be related to epidemiological patterns of S. haematobium
infection in Magaya community.
Consistent with the findings of most studies of human schistosomiasis, S. haematobium
infection intensity followed a typical convex pattern with age. The study cohort was
therefore sub-divided into 3 age groups that reflected this age-infection pattern (full details
given in chapter 2.3.7). For life-long permanent residents of the study area (where S.
haematobium transmission is stable and endemic) these age groups were indicators of both
duration of exposure to schistosome infection (i.e. the youngest age group had the shortest
and the oldest age group has the longest exposure history) and current infection levels (i.e.
11-12 year olds bore the highest mean infection intensity). From this cross-sectional
distribution of infection by age it can be assumed that the 13+ age group is made up of
individuals who have previously harboured high intensity infections that have now declined
due to the development of resistance. In contrast, the 5-10 year olds are yet to reach peak
infection intensity and are likely to acquire increasing numbers of parasites. Whilst this
pattern is evident at a population level the range of infection intensities within each age
group, particularly 11-12 year olds (0-692 eggs/10ml urine), suggests that there is also
considerable variation in the age at which individuals reach their peak level of infection.
Since the immune environment during natural infection comprises cytokine responses
elicited by numerous different antigens and secreted by a range of cell types whole blood
cytokine responses to adult worm and egg antigens were grouped by factor analysis. Factor
analysis has been successfully used to study immune responses to human helminth infections
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previously, but these studies have focused on a limited repertoire of cytokines (Turner et al.
2003; Jackson et al. 2004b; Mutapi et al. 2007b), single or non-parasite antigens (Turner et
al. 2003; Mutapi et al. 2007b) or systemic rather than parasite-specific responses (Milner et
al. 2010). Thus, the current study provides an extension to this powerful approach to
analysing immunology data. Analysis identified clear groupings of cytokines associated with
innate inflammatory, Th1, Th2, Th17 and regulatory-type responses to antigens of both S.
haematobium life-cycle stages. Furthermore, most of the cytokine profiles identified
comprised cytokines associated with more than one of these phenotypes, consistent with
growing evidence that schistosomes elicit a mixed cellular effector phenotype that cannot be
adequately characterised by the Th1/Th2 paradigm alone (reviewed by (Allen and Maizels
1997; Diaz and Allen 2007)). In particular, positive loadings of Th17-type cytokines with
inflammatory (PC1), regulatory (PC2) and Th2 (PC3)-type responses, indicated that
cytokines associated with different cellular phenotypes are co-incident. IL-4 and IL-13,
which are typically associated with Th2 responses, also had opposite loadings onto PC4,
supporting observations in previous studies that Th2-type cytokines are not always co-
expressed and may temporally dissociate during the course of infection (Ghaffar et al. 1997;
Scott et al. 2000). The advantage of factor analysis in this context is that it identifies the
cytokine patterns that account for the majority of variation in cytokine responses within the
population, allowing this complexity to be explored as a smaller number of informative
variables (Sokal and Rohlf 1995a). A mixed profile of pro-inflammatory cytokines (PC1)
accounted for the greatest proportion of variation between participant cytokine responses to
SEA and WWH, which reflects the high levels of these cytokines produced in vitro
(identified in chapter 3). However, these responses were not significantly influenced by host
sex, HIV status or age group and did not account for significant variation in S. haematobium
infectio
-
CAP (Curwen et al. 2004)) rather than a cellular memory response conditioned by parasite
exposure.
SEA and WWH-specific regulatory/Th17 (PC2) and Th17 (PC6)-type cytokine responses
were significantly influenced by host age group and accounted for significant variation in S.
haematobium infection intensity. PC2 responses (reflecting WWH and SEA-specific IL-10
and IL-21) were highest in the youngest age group (5-10 years) and PC6 responses (WWH
and SEA-specific IL-17A) were higher in 5-10 and 11-12 year olds than in 13+ year olds.
Chapter 4 Age, infection intensity and schistosome-specific cytokine profiles
- 142 -
The main distinction between the youngest and oldest age groups, which do not differ in
their mean infection intensities or water contact behaviours, is their history of exposure to
infection and age-dependent physiological changes which may affect their capacity to
respond to S. haematobium antigens. Thus, it is possible that the lower levels of PC2
cytokine responses in 13+ year olds relative to the age groups where infection levels are
increasing (5-10 years) or peaking (11-12 years) may contribute to their development of
resistance to S. haematobium. The significant effect of the interaction between age group and
infection intensity also indicates that the differences between PC2 responses according to
age group were dependent on current levels of infection.
When the reciprocal influence of variation in cytokine profiles on S. haematobium egg
counts was investigated, infection intensity was found to be positively correlated with PC2
responses after accounting for variation due to host sex, HIV status and age group. This
pattern suggests that PC2 responses to adult worm and egg antigens may be induced by
infection leading to high levels in heavily infected individuals but reflect an immune
environment that is ineffective at clearing patent infection and/or limiting acquisition of new
parasites. Alternatively, these responses may be important regulators of morbidity during
heavy infections, but also limit parasite-specific effector responses (refer to recent reviews
(Jackson et al. 2009; Maizels et al. 2009)). For example, IL-10-mediated suppression of
effector cytokines has also been interpreted as mechanism for regulating egg-induced
immunopathology in humans (Grogan et al. 1998b) and murine infection models (Hesse et
al. 2004). Furthermore previous work has shown that a decline in mean IL-10 and reciprocal
rise in mean IL-5 concentrations with age coincides with reduction in mean infection
intensity in a population endemically-exposed to S. haematobium (Mutapi et al. 2007b).
In contrast to PC2 cytokine responses, infection intensity was negatively correlated with
Th17-type (PC6) responses, suggesting that they may promote resistance to infection and/or
be suppressed during infection. These findings agree with the only previous study to
investigate IL-17 responses in an S. haematobium-exposed population, which found that IL-
17A was more frequently detected in the plasma of un-infected individuals than their
infected counterparts (Milner et al. 2010). However, as has been previously observed in
plasma samples (Milner et al. 2010), only a small proportion of participants in the current
study produced detectable levels of IL-17A (SEA n = 37/198, WWH n = 28/198, GST n =
39/198 produced IL-17A at concentrations above those present in un-stimulated cultures).
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Furthermore, those participants who produced detectable levels of S. haematobium-specific
IL-17A did so at low levels (mean SEA-specific IL-17A: 0.0127ng/ml (n = 37), mean
WWH-specific IL-17A: 0.103ng/ml (n = 28), mean GST-specific IL-17A: 0.009ng/ml (n =
39)). Therefore, whilst the relationship between infection intensity and IL-17A identified in
the current study may be of importance, further work will be required to increase the
sensitivity of ELISA-based IL-17A detection in peripheral samples and thus increase the
statistical power of future studies to investigate IL-17A responses in human schistosomiasis.
At first the opposite relationships with infection intensity of the Th17-associated cytokine
profiles (i.e. regulatory/Th17 (PC2) and Th17 (PC6)) appear contradictory, however it is
important to note that whilst both PCs were defined according to their association with the
Th17 lineage, they are loaded with adult worm and egg-specific IL-21 (PC2) and IL-17A
(PC6) respectively. Despite being described as a Th17 cytokine in recent human studies
(chapter 2.3.5.5), the phenotype of IL-21-secreting cells is unclear and its functional role
may differ between the human and murine immune systems (Wurster et al. 2002; Hoeve et
al. 2006; Pesce et al. 2006). Different effects of IL-17A and IL-21 on S. haematobium
infection levels may result from effector functions that are yet to be characterised in humans
(e.g. induction of alternatively activated macrophages (Pesce et al. 2006)). It is also possible
that co-variance between IL-10, a well characterised immunoregulatory cytokine, and IL-21
is due to their shared ability to suppress other cytokine responses (Grogan et al. 1998a;
Wurster et al. 2002). However, the lack of previous studies characterising IL-17 and IL-21
responses relative to epidemiological patterns of helminth infection and their poorly defined
mechanistic roles in human immunology mean that further studies are required to test these
hypotheses.
In addition to the linear correlation between infection intensity and PC2 cytokine responses,
infection intensity was also significantly affected by the interaction between PC2 responses
and age group. This effect was due to a change from a significant positive correlation in 5-10
year olds to no significant correlation in 11-12 and 13+ year olds. A similar age-related
change in correlation has been observed between helminth infection intensity and S.
haematobium-specific IgG3 responses (Mutapi et al. 2006), the proportion of T regulatory
(Treg) to T effector (Teff) cells in an S. haematobium-exposed cohort (Nausch et al. 2011),
Trichuris trichuria-specific IL-10 (Turner et al. 2003) and Necator americanus-specific IgG
(Quinnell et al. 1995). This changing relationship with age has been interpreted as an
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indicator of immune-mediated resistance to infection developing with age and parasite
exposure (Quinnell et al. 1995; Quinnell et al. 2004a; Mutapi et al. 2006). Mathematical
models of infection predict that parasite-specific protective immune responses are initially
positively correlated with infection intensity as they are stimulated by parasite antigens, but
this correlation changes with increasing age as they exert their anti-parasite effects
(Woolhouse 1994). Given the putative role of IL-10 in suppressing schistosome-specific
effector immune responses, it seems unlikely that regulatory/Th17-type responses directly
mediate anti-parasite immunity. It seems more likely that PC2 responses are up-regulated
during infection in young children and subsequently decline due to cumulative antigen
exposure, allowing protective effector responses to be up-regulated in later life. For example,
the results presented here suggest that parasite-specific IL-17 responses are negatively
correlated with infection intensity across all age groups, but the effector function of this
response may be limited in young children with high levels of PC2 cytokines. The latter
would correspond with previous studies proposing that the balance between immune effector
responses and immunoregulatory responses may be a more important determinant of both
anti-parasite and anti-pathology immunity to schistosomes than individual effectors (Corrêa-
Oliveira et al. 1998; Hesse et al. 2004; Mutapi et al. 2007b; Nausch et al. 2011).
Furthermore and in contrast to the suggestion that young children exhibit stereotypical
(Grogan et al. 1996b), regulatory/Th17-type cytokine responses were only higher than in
other age groups in 5-10 year olds with heavy infections (50 eggs/10ml urine or more). Thus,
these observations are consistent with the long-held hypothesis that natural immune-
mediated resistance to schistosome infection is dependent on cumulative exposure to
infection (chapter 1.2.4).
Cytokine profiles elicited by GST differed from those elicited by WWH and SEA,
potentially due to the absence of other immunogenic antigens present in the crude WWH and
SEA preparations. However, similar to SEA and WWH, the cytokine groupings identified in
GST-stimulated cultures suggested a mixed profile of whole blood cytokine responses.
Furthermore, analysis extracted both an inflammatory (GST PC1) component, reflecting
- -12p70 and IL-23 responses, and regulatory/Th17 (GST PC3)-type
component , reflecting IL-10 and IL-21 responses, suggesting similarities in the cytokine
profiles elicited by stimulation with GST, SEA and WWH. The parallels between the
principal components identified for GST and SEA and WWH-stimulated cultures may be
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due to the abundance and immunogenicity of GST, which is a significant component of both
WWH and SEA (Curwen et al. 2004; Mutapi et al. 2005). Both GST-specific PC1 and PC3
had similar patterns with age group to those of their SEA and WWH-specific counterparts
(PC1 and PC2 respectively). GST PC1 cytokine responses were significantly higher in 11-12
year olds, who bore the highest mean infection intensity, than in 5-10 or 13+ year olds,
suggesting that levels of inflammatory cytokines produced in vitro are closely related to
current infection levels (this pattern was the same, though not statistically significant, for
SEA and WWH-specific inflammatory cytokines). GST PC3 cytokine responses were
highest in 5-10 year olds, but this difference was only significant when compared to 11-12
year olds. None of the GST-specific cytokine profiles identified were significantly affected
by the interaction between age group and infection intensity or correlated with S.
haematobium egg counts. Thus, despite the similarities with SEA and WWH-specific
responses, the GST-specific cytokine profiles were not indicators of resistance to infection
within the cohort. The increase in sero-reactivity to GST isoforms within crude S.
haematobium WWH after praziquantel treatment (Mutapi et al. 2005), suggests that
treatment increases exposure to parasite antigens and the effect of treatment on GST-specific
cytokine responses is investigated further in chapters 5 and 6. An alternative hypothesis is
that induction of GST-specific antibodies rather than the type of cytokine profile that it
elicits in vitro are better indicators of protective immunity (Lane et al. 1998; Capron et al.
2001). It is possible that, although GST vaccination can elicit protective immunity in
primates (Boulanger et al. 1995; Boulanger et al. 1999), the amount of GST to which human
hosts are exposed during natural infections is insufficient to generate cytokine responses
associated with anti-parasite immunity. Alternatively, GST-specific antibody responses may
provide a better indicator than cytokine responses of the change in GST-specific immune
responses with age and exposure to infection, as has been proposed by others (Mutapi et al.
2008). Thus, although the results presented here suggest that whole blood cytokine responses
to GST in vitro are not indicative of naturally-acquired resistance to high worm burdens,
they do not preclude the possibility that GST administered as a vaccine could artificially
induce protective immunity (Dupre et al. 1999).
A final consideration is that the GST used (purified from a Senegalese strain of S.
haematobium) and the SEA and WWH (prepared from Egyptian parasites) may elicit
different cytokine profiles than those of the Zimbabwean schistosomes to which Magaya
community are exposed. There is known to be antigenic variation between schistosome
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species (Trottein et al. 1992a) and it has also been proposed to occur between intra-specific
strains by theoretical models of infection (Galvani 2005). However, clear patterns of
cytokine responses to these antigens with age and infection intensity and the known cross-
reactivity of antigens derived from the same Egyptian parasites with serum antibodies from
individuals endemically exposed to Zimbabwean S. haematobium (Mutapi et al. 2003;
Mutapi et al. 2008; Mutapi et al. 2011a), suggest that immune responses are raised against
antigens shared across the different parasite strains.
4.6 Conclusions
The results of the current study are consistent with the initial hypotheses that parasite-
specific cytokine responses vary with age and infection intensity and may also have
reciprocal effects on infection levels. In particular, the 3-way association identified between
age group, infection intensity and the combination of IL-10 and IL-21 (regulatory/Th17)
responses to S. haematobium adult worm and egg antigens provides evidence that whole
blood cytokine responses elicited in vitro are indicators of both exposure history and the
development of immune-mediated resistance to infection. The change in association between
infection intensity and regulatory/Th17-type cytokines with age suggests that 5-10 year olds,
in whom infection is increasing, have a distinct cytokine response to infection than age
groups experiencing peaking and declining levels of infection. The putative function of IL-
10 suggests that it may serve anti-pathology functions and/or limit protective effector
responses in young children with high intensity infections and decline as resistance develops
with age. Conversely, adult worm and egg-specific IL-17A may contribute to immune-
mediated resistance to schistosome infection independent of variation due to age group
alone.
This study is the first to identify how S. haematobium-specific Th17-associated cytokines
may contribute to epidemiological patterns of infection. The association of IL-17A, IL-21
and IL-23 with distinct combinations of innate inflammatory, Th1 and Th2-type responses
suggests that these cytokines may have a range of effector functions in human
schistosomiasis. Further study of these cytokines and their cellular sources is warranted to
test the relevance of these findings to human disease.
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Chapter 5
The effect of anti-helminthic treatment on whole blood
cytokine responses to Schistosoma haematobium antigens
5.1 Introduction
Praziquantel treatment effectively clears schistosome infection, but also alters the host
immune response (chapter 1.8.3). In this chapter I will explore whether S. haematobium
cercariae, adult worm, egg and glutathionine-S-transferase (GST)-specific whole blood
cytokine responses are altered 6 weeks after treatment. By this time-point praziquantel is
fully metabolised (Na-Bangchang et al. 2006; Njomo et al. 2010) and the reduction in urine
egg counts is maximal (Tchuem Tchuente et al. 2004), but newly acquired infections are yet
to reach patency (Loker 1983), allowing cytokine responses to be investigated in the absence
of chronic infection.
I first sought to extend the observations of previous studies which have shown that cytokine
responses to schistosome antigens differ after treatment relative to pre-treatment levels
(Roberts et al. 1987; van den Biggelaar et al. 2002; Fitzsimmons et al. 2004; Joseph et al.
2004b; Reimert et al. 2006), by assaying a broader range of schistosome antigen-specific
cytokine responses. I then investigated whether, in addition to altering individual cytokine
responses, treatment leads to a shift in the overall schistosome-specific cytokine profile of
endemically-exposed individuals. The latter has been inferred from previous observations
showing that -5 responses are inversely associated (Roberts et al. 1993), but has
never been investigated in more than 2 cytokines. Importantly, a combined analysis of pre
and post-treatment innate inflammatory, Th1, Th2 and Th17-type cytokine responses allows
the major sources of variation in the host cytokine phenotype resulting from removal of
schistosome infection to be identified.
In light of pre-treatment differences in the cytokine responses to cercariae, adult worm and
egg-stage parasites (chapter 3), I have also addressed the hypothesis that the relative
cytokine profiles elicited by these 3 life cycle stages differ 6 weeks after treatment. Different
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effects of praziquantel treatment on cytokine responses to different schistosome life-cycle
stages might result from variation in the efficacy of the drug against each stage and/or
removal of stage-specific immunosuppression present during chronic infection. In particular,
praziquantel is proposed to target mainly adult parasites, however there is evidence from
both murine models (Xu et al. 1988; Flisser et al. 1989; Shaw 1990; Giboda and Smith
1994) and human studies (Mutapi et al. 1998b; Caldas et al. 2000; Guidi et al. 2010) that
treatment may also alter immune responses to immature parasites.
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5.2 Hypotheses
Individual S. haematobium-specific cytokine responses are altered 6 weeks after
praziquantel treatment
Praziquantel treatment causes a shift in the S. haematobium-specific cytokine profile
S. haematobium-specific cytokine profiles 6 weeks after treatment differ between the
different parasite life-cycle stages (cercariae, adult worms and eggs)
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5.3 Materials and Methods
5.3.1 Study participants
Of the participants recruited from Magaya community before treatment, 94 provided a
follow-up sample for whole blood culture 6 weeks after treatment and met the inclusion
criteria for the current study: 1) tested negative for S. mansoni, soil-transmitted helminth
(STH), malaria and HIV both before and after treatment, 2) provided a minimum of 2 stool
and 2 urine samples for microscopic analysis of helminth egg counts both before and after
treatment, 3) reported no prior treatment for schistosomiasis and 4) were long-term,
permanent residents of the area. In addition all participants had received a single standard
dose 40mg/kg body weight praziquantel (for schistosome infection) and 400mg albendazole
(for STH infection) irrespective of their infection status according to the recommendations of
the World Health Organisation (WHO) (Montresor et al. 2002) and the ethical permissions
obtained for the study (chapter 2.3.4). To exclude participants who harboured persistent
infections, all participants included in this chapter were confirmed to be S. haematobium
negative 6 weeks after treatment (i.e. successfully cleared of infection) via microscopic
analysis of S. haematobium egg counts in filtered urine (chapter 2.3.5).
5.3.2 Immunological assays
Whole blood cultures were conducted in parallel with CAP, WWH, SEA and GST for each
participant under the same conditions (10µg/ml crude antigen (CAP, WWH and SEA) or
after treatment. Un-stimulated (culture media without antigen) whole blood cultures acted as
negative controls for levels of spontaneous cytokine. Cultures stimulated with 10µg/ml
Phytohaemagglutinin (PHA) acted as positive controls, confirming that cells were viable and
capable of secreting cytokines when stimulated with antigen. For participants who did not
provide sufficient amounts of blood for all antigen stimulations (e.g. due to participant
discomfort during blood collection), cultures were prioritised as follows: SEA, WWH, GST,
control cultures and CAP. For this reason, of the 94 individuals included in this chapter,
CAP-specific cytokine responses were only assayed in 24 participants.
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ELISA was used to quantify IFN , TNF , IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-
13, IL-17A, IL-21 and IL-23p19 in culture supernatants relative to a pre-optimised standard
curve of recombinant cytokine. A mean cytokine concentration (ng/ml) was obtained from
duplicate ELISA wells for each antigen stimulation.
5.3.3 Statistical Analyses
To address the hypothesis that individual cytokine responses to S. haematobium antigens
differ 6 weeks post-treatment relative to pre-treatment levels, all SEA, WWH and GST-
specific (n = 94) and CAP-specific (n=24) cytokines were compared between the pre- and
post-treatment cultures via repeated measures ANOVA. Square-root(x+1)-transformed
cytokine responses were the dependent variables and time point (pre- and 6-weeks post-
treatment) was included as a between-subject factor. The repeated measures analysis was
chosen to account for re-sampling of the same individuals before and after treatment and
comparison of the same cohort of participants before and after treatment meant that variation
due to sex, age, pre-treatment S. haematobium infection status and intensity, genetic factors
etc. were accounted for in the analysis. A separate repeated measures ANOVA of the non-
specific cytokine concentrations present in un-stimulated control cultures was also conducted
least significant difference test was used for post-hoc pair-wise comparisons between pre and
post-treatment cytokine responses in antigen-stimulated and un-stimulated cultures and the t-
ratio (T) and associated p-value are reported for each test (Sokal and Rohlf 1995b).
Exploratory analysis indicated that the square-root(x+1)-transformed cytokine data and
residuals of ANOVA met parametric assumptions for both antigen-specific and un-
stimulated responses.
To investigate whether the treatment-
cytokine response non-metric multidimensional scaling (NMS) was conducted for each
antigen using PC-ORD software. This approach allowed post-treatment cytokine responses
to be visualised relative to pre-treatment patterns via ordination plots. Full details of NMS
procedure are given in chapter 2.5.4. Briefly, square-root(x+1)-transformed concentrations of
all 13 cytokines were entered for all participants both before and after treatment and the
dissimilarity (Sorensen distance) between each participant according to their combination of
cytokine responses was calculated, ranked and plotted according to 2-dimensional axes by
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ordination. The data was transformed in order to reduce the weight of outliers on the
ordination solutions without affecting relative ranks of each participant (Rummel 1970). The
axes reflected the cytokines responsible for the greatest variation between cytokine profiles.
Starting coordinates for each ordination were selected using a random number generator and
Solutions achieved with a final stress of less than 20 were considered to adequately represent
interpretable patterns of cytokine responses (McCune and Grace 2002). The cytokine
responses accounting for the greatest variation in participant cytokine profiles (i.e. correlated
most strongly with the extracted axes) were identified 2-tailed correlation
analysis
Cluster patterns of participant cytokine responses in NMS ordination plots provided a
qualitative indicator of variation between participant cytokine responses. Differences
between the mean dissimilarities of participant cytokine profiles before (i.e. the variation
-treatment cytokine profiles) and 6 weeks after treatment were
plotted for final NMS solutions and compared via multiple response permutation procedure
(MRPP) in PC-ORD software. This analysis specifically tests the hypothesis that variation
between pre- and post-treatment cytokine responses is greater than the variation in cytokine
responses between individuals at either of these timepoints (McCune and Grace 2002).
Homogeneity in cytokine profiles within pre and post-treatment groups was quantified via
the chance corrected within- -
differences identified by MRPP. Given the size of our study cohort, an A <0.1 was
considered as low and A> 0.3 was considered high (McCune and Grace 2002).
To investigate whether CAP, WWH and SEA elicit distinct cytokine profiles 6 weeks after
treatment, the square-root(x+1) transformed post-treatment cytokine concentrations of each
participant to all 3 antigens were first reduced into principal components (cytokine profiles)
by factor analysis (Sokal and Rohlf 1995c). The effect of antigen (i.e. CAP, WWH and SEA)
on each cytokine profile was then assessed via ANOVA. Only participants for whom CAP,
WWH and SEA-stimulated cultures were conducted were included in the analysis (n = 24).
Thus variance in the PCs due to host heterogeneity was accounted for by comparing the
responses of the same 24 individuals to all antigens. Analysis was conducted in exactly the
same way as that of pre-treatment CAP, WWH and SEA-specific cytokine responses in
chapter 3 and exploratory analysis indicated that the regression factor scores met parametric
assumptions.
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The sequential Bonferroni correction was used to identify results that were significant in the
context of the multiple statistical comparisons being made (Holm 1979; Rice 1989). Results
significant after correction are reported alongside raw p-values for all analyses involving
multiple comparisons.
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5.4 Results
5.4.1 Differences between individual parasite-specific whole blood cytokine
responses before and 6 weeks after treatment
Comparisons of mean cytokine levels elicited before and after treatment identified distinct
dynamics according to antigen stimulation. Levels of all cytokine responses, with the
exception of IL-5, to egg antigens were higher 6 weeks post-treatment relative to pre-
treatment levels and this increase was statistically significant for innate inflammatory
( -6 and IL-8) and Th1- -2 and IL-12p70) cytokines and IL-23. GST-
stimulation also elicited higher mean -6, IL-8, IL-12p70 and IL-23 responses.
Mean CAP-specific IL-2, IL-8 and IL-10, responses were higher, but IL-23 was significantly
lower in post-treatment cultures. WWH- -6
and IL-8) and IL-10 were lower post-treatment. For all antigen-stimulated cultures mean
levels of IL-5 were lower, although this was not statistically significant for SEA-stimulated
cultures. Mean IL-21 concentrations were also higher post-treatment, but only significantly
so for CAP and WWH-stimulation. Mean IL-13 concentrations were significantly higher in
response to all antigens, except WWH. These observations are consistent with cytokine
responses to the different schistosome antigens being differentially affected by treatment.
The changes in mean innate inflammatory, Th1, Th2 and Th17-type cytokine concentrations
following treatment are summarised in Table 5.1 and plotted by antigen in Figures 5.1, 5.2,
5.3 and 5.4 respectively. Results of repeated measures ANOVA of pre and post-treatment
cytokine responses are given in Table 5.2 and significant differences from this analysis are
indicated in Figures 5.1-5.4.
Treatment-related changes in cytokine secretion in un-stimulated culture were also observed,
reflecting changes in the systemic cytokine environment. Levels of spontaneous IL-8, IL-2
and IL-5 were lower and IL-12p70, IL-13 and IL-21 responses were higher post treatment
relative to pre-treatment levels. Post-treatment changes in cytokine levels present in un-
stimulated cultures are summarised in Table 5.1 and systemic pre and post-treatment
cytokine responses are plotted in Figure 5.5. Repeated measures ANOVA of cytokine
responses in un-stimulated cultures are summarised in Table 5.2.
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Table 5.1. Change in mean cytokine concentrations present in antigen-stimulated and
un-stimulated cultures 6 weeks post-treatment. Colours indicate the direction of change in
cytokine concentrations for the cohort after treatment relative to pre-treatment levels
(red/orange increase, blue decrease, white no change). Significant results are
highlighted by darker colours. Results significant after Bonferroni correction for multiple
comparisons are indicated by black borders. Only 24 of the 94 participants provided
sufficient volumes of whole blood for CAP cultures to be conducted.
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Figure 5.1. Innate inflammatory cytokine responses to cercariae, egg antigens and GST,
but not adult worm antigens, increase 6 weeks after treatment. Bar charts represent mean
un-transformed concentrations of antigen-specific cytokines (ng/ml) before (grey) and 6
weeks after (black) treatment. Error bars: standard error of the mean. Significant results of
repeated measures ANOVA are indicated. *p<0.05, **p<0.01, ***p<0.001.
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Figure 5.2. Th1-type cytokine responses to cercariae and egg antigens and GST, but not
adult worm antigens, increase 6 weeks after treatment. Bar charts represent mean un-
transformed concentrations of antigen-specific cytokines (ng/ml) before (grey) and 6 weeks
after (black) treatment. Error bars: standard error of the mean. Significant results of repeated
measures ANOVA are indicated. *p<0.05, **p<0.01, ***p<0.001.
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Figure 5.3. Th2-type cytokine responses differ 6 weeks after treatment relative to pre-
treatment levels. IL-5 responses decrease and IL-13 responses increase. Changes in
post-treatment IL-10 responses are antigen-dependent. Bar charts represent mean un-
transformed concentrations of antigen-specific cytokines (ng/ml) before (grey) and 6 weeks
after (black) treatment. Error bars: standard error of the mean. Significant results of repeated
measures ANOVA are indicated. *p<0.05, **p<0.01, ***p<0.001.
Chapter 5 Post-treatment cytokine responses to schistosome antigens
- 159 -
Figure 5.4. Th17-type cytokine (IL-21 and IL-23) concentrations are higher 6 weeks
after treatment than before treatment. Bar charts represent mean un-transformed
concentrations of antigen-specific cytokines (ng/ml) before (grey) and 6 weeks after (black)
treatment. Error bars: standard error of the mean. Significant results of repeated measures
ANOVA are indicated. *p<0.05, **p<0.01, ***p<0.001
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Figure 5.5. Cytokine concentrations in un-stimulated whole blood cultures differed 6
weeks after praziquantel treatment relative to pre-treatment levels. Bar charts show
mean un-transformed concentrations of innate inflammatory (A), Th1 (B), Th2 (C) and Th17
(D)-type cytokines before (grey) and 6 weeks after (black) treatment present in cultures
without antigen. Error bars: standard error of the mean. Significant results of repeated
measures ANOVA are indicated. *p<0.05, **p<0.01, ***p<0.001
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5.4.3 Relative patterns of whole blood cytokine profiles before and after
treatment
Having identified differences between the mean concentrations of individual cytokines
following treatment, the implication of these changes for the whole blood cytokine
environment (i.e. combination of cytokine responses) were investigated in all individuals via
NMS. Ordination plots for each cytokine are shown in Figure 5.6 and the strength and
direction of cytokine correlations with each ordination axis are summarised in Table 5.3.
Pre and post-treatment responses to CAP varied according to 2 axes (Figure 5.6.1) which
negatively correlated with IL-8 (Axis 1) and negatively correlated with a combination of
TN -6 (Axis 2). Distinct pre and post-treatment clusters along Axis 1 reflect the
increase in cercariae-specific IL-8 6 weeks after treatment (Figure 5.1). Thus, of the changes
in individual cytokine responses to cercariae antigens, the majority of variation between
individuals post-treatment is attributable to changes in their IL-8 response. MRPP
comparison of responses before and after treatment confirmed that participant cytokine
profiles significantly differed following treatment (T statistic: -19.40, p<0.001, A: 0.205).
Variation between pre and post-treatment cytokine responses to WWH (Figure 5.6.1) was
mainly due to pre-treatment IL-6 responses (Axis 1). None of the pre or post-treatment
cytokine responses were strongly associated with Axis 2 and thus, WWH-specific cytokine
responses were best characterised by a 1-dimensional ordination solution (Table 5.3).
Although MRPP indicated that WWH-specific cytokine profiles changed following
treatment (T statistic: -11.89, p<0.001, A: 0.026), the low value of the chance-corrected
within-group agreement (A) reflects that pre and post-treatment differences are small and do
not occur in all participants.
SEA-specific cytokine responses exhibited a clear shift after treatment along 2 axes (Figure
5.6.2); -6, IL-8, IL-12p70 and IL- -6, IL-12p70 and IL-23
(Axis 2). 6 weeks after treatment the inflammatory cytokine responses on both axes were
higher than those before treatment and the distinct clustering and low overlap of cytokine
profiles according to treatment status (pre and post-treatment) indicates that this shift was
evident in all participants. The loading of IL-8 onto axis 1, but not axis 2 indicates that
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Figure 5.6.1 Cytokine profiles elicited by S. haematobium cercariae differ 6 weeks post-
treatment relative to pre-treatment responses, but this change is less marked in adult
worm-specific cytokine responses. NMS ordination plots generated from Sorensen Bray-
Curtis distances between participant cytokine responses to CAP (top) and WWH (bottom)
plotted according to 2-dimensional axes. The proportion of variance in participant cytokine
2) is shown. Axis 2 of the WWH-specific
cytokine ordination plot was not strongly associated with any of the pre or post-treatment
cytokine responses assayed. Axes are labelled according to the cytokines with which they are
most strongly correlated (Table 5.2). Mean within-group differences reflect the total
variation between participant cytokine responses before (grey) and after (red) treatment.
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Figure 5.6.2 Cytokine profiles elicited by S. haematobium egg antigens and GST differ 6
weeks post-treatment relative to pre-treatment responses. NMS ordination plots
generated from Sorensen Bray-Curtis distances between participant cytokine responses to
SEA (top) and GST (bottom) plotted according to 2-dimensional axes. The proportion of
2) is shown.
Axes are labelled according to the cytokines with which they are most strongly correlated
(Table 5.2). Mean within-group differences reflect the total variation between participant
cytokine responses before (grey) and after (red) treatment.
Chapter 5 Post-treatment cytokine responses to schistosome antigens
- 165 -
Figure 5.6.3 Spontaneous cytokine production by peripheral blood cells differs 6 weeks
post-treatment relative to pre-treatment responses. NMS ordination plot generated from
Sorensen Bray-Curtis distances between participant cytokine responses in un-stimulated
whole blood cultures plotted according to 2-dimensional axes. The proportion of variance in
2) is shown. Axes are
labelled according to the cytokines with which they are most strongly correlated (Table 5.2).
Mean within-group differences reflect the total variation between participant cytokine
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participants differ in their IL-8 responses, despite the uniform up-regulation of inflammatory
cytokines after treatment. MRPP confirmed that egg-specific pre and post-treatment cytokine
profiles differed significantly more than would be expected by chance (T statistic: -97.01,
p<0.001, A: 0.396).
The 2-dimensional axes extracted from NMS of GST-specific cytokine responses (Figure
5.6.2) correlated negatively with IL-6 responses (Axis 1) and positively with IL-8 responses
(Axis 2). Mean distances differed for both Axis 1 and Axis 2 after treatment reflecting the
increase in inflammatory cytokine responses to GST after treatment (Figure 5.1). The
difference between pre and post-treatment GST-specific cytokines was confirmed by MRPP
(T statistic: -38.60, p<0.001, A: 0.114).
Spontaneous cytokine production was also affected by treatment with mean dissimilarities in
IL-8 (Axis 1) and IL-21 (Axis 2) after treatment differing to pre-treatment cytokine profiles
in un-stimulated whole blood cultures from the same individuals (Figure 5.6.3). However,
pre and post-treatment clusters were less distinct than those of CAP, SEA and GST-specific
responses, suggesting that the shift was less pronounced than in antigen-specific responses.
Dissimilarities between pre and post-treatment cytokine profiles in un-stimulated cultures
were significantly greater than those expected by chance (T statistic: -19.61, p<0.001, A:
0.042).
In addition to identifying significant difference/dissimilarity between pre and post-treatment
responses, NMS also indicates how uniform these treatment-related changes in cytokine
profile are within the cohort as indicated by distinct versus overlapping clusters on
ordination plot plots (Figure 5.6). Whilst CAP and SEA-specific pre and post-treatment
cytokine profiles form distinct clusters in almost all participants (A: 0.205 and 0.396
respectively), overlap between pre and post-treatment cytokine profiles in GST-stimulated
(A: 0.114) and un-stimulated cultures (A: 042), suggests that treatment-related changes in
GST-specific and spontaneous cytokine responses did not occur in all individuals.
Randomisation tests confirmed that patterns of CAP (Figure 5.6.1), SEA and GST (Figure
5.6.2)-specific cytokine responses and those present in un-stimulated cultures were reliably
represented by final 2-dimensional NMS solutions (i.e. relative patterns of pre- and post-
treatment cytokine responses were achieved with lower stress than that expected from
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randomly assorted data). Consistent with the lack of variation in WWH-specific cytokine
responses along axis 2 (Figure 5.6.1), these reliability criteria were met by 1, but not 2-
dimensional ordination of WWH-specific cytokines. Diagnostic statistics for all NMS
solutions are given in Appendix 3.
5.4.1 Cytokine profiles elicited by cercariae, adult worm and egg antigens 6
weeks post-treatment
Since treatment may alter exposure to the antigens of cercariae, adult worms and eggs
differently, I investigated whether the relative cytokine profiles elicited by CAP, WWH and
SEA were different 6 weeks post-treatment. Factor analysis was first used to identify CAP,
WWH and SEA-specific post-treatment cytokine profiles and extracted 3 PCs. As seen prior
to treatment, the majority of variation in cytokine responses was accounted for by
inflammatory cytokines (PC1). In addition, PC2 and PC3 were loaded with Th2 and Th17-
type cytokine responses (IL-2, IL-4, IL-13, IL-17A and IL-21) and a combination of innate
inflammatory and regulatory (IL-8 and IL-10) cytokines respectively. The factor analysis is
summarised in Table 5.4.
When regression factor scores for the extracted cytokine profiles were compared by
ANOVA (degrees of f, inflammatory (PC1, F2, 22: 28.081, p<0.001) and innate
inflammatory/regulatory (PC3, F2, 22:15.989, p<0.001) responses significantly differed
according to antigen stimulation. Th2/Th17-type responses (PC2, F2, 22: 0.608, p = 0.548) did
not differ according to parasite life-cycle stage. Post-hoc pair-wise comparisons between
antigens showed that inflammatory responses were significantly higher in response to egg
antigens relative to those of cercariae (T: 5.124, p<0.001) or adult worms (T: 7.313,
p<0.001). Inflammatory factor scores were also significantly higher in response to cercariae
than to adult worm antigens (T: 2.189, p = 0.031). Mean factor scores for innate
inflammatory/regulatory cytokine responses were highest in CAP-stimulated cultures
relative to SEA (T: 4.062, p<0.001) and WWH (T: 5.438, p<0.001). Results of the ANOVA
and all post-hoc tests were also significant at the Bonferroni-adjusted significance level.
Mean factor scores for each principal component are plotted by antigen in Figure 5.7.









IL-6 0.9 0.1 0.2
IL-8 0.6 -0.1 0.6
0.7 0.1 -0.2
IL-2 0.0 0.5 0.2
IL-12p70 0.8 0.1 -0.3
IL-4 -0.2 0.7 -0.3
IL-5 -0.1 0.1 0.0
IL-10 0.0 0.2 0.9
IL-13 -0.1 0.6 0.4
IL-17A -0.2 0.8 -0.1
IL-21 0.0 0.8 -0.1
IL-23 0.9 0.1 -0.1
% of total variance 30.3 19.8 11.5
Table 5.4. Factor analysis of life-cycle stage-specific whole blood cytokine responses 6
weeks after treatment. Table shows PCs 1-3 extracted by regression factor analysis and the
factor loadings for each of the square-root(x+1)-transformed S. haematobium cercariae, adult
worm and egg-specific post-treatment cytokine variables. Cytokines with factor loadings
-0.5 for an extracted PC are highlighted in bold. The cellular immune phenotype
with which the cytokines are associated is given for each PC. The percentage of total
variance in the dataset accounted for by each PC is given below the relevant column.
Chapter 5 Post-treatment cytokine responses to schistosome antigens
- 170 -
Figure 5.7. Cytokine profiles elicited by antigens of the different S. haematobium life-
cycle stages 6 weeks post-treatment. Mean regression factor scores for principal
components extracted from combined cytokine responses to cercariae (CAP), adult worm
(WWH) and egg (SEA) antigens plotted by antigen. Factor scores were compared between
antigens by ANOVA. Error bars: standard error of the mean,*p<0.05, ***p<0.001
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5.5 Discussion
Praziquantel treatment is known to affect the immune responses to schistosome antigens and
may do so either by directly killing parasites and exposing their antigens to immune
recognition (Harnett and Kusel 1986; Redman et al. 1996) or indirectly by removing
immunosuppressive mechanisms mediated by live parasites. Despite many studies
investigating pre and post-treatment antibody (Grogan et al. 1996b; Mutapi et al. 1998a;
Mutapi et al. 1998b; Mutapi et al. 2003; Fitzsimmons et al. 2004; Mutapi et al. 2005) and
cytokine (Roberts et al. 1987; van den Biggelaar et al. 2002; Fitzsimmons et al. 2004;
Joseph et al. 2004b; Reimert et al. 2006) responses to schistosome antigens, none have
simultaneously assessed changes in responses to cercariae, adult worm, egg and vaccine-
candidate antigens and spontaneous cytokine levels. Furthermore, no previous studies have
incorporated changes in innate inflammatory and Th17-type cytokines into their comparison
of pre and post-treatment responses.
Comparison of pre and 6 week post-treatment cytokine responses to each antigen identified a
dramatic increase in pro-inflammatory cytokine responses to egg antigens and to a lesser
extent cercariae and GST -6, IL-8,
-2, IL-12p70 and IL-23 relative to pre-treatment levels and from the marked shift
towards a more pro-inflammatory cytokine phenotype following treatment. The shift in
SEA-specific inflammatory cytokine profiles after treatment was seen in the vast majority of
individuals, consistent with a uniform increase in cellular responsiveness to SEA antigens in
vitro. With the exception of an increase in IL-13, no significant difference in SEA-specific
Th2-associated cytokines was observed relative to pre-treatment levels. In contrast, adult
worm- IL-6 and IL-8) cytokine responses were lower
post-treatment and no significant difference was observed in the post-treatment cytokine
profile relative to that observed prior to treatment. Consistent with these observations, egg
antigens were found to elicit the most pro-inflammatory cytokine profile of the 3
schistosome life-cycle stages post-treatment. This was in contrast to pre-treatment
inflammatory cytokine responses which where highest in response to cercariae (chapter 3).
It is striking that whilst the effects of anti-helminthic treatment are usually reported for adult
worms (Becker et al. 1980; Hassan et al. 1998; Shuhua et al. 2000; Gnanasekar et al. 2009),
the greatest change in whole blood cytokine responses identified in the current study
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occurred in response to cercariae and egg antigens. Responses to egg and cercariae may also
be boosted by adult worm death since antigens released from dying adult worms upon
treatment will contain a cocktail of adult-worm specific antigens and antigens shared with
cercariae and eggs (Curwen et al. 2004). In particular, death of fecund adult female worms
may also increase exposure to immature eggs, which do not have a fully-developed
(Ashton et al. 2001), and thus immune-recognition of somatic egg antigens may be
particularly enhanced. The low responsiveness to WWH may be partly due to early and rapid
removal of adult worms and their antigens from the circulation following treatment (Hassan
et al. 1998). In contrast to adult worms, repeated exposure to cercariae during domestic
water contacts (Butterworth et al. 1985) and prolonged excretion of live and dead eggs
trapped in host tissues following treatment (McMahon and Kolstrup 1979; Tchuem Tchuente
et al. 2004) may mean that the immune system continues to be exposed to the antigens of
these life-cycle stages during the 6 weeks following treatment. My observations do not
preclude the possibili
earlier post-treatment timepoints, but indicate that these effects have declined by 6 weeks
after treatment. This would be consistent with work in S. mansoni identifying a decline in
adult worm-specific immune responses within 24 hours of treatment (Fitzsimmons et al.
2004) and only short-lived changes in plasma cytokine levels and eosinophil-associated
proteins (Reimert et al. 2006). S. haematobium-specific whole blood cytokine responses also
exhibit distinct patterns of secretion within the first 24 hours of treatment that are no longer
detectable at 72 hours post-treatment (Scott et al. 2000). Whilst these early changes in adult
worm-specific cytokine responses are of interest, it is unclear whether they contribute to
longer-term changes in the host cytokine environment subsequent to the initial release of
antigens from dying worms.
Inflammatory cytokine responses to both cercariae and egg antigens may also increase after
treatment due to disruption of immunosuppression mediated by live adult parasites during
chronic infection (Maizels and Yazdanbakhsh 2003). This hypothesis is supported by the
observation that treatment-induced clearance of adult S. mansoni leads to a decline in
circulating Treg numbers, suggesting that chronic infection may elevate immunoregulatory
responses in the periphery (Watanabe et al. 2007). This may be of particular relevance for
egg-specific cellular responses, which tend to be high during acute infection and hypo-
proliferative in chronically-infected participants prior to treatment (Caldas et al. 2000). For
example, cytokines such as IL- -induced
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immunopathology in mice (Brunet et al. 1997; Chiaramonte et al. 1999) and humans
(Wamachi et al. 2004; Martins-Leite et al. 2008) and Th1- -
12p70), which are a feature of acute schistosomiasis in mice (Grzych et al. 1991; Pearce and
MacDonald 2002) and tend to be lower in chronically-infected than in un-infected humans
(Mduluza et al. 2003; Silveira et al. 2004; Wilson et al. 2008), were significantly higher after
treatment. Perhaps therefore, after clearance of patent infection by treatment and associated
immunoregulation by live parasites, endemically-exposed humans regain the capacity to
-inflammatory cytokine profile. These
changes in the SEA-specific effector cytokine profile do not appear to result from changes in
the egg-specific regulatory cytokine IL-10, which is not significantly affected by treatment.
However, it is possible that alternative mechanisms regulating SEA-specific immune
responses may be reduced by treatment. However in the absence of functional assays, it is
not possible to draw conclusions about the effect of these changes on the shift in post-
treatment cytokine profiles. On-going investigation of the PBMCs collected from the same
individuals may help to elucidate how lymphocyte phenotype and schistosome-specific
cytokine responses relate to those produced in whole blood culture.
In contrast to SEA, post-treatment increases in CAP-specific IL-8, IL-2, IL-13 and IL-21
responses coincided with an increase in IL-10, which is similar to the association between
CAP-specific inflammatory cytokine responses and IL-10 seen before treatment (chapter 3),
albeit at elevated concentrations. Repeated exposure to S. mansoni cercariae is known to up-
regulate both inflammatory and regulatory responses in the skin of mice (Hogg et al. 2003b;
Cook et al. 2011) and fibrotic pathology in baboons (Farah et al. 2000) and exposure to
infective cercariae between treatment and post-treatment follow-up may partly explain this
combined response to CAP in the study cohort. Results from Magaya community suggest
that stimulation of both innate inflammatory and regulatory cytokine production is a
particular characteristic of S. haematobium cercarial antigens, but not WWH and SEA, both
before and after treatment. IL-10 derived from innate immune cells appears to be particularly
important for the regulation of early inflammatory cytokine responses to cercariae in
laboratory mice (Hogg et al. 2003b) and this may also be the case after treatment in humans
where cercariae-specific inflammatory cytokine responses are elevated and potentially
damaging to the host.
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It is interesting that the increase in cytokine responsiveness to SEA and CAP was essentially
uniform throughout the cohort, suggesting that these changes occurred in all participants
regardless of whether they were egg-positive or egg negative at the time of treatment. Thus
the change in cytokine responses due to treatment was not solely attributable to the removal
of live adult worms. It is possible that parasitological examination may have under-estimated
S. haematobium and S. mansoni infections in the cohort and that cytokine responses were
sensitive to removal of these light infections, as has been proposed for S. haematobium egg-
specific antibody responses (Mutapi et al. 1998b). However, even with this possibility in
mind, it is unlikely that all participants who responded differently after treatment were
infected at the time of treatment. It seems more probable that post-treatment changes in the
cytokine responses of participants with no detectable infection may have resulted from the
effect of praziquantel on immature parasites present as pre-patent infections or residuals
from previous infections (e.g. eggs sequestered in host tissues) (McMahon and Kolstrup
1979; Gnanasekar et al. 2009). Although there is evidence for a direct effect of praziquantel
on immature schistosomes in vitro (Liang et al. 2001) and indirect evidence for an effect
after oral administration (Xu et al. 1988; Giboda and Smith 1994) it remains un-clear
whether treatment alters the host immune response in the absence of adult worms. The
relationship between SEA-specific responses and pre-treatment infection intensity is
investigated further in chapter 6, but due to the small number of participants who provided
sufficient sample volumes for CAP-stimulation this was not possible for cercarial antigens.
The increased levels of inflammatory cytokines and IL-13 elicited by GST after treatment is
consistent with studies showing that treatment increases exposure of GST on the adult worm
surface (visualised in adult S. mansoni from praziquantel treated mice (Dupre et al. 1999))
and identification of greater reactivity of serum antibodies to GST isoforms after
praziquantel treatment of S. haematobium-exposed humans (Mutapi et al. 2005). With
respect to its potential as an anti-fecundity vaccine targeting adult worms, post-treatment
changes in GST-specific cytokine responses are of particular interest since pre-treatment
cellular immune responses to S. haematobium GST appear to be low (Remoué et al. 2001)
and high intensity infections are associated with lower levels of GST-specific antibody
responses in human population studies (Remoué et al. 2000). Thus, the results of the current
study suggest that the efficacy of a GST-based vaccine may be enhanced by co-
administration with praziquantel and the associated boost in effector cytokine responses I
have observed. The benefit of co-administering a GST vaccine with praziquantel has been
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previously demonstrated for adult worm-specific vaccination studies in murine infection
models (Doenhoff et al. 1987; Dupre et al. 1999).
Clearance of adult worms after drug-induced paralysis is known to be partially-dependent on
(Doenhoff et al. 1987) and it is tempting to speculate
that GST may be one of several antigens involved in driving this process. However, it is
noteworthy that despite the expression of GST by adult parasites (Balloul et al. 1985;
Curwen et al. 2004), cytokine responses to WWH and GST showed distinct patterns
following treatment. This is perhaps un-surprising given the variety of other antigens present
in WWH; however the large increase in inflammatory cytokine responses to GST, but not to
WWH, suggests that GST is not a dominant immunogen of WWH. It is possible that the
GST used here, which was purified and expressed in E. coli, differ from those present in the
WWH but are similar to those present in other life cycle stages (Curwen et al. 2004) or lacks
the post-translational modifications present in the native protein. Alternatively, cytokine
responses to GST present in WWH may peak at earlier time points following treatment
(Hassan et al. 1998) and those observed 6 weeks after treatment are more reflective of
responses to GSTs expressed by larvae and eggs. The relative contributions of different GST
isoforms to the cytokine responses elicited by crude antigen preparations could be better
assessed in future studies by stimulation of whole blood with equivalent concentrations of
purified GST and combinations of isoforms isolated from the different life-cycle stages. This
approach might also provide information on whether intra-specific variation between the
different parasite strains from which antigens were isolated (i.e. Senegalese and Egyptian)
might influence the efficacy of a GST-based vaccine (Galvani 2005).
Although there is considerable precedent for our findings, the elevated whole blood cytokine
responses to S. haematobium egg antigens after treatment and un-changed responses to adult
worm antigens are in marked contrast to some S. mansoni studies. For example Roberts and
colleagues found that adult worm antigens elicited higher or equivalent cytokine production
-2, IL-4 and IL-5) to that of egg antigens 3 months after treatment (Roberts
et al. 1993). Subsequent studies by the same group have also shown very little change in
SEA-specific cytokine responses 7 weeks after treatment relative to pre-treatment levels
(Joseph et al. 2004b). Importantly, these S. mansoni studies were conducted in an area of
hyper-endemicity and administration of a double dose of praziquantel and the inclusion of
participants with persistent infection (20%) in analyses may also have contributed to the
elevated adult worm-specific responses relative to my findings (Joseph et al. 2004b). The
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variation between the findings of human studies provides a strong case for continued
investigation in this area in order to elucidate how the efficacy of mass treatment programs
implemented in communities with distinct transmission intensities differ and how repeated
treatment may influence immune post-treatment relative to a single anti-helminthic dose.
The latter has been investigated in S. haematobium using treatment at 3 month intervals,
showing that SEA-specific antibody responses to SEA differed (higher IgE and lower IgG4)
in children who received both single and repeated doses relative to un-treated children and
particularly so after multiple treatments, however SEA-specific cytokine responses were not
investigated (van den Biggelaar et al. 2002). Consistent with the observations of my study of
whole blood cytokine responses, PBMC Th2-type cytokine responses were not significantly
higher than un-treated children 3 months after a single dose of praziquantel but were higher
in repeatedly treated children (van den Biggelaar et al. 2002).
Due to the high intensity of infections in Magaya community all participants received
treatment and thus it was not possible to compare post-treatment cytokine responses to an
un-treated control group. Thus, whilst the follow-up study was conducted within weeks of
initial sampling and there were no obvious environmental or behavioural changes during this
period, the possibility that differences in the cytokine profiles measured are due to temporal
changes in cercarial exposure in the study cohort cannot be excluded. However, exclusion of
non-permanent residents of the area and conducting both pre and post-treatment surveys
during the dry season minimised this possibility. Furthermore, the use of identical culture
conditions and antigen preparations in the field and ELISA reagents and protocols for
subsequent cytokine assays mean that methodological differences between pre and post-
treatment cytokine responses are highly unlikely.
5.6 Conclusions
The results of the current chapter suggest firstly that the antigens of S. haematobium
cercariae, adult worms and eggs continue to elicit distinct cytokine profiles following
treatment with praziquantel. Furthermore, a single dose of anti-helminthic is associated with
dramatic changes in the parasite-specific cytokine responses of endemically-exposed
participants that persist for up to 6 weeks after treatment. These treatment-related changes
are predominantly due to an increase in inflammatory cytokines to egg antigens and to a
lesser extent cercarial antigens and the vaccine candidate antigen GST. When considered
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together, the cytokine profiles elicited by adult worm antigens after treatment were not
significantly altered relative to pre-treatment profiles in the same cohort.
Thus, treatment induced changes in the cytokine responses to S. haematobium have potential
relevance to the development of resistance to subsequent re-infection, as explored in chapter
6. In particular the increased cytokine response to GST after treatment is consistent with
studies identifying increased exposure of this antigen after treatment and the potential for
treatment to boost the efficacy of a GST-based anti-schistosome vaccine. The latter
observation supports current recommendations that schistosome vaccine strategies should
incorporate a treatment aspect.
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Chapter 6
Relating changes in post-treatment cytokine profiles to pre-
treatment Schistosoma haematobium infection intensity and
the risk of re-infection
6.1 Introduction
Treatment-re-infection studies have identified an association between parasite-specific
antibody titres (Hagan et al. 1991; Mutapi et al. 1999; Caldas et al. 2000) and cellular
proliferative responses (Colley et al. 1986) and a reduced risk of re-infection. However, the
association between cytokine responses and the risk of re-infection is more controversial
(Roberts et al. 1993; Medhat et al. 1998; van den Biggelaar et al. 2002) due to
inconsistencies in study populations and cytokines assayed in studies conducted to-date
(chapter 1.8.3).
In chapter 5 I showed that treatment of Magaya community lead to a change in parasite-
specific cytokine responses relative to pre-treatment levels and the initial aim of this chapter
is to address how host characteristics and infection levels prior to treatment contribute to
variation in the magnitude of this change. In particular, since the effect of treatment on
parasite-specific immune responses is related to exposure of parasite antigens (Harnett and
Kusel 1986; Dupre et al. 1999) and/or removal of immunosuppression by live parasites
(Woolhouse and Hagan 1999), I hypothesised that post-treatment changes would be
influenced by pre-treatment parasite density (i.e. infection intensity).
Using longitudinal data on re-infection within Magaya community I subsequently investigate
whether post-treatment cytokine profiles affect the risk of re-infection within 18 months of
treatment. As in previous chapters I have assayed a panel of 13 cytokines to avoid inferring
the schistosome-specific cellular immune polarisation from a limited sub-set of biomarkers.
Furthermore, I have focused on adult worm and egg-specific cytokine responses, because
these stages of the schistosome life-cycle are most closely related to infection intensity
quantified via urine egg counts, and because both are simultaneously present during
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infection. This is also the first study to investigate whether post-treatment cytokine responses
to the vaccine candidate glutathionine-S-transferase (GST) correspond to a reduced risk of
re-infection.
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6.2 Hypotheses
Pre-treatment infection intensity influences the magnitude of change in parasite-
specific cytokine responses 6 weeks after treatment
S. haematobium-specific cytokine profiles 6 weeks after treatment influence the risk
of re-infection within 18 months of treatment
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6.3 Materials and Methods
6.3.1 Study participants
This aspect of the study includes the same cohort of participants as chapter 5 (n = 94). These
participants were included according to the following criteria:1) provided a minimum of 2
urine samples before and after treatment for quantification of S. haematobium infection, 2)
were negative for co-infections (S. mansoni, STH, malaria and HIV) before and after
treatment, 3) had received a single dose of praziquantel (40mg/kg) 6 weeks earlier (but had
not received treatment for schistosomiasis prior to recruitment), 4) were successfully cleared
of S. haematobium infection or remained un-infected 6 weeks after treatment (defined as no
eggs detectable in urine samples), 5) were life-long permanent residents of the study area and
6) provided a venous blood sample of sufficient volume to conduct whole blood cultures
both before and 6 weeks after treatment. The demographic and pre-treatment infection
characteristics of the participants followed up post-treatment are summarised in Table 6.1.
Age group (years)
5 - 10 11 12 13+
n 53 18 23
Mean age 7.6 11.6 30.4
Number of males: females 32:21 7:11 11:12
Mean pre-treatment infection intensity*(S.E.M.) 31.52 (12.45) 59.85 (32.00) 10.35 (4.29)
Pre-treatment infection range* 0 - 481 0 - 502 0 - 91
Pre-treatment infection prevalence (%) 52.8 61.1 56.5
Table 6.1. Demographic and pre-treatment S. haematobium infection characteristics of
each age group included in 6 weeks post-treatment cytokine analysis. *Infection
intensity quantified as mean egg counts/10ml urine. S.E.M. standard error of the mean.
The relationship between 6 weeks post-treatment cytokine responses and re-infection status
18 months after treatment was investigated in 53 of the individuals who met the above
inclusion criteria and provided follow-up samples for parasitological analyses at subsequent
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sampling visits. Of these individuals, 43 were followed-up 6 months post-treatment and all
provided samples 18 months post-treatment. The characteristics of the participants included
in the re-infection study are summarised in Table 6.2.
Age group (years)
5 - 10 11 12 13+
n 38 10 5
Mean age 7.6 11.6 13.4
Number of males: females 23:15 4:6 4:1
Mean pre-treatment infection intensity*(S.E.M.) 34.41 (16.32) 21.70 (13.79) 39.75 (19.09)
Pre-treatment infection range* 0 - 481 0 - 137 0 - 91.33
Number of re-infected participants** 11 3 1
Table 6.2. Demographic and pre-treatment S. haematobium infection characteristics of
each age group included in 18 months re-infection analysis. *Infection intensity
quantified as mean egg counts/10ml urine. S.E.M. standard error of the mean. **Re-
infection classified as presence of one or more S. haematobium eggs in urine at 6 months or
18 months post-treatment.
6.3.2 Immunological assays
Whole blood samples collected 6 weeks after treatment were cultured for 48 hours with
S. haematobium whole worm homogenate (WWH), soluble egg antigen (SEA), 2
GST or left un-stimulated as controls for spontaneous cytokine production. Parallel
PHA-stimulated (2 g/ml) cultures acted as positive controls, indicating the viability and
potential of cultured whole blood cells to secrete cytokines in response to non-parasite
antigens.
-6 and IL- -2 and IL-12p70), Th2 (IL-4, IL-
5, IL-10 and IL-13) and Th17 (IL-17A, IL-21 and IL-23)-type cytokines were assayed in
culture supernatants via enzyme-linked immunosorbent assay (ELISA) as described in
Chapter 2.3.5.5.
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6.3.3 Statistical Analyses
The change in cytokine responses to adult worm and egg antigens after treatment was
obtained by subtracting pre-treatment cytokine levels (un-transformed) from 6 weeks post-
treatment cytokine levels (un-transformed). It was considered important to assess the
magnitude of change relative to pre-treatment levels rather than post-treatment cytokine
responses alone to account for the existing variation between participant cytokine responses
observed before treatment (chapter 3). These changes were then grouped by factor analysis
to identify principal components (PCs) corresponding to patterns of treatment-related
changes in cytokine responses to S. haematobium antigens. High regression factor scores for
extracted components correspond to a greater change in cytokine responses positively
) and a lesser change in cytokine responses
-0.5) ) relative to pre-treatment
responses. All WWH and SEA-specific cytokine changes were included in the same analysis
as separate factors so that any differences in SEA and WWH-specific responses would also
be characterised by the resulting PCs. A separate factor analysis was conducted for the
change in GST-specific cytokine responses after treatment.
To address the hypothesis that treatment-related changes in cytokine profiles were dependent
on pre-treatment infection levels, factor scores for each extracted PC (i.e. the cytokine
profiles most affected by treatment) were analysed as dependent variables via analysis of
variance (ANOVA). Sequential sums of squares were used to account for variation due to
sex and age group (5-10, 11-12 and 13+ years). Identification of age groups according to the
age range at which infection intensity is increasing (5-10 years), peaking (11-12 years) and
declining (13+ years) within Magaya community is described in chapter 2.3.7. The
interaction between age group and pre-treatment infection intensity was included in the
ANOVA to identify whether the effect of pre-treatment infection intensity was age-
dependent. Exploratory analysis verified that regression factor scores for all PCs and
residuals of ANOVA models met parametric assumptions. Post-hoc analysis of the
correlation between the residuals of pre-treatment infection intensity and the residuals of the
PC 2-
tailed correlation procedure. Where the interaction between pre-treatment infection intensity
and age group was found to significan
correlation analysis was also conducted separately for each age group to investigate how age
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influenced the relationship between the residual variation in post-treatment changes in host
cytokine profiles and the residual variation in pre-treatment infection intensity after
accounting for variation due to age and sex.
To characterise the cytokine profiles that result from treatment square root(x+1)-transformed
6 weeks post-treatment cytokine responses were reduced into a smaller number of variables
by factor analysis. This analysis only included the cytokine responses of participants who
provided samples for parasitological analysis 18 months after treatment (n = 53). WWH and
SEA-specific cytokine responses 6 weeks post-treatment were entered into a single factor
analysis and a separate analysis was conducted for GST-specific responses.
Binary logistic regression was subsequently used to investigate whether S. haematobium-
specific 6 weeks post-treatment cytokine profiles were significant predictors of re-infection
within 18 months of treatment. I chose to investigate the effect of post-treatment cytokine
responses, rather than pre-treatment responses as investigated in previous studies (Hagan et
al. 1991; Mutapi et al. 1999; Caldas et al. 2000), since re-infection occurs in the context of
treatment-altered immune responses. Binary logistic regression was conducted for WWH
and SEA-specific cytokine profiles and separately for GST-specific cytokine profiles The
dependent variable was re-infection status and indi -
if they had 1 or more S. haematobium eggs detectable in any of their urine samples 6 months
or 18 months post- - -treatment
timepoints. Sex (male, female), age (covariate), pre-treatment infection intensity (covariate)
and all adult worm and egg-specific cytokine profiles at 6 weeks post-treatment (i.e. 6 week
post-treatment PC factor scores) were included as predictors in the final model so that each
was analysed holding all other potential predictors constant. The Wald X2 statistic was used
to assess whether the coefficient (B) of each linear predictor in the model was greater than 0
(Sokal and Rohlf 1995d) and predictors were considered to contribute significantly to the
risk of re-infection if p<0.05. Hosmer Lemeshow (H-L) tests, which compare model
predictions with the original re-infected/and un-infected data, were used to determine
whether regression models appropriately fit the original data. Models were considered an
acceptable fit when the significance of the associated H-L test statistic was >0.05. For
significant predictors of re-infection status, mean scores of cytokine profiles were compared
between un-infected and re-infected groups by post-hoc un-paired, 2- -test.
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Results of each set of comparisons were corrected for multiple comparisons using the
sequential Bonferroni method (Holm 1979; Rice 1989) and results significant after
correction are indicated alongside raw p-values.
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6.4 Results
6.4.1 The effect of pre-treatment infection intensity on the change in adult
worm and egg-specific cytokine profiles 6 weeks post-treatment
Changes in WWH and SEA-specific cytokine responses 6 weeks after treatment were
grouped into 4 PCs (Table 6.3). Unlike factor analysis of pre-treatment cytokine responses,
for which SEA and WWH-specific responses grouped into similar cytokine profiles (chapter
4), post-treatment changes in SEA- and WWH-specific cytokine responses loaded onto
distinct PCs. The latter reflects the large increase in cytokine responses to SEA, but less
pronounced changes in WWH-specific cytokine responses post-treatment (chapter 5).
The greatest change in cytokine responses due to treatment was seen in PC1, which
corresponded to a mixed profile of egg-specific cytokines including innate inflammatory (IL-
6), Th1 -12p70), Th2 (IL-4) and Th17 (IL-23)-type cytokines. The change in
IL-4 responses to adult worm antigens was also significantly loaded onto this component
(PC1). PC2 reflected changes in all adult-worm-specific Th17-type cytokines (IL-17A, IL-21
and IL-23) and was negatively correlated with changes in egg- -13.
Changes in adult worm-specific innate (IL-6 and IL- -23)-type
pro-inflammatory cytokines were grouped in PC3. PC4 was negatively correlated with
changes in adult worm and egg-specific IL-21.
Factor scores for the post-treatment change in mixed cytokine responses to egg antigens
(PC1) and egg and adult worm-specific IL-21 (PC4) were significantly affected by pre-
treatment infection intensity (not significant after Bonferroni correction). Post-
correlation analysis indicated that the relationship was positive for both PC1 and PC4. The
positive correlation between pre-treatment infection intensity and PC4 is indicative of a
negative correlation with the change in IL-21 responses to adult worm and egg antigens,
which are negatively loaded onto the component. Thus, whilst participants with high pre-
treatment infection intensity had a greater increase in PC1-type responses, treatment lead to
lesser changes in PC4-type responses in these individuals. These patterns were independent
of host age group and the interaction between host age group and pre-treatment infection
intensity. Factor scores for each component are plotted against pre-treatment infection
intensity in Figure 6.1. Results of ANOVA and post-hoc tests are summarised in Table 6.4.
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Principal component
1 2 3 4




SEA 0.4 -0.5 0.1 -0.3
WWH 0.2 0.4 0.7 0.2
-6 SEA 0.7 -0.2 0.4 -0.1
WWH -0.1 0.3 0.6 -0.1
-8 SEA -0.1 -0.2 0.2 -0.1
WWH 0.0 0.4 0.0 -0.3
SEA 0.5 -0.3 0.1 -0.3
WWH 0.0 0.3 0.5 0.3
-2 SEA -0.2 -0.1 0.1 0.4
WWH -0.2 0.2 -0.1 0.3
-12p70 SEA 0.6 -0.3 0.3 0.1
WWH 0.0 0.3 0.3 0.2
-4 SEA 0.5 0.1 -0.3 0.4
WWH 0.5 0.1 -0.1 0.3
-5 SEA 0.3 0.0 -0.2 0.4
WWH 0.4 0.0 -0.2 0.4
-10 SEA -0.3 0.0 0.3 -0.2
WWH -0.3 -0.1 0.2 -0.3
-13 SEA -0.4 -0.5 0.1 0.3
WWH -0.4 -0.4 0.1 0.3
-17A SEA 0.3 0.4 -0.2 0.2
WWH 0.4 0.5 -0.2 0.0
-21 SEA 0.0 0.3 -0.2 -0.5
WWH -0.1 0.5 -0.3 -0.5
-23 SEA 0.6 -0.4 0.3 -0.3
WWH 0.1 0.5 0.5 0.1
% of total variance 12.2 10.3 9.4 8.4
Table 6.3. Factor analysis of the change in adult worm and egg-specific cytokine
responses 6 weeks post-treatment relative to pre-treatment levels (n = 94). Table shows
PCs 1-
between post-treatment and pre-treatment cytokine responses elicited by S. haematobium
whole worm homogenate (WWH) and soluble egg antigen (SEA). Cytokines with factor
loadings -0.5 for an extracted PC are highlighted in bold. The cellular immune
phenotype with which the cytokines are associated is given for each PC. The percentage of
total variance in the dataset accounted for by each PC is given below the relevant column.
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Figure 6.1. Post-treatment changes in a mixed profile of egg-specific cytokine responses
(PC1) and in adult worm and egg-specific IL-21 (PC4) are associated with pre-
treatment infection intensity (n = 94). Residual variation in PC factor scores for each
cytokine profile after accounting for sex and age group are plotted against residuals of pre-
treatment infection intensity (log10(mean egg counts/10ml urine +1)-transformed
r and the associated p-value are given to indicate direction and significance of the
correlation. Significant correlations are highlighted in bold and under-lined. ve IL-21 IL-
21 is negatively associated with PC4 and therefore higher PC4 factor scores correspond to a
lesser change in IL-21 responses
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6.4.2 The effect of pre-treatment infection intensity on the change in GST-
specific cytokine profiles 6 weeks post-treatment
Factor analysis of the change in GST-specific cytokine responses extracted 3 cytokine
profiles associated with the greatest magnitude of change post-treatment. PC1 was loaded
with chang -6, IL-12p70 and IL-23) and
negatively loaded with the change in IL-10, indicating that individuals with large changes in
pro-inflammatory cytokines after treatment had less marked changes in IL-10. PC2 had a
positive loading with changes in IL-2 and IL-13, but a negative loading with changes in IL-4.
PC3 reflected changes in both innate inflammatory (IL-8) and Th17 (IL-21)-associated
cytokines. The factor analysis is summarised in Table 6.5.
GST-specific inflammatory cytokine responses (PC1) were not significantly correlated with
pre-treatment infection intensity alone, but were significantly influenced by the interaction
between host age group and pre-treatment infection intensity (not significant after Bonferroni
correction). Correlation analysis of this relationship by age group indicated that the change
in GST-specific inflammatory cytokines was significantly negatively correlated with pre-
treatment infection intensity in 11-12 year olds, in whom infection intensity is peaking.
Interestingly 5-10 year olds, in whom infection intensity is increasing, showed the opposite
relationship, although this trend was not statistically significant.
Changes in PC2, reflecting a greater change in IL-2 and IL-13 and lesser change in IL-4,
were significantly negatively correlated with pre-treatment infection intensity, although the
effect of infection intensity was not significant after Bonferroni correction for multiple
comparisons. This relationship was independent of host age group and sex.
PC3 was not significantly affected by sex, age group, pre-treatment infection intensity or the
interaction between age group and pre-treatment infection intensity.
Factor scores for each GST-specific PC are plotted in Figure 6.2 and GST-specific
inflammatory cytokine responses (PC1) are plotted by infection intensity for each age group
in Figure 6.3. Statistical analyses are summarised in Table 6.6.










GST 0.8 0.1 0.3
-6 GST 0.6 0.1 0.5
-8 GST 0.1 0.4 0.1
GST 0.4 -0.1 0.4
-2 GST 0.0 0.5 -0.2
-12p70 GST 0.6 -0.2 -0.2
-4 GST -0.1 -0.5 0.2
-5 GST -0.1 -0.2 0.3
-10 GST -0.6 0.3 0.4
-13 GST 0.2 0.7 -0.3
-17A GST -0.2 -0.4 0.2
-21 GST -0.3 0.4 0.6
-23p19 GST 0.6 0.0 0.1
% of total variance 18.7 12.6 10.6
Table 6.5. Factor analysis of the change in GST-specific cytokine responses 6 weeks
post-treatment relative to pre-treatment levels (n = 94). Table shows principal
components (1-3) extracted by regression factor analysis and the factor loadings for the
-treatment and pre-treatment cytokine responses elicited by S.
haematobium GST. Cytokines with factor loadings -0.5 for an extracted PC are
highlighted in bold. The cellular immune phenotype with which cytokines are associated is
given for each PC. The percentage of total variance in the dataset accounted for by each PC
is given below the relevant column.
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Figure 6.2. Variation in the magnitude of change in GST-specific IL-2, IL-13/ IL-4
responses (PC2) after treatment is associated with pre-treatment infection intensity (n
= 94). Residual variation in factor scores for each cytokine profile after accounting for sex
and age group are plotted against residual variation in pre-treatment infection intensity
(log10(mean egg counts/10ml urine+1)-transformed -value
are given to indicate direction and significance of the correlation. Significant correlations are
highlighted in bold and under-lined. ve IL-4 - IL-4 is negatively associated with PC2 and
therefore higher PC2 factor scores correspond to a lesser change in IL-4 responses




































Figure 6.3. The increase in GST-specific inflammatory cytokine responses is negatively
correlated with pre-treatment infection intensity in 11-12 year olds. Factor scores for
-6, IL-12p70 and IL-23 responses, are plotted against
pre-treatment infection intensity (mean egg counts/10ml urine) for each age group. Since
PC1 is negatively associated with IL-10, high factor scores reflect a lesser change in IL-10.
-value are given to indicate direction and significance of the
correlation within each age group. Significant correlations are highlighted in bold and under-
lined.
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6.4.4 Re-infection 6 months and 18 months post-treatment
Of the 53 individuals included in the longitudinal post-treatment follow-up of S.
haematobium infection levels, 15 were re-infected within 18 months of infection clearance
by treatment. Infection intensity and prevalence of S. haematobium eggs in urine before, 6
weeks, 6 months and 18 months post-treatment are shown in Figure 6.4.
Figure 6.4. S. haematobium infection intensity and prevalence before and 6 weeks, 6
months and 18 months after praziquantel treatment. Bar chart shows mean infection
intensity of the cohort prior to treatment (n = 53) and at each follow-up visit post-treatment:
6 (n = 53), 24 (n =43) and 72 (n = 53) weeks. Black line indicates change in infection
prevalence over time. Error bars: standard error of the mean.
6.4.4 Adult worm and egg-specific cytokine profiles 6 weeks post-treatment
and the risk of re-infection
Adult worm and egg-specific cytokine responses at 6 weeks post-treatment for the 53
individuals with re-infection data were grouped into 7 PCs which reflected distinct patterns
of responses to adult worm and egg-stage parasite antigens. The factor analysis is
summarised in Table 6.7.
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Principal components






















TNF SEA -0.5 0.4 0.0 -0.3 0.1 0.5 -0.1
WWH 0.5 0.3 0.1 -0.1 0.0 0.0 -0.4
IL-6 SEA -0.6 0.7 0.0 0.0 0.3 0.1 0.0
WWH -0.1 0.2 0.8 0.2 0.1 0.1 0.3
IL-8 SEA -0.2 0.2 -0.2 -0.4 -0.2 0.0 0.5
WWH -0.1 0.2 0.8 0.3 0.2 0.0 0.3
SEA -0.2 0.6 -0.2 -0.4 0.0 -0.1 -0.3
WWH 0.2 0.3 -0.2 -0.2 -0.1 -0.6 0.5
IL-2 SEA 0.7 0.1 0.1 -0.1 0.2 -0.3 0.0
WWH 0.8 0.1 0.1 0.0 0.2 0.1 -0.2
IL-12 SEA -0.3 0.7 0.0 -0.2 0.0 -0.3 0.1
WWH 0.4 0.1 0.2 -0.2 0.5 -0.1 -0.1
IL-4 SEA 0.2 0.1 -0.4 0.5 0.6 0.1 0.1
WWH 0.1 0.1 -0.4 0.6 0.3 0.0 0.1
IL-5 SEA 0.0 0.2 -0.4 0.4 0.5 0.1 0.2
WWH -0.1 0.4 -0.4 0.3 0.2 0.1 -0.1
IL-10 SEA 0.7 0.1 0.0 -0.3 0.0 0.3 0.2
WWH 0.6 0.3 0.1 -0.5 0.3 -0.2 -0.2
IL-13 SEA 0.6 0.1 -0.1 -0.4 0.0 0.5 0.3
WWH 0.7 0.1 0.0 -0.2 -0.1 0.4 0.2
IL-
17A
SEA 0.3 0.4 0.4 0.5 -0.4 0.1 0.0
WWH 0.4 0.3 0.2 0.5 -0.5 0.1 -0.2
IL-21 SEA 0.2 0.5 -0.3 0.2 -0.3 -0.3 0.0
WWH 0.5 0.5 -0.2 0.3 -0.4 0.0 -0.1
IL-23 SEA -0.5 0.6 0.0 -0.2 0.0 0.3 -0.1
WWH 0.1 0.2 0.7 0.0 0.3 -0.2 -0.1
% of total variance 19.2 12.9 11.1 9.9 7.6 6.0 5.4
Table 6.7. Factor analysis of adult worm and egg-specific cytokine responses at 6 weeks
post-treatment (n = 53). Table shows PCs 1-7 extracted by regression factor analysis and
the factor loadings for post-treatment cytokine responses elicited by S. haematobium whole
worm homogenate (WWH) and soluble egg antigen (SEA). Cytokines with factor loadings
0.5 or -0.5 for an extracted PC are highlighted in bold. The cellular immune phenotype
with which the cytokines are associated is given for each PC. The percentage of total
variance in the dataset accounted for by each PC is given below the relevant column.
inflamm - inflammatory
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Having characterised the main post-treatment cytokine profiles mounted in response to
WWH and SEA in vitro, I investigated whether these responses were related to the risk of
subsequent re-infection. Binary logistic regression of re-infection status within 18 months of
treatment holding other potential risk factors for re-infection (sex, age group, pre-treatment
infection intensity and all other principal components) constant indicated that factor scores
for IL-21 and SEA-specific inflammatory cytokine responses (PC2) were a significant
predictor of re-infection status (Wald X2: 4.515, p = 0.034, H-L X2: 12.12, p = 0.146)
however this effect was not significant when significance levels were adjusted for multiple
comparisons (sequential Bonferroni correction). The odds ratio indicates that for each 1 point
increase in PC2 factor scores, indicating a heightened PC2-type response to schistosome
antigens, there was a reduction in the risk of re-infection by a factor of 0.37. The results of
the analyses are summarised in Table 6.8.
Post-hoc t-test comparison of PC2 factor scores between un-infected individuals and those
re-infected within 18 months of treatment confirmed that IL-21 and SEA-specific
inflammatory responses were higher in participants who remained un-infected than those
who were re-infected (t51: 2.151, p = 0.036). Sex, age group, pre-treatment infection intensity
and the other adult worm and egg-specific cytokine profiles at 6 weeks post-treatment were
not significant predictors of re-infection. PC2 factor scores are plotted by re-infection status
in Figure 6.5.








Sex 0.227 0.096 0.757 1.255 0.30 - 5.28
Age -0.212 1.227 0.268 0.809 0.56 - 1.18
Pre-treatment infection intensity 0.004 0.873 0.350 1.004 1.00 - 1.01
SEA & WWH-specific cytokine profile:
SEA Th1/Th2 & WWH mixed (PC1) 0.349 0.933 0.334 1.418 0.70 - 2.88
IL-21 & SEA inflammatory (PC2) -1.194 5.570 0.018 .303 0.11 - 0.82
WWH inflammatory (PC3) 0.233 0.199 0.655 1.262 0.45 - 3.51
Th2/Th17 (PC4) 0.229 .292 0.589 1.257 0.55 - 2.89
SEA Th2 & WWH Th1 (PC5) 0.305 0.764 0.382 1.357 0.69 - 2.69
SEA innate inflammatory/Th2 (PC6) 0.570 1.218 0.270 1.768 0.64 - 4.86
SEA innate inflammatory & WWH Th1 (PC7) -0.845 2.232 0.135 0.430 0.14 - 1.30
Table 6.8. Adult worm and egg-specific cytokine responses at 6 weeks post-treatment
influence the risk of re-infection (n = 53). Results of binary logistic regression analysis of
participant re-infection status within 18 months of praziquantel treatment. Significant
predictors of re-infection (p<0.05) are highlighted in bold. B beta coefficient, 95% CI
95% confidence interval for odds ratio.
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Figure 6.5. Individuals re-infected with S. haematobium within 18 months of treatment
have lower levels of IL-21 and egg-specific inflammatory cytokines (PC2) than those
who remained un-infected. Mean factor scores for adult worm and egg-specific PC2 at 6
weeks post-treatment are plotted by re-infection status within 18 months of treatment. Un-
infected (n = 38) and re-infected (n = 15) groups were compared via 2-tailed un-paired t-test,
*p<0.05. Error bars: standard error of the mean.
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6.4.5 GST-specific cytokine profiles 6 weeks post-treatment and the risk of re-
infection
Factor analysis of GST-specific cytokine responses at 6 weeks post-treatment for the 53
individuals with re-infection data extracted 5 PCs (Table 6.9). However, none of these post-
treatment GST-specific cytokine profiles were significant predictors of re-infection status
within 18 months of treatment (H-L X2: 9.28, p = 0.320). Results of the analysis are
summarised in Table 6.10.
Principal components









TNF GST 0.8 0.3 0.0 -0.2 -0.2
IL-6 GST 0.9 0.1 0.1 0.1 0.0
IL-8 GST 0.4 0.0 0.1 0.8 0.1
GST 0.4 0.2 -0.1 -0.1 0.7
IL-2 GST -0.3 0.6 -0.2 -0.2 -0.1
IL-12p70 GST 0.6 0.1 0.0 -0.5 0.0
IL-4 GST -0.2 -0.1 0.6 -0.3 0.0
IL-5 GST 0.3 0.1 0.7 -0.1 0.0
IL-10 GST -0.3 0.5 0.0 -0.1 0.5
IL-13 GST 0.0 0.7 -0.3 0.1 -0.3
IL-17A GST -0.3 0.6 0.4 0.2 -0.3
IL-21 GST -0.3 0.4 0.3 0.3 0.2
IL-23p19 GST 0.9 0.2 -0.1 0.0 0.0
% of total variance 24.8 13.9 10.7 9.5 7.9
Table 6.9. Factor analysis of GST-specific cytokine responses at 6 weeks post-treatment
(n = 53). Table shows PCs 1-5 extracted by regression factor analysis and the factor loadings
for post-treatment cytokine responses elicited by S. haematobium GST. Cytokines with
factor loadings -0.5 for an extracted PC are highlighted in bold. The cellular
immune phenotype with which the cytokines are associated is given for each PC.
.
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Predictor B Wald 2 p Odds Ratio 95% CI
Sex 0.384 0.314 0.575 1.468 0.38 - 5.62
Age 0.036 0.049 0.826 1.037 0.75 - 1.43
Pre-treatment infection intensity 0.002 0.407 0.524 1.002 1.00 - 1.01
GST-specific cytokine profile:
Inflammatory (PC1) -0.432 1.101 0.294 0.649 0.29 - 1.46
Th2/Th1/Th17 (PC2) 0.245 0.520 0.471 1.277 0.66 - 2.49
Th2 (PC3) -0.134 0.166 0.684 0.875 0.46 - 1.67
Innate inflammatory (PC4) 0.360 0.709 0.400 1.433 0.62 - 3.31
Th1/Regulatory (PC5) -0.544 1.349 0.246 0.580 0.23 - 1.45
Table 6.10. GST-specific cytokine responses at 6 weeks post-treatment do not influence
risk of re-infection (n = 53). Results of binary logistic regression analysis of participant re-
infection status within 18 months of praziquantel treatment. B beta coefficient, 95% CI -
95% confidence interval for odds ratio.
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6.5 Discussion
Mass treatment programs for schistosomiasis target heterogeneous communities comprising
a range of ages and infection intensities (Montresor et al. 2002) and this was also the case in
Magaya community. Thus, in addition to characterising how schistosome-specific immune
responses are changed following treatment (chapter 5), it was also important to investigate
whether heterogeneity between participants at the time of treatment influenced the
magnitude of this change. Although previous studies have shown that age and pre-treatment
infection intensity can influence post-treatment levels of individual antibody and cytokine
responses (Roberts et al. 1993; Grogan et al. 1996b; Mutapi et al. 2002; Reimert et al. 2006)
this is the first study to investigate the effect of these factors on changes in groups of
cytokines associated with innate inflammatory, Th1, Th2 and Th17-type responses.
Furthermore, an important question raised by observations that schistosome-specific
cytokine profiles are changed after treatment is whether these changes affect the risk of
subsequent re-infection.
In the first part of this chapter, I investigated the hypothesis that pre-treatment infection
levels would influence the magnitude of change in S. haematobium-specific whole blood
cytokine profiles. This hypothesis stems from the predictions of mathematical models of
human schistosome infection, which predict that exposure to parasite antigens is related to
parasite density (Woolhouse 1994) and the same has also been assumed of the degree of
immunosuppression mediated by live parasites (Mitchell et al. 2008). Therefore, since
praziquantel treatment leads to parasite death and a release of parasite antigens (Harnett and
Kusel 1986; Redman et al. 1996), the amount of antigen released after treatment is predicted
to be proportionate to the number of parasites present at the time of treatment (i.e. pre-
treatment infection intensity). Consistent with this hypothesis I have shown that individuals
with high egg counts in their urine prior to treatment had a greater change in a mixed profile
of egg- -4, IL-6, IL-12p70 and IL-23) and adult worm-specific
IL-4 (PC1) than those who had no detectable schistosome eggs in their urine or low intensity
infection.
In contrast to SEA and WWH-specific inflammatory cytokine responses (PC1), the change
in IL-21 responses to these antigens (PC4) after treatment was negatively correlated with
pre-treatment infection intensity. In chapter 5 I showed that post-treatment IL-21 was higher
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than pre-treatment levels in response to all of the S. haematobium antigen preparations
(CAP, WWH, SEA, and GST) and also in un-stimulated cultures, suggesting that treatment-
induced exposure to parasite antigens promotes IL-21 secretion. However the results of this
chapter suggest that individuals with high intensity infections had a less pronounced change
in IL-21 levels than those harbouring low intensity or un-detectable infections. There are
several potential mechanisms that could account for this pattern. Firstly, since participants
(particularly young children) with the highest pre-treatment infection intensities also had the
highest pre-treatment egg and adult-worm-specific IL-21 responses (chapter 4), the existing
high numbers of circulating IL-21+ cells in these participants may mean that IL-21
production cannot increase further, potentially due to the physiological restrictions of the
peripheral cell pool (Rocha et al. 1989). High and sustained IL-21 secretion before and after
treatment may be particularly important in individuals with high intensity helminth
infections since observations in experimental S. mansoni (Pesce et al. 2006) and
Heligmosomoides polygyrus infections (Fröhlich et al. 2007) suggest that IL-21 receptor
signalling is required for initiation and maintenance of granulomatous responses to egg
antigens, which may persist in host tissues even after clearance of adult parasites..
Alternatively, since IL-21 responses remain similar to pre-treatment levels, but the change in
alternative egg-specific effector cytokines (PC1) is the most pronounced in participants with
high intensity infection, treatment may render the IL-21 responses to parasite antigens
relatively less prominent. As the first study to investigate antigen-specific IL-21 responses in
human schistosomiasis it is unclear what the functional relevance of this change might be.
However, murine studies suggest that IL-21 may regulate effector immune responses in a
variety of contexts, including via induction of alternatively activated macrophages during
helminth infection (Pesce et al. 2006) and via limiting peripheral T cell expansion (Datta and
Sarvetnick 2008). An alternative possibility is that expression of IL-21 may be limited in
participants with a large increase in PC1 cytokines, since T-bet, a transcription factor that
promotes Th1 differentiation, inhibits IL-21 gene expression by murine T cells (Mehta et al.
2005). Clearly, further studies are required to investigate whether the putative roles of IL-21
identified in murine studies apply to human IL-21 and to elucidate the role of this cytokine
during schistosome infections.
Of the GST-specific cytokine profiles, PC4 responses were significantly negatively
correlated with pre-treatment infection intensity, indicating that the change in adult worm
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and egg-specific IL-2 and IL-13 responses was smaller and the change in IL-4 responses was
larger in individuals with high intensity infections. The opposite patterns of change in IL-4
and IL-13 provide further support for a context-dependent dissociation between Th2-type
effector cytokine responses in human schistosome infections (Scott et al. 2000) and, in this
case, the change in IL-4 appears to be more closely related to the number of parasites (or
exposure of their antigens) than IL-13 responses.
The reciprocal change in GST-specific inflammatory cytokine responses and IL-10 (GST
PC1) was also negatively correlated with pre-treatment infection intensity suggesting that
individuals with the highest pre-treatment infection intensity had the least change in
inflammatory responses and the greatest change in IL-10 responses following treatment. This
relationship was only significant in 11-12 year olds, the age group at which mean pre-
treatment infection intensities were highest (see chapter 2.3.7). The importance of reciprocal
changes in GST-specific inflammatory cytokines and regulatory IL-10 responses may be
particularly important in this age group since systemic exposure of GST (Mutapi et al.
2005), and GST-specific inflammatory cytokine responses (chapter 5) increase following
treatment and may also increase the risk of immunopathology. For example, IL-10 can
regulate effector cytokine responses to crude schistosome antigens in whole blood samples
collected from schistosome-exposed participants (Grogan et al. 1998a; Mutapi et al. 2007b).
Cross-sectional population studies suggest that pre-treatment titres of schistosome-specific
antibody isotypes exhibit reciprocal changes at the age of peak infection intensity that
correspond to declining levels of schistosome infection with age and persist into adulthood
(Mutapi et al. 1997; Mutapi et al. 2007b). This pattern has been attributed to exposure to a
threshold amount of parasite antigen during cumulative exposure to infection in childhood
(Mutapi et al. 1998a; Mutapi et al. 2008) and is accelerated by praziquantel treatment which
increases exposure to schistosome antigens in all age groups (Mutapi et al. 1998a; Mutapi et
al. 2003). Thus increased exposure to GST following treatment may accelerate the
development of GST-specific responses in participants with low intensity infections whereas
high intensity infections in others may mean that immunological changes dependent on a
threshold level of exposure to GST have already occurred before treatment.
This hypothesis is consistent with the observations of a study of S. haematobium-specific
IgE and IgG4 titres in Gabon, where adults (post-peak infection intensity) were found to
have a lower magnitude of change relative to children (pre-peak and peak infection intensity)
following treatment (Grogan et al. 1996b). Notably the relationship between the change in
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GST PC1 cytokines and pre-treatment infection intensity was positive in young children
(though not statistically significant) consistent with the effect of treatment on GST-specific
cytokine profiles changing with age.
It is interesting that, unlike GST, changes in SEA and WWH-specific cytokine responses
after treatment were not related to host age, although this lack of association has also been
noted in previous studies of post-treatment immune responses to crude schistosome antigens
(Grogan et al. 1998b; Mutapi et al. 1998b; Joseph et al. 2004b). This may be due to the
simultaneous and polyclonal activation of innate, naïve and memory cells by the release of
antigens from dying worms upon treatment , which would making the relative contributions
of antigen-specific memory cells to in vitro cytokine responses less distinguishable. Thus,
the relationship between the change in SEA and WWH-specific responses and pre-treatment
infection intensity may be less clear than for the change in cytokine responses to purified
GST. Memory cells are of particular interest in this context since immunological memory is
generated by exposure to parasite antigens and these responses may provide the most direct
means of assessing how exposure history relates to cellular immunity (Ahmed and Gray
1996). Development of protocols for the isolation and identification of activated cells in
cultured whole blood would provide a useful tool to investigate whether effector memory
cells to SEA and/or WWH constituents vary with age post-treatment in future studies and to
investigate the cell types specifically activated by GST (Maino 1998; Suni et al. 1998).
Having characterised the relationship between the change in parasite-specific cytokine
responses and pre-treatment infection intensity, I subsequently investigated whether
treatment-altered cytokine responses varied between individuals who remained un-infected
18 months after treatment and those that had acquired new infections in this time. Whilst
some studies in human helminthiases have focused on how pre-treatment immune responses
relate to the risk of re-infection (Mutapi et al. 1999; Jackson et al. 2004a), I focused on post-
treatment cytokine responses since any re-infection will occur in the context of this altered
immune environment rather than those observed prior to treatment. Post-treatment SEA-
specific inflammatory cytokine responses and adult worm and egg-specific IL-21 (PC2) were
associated with a reduced risk of re-infection within 18 months of treatment. This
observation is consistent with the long held view that the development of resistance to re-
infection is immune-mediated rather than due to age-related changes in water contacts or
immune physiology alone (Colley et al. 1986; Hagan et al. 1991; Roberts et al. 1993;
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Grogan et al. 1998b; Mutapi et al. 1999; Caldas et al. 2000). It is noteworthy that, although I
have classified egg-specific responses associated with a reduced risk of re- -
g Th1- -
12p70) and Th17-type (IL-23) effectors as well as IL-
-regulated in conjunction with Th1 effectors (Curfs
et al. 1997; Oppenheim 2001). Whilst higher schistosome- been previously
observed in endemically-exposed, but un-infected individuals relative to their infected
counterparts (Grogan et al. 1998b; El Ridi et al. 2001) this is the first study to investigate
ability to promote human macrophage activation (Nathan et al. 1984) make it unsurprising
co-varies with innate inflammatory cytokines. As discussed above, the absence of
mechanistic studies of IL-21 function in humans and particularly during helminth infection
make it impossible to conclude whether the positive loading of IL-21 onto a PC with
inflammatory cytokines and its association with a reduced risk of re-infection in this context
is due to its pro-inflammatory function or co-incidental up-regulated as an immunoregulator
or a marker of heightened immune-responses. It is also important to note that, due to the
small number of re-infected participants 1 year after treatment (15 of 53 participants
included in the re-infection analysis), the statistical power of my observations are limited.
Thus, whilst the results of the current chapter have identified a novel association between
post-treatment cytokine phenotype and the risk of re-
observations will be to investigate whether similar associations can be identified in larger
treatment-re-infection cohorts and in other human populations affected by urinary
schistosomiasis.
Importantly, since eggs are only produced after an infection has already been established, it
is unlikely that immune responses targeting egg antigens alone would lead to a reduced risk
of re-infection. What seems more likely is that post-treatment inflammatory cytokine
responses to schistosome egg antigens correspond to responses that limit de novo infection,
migration or maturation of larval parasites or the fitness/fecundity of adult worms. For
example, CAP-specific cytokine responses were also increased after treatment (chapter 5)
and it is possible that changes in these responses would also be higher in the participants
who remained un-infected 18 months after treatment relative to re-infected individuals.
Furthermore, SEA contains a range of antigens which cross-react with CAP, WWH and
schistosomula antigens (Curwen et al. 2004; Jang-Lee et al. 2007) and therefore increased
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reactivity to egg-stage parasites may also promote anti-larval and anti-adult worm immune
adult
worms in experimental schistosomiasis (Smithers and Terry 1967) and during chronic
filariasis (Day et al. 1991a; Day et al. 1991b; MacDonald et al. 2002), mathematical models
predict that schistosome egg antigens may also act as a stimulus for changes in the host
immune response associated with resistance to high intensity infection prior to treatment
(Woolhouse 1994; Mitchell et al. 2008; Mitchell 2010). The observation that effector
cytokine responses are higher in un-infected than in re-infected participants is also consistent
with the findings of earlier empirical investigations in Egypt, which showed that individuals
with low PBMC proliferative responses to S. mansoni SEA (and CAP) in vitro were more
likely to be re-infected after treatment and that this relationship was independent of variation
in host age, sex and pre-treatment infection intensity (Colley et al. 1986). However, the
association between egg-specific cellular proliferative responses to S. mansoni antigens and
the risk of re-infection remains controversial (Grogan et al. 1998b; Caldas et al. 2000). For
S. haematobium the association between immune response and re-infection rates is similarly
un-clear (and notably under-studied) and few studies have investigated the association
between SEA-specific cytokines and the risk of re-infection. S. haematobium SEA-specific
antibody responses are known to increase following treatment (Hagan et al. 1991; Mutapi et
al. 1999; van den Biggelaar et al. 2002), but previous studies have not identified a protective
role for SEA-specific PBMC cytokine responses (Medhat et al. 1998). However, the latter
-4, IL-5 and IL-10) and only
adolescent boys were included in the cohort (Medhat et al. 1998). Thus, the current study
provides a more comprehensive analysis of the parasite antigens and cytokine responses that
may mediate the development of immune-mediated protection than any previous
investigation.
Post-treatment cytokine responses to GST were not related to a reduced risk of re-infection
after treatment, despite suggestions that increased exposure to GST following treatment may
promote protective immunity (Dupre et al. 1999). Since re-infection was defined by the
presence of eggs in urine samples it is possible that the GST-specific cytokine responses
discussed in this chapter contribute to anti-fecundity effects similar to those seen in animal
models (Boulanger et al. 1991) and/or that post-treatment antibody responses to GST
promoted resistance to re-infection (Grzych et al. 1993), although this was not investigated.
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6.6 Conclusions
As initially hypothesised, the changes observed in whole blood cytokine responses to SEA,
WWH and GST after treatment were influenced by pre-treatment infection intensity. This is
consistent with studies suggesting that artificially-induced parasite death may boost immune-
responsiveness to parasite antigens (Woolhouse and Hagan 1999). Since variation in S.
haematobium infection intensity is associated with variation in both the magnitude and
phenotype of the whole blood cytokine response, this may also contribute to heterogeneity in
the long-term efficacy of praziquantel treatment between individuals included in mass
treatment programmes for schistosomiasis.
Of the cytokine profiles identified at 6 weeks post-treatment, SEA-specific inflammatory
cytokines (IL- -12p70 and IL-23p19) and egg and adult-worm-specific IL-
21 were associated with a reduced risk of re-infection within 18 months of treatment that was
independent of age, sex or pre-treatment infection intensity. Thus, the current study suggests
that a single dose of praziquantel may promote the development of immune-mediated
resistance to S. haematobium re-infection in some, but not all treated individuals.
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Chapter 7
Systemic and antigen-specific cytokine responses during
experimental Trichuris suis infection in seasonal allergy
sufferers
7.1 Introduction
The prevalence of immune-mediated diseases, including allergies and auto-immunity, is
increasing globally (Asher et al. 2006). Current immunotherapy for allergies is based on
allergen injections (Varney et al. 1991; Movérare et al. 2000; Wachholz et al. 2002), which
require repeated doctor visits over several years and pose a significant risk of adverse side-
effects (Varney et al. 1991). In light of studies showing that host immune responses are
modified by nematode and trematode worms (Maizels et al. 1993; Maizels and
Yazdanbakhsh 2003; Maizels et al. 2004; Figueiredo et al. 2010), interest has developed in
how helminth infection may impact upon the course of immune-mediated diseases
(Leonardi-Bee et al. 2006; Flohr et al. 2009; Feary et al. 2011). However, in human
populations endemically exposed to parasitic helminths it is difficult to dissect the course of
helminth infection from that of allergy and vice versa since there is a lack of helminth naïve
controls. An alternative approach is to investigate the immunobiology of experimental
helminth infections of allergic individuals in a helminth non-endemic setting, which is the
subject of the current chapter.
Recent pilot studies in helminth-naïve humans have shown that ingestion of the ova or larvae
of gastrointestinal (GI) nematodes can effectively reduce clinical manifestations of
autoimmune disease in the gut (Summers et al. 2005a; Summers et al. 2005b; Croese et al.
2006). However, despite these promising clinical observations, the immunological basis of
how helminths alter the course of immune-mediated diseases during short-term infections
has not been characterised. In particular, it is unclear how GI helminths may modulate
hyper-reactive immune responses to environmental allergens or auto-antigens at sites outside
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not effective against common allergies in the airways (Feary et al. 2009; Bager et al. 2010a;
Feary et al. 2010). Therefore, the aim of this chapter is to investigate how experimental
Trichuris suis infection affects the systemic cytokine environment and parasite and allergen-
specific cytokine responses of a helminth-naïve human cohort with established allergic
rhinitis. Furthermore, since the clinical symptoms of the cohort were seasonally-exacerbated
by high grass pollen counts, it was possible to investigate how these immune responses
changed at different timepoints over the course of the grass pollen season in individuals
treated with T. suis ova (TSO) relative to un-infected placebo-treated controls. These
cytokine analyses are discussed in the context of existing clinical data on the study cohort,
who were enrolled in a phase II clinical trial of TSO as an immunotherapy (Bager et al.
2010a).
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7.2 Hypotheses
Systemic and antigen-specific cytokine responses differ in individuals treated with T.
suis ova relative to placebo-treated controls
Systemic and antigen-specific cytokine responses during the grass pollen season
differ to those outside the grass pollen season
Cytokine responses to T. suis excretory/secretory antigens and environmental pollen
allergens differ between T. suis ova treated and placebo treated groups
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7.3 Materials and Methods
7.3.1 Study design
The current study is part of a phase II randomised double-blind, placebo controlled clinical
trial of TSO as an immunotherapy for allergic rhinitis (Registration number: R000001298,
Trial ID: UMIN000001070). Full details of the study design and ethical permissions are
published (Bager et al. 2010a) and summarised in chapter 2.4. Briefly, volunteers with
pollen allergen-exacerbated allergic rhinitis and no previous exposure to T. suis infection
were randomly assigned to TSO or placebo treatment groups and received 8 doses of 2500
TSO suspended in sulphate stabilised 0.015moles/L H2SO4 or the H2SO4 alone (placebo) in
double-blinded preparations at 21 day intervals. Blood samples were collected for plasma
and PBMC isolation at 3 timepoints; prior to treatment (baseline), during the peak grass
pollen season (grass pollen season) and 21 days after the last treatment was administered
(end). PBMCs were stimulated in parallel cultures with T. suis excretory/secretory products
(E/S), grass pollen allergen (g6) and birch pollen allergen (t3). Un-stimulated cultures acted
as negative controls for these assays. The design for the study is summarised in Figure 7.1.
For this chapter cytokine responses were quantified in plasma samples and PBMCs isolated
from volunteers enrolled in the study to investigate the effect of 3 variables; treatment group,
timepoint and antigen-stimulation.
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Figure 7.1. Study design and participant record for the assessment of cytokine
responses in a clinical trial of T. suis ova as an immunotherapy for allergic rhinitis
(adapted from (Bager et al. 2010a)). Volunteers were randomly assigned to TSO or
placebo treatment groups and received 8 treatments at 21 day intervals. PBMCs were
isolated from a randomly selected sub-set (n = 15) of each treatment group. Serological
samples were collected at 3 timepoints (baseline, grass pollen season and end). Participants
who left the study or provided insufficient samples (number or volume) for inclusion in the
cytokine analysis are indicated.
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7.3.2 Study participants
100 volunteers were initially recruited to the clinical trial and provided a plasma sample
prior to ingestion of the first treatment (baseline). Of these, PBMCs were isolated from 30
volunteers.
Participants were included in plasma cytokine analyses according to the following inclusion
criteria: 1) completed the 8 dose treatment regime, 2) provided a blood sample at each of the
three timepoints (baseline, grass pollen season and end) and 3) provided sufficient sample
-4, IL-5, IL-10 and IL-13). For inclusion in
the antigen-specific PBMC cytokine cohort individuals were also required to provide a
supernatant sample for each of the 3 antigen stimulations: birch pollen allergen (t3), timothy
grass pollen allergen (g6) and T. suis excretory/secretory product (E/S), and an un-stimulated
control at sufficient volume to assay TN -4, IL-5, IL-10, IL- 89
individuals met the inclusion criteria for analysis of plasma cytokine responses and, of these,
22 met the inclusion criteria for analysis of PBMC cytokine responses. Details of the number
of participants excluded at each stage of the reasons for their exclusion are given in Figure
7.1 and the demographic characteristics of the selected participants are summarised in Table
7.1.
Plasma cohort PBMC supernatant cohort
Treatment Placebo TSO Placebo TSO
n 44 45 10 12
Mean age (range) 38.4 (19 - 63) 35.3 (20 - 61) 40.3 (21 - 63) 29.9 (20 - 39)
Gender (m/f) 42/2 43/2 9\1 12/0
Table 7.1. Demographic characteristics of the plasma and PBMC supernatant cytokine
study cohorts. Adult volunteers were randomly assigned to either the TSO or placebo
treatment groups and a subset of individuals from each group were randomly selected for
PBMC isolation and subsequent antigen stimulation. Data in the table relates only to those
individuals that met inclusion criteria for cytokine analysis. m male, f female
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7.3.3 Immunological assays
7.3.3.1 Cytometric bead array (CBA)
CBA was favoured over cytokine ELISA for this aspect of the study since multiple cytokines
can be assayed in a smaller volume of plasma/supernatant and available sample volumes
were limited. -4, IL-5, IL-10 and IL-13 were
-4), 558278 (IL-5), 558274 (IL-10) and 558450 (IL-13)). The assay
protocol and parameter settings for cytokine quantification were adapted from commercial
protocols and the recommendations of a BD Biosciences systems specialist respectively.
Plasma cytokine assays were conducted with the help of an undergraduate student, Dana
Photiou.
-4, IL-5, IL-10 and IL-13-specific bead populations were vortexed and
pooled in capture bead diluent and 25µl/well added to a 96 well immunoplate (NUNC).
Lyophilised recombinant standards for all cytokines were pooled and reconstituted in 4ml
assay diluent to give a concentration per cytokine of 2500pg/ml (IL-4, IL-5, IL-10 and IL-
13) and 5000pg/ml ( ). 9x 25µl/well doubling dilutions were prepared in
assay diluent on the plate with a 10th well containing assay diluent alone (blank). 25µl/well
of PBMC supernatant samples were added to the remaining wells in duplicate and the plate
was incubated at room temperature for 1 hour. Plasma samples were not assayed in
duplicate. All incubations were conducted on a plate shaker to prevent aggregation of beads.
PE-conjugated detection antibodies specific for each cytokine were pooled in PE-reagent
diluent and 25µl/well added. Plates were incubated for 2 hours at room temperature and
protected from light to prevent bleaching of the PE dye. Beads were centrifuged at 200G for
5min and washed twice in wash buffer, before re-suspension in 100µl/well.
Assay plates were read on a BDFACSArray bioanalyser using settings that accounted for
optical spill-over of fluorescent dyes and thus maximised assay sensitivity. Quality control
assays using SPHERO 8-peak beads (BD Pharmingen, Catalogue#558542) were run prior to
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each experiment to ensure that the bioanalyser laser alignment and calibration was identical
for each assay.
CBA results were filtered for non-specific fluorescence using the BD FCSFilter program and
the same filter gate was used to standardise analysis of all assays. Filtered cytokine data was
analysed using BD FCAP software, which quantifies PE fluorescence intensity for each
cytokine relative to that of the 10-point recombinant standard curve.
7.3.3.2
Heat- ed in t3, g6, E/S and un-stimulated PBMC culture
supernatants via bioassay using the same supernatant aliquot as that used for CBA cytokine
analysis. A bioassay was favoured over CBA or ELISA-
these methods detect both act
inert (Khalil 1999).
The assay uses mink lung epithelial cells (MLEC, clone 32) transfected with a 800bp insert
-799 to +71) of the human
plasminogen activator inhibitor-1 (PAI- The insert
was introduced as part of a p19LUC-based vector construct containing the neomycin-
resistance gene from pMAMneo (Abe et al. 1994). Transformed reporter MLEC were
provided by Dr. Matthew Taylor, Institute of Immunology and Infection Research,
University of Edinburgh and originally generated by Daniel B. Rifkin of the Rifkin
Laboratory, Department of Cell Biology, New York University Medical centre.
MLECs were cultured in DMEM with 10% FCS, 100 U/ml penicillin/streptomycin and
-glutamine and harvested using trypsin/EDTA when confluent. Cells were then
diluted to 3.2x105 cells/ml in RPMI with 0.5% mouse sera and 50µl/well added to opaque
white fluoroplates (NUNC, Cat#136101). Cells were incubated at 37oC for 3 hours to allow
MLEC to adhere. Adherence was assessed in a separate clear-bottomed immunoplate run in
parallel with the assay plate.
PBMC supernatant samples were heat activated at 80o
its latent form and 50µl/well added to th
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(Boehringer) were run in parallel in doubling dilutions from a top concentration of 500pg/ml.
RPMI with 0.5% mouse sera was added to duplicate wells to act as a negative control for the
assay (blank).
After incubation for 14 hours at 37 C culture plates and Bright-glo luciferase assay substrate
(Promega, Cat#E-2620) were equilibrated to room temperature. 100µl/well of substrate was
added to each well for 2 minutes to allow cell lysis and plates were then read on a
luminometer and TGF
7.3.4 Statistical analyses
Preliminary analysis of supplementary immunological data on eosinophil counts,
lymphocyte counts, serum histamine levels, grass pollen and T. suis E/S-specific antibody
titres and total IgE confirmed that the 2 treatment groups did not differ significantly in any of
these parameters prior to treatment in either the plasma or PBMC cytokine cohort (see
Appendix 2). These results are consistent with the published analysis of this data including
all participants recruited to the original study (Bager et al. 2010a).
The effects of timepoint and treatment group on the dynamics of individual plasma and
PBMC cytokines were investigated via repeated measures ANOVA. Exploratory analyses
indicated that residuals of ANOVA models for both plasma and PBMC cytokines met the
assumptions of parametric tests and cytokine concentrations (pg/ml) were subsequently
analysed un-transformed. Cytokines were included as dependent variables and compared by
timepoint (baseline, peak grass pollen season and end) as a within-subject effect and
treatment group (TSO and placebo) as a between-subject effect and the interaction between
timepoint and treatment group. The repeated measures design was chosen to account for
multiple sampling from the same individual at different timepoints since cytokine responses
are expected to be more similar within an individual subject at different timepoints than
between different participants (Mutapi and Roddam 2002). Since the difference in variance
between each timepoint was unequal, significance levels for univariate tests of the effect of
treatment, timepoint and the timepoint-treatment interaction were determined at the Lower-
bound epsilon -adjusted degrees of freedom, which provides a conservative estimate of
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significance accounting for un-equal variances (Geisser and Greenhouse 1958; Vasey and
Thayer 1987).
Prior to analysis of cytokine responses, antigen-stimulated PBMC supernatant cytokines had
levels of cytokine secreted by PBMCs cultured without antigen (un-stimulated controls)
subtracted to account for non-specific background cytokine secretion prior to analysis.
PBMC cytokine responses were then compared by timepoint and treatment group using
repeated measured ANOVA (described above) conducted separately for each antigen (t3, g6
and E/S).
Temporal variations in the plasma cytokine responses of the 2 treatment groups were further
explored via non-metric multidimensional scaling (NMS) conducted using PC-ORD
software. The advantage of this approach was that the cytokines contributing to variation
between the individuals at all 3 timepoints could be visualised and compared in the context
of their co-incident cytokine responses. Prior to analysis concentrations of all cytokines were
square-root(x+1)-transformed for each participant to reduce the influence of outlier values on
the ordination (Rummel 1970) and to allow participants without detectable levels of one or
more cytokines to be included in the analysis (Osborne 2002). The Sorensen (Bray and
combination of T -4, IL-5, IL-10 and IL-13 responses at each timepoint. The
reflect cytokine responses that account for the greatest variation within the data set as a
whole. Full details of the NMS procedure are given in chapter 2.5.4.
The contribution of different cytokine responses to the variation between individuals in the
responses and each axis. Only cytokines responses with an r2>0.5 were considered to be
adequately reflected by the axis. The amount of variance in participant cytokine responses
represented by each axis (i.e. the coefficient of determination (r2) between the original
cytokine profiles and the relative positioning of participants on the ordination plot generated
by NMS) is given for each plot. Clusters of participant cytokine responses relative to these
axes were identified visually and related to timepoint and treatment group using colour-
coded overlays of the ordination plot. The difference between the mean dissimilarities for
each treatment group and timepoint were confirmed quantitatively using the multiple
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response permutation procedure (MRPP). The test statistic (T), p-value and chance-corrected
within-group variation (A, a measure of effect size) are reported for comparisons and full
details of how these statistics are calculated is given in chapter 2.5.5.
To address the hypothesis that the difference in cytokine responses between the 2 treatment
groups at the 3 study timepoints was influenced by antigen stimulation, NMS was also used
to compare PBMC cytokine responses -4, IL-5, IL-10, IL-
described above. NMS allowed the patterns of PBMC cytokine responses elicited by T. suis
E/S, t3 and g6 to be directly compared, which was not possible using repeated measures
ANOVA due to differences in the variance of cytokine concentrations between parasite
antigen and allergen-stimulated cultures. Each participant was plotted according to their
cytokine responses to each antigen (t3, g6 and E/S) at each timepoint (baseline, grass pollen
season and end). MRPP was subsequently used to compare cytokine responses between
treatment groups, timepoints and the different antigens.
To account for the multiple comparisons made between groups for ANOVA, repeated
measures models and MRPP, the sequential Bonferroni-adjustment was used for each set of
comparisons (Holm 1979; Rice 1989). Raw p-values are reported for all tests and those
significant at the Bonferroni-adjusted significance level are indicated where appropriate.
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7.4 Results
7.4.1 Individual plasma cytokine responses by timepoint and treatment group
The immunological impact of TSO was first investigated in plasma samples, which provided
an indicator of systemic immune responses at all 3 timepoints (baseline, grass pollen season
and end). Levels of IL-5 were significantly higher in T. suis infected participants relative to
the placebo-treated group. The treatment-dependent increase in plasma IL-5 occurred in the
context of a post-treatment increase in eosinophil counts and T. suis-specific antibodies
(Appendix 2). None of the other plasma cytokines significantly differed between the
treatment groups (Table 7.2).
Mean T -4, IL-5 and IL-10 concentrations in both treatment groups were significantly
affected by timepoint, suggesting that levels of environmental grass pollen influenced the
systemic cytokine response declined with time and IL-10 was
lower at the end of the study than at recruitment. Interestingly, despite their mutual
association with Th2-polarised immune responses IL-5 was elevated during the peak grass
pollen season relative to the end of the study, but IL-4 levels declined after initial treatment
and were lowest during the grass pollen season.
Levels of IL-5 were also significantly affected by the interaction between treatment and
timepoint, which confirmed that the elevation of IL-5 in the TSO-treated group above levels
in placebo-treated individuals occurred at both post-treatment timepoints (grass pollen and
end), but was not evident prior to treatment (baseline).
Mean concentrations of plasma cytokines by timepoint and treatment group are shown in
Figure 7.2 and results of repeated measures ANOVA are summarised in Table 7.2.
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Figure 7.2. Systemic cytokine responses differ according to treatment group, timepoint
and the interaction between treatment group and timepoint. Bar charts represent the
mean plasma cytokine responses of placebo (white) and TSO (black)-treated groups at
baseline (B), during the grass pollen season (G) and at the end of the study (E). Effects of
treatment, timepoint and the interaction between treatment and timepoint on cytokine levels
assessed by repeated measures ANOVA are indicated for each cytokine. Rx first dose of
treatment administered. Error bars: standard error of the mean. *p<0.05, **p<0.01, ***p
<0.001, ns not significant












2.634 0.075 0.130 0.720 0.135 0.714
8.451 0.005 G > B, E>B 0.099 0.754 0.475 0.493
IL-4 176.140 <0.001 B > G, B> E, E>G 0.287 0.593 0.618 0.434
IL-5 32.963 <0.001 B > E, G > E 9.539 0.003 T. suis>Placebo 11.247 0.001
IL-10 9.961 0.002 B > G, B > E 2.869 0.094 0.495 0.484
IL-13 3.465 0.066 0.006 0.936 1.920 0.169
Table 7.2. Systemic cytokine responses differ according to treatment group, timepoint
and the interaction between treatment group and timepoint. Results of repeated
measures ANOVA of plasma cytokine responses are summarised and significant differences
are highlighted in bold. Results significant after sequential Bonferroni correction for multiple
comparisons are shaded grey. Treatment*Treatment interaction between treatment group
and timepoint. B baseline, G grass pollen season, E end. Degrees of freedom (Lower-
-adjusted): 1, 87
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7.4.2 Parasite and allergen-specific PBMC cytokine responses
Having identified an association between TSO and temporal variations in grass pollen and
the systemic cytokine environment, I investigated whether this was also the case for T. suis-
specific and allergen-specific PBMC cytokine responses in a subset of the cohort from whom
PBMC were isolated (TSO group: n = 12, placebo-treated group: n = 10). Assaying the
cytokine responses of T. suis E/S (Figure 7.3), g6 (Figure 7.4) and t3 (Figure 7.5)-stimulated
PBMCs allowed the influence of different stimuli on peripheral cellular immune responses to
be assessed. Mean concentrations of T. suis E/S, g6 and t3-specific PBMC cytokines are
plotted by treatment group and timepoint in Figures 7.3, 7.4 and 7.5 respectively. Results of
repeated measures ANOVA are summarised for T. suis E/S-specific cytokine responses in
Table 7.3, t3-specific responses in Table 7.4 and g6-specific responses in Table 7.5.
Consistent with initial hypotheses, mean concentrations of T. suis E/S-specific PBMC
cytokines differed according to treatment group. Concentrations of all Th2-type cytokines
(IL-4 (Figure 7.3C), IL-5 (Figure 7.3D) and IL-13 (Figure 7.3F)) and IL-10 (Figure 7.3E)
were significantly higher in TSO-treated participants relative to placebo controls. The latter
is consistent with induction of a Th2/regulatory cytokine response by helminth secreted
antigens.
PBMC cytokine responses also differed according to
7.3A) and IL-10 (Figure 7.3E) peaked during the grass pollen season. The latter also
appeared to be the case for mean concentrations of T. suis-E/S-specific IL-4, IL-5, IL-10 and
IL-13; however this trend was not statistically significant.
Of the allergen-
significantly differed between the 2 treatment groups (Figure 7.4G). Mean t3-
concentrations were higher in T. suis-treated group relative to placebo controls, but were not
significantly affected by the interaction between the effects of treatment group and
timepoint. None of the birch or grass pollen allergen-specific cytokine responses differed
significantly between timepoints.
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Figure 7.3. Levels of T. suis E/S-specific PBMC cytokines are affected by treatment
group and timepoint. Bar charts represent the mean T. suis E/S-specific cytokine responses of
placebo (white) and TSO (black)-treated groups at baseline (B), during the grass pollen season (G)
and at the end of the study (E). Effects of treatment, timepoint and the interaction between treatment
and timepoint on cytokine levels assessed by repeated measures ANOVA are indicated for each
cytokine. Rx first dose of treatment administered. Error bars: standard error of the mean. *p<0.05,
ns not significant
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Figure 7.4. Birch pollen- T. suis ova-treated
group than in the placebo-treated group. Bar charts represent the mean t3-specific cytokine
responses of placebo (white) and TSO (black)-treated groups at baseline (B), during the grass pollen
season (G) and at the end of the study (E). Effects of treatment, timepoint and the interaction between
treatment and timepoint on cytokine levels assessed by repeated measures ANOVA are indicated for
each cytokine. Rx first dose of treatment administered. Error bars: standard error of the
mean. *p<0.05, ns not significant
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Figure 7.5. Grass pollen allergen-specific PBMC cytokine responses are not significantly
affected by T. suis ova treatment or timepoint. Bar charts represent the mean g6-specific
cytokine responses of placebo (white) and TSO (black)-treated groups at baseline (B), during the grass
pollen season (G) and at the end of the study (E). Effects of treatment, timepoint and the interaction
between treatment and timepoint on cytokine levels assessed by repeated measures ANOVA are
indicated for each cytokine. Rx first dose of treatment administered. Error bars: standard error of the
mean. ns not significant
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7.4.3 Temporal variations in systemic cytokine responses due to T. suis ova
treatment
Since individual cytokine responses occur in the context of multiple cell types and co-
incident cytokines I sought to investigate whether mean dissimilarities between participant
-4, IL-5, IL-10
and IL-13 responses of each participant and those of other participants at all timepoints) also
differed according to treatment group and timepoint. NMS identified 2 main axes,
corresponding to the major sources of variation between participant cytokine profiles. Axis
2, which had a strong positive correlation with IL-4 responses (Table 7.6), accounted for the
greatest proportion of variation between participant cytokine profiles (Figure 7.6). Axis 1
accounted for a lower proportion of variation (Figure 7.6) and was positively correlated with
IL-10 responses (Table 7.6). Despite treatment and timepoint-specific patterns of plasma IL-
5 in isolation (see above), IL-
Participant cytokine profiles are plotted relative to each other in NMS ordination plots
(Figure 7.6) and identified by timepoint (Figure 7.6A) and treatment group (Figure 7.6B) in
colour-coded overlays. The final 2-dimensional NMS of plasma cytokine responses had a
final stress of 19.1 and instability of 0.002 after 500 iterations.
Participant cytokine profiles formed distinct clusters along the NMS axes according to
timepoint and mean dissimilarities in IL-4 (axis 2) were higher at baseline than at either of
the post-treatment timepoints (Figure 7.6A), consistent with the individual cytokine analysis
described above. MRPP confirmed that cytokine profiles differed according to timepoint (T:
-56.267, p<0.001, A: 0.152) and pair-wise comparisons indicated that cytokine profiles
differed significantly between participants at all timepoints (baseline vs. grass pollen season
T: -53.88, p<0.001, A: 0.159, baseline vs. end T:-44.83, p<0.001, A: 0.139, grass pollen
season vs. end T: -14.68, p<0.001, A: 0.039).
There was considerable overlap between the cytokine profiles of the 2 treatment groups at all
timepoints; however mean dissimilarities in IL-10 responses (axis 1) were higher in TSO-
treated individuals than placebo-treated controls (Figure 7.6B). MRPP confirmed that the
cytokine responses significantly differed according to treatment group (T:-3.662, p = 0.007),
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Figure 7.6. Plasma cytokine responses are influenced by timepoint and treatment group
(n = 89). Participants are plotted according to relative dissimilarities in their plasma cytokine
responses and groups are identified by overlays of the ordination plot according to timepoint
(A) and treatment group (B). C 2>0.5
and the proportion of total variance accounted for by each axis (r2) are indicated. Mean
within-group difference - mean dissimilarities between participant cytokine responses in
each timepoint (A) or treatment group (B).
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Table 7.6. Temporal variation in plasma cytokine profiles relate to changes in IL-10
and IL-4. 2) for
each cytokine relative to the 2 dimensional axes identified by NMS are given. Cytokine
responses with r2> 0.5 are highlighted in bold and shaded grey. Proportion of variance refers
to the r2 value of each ordination axis relative to the original square-root(x+1)-transformed
cytokine data.
Plasma cytokines
Axis 1 Axis 2
Pearson's r r2 Pearson's r r2
0.2 0.0 0.3 0.1
0.1 0.0 0.4 0.2
IL-4 -0.1 0.0 0.9 0.7
IL-5 0.0 0.0 0.4 0.2
IL-10 0.8 0.6 0.5 0.2
IL-13 0.2 0.0 0.3 0.1
Proportion of variance: 0.324 0.531
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although the variation within both groups meant that the effect size of this difference was
low (A: 0.007).
7.4.4 Variation in PBMC cytokine profiles due to timepoint, treatment group
and antigen stimulation
MS, variation
between participants was attributable to 2 main types of cytokine responses: 1) a
combination of -10 responses, which correlated positively with axis 1 and 2) a
combination of IL-5 and IL-13 responses, which correlated negatively with axis 2 (Table
7.7).
Ordination plots indicated that PBMC cytokine profiles formed clusters according to antigen
stimulus (Figure 7.7). T. suis E/S-specific PBMC responses were higher on axis 1 and lower
for axis 2 than those elicited by the 2 allergens (Figure 7.7A), which corresponds to higher
-5, IL-10 and IL-13 in T. suis E/S-stimulated cultures and the induction of
a more mixed Th1/Th2/regulatory-type immune response by T. suis antigens relative to
allergen-specific cytokine profiles. MRPP confirmed that mean dissimilarities between
participant cytokine profiles differed according to antigen with significant differences
between T. suis E/S and g6 and E/S and t3, but not between the 2 allergens (Table 7.8).
Participant PBMC cytokine profiles to all antigens overlapped between timepoints (Figure
7.7B); however timepoint was still a significant contributor to variation between antigen-
specific cytokine profiles. Mean dissimilarities of participant responses during the grass
pollen season were distinct along both axes relative to those at baseline and the end of the
study (Figure 7.7B). These differences were confirmed by pair-wise comparisons using
MRPP (Table 7.8). Cytokine profiles did not significantly differ between the baseline and
end timepoint (Table 7.8).
PBMC cytokine responses of the 2 treatment groups (Figure 7.7C) were similar for all
antigens and at all timepoints as can be seen from overlap between the TSO and placebo-
treated participants in Figure 7.7C. MRPP confirmed that dissimilarities in PBMC cytokine
responses did not significantly differ according to TSO treatment (Table 7.8).
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Figure 7.7 PBMC cytokine responses are influenced by the type of antigen stimulation
and timepoint (n = 22). Participants are plotted according to relative dissimilarities in their
PBMC cytokine responses and groups are identified by overlays of the ordination plot
according to antigen stimulation (A), timepoint (B) and treatment group (C). Cytokines
2>0.5 and the proportion of total variance
accounted for by each axis (r2) are indicated. Mean within-group difference mean
dissimilarities between participant cytokine responses for each antigen (A), timepoint (B)
and treatment group (C)
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Table 7.7. Temporal patterns of parasite and allergen-specific PBMC cytokines profiles
-10 (Axis 1) and IL-5 and IL-13 (Axis 2). The
2) for each cytokine
relative to the 2 dimensional axes identified by NMS of PBMC cytokine responses are given.
Cytokine responses with r2> 0.5 are highlighted in bold and shaded grey. Proportion of
variance refers to the r2 value of each ordination axis relative to the original square-
root(x+1)-transformed cytokine data.
Table 7.8. PBMC antigen-specific cytokine responses differ according to the type of
antigen and timepoint. Table gives results of MRPP comparison of mean Sorensen (Bray
and Curtis) dissimilarities between each antigen (t3 birch pollen allergen, g6 grass pollen
allergen and E/S T. suis excretory/secretory product), timepoint (B baseline, G grass
pollen season and E - end) and treatment group (TSO and placebo-treated). Significant
differences (p<0.05) are highlighted in bold and those significant after Bonferroni correction
for multiple comparisons are shaded grey. A chance-corrected within-group agreement
PBMC cytokines
Axis 1 Axis 2
Pearson's r r2 Pearson's r r2
0.8 0.6 -0.4 0.1
0.4 0.2 -0.6 0.3
IL-4 0.2 0.1 -0.7 0.4
IL-5 0.1 0.0 -0.8 0.7
IL-10 0.7 0.5 -0.4 0.1
IL-13 0.3 0.1 -0.8 0.7
TGFß 0.1 0.0 -0.1 0.0
Proportion of variance: 0.351 0.524
Variable Pair-wise comparisons T statistic p A
Antigen
t3 vs. G6 0.159 0.435 -0.001
t3 vs. T. suis E/S -25.92 <0.001 0.095
g6 vs. T. suis E/S -25.99 <0.001 0.095
Timepoint
Baseline vs. Grass pollen season -4.49 0.003 0.016
Baseline vs. End -1.07 0.131 0.004
Grass pollen season vs. End -2.72 0.024 0.024
Treatment T. suis vs. Placebo -0.964 0.145 0.002
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7.5 Discussion
Parasitic helminth infection can modulate the host immune response to parasite and non-
parasite antigens and may contribute to the lower prevalence of allergic disease in helminth-
endemic areas relative to areas where helminths are non-endemic or have been eradicated
(Yazdanbakhsh et al. 2002; Fumagalli et al. 2009). What is less clear is whether
experimental helminth infections may exert similar effects in helminth-naïve individuals
already sensitised to allergens. The current study, which assayed cytokine responses of
participants enrolled in a clinical trial of TSO therapy for allergic rhinitis (Bager et al.
2010a), allowed both the cytokine responses to experimental helminth infection and the
effect of infection on allergen-specific responses to be investigated. Since all participants
were allergic to grass pollen allergen, cytokine responses were expected to be influenced
both by changes in grass pollen counts over time and, for infected cases, the development of
an anti-parasite response. The results of this study show for the first time that ingestion of
repeated doses of TSO alters the systemic and PBMC cytokine environment of helminth
naïve human hosts relative to placebo-treated controls. Although previous studies of
cytokine responses to single low-dose experimental hookworm infections in allergic rhinitis
sufferers lead to transient changes in PBMC cytokine responses (Blount et al. 2009), this is
the first study to demonstrate that repeated doses of T. suis ova induce more sustained
alterations to spontaneous and T. suis-specific cytokine responses. In addition to the general
observation that the host cytokine environment is altered by experimental helminth infection,
the results of the study highlight 3 major characteristics of the cytokine response to T. suis:
1) experimental infection and T. suis antigens elicit a Th2-polarised response, 2) Th2-
cytokines exhibit distinct dynamics according to the treatment received by each participant
and the timepoint at which responses were assayed and 3) T. suis infection does not
significantly influence allergen-specific cytokine responses in the periphery. The latter
observation is consistent with initial predictions that PBMC cytokine responses elicited over
the course of the study would vary according to antigen stimulation.
The study showed that repeated doses of TSO result in the maintenance of systemic IL-5
responses, which declined during the grass pollen season in the placebo-treated group. The
difference between the 2 treatment groups was most pronounced at the end of the study at
which point the T. suis treated cohort had received the maximum dose of parasite ova. Since
T. suis E/S-specific PBMC IL-5, but not allergen-specific IL-5, was elevated in the infected
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group it also seems likely that temporal changes in plasma IL-5 reflect the course of T. suis
infection rather than changes in environmental grass pollen counts over the course of the
study. Elevated plasma IL-5 responses coincided with higher T. suis-specific antibody titres
and eosinophil counts (refer to Appendix 2 and published data (Bager et al. 2010a)) in the
infected group. T. suis E/S also up-regulated Th2-type PBMC cytokine (IL-4, IL-5, IL-10
and IL-13) responses, as has been seen in numerous in vitro studies of cytokine responses to
helminth antigens (e.g. schistosome eggs (Schramm et al. 2003; Everts et al. 2009) and
somatic hookworm antigens (Wright and Bickle 2005)). Although temporal changes in these
cytokines indicative of an increase in Th2 responses after initial infection were observed,
these were not statistically significant, which may reflect both the small size of the PBMC
cohort (n = 22) and variability of their cytokine responses. In addition to Th2-type cytokines,
T. suis E/S elicited significantly elevated levels -
infected groups during the grass pollen season, indicating that the E/S preparation may also
contain Th1/inflammatory stimuli. Similarly soluble egg antigens (SEA) of schistosome
parasites, which are known to be potent Th2-inducers, contain Toll-like receptor (TLR)
ligands capable of inducing innate inflammatory cytokine secretion (van der Kleij et al.
2002a; van der Kleij et al. 2004).
In contrast to plasma IL-5, plasma -4, IL-10 and IL-13 responses were not
significantly affected by treatment. Similar to the IL-5 responses of the placebo-treated
group but in contrast to those of the TSO- -4 and IL-10 levels
declined relative to baseline levels in both treatment groups. The dissociation between Th2-
type cytokine responses, has also been previously observed in studies of natural helminth
infections in endemically-exposed populations (Grogan et al. 1996a; Sartono et al. 1997;
Scott et al. 2000) and in murine models of chronic immune hyper-reactivity in the airways
(Leigh et al. 2004). Given the increased proliferation of IL-4 producing cells in T. suis-
infected pigs (Steenhard et al. 2007) and the association between IL-4 and chronic GI
helminth infections in humans (Cooper et al. 2000), it was particularly surprising that plasma
IL-4 levels did not differ between the T. suis-infected group and placebo controls. However,
during porcine T. suis infections IL-4 production appears more pronounced in the ileo-caecal
lymph nodes than in peripheral blood samples and, if these changes in IL-4 occur in our
human cohort, they may be too subtle to detect in peripheral plasma samples (Steenhard et
al. 2007). Perhaps more surprising is that levels of plasma IL-4 declined in both treatment
groups during the grass pollen season, during which peripheral IL-4 responses might be
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expected to peak (Benson et al. 1997). This was not due to an absence of clinical allergy
since over 80% of the cohort reported moderate/severe allergic symptoms during the course
of the study (Bager et al. 2010a). However, the decline in plasma IL-4 during the grass
pollen season relative to baseline observed here is corroborated by observations in human
hay-fever sufferers in whom IL-4 levels were reduced during the grass pollen season relative
to baseline levels despite exacerbated allergy and elevated eosinophil markers (Jones et al.
2000). Thus, whilst IL-4 appears to be a key mediator of local immune responses in allergen-
sensitised tissues (e.g. in human nasal fluid (Benson et al. 1997; Scavuzzo et al. 2003)), it is
possible that IL-4+ cells are recruited to and sequestered in the airway mucosa when pollen
counts lead to exacerbated allergy. In the case of T cells the latter is supported by
observations in human allergic rhinitis sufferers in whom spontaneous and pollen allergen-
specific PBMC IL-4 production was lower during the grass pollen season (Jepsen et al.
1998), but inconsistent with observations in experimental human hookworm infection of
allergic rhinitis sufferers where circulating T cell numbers and IL-4+ T cells were unaffected
by infection (Blount et al. 2009). For eosinophils, an IL-4-dependent increase in eosinophil
chemoattractants and receptors by endothelial cells (Foster 1996; Schnyder et al. 1996)
would be expected to limit the number of IL-4+ eosinophils and other eosinophil-derived
cytokines detectable in the periphery. Murine models also suggest that cytokine responses
can be highly localised at the site of allergen sensitisation and un-detectable in adjacent
tissues (Denburg et al. 1990; Saito et al. 2001). In light of these studies, IL-4 may not be the
best peripheral correlate of human allergic rhinitis, as has been suggested by others (Jones et
al. 2000). Collection of nasal lavage fluids or biopsy samples to complement plasma and
PBMC cytokine measurements and/or assaying alternative markers of allergy (e.g.
eosinophil cationic protein (Jones et al. 2000)) would provide further evidence to
support/refute this hypothesis in future studies.
Of the allergen-specific PBMC cytokine responses assayed, only birch pollen-
significantly differed significantly in the TSO-treated group relative to placebo controls.
Mean grass pollen allergen and T. suis E/S- re also higher
in the TSO-treated group, although these patterns were not statistically significant. However,
was not significantly affected by timepoint it is unclear whether the marginally
higher mean concentrations in the T. suis-infected group at baseline or the effect of
subsequent treatment was responsible for this difference at the post-treatment timepoints.
There was also considerable variation in PBMC cytokine responses between individuals,
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particularly in response to grass pollen allergens, which may have been due to the range of
grass pollen sensitivities within the cohort identified at recruitment (Bager et al. 2010a).
Since sensitivity was detected by skin-prick test (Bager et al. 2010a), it was not possible to
quantify this variation in the current study. This could be addressed in future studies if
PBMC samples were collected from a larger cohort or clinical atopy was scored for all
participants and accounted for in statistical comparisons.
With respect to the original aim of the clinical trial (i.e. to alleviate allergic rhinitis
symptoms), induction of IL-10 secretion by T. suis antigens in vitro, an IL-10-polarised
plasma cytokine profile in infected individuals and the treatment-associated increase in birch
pollen allergen- TSO therapy to induce
immunoregulatory cytokines. However, no clinical improvement in the TSO-treated group
relative to the placebo-treated group was recorded over the course of the clinical trial (Bager
et al. 2010a)
infection occurred in the context of heightened effector cyto -4, IL-5,
IL-10 and IL-13) to T. suis E/S and systemic IL-5, which may have limited the therapeutic
efficacy of treatment. Consistent with this hypothesis IL-
which are associated with regulation of excessive Th2 polarisation and allergen-induced
inflammatory pathology (Borish et al. 1996; Comoy et al. 1998; Wosinska-Becler et al.
2004), were less pronounced during the grass pollen season relative to the Th2-effector
cytokines IL-5 and IL-13 (axis 2), as might be expected during exacerbated allergic airway
responses. These observations are consistent with immunological studies of T. suis infection
in pigs, which show that effector Th2 responses develop readily within weeks of infection
(Kringel et al. 2006; Kringel and Roepstorff 2006; Steenhard et al. 2007). Thus, since T. suis
infection is spontaneously cleared by infected humans (Summers et al. 2005c), significantly
more doses of TSO may be required to induce the immunosuppressive environment
associated with chronic helminth infections (Yazdanbakhsh et al. 2002; Jackson et al. 2009).
It is also possible that elevated IL-5, eosinophil counts, histamine levels and parasite-specific
IgE in T. suis infected participants (see Appendix 2 and published study (Bager et al. 2010a))
may have exacerbated rather than ameliorated airway hyper-reactivity (Foster et al. 1996;
Wosinska-Becler et al. 2004). It is noteworthy that during the clinical trial adverse GI
symptoms (including discomfort and diarrhoea) were more prevalent in the TSO-treated
group relative to the placebo controls (Bager et al. 2010b). Of the plasma cohort, 46.7% of
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the placebo-treated cases and 73.3% of the T. suis-treated cases reported gastrointestinal
discomfort or diarrhoea between initial treatment and the end of the study. In the PBMC
supernatant cohort 50% of the placebo-treated cases and 91.7% of the TSO-treated cases
reported GI symptoms post-treatment. Although the trial by Bager and colleagues is the first
to report adverse side-effects of TSO treatment, the co-incidence of eosinophilia and adverse
GI symptoms has been consistently noted in trials of experimental hookworm infection
(Croese et al. 2006; Daveson et al. 2009a; Feary et al. 2009). Since the current study is
reliant on peripheral blood samples it is unclear whether these responses were specifically
elevated in the GI tract where the parasites reside and/or in the airways where allergic
symptoms manifest.
A recent commentary on the clinical results of the trial (Bager et al. 2010a) has suggested
that provision of treatment for GI side-effects in the T. suis-treated group may have
abrogated development of allergy-regulating responses (Summers et al. 2010). Since some
participants received only 2 doses of TSO prior to the peak grass pollen season, it is also
possible that the dose of parasites was insufficient to induce therapeutic immunoregulatory
responses achieved during trials of TSO (Hepworth et al. 2010;
Summers et al. 2010). In light of this discussion, a more important consideration may be that
diarrhoeal episodes, particularly between baseline and the grass pollen season (Bager et al.
2010a), may have cleared or reduced establishment of adult parasites in the gut independent
of the number of TSO doses or treatment of side-effects. Whilst presence of parasite-specific
antibodies indicates recent exposure to infection (Bager et al. 2010a; Bager et al. in press),
without an indicator of infection intensity (e.g. faecal egg counts) it is unclear whether this
was the case in the current study. Unfortunately, the small number of participants and high
prevalence of GI symptoms meant that it was not possible to account for the incidence of
side effects in cytokine analyses or exclude cases on this basis.
7.6 Conclusions
This study has shown that experimental T. suis infection alters both the plasma and antigen-
specific cytokine environment of the human host. In particular, infected individuals have
higher levels of plasma IL-5 and on stimulation with T. suis E/S their PBMCs secrete more
IL-4, IL-5 and IL-10 than placebo-treated controls. T. suis
responses to birch pollen allergens.
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Cytokine responses varied temporally, reflecting immunological changes due to the duration
of exposure to T. suis and variation in environmental grass pollen counts and, in the case of
plasma IL-5, treatment related changes were timepoint-dependent. However, the cytokine
environment elicited by T. suis infection did not alter grass-pollen allergen-specific
responses, which may underlie the lack of clinical efficacy reported during the original trial
of TSO therapy for allergic rhinitis (Bager et al. 2010a)
Thus, the current study provides preliminary evidence that a small number of doses of TSO
induce potentially relevant immunological changes in a T. suis-naïve allergic cohort. These
changes were observed within 2 months of enrolment in the study. Thus it is possible that
with an increased duration of infection and adjusted dose of TSO the proposed
immunotherapeutic applications of T. suis infection in allergic rhinitis may be realised and
the observed side-effects avoided (Bager et al. 2010a).
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In this thesis I have investigated whether our increased understanding of murine cellular
immunology, particularly identification of novel effectors and cross-regulation between
different cellular phenotypes (Diaz and Allen 2007; Jenkins and Allen 2010), can improve
our understanding of the human immune phenotype during parasitic helminth infection. In
individuals naturally exposed to S. haematobium infection I have shown that cercariae elicit
a more pro-inflammatory cytokine profile than those elicited by adult worms and eggs
(chapter 3). S. haematobium-specific cytokine profiles also differ according to participant
age and the changing relationship between regulatory and Th17-polarised responses and
infection intensity with age are consistent with these responses contributing to
epidemiological patterns of infection (chapter 4). In chapters 5 I have shown that anti-
helminthic treatment not only alters parasite-specific cytokine responses, but leads to a
specific increase in pro-inflammatory responses particularly to egg antigens. Treatment-
induced changes in the schistosome-specific cytokine profile were dependent on pre-
treatment infection intensity and were also associated with a reduced risk of re-infection 18
month after treatment (chapter 6), suggesting that both the effects of treatment and its
implications for resistance to infection are dependent on parasite exposure. During
experimental T. suis infections in a helminth-naïve cohort I have shown that both systemic
and parasite-specific cytokine profiles become Th2-polarised relative to un-infected controls
(chapter 7), but infection does not significantly alter cytokine responses to allergens (chapter
7).
In this chapter I will discuss how these findings relate to one another and the initial aims of
the study (chapter 2.2) and how they extend existing literature on the immunobiology of
human helminth infections. I will also highlight key questions raised by this thesis and
propose how these questions might be addressed by future studies.
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Cytokines responses reflect both the type and magnitude of cellular immune responses to
helminth infections (Pearce et al. 1991; Montenegro et al. 1999a; Diaz and Allen 2007;
Mutapi et al. 2007b; de Morais et al. 2008; Milner et al. 2010) and thus provide an indicator
of how parasites may prime different cellular effector phenotypes during infection.
Throughout this thesis I have attempted to extend the observations of previous studies
suggesting that it is the balance between different immune responses rather than the
dynamics of individual molecules that determines anti-parasite and anti-pathology immunity
(e.g. IgE and IgG4 (Hagan et al. 1991; Demeure et al. 1993), IgA and IgG1 (Mutapi et al.
1997), -10 (Wamachi et al. 2004), IL-5 and IL-10 (Mutapi et al. 2007b) and
Teff:Treg (Nausch et al. 2011)). Whilst the latter has been inferred from a limited number of
antibody or cytokine responses in previous studies, this is the first study to simultaneously
assay Th1, Th2, Th17 and innate inflammatory-type responses in human schistosomiasis
(chapters 3-6). It is also the first study showing that schistosome-specific cytokines
associated with the Th17 lineage vary in response to different parasite antigens (chapter 3),
relate to epidemiological patterns of infection (chapter 4), are altered by treatment (chapter
5) and contribute to resistance to re-infection post-treatment (chapter 6).
These observations strongly support further investigation of Th17 responses during human
schistosomiasis, particularly in light of murine studies suggesting that they may mediate egg-
induced granulomatous pathology (Rutitzky et al. 2008; Shainheit et al. 2008; Rutitzky et al.
2009) and the association of these responses with exacerbation of chronic inflammatory
diseases in humans (Juszczak and Glabinski 2009; Hammerich et al. 2011) and lymphedema
in filarial helminth infections (Babu et al. 2009).
In addition to advocating an extension to the current cytokine panels used in human studies,
the results of this thesis suggest that the way in which immunological data is analysed can be
improved. Although factor analysis and non-metric multidimensional scaling (NMS) have
been used to analyse immunological data in only a small number of studies to-date (Turner et
al. 2003; Wilson et al. 2008; Milner et al. 2010; Groer and Beckstead 2011; Imai et al.
2011), they are routinely used for analysis of large and heterogeneous ecological data-sets
where, like cytokine data, multiple variables are quantified on a range of scales, rarely meet
parametric assumptions, and exhibit temporal and inter-dependent non-linear variations that
are un-detectable using alternative statistical methods (Moore-Kucera and Dick 2008;
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Walker 2008; Smith et al. 2009; Turcotte et al. 2009). Comparing the results of the
individual cytokine analyses to the results of the factor analysis of the same responses
conducted in chapter 3 clearly shows that the dynamics of individual cytokines can be
accurately and more concisely reflected by a single factor analysis. Furthermore, NMS
ordination plots provide an easily interpretable 2-dimensional representation of these
complex patterns and their reliability can be readily assessed using diagnostic criteria (e.g.
stress values, stability criteria, Monte-Carlo randomisation tests (McCune and Grace 2002))
as seen in chapters 5 and 7.
8.2 Do cytokine responses to schistosome cercariae, adult worm and egg
antigens inherently differ?
A common feature of many parasitic helminths is a complex phasic life-cycle, progression
through which has been shown to alter the host immune response in experimental models
(Grzych et al. 1991; Pearce et al. 1991). A number of immunoepidemiological studies in
human schistosomiasis also suggest that, even when hosts are simultaneously exposed to
multiple life-cycle stages during chronic infection, the cytokine responses to eggs and adult
worms may differ (El Ridi et al. 1997; Joseph et al. 2004a; Joseph et al. 2004b). It has long
been proposed that resistance to schistosome infection may develop via reduced accrual of
new infections over years of exposure, allowing patent infections to plateau and then decline
as adult worms die, but cercariae are prevented from reaching maturity (see chapter 1.6).
However, for this to be the case in vivo hosts must inherently respond to cercariae differently
from how they respond to adult worms and eggs. Thus one of the initial aims of this thesis
(chapter 2.2) was to directly compare the cytokine profiles elicited these life-cycle stages.
Proteomic comparisons of crude homogenate antigens of schistosome cercariae, adult worms
and eggs provide a precedent for antigenic differences between the 3 life-cycle stages
(Curwen et al. 2004). Furthermore, whilst studies in the 1970s, 80s and 90s have compared
the magnitude of immune responses to CAP, WWH and SEA, including PBMC proliferation
(Todd et al. 1979; Gazzinelli et al. 1983; Colley et al. 1986; Contigli et al. 1999), in vitro
granuloma formation (Contigli et al. 1999), comparison of isotype-specific serum antibody
titres (Butterworth et al. 1985; Viana et al. 1995) and isolation and culture of T cell clones
(Contigli et al. 1999), none have investigated whether these patterns are due to phenotypic
differences in the immune environment. Thus my observations in chapter 3 that cercarial
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antigens elicit a more pro-inflammatory profile of cytokine response than adult worm and
egg-stage antigens provides evidence for distinct polarisation of immune responses at
different stages of the schistosome life-cycle. For example, pro-inflammatory cytokine
responses appear to dominate the early immune response to cercariae as they invade the skin
during murine infections (Hogg et al. 2003a; Jenkins et al. 2005a). In contrast, polarisation
of the host immune response by egg antigens, which elicited higher levels of Th2 and Th17-
type cytokines than cercariae in the current study (chapter 3), may reflect the putative role of
Th2 and Th17-type cytokines in granuloma formation around eggs trapped in host tissues
(Chiaramonte et al. 1999; Rutitzky et al. 2008; Shainheit et al. 2008). Thus these results
represent an important step forward in our understanding of how exposure to different
parasite life-cycle stages may influence human immune responses and the types of effector
cytokines that may predominate in different tissues and at different stages of infection.
Inherent differences in the cytokine profiles elicited by cercariae, adult worms and eggs were
also evident 6 weeks after treatment (chapter 5), when chronic infection had been removed.
But contrary to pre-treatment responses, and despite an increase in pro-inflammatory
cytokine responses to cercariae, schistosome eggs elicited the most pro-inflammatory
cytokine profile. Although early studies in murine S. mansoni have led to the supposition
that immature parasites are relatively un-affected by treatment when compared with adult
worms (Andrews 1985; Sabah et al. 1986; Shaw 1990), my observations suggest that adult
worm death and the associated release of adult worm antigens are not the sole effect of
treatment and raise the possibility that immature infective and transmission-stage
schistosomes may also be targeted by praziquantel as has been observed in laboratory
animals (Flisser et al. 1989; Giboda and Smith 1994; Liang et al. 2001) and in vitro (Harnett
and Kusel 1986). There are 2 main hypotheses that may account for the increase in cytokine
and antibody responses to parasite antigens after treatment and both would be consistent with
increased responsiveness to egg and cercariae. Firstly, treatment may release a burst of
parasite antigens by damaging their tegument and revealing somatic antigens to immune
recognition. Increased exposure to egg antigens after treatment, evident from the elevated
egg-specific antibody titres (Mutapi et al. 1998b), increased levels of egg antigens in urine
(Nibbeling et al. 1998) and protracted excretion of eggs (Tchuem Tchuente et al. 2004)
identified after treatment-induced clearance of infection, suggest that schistosome egg
antigens may be particularly relevant stimuli for post-treatment immune responses.
Alternatively, parasite death may alleviate immunoregulatory mechanisms that limit immune
responses during chronic infection. The latter may be particularly evident for egg and
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cercariae-specific effector cytokine responses due to their immunopathogenic potential in the
skin (Appleton 1984), liver (Dunne and Pearce 1999; Wilson et al. 2008) and urogenital tract
(Wamachi et al. 2004).
Differential polarisation of cellular immune responses is an area of active interest for
immunological studies. For example, murine models routinely use schistosome eggs as Th2-
polarising agents to investigate type 2 immune processes (Grzych et al. 1991; Wynn et al.
1994; Fallon and Dunne 1999; Okano et al. 2001; van de Vijver et al. 2006) and there are
already several constituent antigens of crude schistosome egg antigens known to polarise the
cytokine responses of human cells in vitro (van der Kleij et al. 2002b; Schramm et al. 2003;
Everts et al. 2009; Steinfelder et al. 2009). Thus, the current study could be extended to
identify the functional roles of stage-specific cytokine phenotypes and may also facilitate
- s (e.g. via modification of proteins or combining different
antigens in a single vaccine) to promote immune responses associated with anti-parasite
immunity.
.
8.3 Do the schistosome-specific cytokine responses contribute to the
development of anti-parasite immunity?
In this thesis I have investigated how peripheral cytokine responses relate to 2 scenarios
proposed to generate immune-mediated resistance to schistosome infection: 1) evidence
from epidemiological patterns of infection that resistance to high intensity infections
develops gradually with age/exposure to infection (Woolhouse 1998) (chapter 4) and 2)
removal of infection by treatment alters exposure to parasite antigens and promotes
resistance to subsequent re-infection (chapter 6) (Woolhouse and Hagan 1999; Mutapi et al.
2003; Mutapi et al. 2005). The former hypothesis is supported by cross-sectional studies
showing that reciprocal changes in schistosome-specific cytokine (Mutapi et al. 2007b) and
antibody (Mutapi et al. 1997) responses correspond to the age-dependent decline in infection
intensity and I therefore sought to extend these studies. The latter hypothesis is more
controversial since although anti-helminthic treatment has been previously shown to elicit
beneficial changes in the parasite-specific immune response (Mutapi et al. 1998a; Mutapi et
al. 2003; Mutapi et al. 2005; Watanabe et al. 2007) longitudinal treatment-re-infection
studies suggest that it has only short-term effects on infection intensity and associated
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immunopathology even after repeated doses (van den Biggelaar et al. 2002; Guidi et al.
2010).
8.3.1 What cytokine profiles are associated with natural development of
resistance to schistosomiasis?
To investigate whether pre-treatment schistosome-specific cytokine responses are related to
the development of a protective immune phenotype it was first necessary to define which
approaches; whilst some have relied on participant infection status or intensity (Viana et al.
1995; Corrêa-Oliveira et al. 1998; Al-Sherbiny et al. 2003), I have favoured an age-
structured analysis as advocated by numerous previous empirical and theoretical studies in
human helminthiases (Hagan et al. 1991; Woolhouse 1992, 1994; Grogan et al. 1996b;
Turner et al. 2003; Quinnell et al. 2004b; Mutapi et al. 2008). This approach is favourable
since it reflects consistently observed population-level patterns of schistosome infection
(reviewed by Woolhouse, 1998). Furthermore, the aggregation of infection in certain age
groups and by gender means that defining resistance solely by their current infection levels
leads to a biased distribution of ages and sexes between groups (e.g. Al-Sherbiny et al.,
2003). Both age and sex are also known to influence infection and immunity (Fulford et al.
1992; Webster et al. 1997b; Fulford et al. 1998) and were also influential factors for current
infection levels in Magaya community (chapter 4).
It is not practicall
from initial exposure without providing treatment, therefore an age-structured approach to
characterising resistance is based on the assumptions that; a) cross-sectional patterns of
schistosome infection in the community reflect patterns of infection experienced throughout
life and b) exposure to infection is relatively constant for permanent residents of an area
where transmission is stable and endemic. Thus an important aspect of this study was to
characterise potential sources of variation in cytokine responses (e.g. co-infection, residential
and treatment history and water contact behaviour) within the cohort in order to validate
these limitations/assumptions prior to immunological analyses. In particular, extensive water
contact surveys conducted as part of previous studies in endemic areas indicate that, as
would be expected, the risk of infection is dependent on how often individuals are exposed
ites of parasite transmission) (Chandiwana and Woolhouse
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1991; Woolhouse et al. 1991; Rudge et al. 2008). However, in this study age-dependent
variations in water contact behaviour alone were not responsible for the distribution of
infection by age (chapter 4). The latter meant that, cross-sectional patterns of infection in
Magaya community could be more reliably related to exposure history (Woolhouse 1992,
1994, 1998) since young children (5-10 years), who were considered as being likely to
accumulate increasing levels of infection, and older children and adults (13+ years), who
were considered as having developed resistance to high intensity infections, had equivalent
mean infection levels and contact with sites of parasite transmission (chapter 4.4.1). 11-12
year olds were considered to be in a transitory stage whereby they had the highest intensity
infections of the 3 age groups, but according to cross-sectional patterns of infection in the
population as a whole, these levels were predicted to decline with age. Inclusion of all 3 age
groups was considered an important extension to studies comparing the immune responses of
Grogan et al. 1996; Nausch et al. 2011) since children in
the 11-12 age group represent a distinct stage of immune development evident from their
greater range of infection intensities (0 - 639 eggs/10ml urine) and distinct parasite-specific
cytokine responses relative to 5-10 and 13+ year olds both before and after treatment
(chapters 4 and 6).
Although numerous previous studies support an age-dependent change in immune responses
or a relationship between immune responses and infection after accounting for the effects of
age (chapter 1.6), I investigated both patterns since infection and immunity are inter-
dependent and both are influenced by participant age. The results of these analyses are
consistent with an exposure-dependent shift in schistosome-specific cytokine responses
contributing to the development of immune-mediated resistance to infection. This assertion
is supported firstly by the observation that young children mount a more regulatory/Th17-
polarised immune response to infection than 11-12 or 13+ year olds (chapter 4). However, as
initially suggested for parasite-specific antibodies (Woolhouse 1992; Mutapi et al. 1999), a
difference between cytokine profiles with age is insufficient evidence for the contribution of
these responses to immune-mediated resistance to infection since an immune response will
correlate positively with infection intensity if it is stimulated by parasites and their antigens
but also stimulated by parasite antigens in a
population with high infection prevalence or if it is co-produced with/activated by/regulated
have also shown that the relationship between schistosome infection intensity and
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schistosome-specific regulatory/Th17-polarised responses changed from a significant
positive correlation in 5-10 year olds to no correlation in 11-12 and 13+ year olds (chapter
4). This pattern is consistent with observations that immunological changes with age may
correspond with the development of resistance to helminth infections (Quinnell et al. 1995;
Turner et al. 2003; Mutapi et al. 2006; Nausch et al. 2011), but extends these previous
studies by inclusion of a broader range of cytokines, antigen-specificities and age groups
within a single population that had not received prior treatment. In contrast to previous
studies assaying only a small number of cytokines, I could exclude the possibility that these
patterns simply reflected those of other (un-measured) cytokine responses. However, it will
be important in future studies to characterise what other soluble molecules, cellular effectors
and functional effects can be attributed to a regulatory/Th17-polarised immune response to
schistosome antigens.
8.3.2 Does anti-helminthic treatment promote resistance to re-infection?
Another important indicator of anti-parasite immunity is whether endemically-exposed
individuals are resistant to re-infection post-treatment in the context of continued exposure to
infective cercariae. In order for treatment to promote immune-mediated resistance to re-
infection it is first necessary to demonstrate that treatment changes the immune response to
parasite antigens. A number of studies provide a precedent for a treatment-dependent change
in the immune profile of schistosome-exposed cohorts (Grogan et al. 1996b; Mutapi et al.
1998a; Mutapi et al. 2002) and treatment also affects different cytokines differently (Medhat
et al. 1998; van den Biggelaar et al. 2002; Joseph et al. 2004b; Reimert et al. 2006; Mduluza
et al. 2009). However, studies focusing only on the responses to adult worm antigens
(Medhat et al. 1998; van den Biggelaar et al. 2002) or systemic responses (Reimert et al.
2006) profile.
The results of chapter 5 show that treatment not only affects different cytokine responses
differently, but these effects correspond to a shift in the overall cytokine polarisation of an
individual. Furthermore, consistent with a boost in exposure to parasite antigens (Mutapi et
al. 2005), but in contrast to the assumption that these changes are mainly in response to adult
worm antigens (Roberts et al. 1993; Joseph et al. 2004b), I identified a marked increase in
pro-inflammatory cytokine responses to CAP, SEA and GST, but not WWH, relative to pre-
treatment responses. Since resistance to infection appears to develop from a decline in
parasite-specific regulatory/Th17-type cytokine responses with age/exposure prior to
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treatment (chapter 4), the increased exposure to parasite antigens upon treatment might be
expected to accelerate their reduction allowing effector responses to predominate. Consistent
with this hypothesis, the observed increase in pro-inflammatory cytokine responses occurred
in the absence of an increase in parasite-specific IL-10 (with the exception of cercariae-
specific IL-10) (chapter 5), which is known to reduce levels of effector cytokines in human
whole blood cultures (Grogan et al. 1998a; Mutapi et al. 2007b). Notably, although parasite-
specific and spontaneous IL-21 responses increased in response to all antigens and in un-
stimulated cultures after treatment, unlike pre-treatment patterns these responses were not
associated with post-treatment IL-10. Collectively these results suggest that treatment
induces a switch from a relatively hypo-responsive cytokine profile to adult worm and egg
antigens, which do not elicit significantly different profiles prior to treatment (chapter 3), to
a dramatic increase in egg-specific effector responses (chapter 5). Furthermore, whilst pro-
inflammatory cytokines were not associated with resistance to infection before treatment
(chapter 4), egg-specific pro-inflammatory cytokines and adult-worm and egg-specific IL-21
were higher in individuals who remained infection-free than in their re-infected counterparts
(chapter 6). Thus, in addition to reducing infection prevalence and intensity (Tchuem
Tchuente et al. 2004; Midzi et al. 2008a), praziquantel treatment may also lead to a
generalised increase in immune responsiveness that may boost anti-parasite immunity.
Similar associations with a reduced risk of re-infection have also been noted for
schistosome-specific antibody titres (Hagan et al. 1991; Mutapi et al. 1999; Caldas et al.
2000) and PBMC proliferative responses (Colley et al. 1986). Since both the boost in
cytokine responses to crude parasite antigens post-treatment (chapter 5) and the association
between post-treatment cytokine profiles and resistance to re-infection (chapter 6) were
independent of host age, my findings also suggest that treatment may alter the relationship
between age, exposure history and immune responses observed prior to treatment (chapter
4). For example, exposure to dying worms may be dependent on the natural parasite life-
span in un-treated populations and therefore particularly limited in young children with a
short history of exposure (Woolhouse and Hagan 1999; Mutapi et al. 2008), but treatment
may accelerate exposure to these antigens making the immune responses of children more
- (Grogan et al. 1996b; Mutapi et al. 2003).
It is interesting that I have identified an association between egg-specific cytokine responses
and resistance to re-infection since egg-specific immune responses have been described as
(Mutapi et al. 1999) - (Woolhouse and Hagan 1999) since
their abundant carbohydrate antigens elicit high titres of IgM (Mutapi et al. 1999) and cannot
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be directly presented to the T cell receptor via MHC II. Pro-inflammatory glycan-specific
responses to both eggs and cercariae, which are also enriched with carbohydrate molecules
(Samuelson and Caulfield 1985; Jang-Lee et al. 2007), have also been proposed to act as
-specific effector and memory
responses (Eberl et al. 2001; Kariuki et al. 2008). However, in light of my observations, it is
also possible that immune cross-reactivity between cercariae and egg glycans (Jang-Lee et
al. 2007; Kariuki et al. 2008) are of relevance to protective immunity. For example, in vitro
studies suggest that glycolipids from S. mansoni eggs, but not adult worms, induce secretion
of IL- -10 by monocytes isolated from praziquantel-treated participants
endemically exposed to S. haematobium (van der Kleij et al. 2002b). Both IgM titres
(Mutapi et al. 2003) and eosinophils counts (Ganley-Leal et al. 2006) have been shown to
increase after praziquantel treatment. Thus, activation of innate non-T cell cytokine
responses by egg antigens after treatment may alter the environment in which schistosome
peptide antigens are presented to T cells (reviewed by others (Jenkins and Allen 2010)) and
immune cross-reactivity, particularly between cercariae and eggs (Jang-Lee et al. 2007;
Kariuki et al. 2008), may also contribute to the development of adaptive memory responses
to other life-cycle stages. Since resistance to high intensity infections takes years to develop
naturally (Yazdanbakhsh and Sacks 2010) and adult worm antigens do not elicit large
amounts (relative to CAP or SEA) of any of the cytokines measured before or after treatment
(chapter 3 and 5), treatment may be required to trigger this process and overcome tolerance
of infection. This assertion is supported by observations that PBMC proliferative responses
to S. mansoni cercariae and egg antigens, but not adult worms, were consistently lower in
individuals who were subsequently re-infected than in individuals who did not acquire new
infections up to 2 years after treatment (Colley et al. 1986). Mathematical models also
predict that immune responses elicited by one life-cycle stage, including eggs, and targeting
another could induce protective immunity in such a way as to replicate the distribution of
infection by age frequently observed in schistosome-endemic communities prior to treatment
(Woolhouse 1994; Mitchell et al. 2008).
Clearly both the time after treatment at which cytokine responses were assessed and the
duration of whole blood antigen re-stimulation in culture are important considerations for
interpreting whether cytokine profiles are related to anti-parasite immunity after treatment.
For example, previous human schistosome studies have used different culture durations for
different cytokines to assess individual responses at their peak level (van den Biggelaar et al.
2002; Joseph et al. 2004a; Joseph et al. 2004b), whereas I have chosen to measure all
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cytokines at a single timepoint to allow characterisation of the cytokine profile as a whole.
The advantage of my approach is that it enables simultaneous interactions between cytokines
in cultured whole blood to be characterised, which are not biased by the effect of different
culture duration. Furthermore, direct comparisons with other studies are made with caution
since for those investigating re-infection over a longer period (e.g. 2 years (van den
Biggelaar et al. 2002) and 21 months (Caldas et al. 2000)), individuals who appeared
resistant to re- - 18 months post-treatment) may not
qualify as such due to re-infection occurring at later post-treatment timepoints.
8.4 Are glutathionine-S-transferase-specific cytokine responses associated
with anti-parasite immunity?
Although S. haematobium GST is considered to be the most promising of the vaccine
candidate antigens against human schistosomiasis (Capron et al. 2002) I have not identified
an association between the cytokine profile elicited by GST and resistance to high intensity
infections before treatment (chapter 4) or a reduced risk of re-infection after treatment
(chapter 6). Furthermore, I did not identify the strong gender-dependent variation in immune
responses to GST noted elsewhere (Remoué et al. 2000; Remoué et al. 2001), although this
may be due to inclusion of a broad age-range (5-84 years) where previous studies restricted
their analyses to older children and adults (aged 12 years and above (Remoué et al. 2000)
and aged 35 years and above (Remoué et al. 2001)). Thus, what may have been over-looked
in these previous studies is the age-dependent cytokine response to GST, which has also
been observed in antibody responses to GST isoforms present in WWH both before (Mutapi
et al. 2008) and after (Mutapi et al. 2003) treatment.
GST-specific pro-inflammatory cytokine responses are highest at the age of peak-infection
intensity prior to treatment (chapter 4) and those individuals in the 11-12 year age group that
bore the highest infection intensity had the lowest increase in pro-inflammatory cytokine
responses to GST after treatment (chapter 6). Since GST is abundantly expressed at various
stages of the schistosome life-cycle (Curwen et al. 2004) it is unsurprising that changes in
parasite exposure (i.e. with age or following treatment) would influence GST-specific
responses. Accordingly I have shown that the predominant cytokine profiles elicited by GST
(e.g. pro-inflammatory (GST PC1) and regulatory/Th17 (GST PC3) (chapter 4)) correspond
to those elicited by WWH and SEA and the age and treatment-dependent dynamics of GST
Chapter 8 General Discussion
- 256 -
and SEA/WWH cytokine profiles are also similar. In particular, 11-12 year olds may have
the highest pre-treatment GST responses because of their high levels of infection and these
responses may decline less rapidly after treatment due to the slower decline in GST levels
due to their large numbers of patent worms. Thus, these dynamics suggest that GST-specific
responses more accurately indicate current infection levels than development of immunity.
It is important to note that because both pre and post-treatment protection was defined
according to egg counts in urine in this study the purported effect of anti-GST responses on
parasite fecundity (Boulanger et al. 1991) could not be investigated. Furthermore, whilst
exposure to GST at the concentrations present in a typical schistosome infection may be
insufficient to promote protective cytokine responses, my studies do not preclude the
induction of protective GST-specific antibody responses (Grzych et al. 1993) or beneficial
effects of GST vaccination at higher doses, which appear to induce antibody-mediated
protection in animal models (Lane et al. 1998; Capron et al. 2001). In support of the latter
hypothesis, the post-treatment increase in GST-specific cytokines, most notably IL-6 and IL-
-12p70, IL-13 and IL-23 (chapter 5), were consistent with a treatment-
induced increase in the priming of effector cells by GST after treatment. Thus my results
confirm the importance of treatment for boosting cytokine responses to GST only shown
previously for antibody responses in human (Mutapi et al. 2003; Mutapi et al. 2005) and
murine studies (Doenhoff et al. 1987; Dupre et al. 1999). Importantly, co-administration of a
GST-based vaccine with praziquantel is the subject of an on-going Phase III clinical trial
(NIH 2009), the first of its kind in human schistosomiasis. It is hoped that this approach will
allow a more comprehensive analysis of cytokine, cellular and antibody responses to this
antigen since after many years of focus on both S. mansoni and S. haematobium GST there
remains little published data, but much published discussion (Capron et al. 1987; Capron et
al. 2002; Capron et al. 2005; Wilson and Coulson 2006), on its efficacy in endemically-
exposed humans.
8.5 Can short-term helminth infections limit immune-mediated pathologies
during allergy?
Although natural helminth infections are currently aggregated in developing areas of Africa,
Asia, and Latin America (Hotez et al. 2008) it is only in the relatively recent past (40-50
years (Stoll 1947; Mannino et al. 1998)) and as a result of dramatic improvements in
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sanitation and healthcare that helminth infections have ceased to be ubiquitous in affluent,
urbanised countries. Thus, notwithstanding their devastating impact on global health, the
reduced prevalence of helminth infection and their immunomodulatory effects on the
immune system may have had repercussions for diseases caused by immune hyper-reactivity
to innocuous antigens (e.g. allergens and auto-antigens). However, the jury is still out on
whether short-term experimental helminth infections can reduce allergic and auto-immune
reactivity in the same way as chronic infection in an endemic setting (Leonardi-Bee et al.
2006; Flohr et al. 2009; Feary et al. 2011) and immunotherapeutic helminth infections are
the subject of on-going clinical trials (Summers et al. 2005a; Summers et al. 2005b; Croese
et al. 2006; Daveson et al. 2009a; Daveson et al. 2009b; Bager et al. 2010a; Feary et al.
2010; Daveson et al. 2011; Fleming et al. 2011). In chapter 7 I provide the first and largest
analysis of cytokine responses to experimental Trichuris suis infection in helminth naïve
humans and the first assessment of the effect of these infections on responses to pollen
allergens during allergic airway disease.
It is clear from the results of chapter 7 that T. suis ova (TSO) therapy for allergic rhinitis
represents a complex balance between the natural course of a GI nematode infection and,
particularly for seasonally exacerbated allergy, the dynamics of the allergic response.
However, despite marked changes in the cytokine environment elicited by infection and T.
suis excretory/secretory (E/S) antigens, these did not correspond to a reduction in clinical
symptoms of allergic rhinitis (Bager et al. 2010a). Notably, the grass pollen season was
characterised by elevated Th2-type PBMC responses typical of allergic responses (Benson et
al. 1997; Klimek et al. 1999; Wachholz et al. 2002; Scavuzzo et al. 2003) in infected and un-
infected participants despite elevated T. suis-specific PBMC IL-10 and IFN responses,
which might be expected to regulate Th2 responses.
To-date the most successful trials of helminth infection as an immunotherapy for
(Summers et
al. 2005a; Summers et al. 2005b; Croese et al. 2006) , where infection and inflammation
occur within the same locale. Since helminth-mediated suppression of allergen-specific
responses may occur more readily at the site of infection than at distal allergic foci (e.g. the
airways) care should also be taken when directly comparing the clinical efficacy observed in
the cohort selected for the current study (Bager et al. 2010a) with that of previous trials.
Allergic immune responses may be restricted to the site of allergen sensitisation (Denburg et
al. 1990; Saito et al. 2001) and may therefore be unaffected by changes in circulating
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immune cells or the gut mucosa. -
polarised immunopathology (Brand 2009) and these responses may be more readily altered
by helminth-induced Th2-type responses than allergic disease where pathogenesis is Th2-
mediated. Thus, as proposed by others (Summers et al. 2010), a longer duration of exposure
to T. suis may be also be required prior to the grass pollen season in the current model than
in those described previously. It is also important to note that T. suis treatment of the study
cohort investigated in chapter 7 corresponds to a relatively short-term and primary exposure
to infection and studies of natural infection with other helminth species have shown that
cytokine responses in acute phase infection differ markedly to those that develop in the
chronic setting (Montenegro et al. 1999a; Babu and Nutman 2003). Notably, a recent
immunological characterisation of self-administered T. trichiura indicated that protection
against irritable bowel syndrome (IBD) only manifested after several months-years of
treatment and particularly during periods of high intensity infection (Broadhurst et al. 2010).
However, establishment of intense and chronic infections with a natural human parasite,
such as that seen in the latter study (Broadhurst et al. 2010), would be unlikely to meet the
safety requirements of most clinical trials. Thus, despite its limitations, an adapted regime of
TSO remains a more realistic option for helminth-based targeting of allergic disease,
particularly in light of the regulatory cytokine responses (T. suis-specific IL-10 and a
tendency for higher allergen-specific TGF responses) in the infected group relative to
placebo-treated controls (chapter 7).
Alternatively, promising results from murine studies suggest that administration of helminth
peptides, rather than live infections have potential as immunotherapies in humans. For
example, nematode excretory/secretory products have been shown to directly reduce airway
hyper-reactivity (eosinophilia, serum antibody titres, IL-4 and IL-5) if co-administered with
allergen and these effects occurred in the context of elevated parasite-specific Th2 response
(Trujillo-Vargas et al. 2007). T. suis E/S also elicited high levels of effector cytokines in
both TSO- and placebo-treated participants (chapter 7), suggesting that E/S can effectively
polarise human immune responses in the absence of infection. A helminth antigen-based
approach would have the added advantage of negating the risk of the adverse side-effects
during live parasite infection and the potential for combination with existing intravenous and
intralymphatic allergen-based therapies with known clinical efficacy (Senti et al. 2005; Senti
et al. 2008).
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8.6 Is there a stereo-typical cytokine response to parasitic helminth infection
in humans?
The results of this thesis have increased the range of cytokines assessed in human S.
haematobium infection and suggest that immune responses both before and after treatment
constitute a variety of cellular effector phenotypes. Interestingly, despite the generally-
accepted view that helminth infections induce a stereotypical Th2-polarised immune
responses, whole blood Th2-type effector cytokine responses (IL-4, IL-5 and IL-13) did not
significantly vary according to S. haematobium infection intensity (chapter 4) and, with the
exception of the decline in IL-5 responses, were not significantly affected by treatment
(chapter 5) in Magaya community. In contrast, systemic IL-5 and T. suis specific PBMC IL-
4, IL-5 and IL-13 responses were markedly elevated during experimental T. suis infection
relative to placebo-treated controls (chapter 7). Inconsistencies between these studies,
particularly the life-history of the 2 helminth species, assay of whole blood versus plasma
and PBMC responses and predisposition of allergic individuals towards a Th2-polarised
response, make it impossible to draw direct comparisons between them. However these
observations do raise the question of whether helminth specific responses can be considered
Although I have shown that a variety of alternate effector cytokines are simultaneously
elicited and these responses vary more markedly than Th2-type cytokines between
schistosome antigens (chapter 3), according to host age and infection intensity (chapter 4),
my results clearly do not preclude the importance of the Th2 phenotype during S.
haematobium infection. For example, although whole blood Th2-type cytokines were not
detected at high levels relative to previous observations in a schistosome hyper-endemic area
(Joseph et al. 2004a; Joseph et al. 2004b), the changes observed after treatment in the current
study (chapter 5) suggest that a Th2-polarised environment is relatively more predominant in
peripheral whole blood responses to S. haematobium SEA and WWH during infection
(chapter 3). However, a variety of studies suggest that levels of different immune markers
vary according to the duration of helminth infection (Ottesen et al. 1978; Colebunders et al.
1995; Montenegro et al. 1999a; Barbosa et al. 2001; Caldas et al. 2008; de Morais et al.
2008), local transmission intensity(Mutapi et al. 1997, 1999; Scott et al. 2001; Mduluza et
al. 2003), age (Day et al. 1991b; Agnew et al. 1996; Fulford et al. 1998; Faulkner et al.
2002; Mutapi et al. 2003; Mutapi et al. 2008; de Moira et al. 2010), gender (Webster et al.
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1997b; Remoué et al. 2001), antigen-specificity (Joseph et al. 2004a; van der Kleij et al.
2004; Everts et al. 2009) and co-infection (Ganley-Leal et al. 2006; Geiger 2008; Wilson et
al. 2008; Diallo et al. 2010) among other factors, and thus the immune response to human
type, consistent with my
observations. Furthermore, the distinct life-histories of GI parasites, such as T. suis, and
tissue-dwelling parasites, such as S. haematobium, may lead to differences in the immune
responses they elicit (Bourke et al. 2011). The most widely cited evidence for direct Th2-
polarisation of human cells by helminth antigens comes from observations in cell-specific
cultures from helminth-naïve humans (Schramm et al. 2003; Everts et al. 2009), which may
belie the role of alternate cell types and the effect of long-term conditioning by endemic
exposure from birth. Genetic studies also suggest that polymorphisms in the 5q31-q33
region, where Th2-type cytokine genes are located, is associated with resistance to infection
across a range of human populations and for both S. mansoni and S. haematobium, but
resistance to peri-portal fibrosis in the
(Dessein et al. 2004). Thus, protective immunity (comprising both anti-parasite and anti-
pathology responses) may require development of compartmentalised responses within
-
exposed human populations. Evidence for the latter comes from population genetic analyses
indicating that exposure to a diverse range of micro and macro-parasitic species has
promoted variability in human interleukin genes across 52 human populations (Fumagalli et
al. 2009). Murine models of helminth infection also highlight the importance of Th2-type
responses in the tissues where parasites are present (Cook et al. 2011; Jenkins et al. 2011)
and suggest that sensitivity to IL-4 may be relatively limited in the periphery (Perona-Wright
et al. 2010).
Although local immune responses can be investigated in humans, for example via collection
of gut biopsies (Broadhurst et al. 2010), collection of these samples is invasive, time-
consuming and requires technical equipment that is unavailable during most field studies in
endemic areas. Thus a challenge for researchers of both human infections and animal models
is to identify how peripheral immune markers relate to the mechanisms of protection and the
clinical features of disease. The first step for human studies is to address whether novel
cellular effectors identified in laboratory infections are detectable in peripheral samples and
vary during natural helminth infections, as I have done for Th17-type cytokines in urinary
schistosomiasis (chapters 3-6). Testing these paradigms will enable both shared
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characteristics of the immune responses to different parasite species and the differences
between them to be identified in future studies.
8.8 Future prospects
Due to the breadth of the immunoepidemiological field study of which chapters 3-6 are
constituent parts, there are several questions arising from this thesis that can be immediately
addressed. Firstly, an important consideration is how the secreted cytokine profiles observed
can be more directly linked to the phenotypes of cultured whole blood cells. This could be
achieved by measuring the expression of transcription factors associated with different
cellular effector phenotypes in cultured whole blood cells. Of particular interest would be
expression of T-bet (Th1), GATA3 (Th2) and RORC2 (the human orthologue of , the
characteristic transcription factor driving murine Th17 differentiation (Unutmaz 2009))
(Diaz and Allen 2007). Although mRNA expression analysis was beyond the scope of the
current study, I collected and stored lymphocyte-enriched samples of cultured whole blood
in RNA preservation buffer throughout the pre and 6 weeks post-treatment sampling visits to
Magaya and analysis of these samples will allow the correspondence between cytokine
profiles and molecular markers of cellular phenotype to be compared. Another means of
relating cytokine responses to cellular effector responses would be to phenotype PBMCs (via
surface receptor expression, schistosome-specific proliferation assays and intracellular
cytokine staining) isolated from the same individuals. Analyses of purified monocytes,
granulocytes and various effector B and T cell subsets present in PBMC isolates from
Magaya community are being conducted by my fellow researchers at the University of
Edinburgh. The latter will also allow the relationship between these cell types and age and
infection intensity to be explored as I have done for whole blood cytokine profiles in
chapters 4 and 6.
In order to validate the observed association between post-treatment schistosome-specific
cytokine profiles and the risk of subsequent re-infection discussed in chapter 6, it will also be
important to assess the duration of treatment-induced changes in these responses beyond 6
weeks. The latter can be directly assessed using supernatants I have collected from whole
blood cultures conducted 6 months after praziquantel treatment of Magaya community.
Although, previous studies have assessed immune responses over longer post-treatment
periods (Colley et al. 1986; van den Biggelaar et al. 2002), analysis of these samples would
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provide the most comprehensive longitudinal assessment of schistosome-specific cytokine
responses to date and add greatly to our understanding of the longer-term implications of
treatment on the development of protective immune profiles.
The results of this thesis also highlight several important areas of investigation for future
studies. In particular, the limited available sample volumes from many participants meant
that fewer CAP-stimulated whole blood cultures were conducted than for SEA and WWH
meaning that the age range and infection ranges were insufficient to conduct an age-
structured analysis of cercariae-specific cytokine responses. The results presented in chapters
3 and 5 suggest that immune responses targeting cercariae warrant further study. More
specifically I would advocate regular inclusion of CAP in whole blood culture studies
conducted in the field and a more detailed comparison of which constituent molecules of
CAP are recognised by serum antibodies both before and after treatment (as has been
conducted for WWH (Mutapi et al. 2005; Mutapi et al. 2008; Mutapi et al. 2011a).
The relative contribution of different parasite antigens to the increase in post-treatment
cytokine responses identified in chapter 5 could be explored in more detail in future studies
by assaying changes in the levels of circulating antigen in sera or urine. Of specific relevance
to the increase in SEA-specific cytokine responses I observed 6 weeks after treatment
(chapter 5), previous studies indicate that egg antigens continue to be detected up to 6 weeks
after treatment (Nibbeling et al. 1998) and thus may have a prolonged impact on the post-
treatment cytokine environment. Circulating antigen assays might also allow inferences to be
made as to whether treatment influences parasite fecundity (Agnew et al. 1996; van Lieshout
et al. 1998) and might be more sensitive to low intensity infections than urine egg counts.
Importantly, the absence of data on the clinical morbidity in Magaya community also means
that my observations cannot be related to the development of anti-pathology immunity
during schistosomiasis. Thus an important extension to future studies would be to quantify
markers of host pathology (e.g. ultrasound evaluation of the bladder, liver and spleen,
assessment of proteinurea and haematuria) and investigate the relationship between these
markers and the schistosome-specific cytokine profile. There are already a number of cross-
sectional studies suggesting that the balance between different effector cytokines influences
immunopathology during schistosomiasis (Wamachi et al. 2004; Wilson et al. 2008) and, in
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light of my observations, it will be particularly important to test whether the role of Th17-
type cytokines in murine pathology (Rutitzky et al. 2008; Rutitzky et al. 2009) is also
evident in human disease.
During future field studies, it will continue to be important to investigate whether immune
mechanisms identified during experimental helminth infections translate into detectable
patterns in natural human infections. In particular, since the effector function of secreted
cytokines relies on the expression of the appropriate receptors (discussed above), assaying
cytokine receptor expression in cells isolated from the human periphery would be a useful
complement to quantifying cytokine production and this has not been assessed in human
field studies or clinical trials of helminth infection to-date. For example, the latter may yield
insights into why different Th2-type cytokines dissociate in response to schistosome antigen
stimulation as observed in the current study and by others (Grogan et al. 1998b; Scott et al.
2000).
Clinical trials of experimental helminth infection in humans also provide a rare opportunity
to investigate how helminth infections can modify their local immune environment and may
impact upon immunopathology in auto-immune (Broadhurst et al. 2010) and allergic disease
(Benson et al. 1997; Scavuzzo et al. 2003). Thus collection of samples for immunological
analyses should be a key consideration in the design of future studies and an important
means of assessing the immunological impact of helminth-based therapies. An immediate
extension to chapter 7 would be to assay IL-2, IL-6, IL-8, IL-12p70, IL-17A, IL-21 and IL-
23 in the plasma and PBMC supernatant samples from the clinical trial of TSO therapy. This
would provide a more complete cytokine analysis of treated individuals relative to placebo
controls and is of particular interest in light of recent data showing that Trichuris trichuria
can therapeutically alter GI IL-17-production during inflammatory bowel disease
(Broadhurst et al. 2010).
8.9 General conclusions
The major conclusion from this thesis is that cytokine profiles elicited by parasitic helminths
and their antigens are influenced by variations in the human host, parasite life-history and
their shared environment. This was evident in a community endemically-exposed to S.
haematobium where cytokine responses were influenced by host sex, age and exposure
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history, parasite cycle stage and infection intensity and anti-helminthic treatment. In allergic
T. suis cytokine responses were affected both
by infection and by temporal variations in environmental pollen allergens. Characterising
immune heterogeneity is essential for understanding how immune responses to helminth
infection can develop in different contexts.
As we learn more about the complexity of the human immune response to infection, it is
becoming increasingly important to find meaningful ways of identifying and interpreting
patterns of these responses. The results of this thesis highlight both the importance of
assaying a greater range of cytokine responses during human field studies and the usefulness
of analysing cytokines as co-incident and interacting immune responses rather than in
isolation. This integrated approach provides a powerful means of relating the immune
phenotype elicited by parasite antigens in the periphery to epidemiological patterns of
natural helminth infection and an effective means of assessing the immunological impact of
experimental infection on immune-mediated disease.
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Magaya community baseline population census questionnaire. Questionnaire administered to all
participants at recruitment in September 2008 to assess sex, age, date of birth, residential history,
treatment history, water contact behaviour and a priori knowledge of schistosomiasis and malaria.
Questionnaires were administered on a one-to-one basis in the local language (Shona) by a native speaker.
Appendix 2
Magnitude of S. haematobium egg, adult worm, GST and MBP-specific cytokine responses and
cytokine concentrations present in un-stimulated cultures of the cohort analysed in chapter 4 (n =
198). Mean of antigens-specific cytokine responses (un-transformed) after subtraction of concentrations
present in un-stimulated cultures are given alongside un-transformed means of raw cytokine concentations
present in un-stimulated cultures. S.E.M.: Standard error of the mean
Appendix 3a
Immunological characteristics of the plasma cohort differ between T. suis and placebo-treated
participants after, but not before initial treatment (n = 89). Results of ANOVA comparisons between
treatment groups at each timepoint. Exploratory analysis verified that un-transformed data and residuals of
ANOVA models met parametric assumptions. Significant differences (p<0.05) are highlighted in bold and
those significant after Bonferroni adjustment are shaded grey. df degrees of freedom.
Appendix 3b
Immunological characteristics of the PBMC supernatant cohort differ between T. suis and placebo-
treated participants after, but not before initial treatment (n = 22). Results of ANOVA comparisons
between treatment groups at each timepoint. Exploratory analysis verified that un-transformed data and
residuals of ANOVA models met parametric assumptions. Significant differences (p<0.05) are highlighted
in bold and those significant after Bonferroni adjustment are shaded grey. df degrees of freedom.
Appendix 4
Diagnostic statistics of final NMS solutions for pre and 6 weeks post-treatment cytokine responses to
S. haematobium antigens. All values were consistent with the a priori stress criteria for stable ordination
solutions (final stress value <20) obtained at or within 500 iterations. All solutions were also achieved
with a final stress value that was significantly lower than that obtained from randomly assorted data as
assessed by Monte-Carlo randomisation tests (p<0.05).
Appendix 5
Publications of work related to this thesis.
Appendix 1.
Bilharzia Questionnaire
1. This questionnaire is 4 pages long- please complete ALL pages.
2. Questionnaire to be completed at the time of enrolment of children into the study and




Participant Name_________________________________________ ID #___________________
Gender M F (circle one)
Date of birth (DD MM YY)_____________ Age____________(years)
Age group:7-10 11-14 15-17 18-25 26-35 36+ (circle one)
Body weight ________kg Height _______________cm
School _________________________ Village
Name_____________________________
Have you lived in this village all your life?Y N (circle either yes or no)
If no, which other villages have you lived in and for how long?
(complete in order of residence)
Village name District How long (years)?
1 (Born here) __________________ __________________ __________________
2. __________________ __________________ __________________
3. __________________ __________________ __________________
3. __________________ __________________ __________________
Which primary school did you attend? _______________________
Which secondary school did you attend? _____________________
Do you make regular visits to other villages? Y N (circle either yes or
no)
If yes, Where? _______________________________
When? ________________________________
Do you participate in sports? Y N (circle either yes or no)
If no, why not? _______________________
Have you ever had Schistosomiasis (bilharzia) infection? Yes / No / Do not know (circle one)
If yes, were you treated? Yes / No / Do not know (circle one)
If yes, do you remember when you were treated?_________________ How?_______________
Have you ever had Malaria? Yes / No / Do not know (circle one)
If yes, were you treated? Yes / No / Do not know (circle one)
If yes, do you remember when you were treated?__________________ How?______________
Other Signs and symptoms (ask then prompt from list)
Haematuria (Blood in urine) __________________________________________
Dysuria (Difficulty in urination)_______________________________________









Arthralgia (Pain in joints) ___________ Myalgia (Muscle pain) __________
Backache _______ Lethargy (Sleepy)____________
Diarrhoea:_________
Other symptoms__________________________________________________
Splenomegaly (enlarged spleen) ____________________________________
Hepatomegaly (enlarged liver) ______________________________________
Hepatitis B antibody (if known)_______________________________________
Which village were you born in?_____________________________
(check this matches village they live in now if not check have full list of all villages lived in)
The following information is being collected to assess various likely or probable risk factors
associated with malaria and / or schistosomiasis infection
A. Domestic water source (circle as many as appropriate)
1 unprotected well 2 river 3 dam 4 Upgraded well 5 Borehole
6 Tap 7 Other (specify) ______________________
B. Where do you normally go to the toilet? (circle as many as appropriate)
1 bush 2 cat sanitation 3 Latrine/toilet 4.Other (specify) ______________________
C. Is there a latrine at your home? Y N (circle either yes or no)
D. If yes, are there any problems in using it? Y N (circle either yes or no)
If yes, explain ________________________________________________________
E. Do you pass through water on your way to and from school? Y N (circle one)
If yes, where? (describe and/or give site name)______________________________

G. In the last 7 days, have you carried out any of these activities at the river or dam?
(circle as many as appropriate)
If yes, how many If yes, how many
Swimming ______________ Washing (face and legs) ______________
Playing in the ______________ Collecting water ______________
Bathing ______________ Fishing ______________
Laundry ______________ Crossing river ______________
Washing dishes ______________ Other_______________ ______________
The following questions are simply to assess knowledge of the participants and are not to be used
for inclusion / exclusion)
H. Do you know what bilharzia is? Y N (circle either yes or no)








I. Do you know what the symptoms of bilharzia are? (circle as many as appropriate)
1. Blood in urine
2. Tiredness
3. Mental illness
4. Pain upon urination
5. Other ___________________________________________________________
J. Do you know how bilharzia is spread? (circle as many as appropriate)
1. Urinating in water
2. Defecating in water
3. Swimming
4. Stepping on urine
5. Drinking dirty water
6. Snails
7. Other ___________________________________________________________







L. Do you try to protect yourself from getting bilharzia? Y N (circle one)
If yes, how? _______________________________
If no, why not? (circle as many as appropriate)
Economic reasons
Distance to clinic
Lack of knowledge of treatment options,
Religious reasons
Other __________________________
M. Do you have any questions or comments concerning this study?
Appendix 2.
WWH* SEA* GST* MBP* Media
n 198 198 198 198 198
Mean 0.017 0.015 0.019 0.265 0.016
S.E.M. 0.006 0.004 0.007 0.027 0.004
IL-6 Mean 0.382 0.599 0.621 6.650 0.215
S.E.M. 0.101 0.103 0.097 0.426 0.043
IL-8 Mean 0.094 0.387 0.152 0.719 0.862
S.E.M. 0.017 0.068 0.025 0.103 0.134
Mean 0.043 0.046 0.081 0.460 0.050
S.E.M. 0.017 0.013 0.033 0.090 0.021
IL-2 Mean 0.009 0.008 0.013 0.006 0.020
S.E.M. 0.003 0.002 0.004 0.003 0.005
IL-12p70 Mean 0.015 0.014 0.023 0.115 0.010
S.E.M. 0.006 0.004 0.007 0.022 0.002
IL-4 Mean 0.001 0.001 0.000 0.000 0.002
S.E.M. 0.000 0.000 0.000 0.000 0.000
IL-5 Mean 0.010 0.014 0.010 0.007 0.030
S.E.M. 0.002 0.004 0.002 0.002 0.005
IL-10 Mean 0.009 0.012 0.014 0.029 0.026
S.E.M. 0.003 0.003 0.004 0.005 0.007
IL-13 Mean 0.031 0.026 0.025 0.022 0.126
S.E.M. 0.011 0.006 0.007 0.010 0.037
IL-17A Mean 0.001 0.002 0.002 0.002 0.006
S.E.M. 0.000 0.001 0.001 0.001 0.002
IL-21 Mean 0.071 0.081 0.069 0.083 0.428
S.E.M. 0.013 0.019 0.009 0.018 0.111
IL-23 Mean 0.040 0.048 0.066 0.654 0.028
S.E.M. 0.012 0.010 0.014 0.051 0.006




Antigen Dimensions Final stress Final instability Number of iterations
CAP 2 9.5 <0.000001 92
WWH 1 18.08 0.00001 500
SEA 2 7.03 <0.000001 118
GST 2 9.59 0.00021 500
Un-stimulated 2 8.5 <0.000001 290
Appendix 5
Bourke, C.D., Maizels, R.M. and Mutapi, F. (2010). Acquired immune heterogeneity and its
sources in human helminth infection. Parasitology: 138 (2): 139-159*
Imai, N., Rujeni, N., Nausch, N., Bourke, C.D., Appleby, L.J., Cowan, G., Gwisai, R.,
Midzi, N., Cavanagh, D., Mduluza, T., Taylor, D. and Mutapi, F. (2011). Exposure,
infection, systemic cytokine levels and antibody responses in young children concurrently
exposed to schistosomiasis and malaria. Parasitology: 138 (12): 1519-1533
Mutapi, F., Bourke, C.D., Harcus, Y., Midzi, N., Mduluza, T., Turner, C. M. and Maizels,
R.M. (2011a). Differential recognition of Schistosoma haematobium adult worm antigens by
the human antibodies IgA, IgE, IgG1 and IgG4. Parasite Immunology: 33 (3): 181-192.
Mutapi, F., Imai, N., Nausch, N., Bourke, C.D., Rujeni, N., Mitchell, K.M., Midzi, N.,
Woolhouse, M.E.J., Maizels, R.M. and Mduluza, T. (2011b). Schistosome infection intensity
is inversely related to auto-reactive antibody levels. PLoS ONE: 6 (5): e19149
Mutapi, F., Rujeni, N., Bourke, C.D., Mitchell, K.M., Appleby, L., Nausch, N., Midzi, N.,
Woolhouse, M.E.J., Maizels, R.M. and Mduluza, T. (2011c). Schistosoma haematobium
treatment in 1-5 year old children: Safety and efficacy of the anti-helminthic drug
praziquantel. PLoS Neglected Tropical Diseases: 5 (5): e1143
*a copy is provided overleaf
REVIEW ARTICLE
Acquired immune heterogeneity and its sources in human
helminth infection
C. D. BOURKE*, R. M. MAIZELS and F. MUTAPI
Institute of Immunology and Infection Research, University of Edinburgh, Ashworth Laboratories, West Mains Road,
EH9 3JT
(Received 12 July 2010; revised 18 July 2010; accepted 18 July 2010)
SUMMARY
Similarities in the immunobiology of different parasitic worm infections indicate that co-evolution of humans and
helminths has shaped a common anti-helminth immune response. However, recent in vitro and immuno-epidemiological
studies highlight fundamental differences and plasticity within host-helminth interactions. The ‘trade-off’ between
immunity and immunopathology inherent in host immune responses occurs on a background of genetic polymorphism,
variable exposure patterns and infection history. For the parasite, variation in life-cycle and antigen expression can influence
the effector responses directed against them. This is particularly apparent when comparing gastrointestinal and tissue-
dwelling helminths. Furthermore, insights into the impact of anti-helminthic treatment and co-infection on acquired
immunity suggest that immune heterogeneity arises not from hosts and parasites in isolation, but also from the environment
in which immune responses develop. Large-scale differences observed in the epidemiology of human helminthiases are a
product of complex host-parasite-environment interactions which, given potential for exposure to parasite antigens in utero,
can arise even before a parasite interacts with its human host. This review summarizes key differences identified in human
acquired immune responses to nematode and trematode infections of public health importance and explores the factors
contributing to these variations.
Key words: heterogeneity, helminth, human, nematode, trematode, schistosome, immune response.
INTRODUCTION
Over a third of the human population is currently
infected by one or more species of parasitic helminth
(Hotez et al. 2008). Chronically-infected hosts must
strike a balance between anti-parasite protective
responses and limiting immune-mediated pathology
(Hoffmann et al. 2002), whilst parasites have devel-
oped strategies to prolong intra-host survival and
fecundity. Throughout their co-evolutionary history
these forces, as often in concert as in opposition, have
driven diversity in both parasites (Maizels et al. 2001)
and the genetics of the host immune response
(Fumagalli et al. 2009; Maizels, 2009), the latter es-
pecially evident in the human population. Experi-
mental models are invaluable in mechanistic studies
of helminth-induced immune responses in vivo;
however, reductionist laboratory models inevitably
seek to minimize variation in the host, the context of
infection and polymorphism in the parasite itself.
Moreover, integral differences in the immune
systems of different host species (Mestas andHughes,
2004) and the inability of many anthropophilic hel-
minths to naturally infect laboratory animals mean
that current experimental models do not reflect the
complexity of human helminth immunobiology.
Most importantly, models cannot easily replicate the
major sources of human immune heterogeneity such
as parasite transmission dynamics (Mutapi et al.
1997), distribution of intermediate hosts (Gryseels
et al. 2006), distinct intra-population exposure pat-
terns (Rudge et al. 2008), therapeutic interventions
(Mutapi et al. 2005) and concurrent or previous infec-
tions with other pathogen species (Correa-Oliveira
et al. 2002).
This review highlights differences in the human
acquired immune response to a variety of nematode
and trematode infections of public health importance
and explores some of the factors contributing to these
variations, particularly differences arising from hel-
minth life-history traits.
COMMON FEATURES OF THE ACQUIRED
IMMUNE RESPONSE
The most prevalent human helminthiases are caused
by nematode species including filarial worms (Brugia
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malayi, Onchocerca volvulus and Wuchereria bancrof-
ti) and soil-transmitted helminths (Hotez et al. 2008):
Ascaris lumbricoides, Trichuris trichiura, hookworm
(Ancyclostoma duodenale and Necator americanus),
Strongyloides spp., and Enterobius vermicularis. Of
the trematodes, Schistosoma spp. are of greatest pub-
lic health importance, with the 3 predominant species
(S. haematobium, S. japonicum and S. mansoni) ac-
counting for over 200 million current infections
worldwide (Gryseels et al. 2006). In addition, and
beyond the scope of this article, there are many
important human cestode parasites which have been
expertly discussed elsewhere (Zhang et al. 2008).
The principal cellular mediators of human-
helminth interactions are CD4+ T cells, which can
differentiate into alternative lineages once activated;
Th1, Th2, Th17 and T regulatory (Treg), as sum-
marized in Fig. 1. Selective differentiation is first
driven by innate antigen-presenting cells (APC) but,
as responses mature during the course of chronic in-
fection, cytokine-mediated cross-regulation between
Tcell subsetsbecomes increasingly important.Differ-
ences in acquired immune responses to helminth
infection can arise via heterogeneity in how parasites
initially interact with host cells, polarize local and sys-
temic responses and/or modulate effector responses
in chronic infection. There are two principal
immunological features believed to be common
amongst helminth infections. (1) Polarization of
CD4+ T cells towards a Th2 phenotype. In humans,
this phenotype is associated with production of inter-
leukins (IL-)4, 5, 9, 10 and 13 (Turner et al. 2003;
Jackson et al. 2004b; Quinnell et al. 2004), secretion
of IgE and IgG4 isotypes by plasma cells (Hagan
et al. 1991) and activation of downstream effector
cells such as eosinophils (reviewed by (Klion and
Nutman, 2004)). (2) Immunosuppression of both
worm-specific and generalized immune responses.
Inducible mechanisms include secretion of suppres-
sive cytokines, such as IL-10 and TGF-β, and
expansion of regulatory cell populations, particularly
Tregs (Doetze et al. 2000;Watanabe et al. 2007; Babu
et al. 2009). The progression of host responses from
effector Th2 to a so-called ‘modified Th2’ phenotype
associated with elevated levels of Treg-associated
molecules and reduced Th2 effector cytokine re-
sponses (Maizels and Yazdanbakhsh, 2003), suggests
that both features play a functional, and potentially
cross-regulatory, role in helminth immunobiology.
Despite similarities in the immune responses eli-
cited by different helminths, immunological studies
often yield contradictory results in different human
populations and different species of helminth infec-
tion, which are discussed below. To an extent this is
Fig. 1. Summary of the major CD4+ T cell differentiation pathways following activation in the periphery. Cytokines
and transcription factors involved in T cell polarization are shown in boxes and within cells respectively. Effector cell
types and cytokines associated with each CD4+ T cell phenotype are given adjacent to relevant cells. Th0 – naïve T cell,
* RORγt –murine transcription factor, the human orthologue is RORC2. Figure adapted from Deenick and Tangyne
(2007) and Diaz and Allen (2007).
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unsurprising as expanding research into human
helminthiases has inevitably led to a greater appreci-
ation of the intricacies of their immunobiology.
The discovery of new cell populations including
Treg and Th17 and the more recent description of
IL-5 and IL-9 producing CD4+ T cells, which
differentiate from Th2 cells in an IL-33 or TGF-β/
IL-4-dependent manner respectively, has led to a
re-evaluation of the classical Th1-Th2 paradigm
(Dardalhon et al. 2008; Kurowska-Stolarska et al.
2008; Veldhoen et al. 2008). Furthermore the CD4+
T cell axis can be regulated both by effector cytokines
from CD4+ T cell populations themselves (IFNγ,
IL-4 and IL-21 (Wilson et al. 2008; Babu et al. 2009))
and innate and adaptive non-T cell populations,
which both present antigen to activate T cells and
contribute significant levels of these same cytokines.
Helminth-induced alternatively activated macro-
phages exhibit particular plasticity in this respect
(Jenkins and Allen, 2010). Studies showing that Th2
IL-4 and IL-5 responses can be dissociated in human
nematode (Sartono et al. 1997) and trematode (Scott
et al. 2000) infections indicate that even established
immune phenotypes involve heterogeneous effector
responses to helminth infection. As more data
become available on human anti-helminth responses,
particularly in terms of the more recently described
cytokines (e.g. IL-17, IL-21, IL-23, IL-33), com-
parative studies between helminth groups will be
better able to identify similarities and differences in
these responses.
HETEROGENEITY IN PROTECTIVE IMMUNE
RESPONSES
Protective immunity in human helminthiases en-
compasses a range of overlapping mechanisms: (a)
complete elimination of parasites (sterile immunity),
(b) resistance to de novo infection (non-sterile im-
munity, also called ‘concomitant immunity’) and
(c) reduction of immunopathology (tolerance). The
former two processes can be grouped as anti-parasite
immunity, whilst the latter involves immune-medi-
ated regulation of pathological effector responses.
The high prevalence of chronic helminth infection in
endemic populations suggests that sterile immunity
is rarely generated (Hotez et al. 2008). However, the
decline in infection intensity at an earlier age in popu-
lations with high infection intensity (Woolhouse,
1998) and more rapid development of resistance to
re-infection post-treatment in individuals with long-
term exposure to infection (Black et al. 2010) indi-
cates that non-sterile immunity, though slow to
develop, does occur with cumulative exposure. Con-
versely, since the majority of helminth infections are
asymptomatic, it is clear that tolerance of low-level
infection can be readily elicited to limit immuno-
pathology (Dessein et al. 2004). The balance be-
tween anti-parasite and anti-pathology responses is
inevitably shaped by the specific immunopatho-
genesis of different helminth species. Contrary to
phylogenetic distinctions between nematodes and
trematodes, one of the main functional delineations
between helminth infections is that between species
where adult worms reside in the gastrointestinal (GI)
tract and those that inhabit host tissues.
Anti-parasite immune responses
Expulsion of GI nematodes is dependent on highly
polarised Th2 responses (reviewed by (Jackson et al.
2009; Jenkins and Allen, 2010)) and elevated titres of
systemic andparasite-specificTh2 cytokines arenega-
tively associated with infection intensity in untreated
populations (Turner et al. 2003). Th2-induced
smooth muscle hypercontractility and mucus secre-
tion by goblet cells are known to facilitate clearance of
murine GI nematode infections (Finkelman et al.
2004), but these physical means of worm expulsion
are absent in the tissues. The immunological rel-
evance of these differences has not been tested in
humans.
Resistance to re-infection by GI nematodes
post-treatment also tends to be unequivocally Th2-
mediated (Jackson et al. 2004a,b; Quinnell et al.
2004). Post-treatment resistance to hookworm and
T. trichiura infection is associated with pre-treatment
levels of IL-5 (Jackson et al. 2004a; Quinnell et al.
2004) and negative associations have also been shown
between IL-5/IL-13 and re-infection with A. lum-
bricoides and T. trichiura (Jackson et al. 2004b).
However, even between GI nematode species the
relationship between Th2 cytokines and resistance to
re-infection has been shown to vary according to
parasite life-history. For example despite multiple
shared risk factors for co-infection with A. lumbri-
coides and T. trichiura, pre-treatment Th2 cytokine
titres were only associated with post-treatment resis-
tance to the latter (Jackson et al. 2004a). Further-
more, parasite-specific IL-10 was found to be an
indicator of species-specific susceptibility, being
negatively associated with T. trichiura but positively
associated with A. lumbricoides egg counts (Jackson
et al. 2004a).
Th2-type responses are also involved in protective
immunity in tissue-dwelling helminths; however,
chronically infected individuals tend to mount
Th1-Th2 mixed responses (Joseph et al. 2004;
Mutapi et al. 2007), thought to be involved in limit-
ing infection intensity (Turaga et al. 2000). In an
O. volvulus-endemic population in Cameroon, de-
spite a predominant Th2 bias, putative immunity
correlated with elevated titres of parasite-specific
Th1 (IFNγ), Th2 (IL-5) and innate (granulocyte-
macrophage colony-stimulating factor (GM-CSF))
effector cytokines (Turaga et al. 2000). Similarly,
schistosome-specific IFNγ production by peripheral
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blood mononuclear cells (PBMC) correlates with im-
munity to schistosomiasis (Viana et al. 1994). Mixed
Th1-Th2 cytokine responses are observed in chronic
trichuriasis in the gut but have not been significantly
associated with infection intensity (Faulkner et al.
2002).
Antibody-mediated protection from helminths
is typically attributed to elevated titres of parasite-
specific IgE (Faulkner et al. 2002; Pearce and
MacDonald, 2002), whilst a low IgE:IgG4 is as-
sociated with susceptibility to schistosome (Hagan
et al. 1991) andGI infections (Figueiredo et al. 2010).
However, positive correlations between parasite-
specific IgE and other isotypes (Viana et al. 1995)
and studies identifying more pronounced associa-
tions between infection intensity and non-IgE iso-
types (Webster et al. 1997) suggest that there is
redundancy in antibody-mediated protective im-
munity. In addition, given the potentially im-
munopathogenic outcomes of IgE-mediated cellular
effector responses (Nutman and Kumaraswami,
2001; Cooper et al. 2004), it is unsurprising that
propagation of alternate antibody isotypes in chroni-
cally infected hosts may be favourable. A variety
of studies investigating other antibody isotypes in
schistosomiasis provide conflicting evidence for their
role in resistance to infection with different species.
For example, whilst polyclonal adult worm-specific
IgA titres decline with age and infection intensity
in S. haematobium endemic areas (Mutapi et al.
1997), the opposite pattern has been observed for
S. japonicum-specific IgA in the Philippines (Acosta
et al. 2004). Similarly, whilst the former study found
that S. haematobium adult worm-specific IgG1
increased with age and peaked in individuals with
low infection intensity (Mutapi et al. 1997), IgG1
titres were significantly positively associated with
intensity of S. mansoni infection in Brazil (de Jesus
et al. 2000) and Kenya (Naus et al. 1999). The role of
IgM in anti-schistosome responses is also controver-
sial as adult worm and egg-specific IgM increase with
S. haematobium and S. japonicum infection intensity
in some populations (Mutapi et al. 1997; Acosta et al.
2004), but adult-worm-specific titres were lowest in
individuals patently infected with S. mansoni else-
where (Viana et al. 1995; Caldas et al. 2000). Potential
sources of variation in protective immunity within
and between schistosome-infected populations are
discussed in the following sections.
For filarial infections larvae-specific antibodies ac-
quired with age have been shown to confer resistance
to re-infection post-treatment (Day et al. 1991b);
however, the immunogenic epitopes within the larval
proteome could not be identified (Day et al. 1991a).
Few studies have directly compared schistosome
and nematode-specific antibody responses; however,
studies to date suggest that differences do exist.
W.bancroftimicrofilaria and circulating antigen nega-
tive individuals were found to have the lowest
parasite-specific IgG4:IgE (Jaoko et al. 2006) as has
been observed in schistosome studies (Hagan et al.
1991). However, unlike in chronic schistosomiasis,
the ratios did not differ between communities with
high and low intensity infection indicating that rela-
tive changes in these isotypes may be less depen-
dent on host exposure history (Jaoko et al. 2006).
IgG2 also appears to limit infection intensity when
directed againstW. bancroftimicrofilaria (Jaoko et al.
2006), but is ineffective against schistosome larvae
(Demeure et al. 1993).
The specific target of antibody responses is par-
ticularly important for development of protective
immunity, although the majority of field studies
focus on crude antigen preparations. Early schisto-
some studies identified isotype-specific antibody re-
sponses to different antigen types within the parasite
proteome (Langley et al. 1994), but it was not until
the advent of mass spectrometric analysis that para-
site peptides recognized by different antibody iso-
types could be identified within crude preparations
(Mutapi et al. 2005, 2008). Relative exposure of im-
munogenic peptides clearly plays a role in cumulative
development of protective antibodies. For example,
antibodies against the larval surface are associated
with protection against W. bancrofti (Day et al.
1991a) and antibodies targeting cryptic antigens
released by dying adult worms may influence the
course of schistosome infection (Woolhouse and
Hagan, 1999). It remains unclear whether there is a
single antibody isotype that uniformly protects
against helminth infection and it seems likely that
redundancy within host antibody responses, vari-
ation between parasite species and/or host popu-
lations have all contributed to isotype-specific
variations observed in the field.
Anti-pathology immune responses
Limiting immunopathology inpatent helminth infec-
tion is a combination of parasite and host-mediated
processes that synergize to limit aberrant immune
reactivity and damage to the host. This is necessarily
a compromise as dampening immune responses to
infection also limits their efficacy at clearing infection
(Maizels and Yazdanbakhsh, 2003). For tissue-
dwelling helminths close association with host tissues
throughout their life-cycle means that effector
responses to adult worms and migrating larvae in
these loci must be tightly regulated (Montenegro
et al. 1999). In chronic schistosomiasis, for example,
Th2-polarized responses account for the majority of
host pathologies including hepatic fibrosis (Coutinho
et al. 2007) and egg-specific responses promote granu-
loma formation (ElRidi et al. 1997), whilst Th2-
mediated damage is mitigated by Th1-type (Henri
et al. 2002; Dessein et al. 2004) and innate inflam-
matory cytokines (TNFα and IL-6 (Booth et al.
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2004a; Wilson et al. 2008)). The importance of Tregs
in balancing Th1 and Th17 responses in human
filarial infections has been recently highlighted by
Babu and colleagues who identified a positive cor-
relation between lymphoedema and Th1/Th17 cyto-
kine and Toll-like receptor expression in individuals
with low expression of Treg-associated molecules
(Babu et al. 2009).
Ubiquitous exposure to commensal bacteria and
food antigens means that antigen-presentation and
inflammatory responses are highly regulated in the
gut to maintain a physical barrier between the lumen
and host tissues (Mayer, 2000). GI nematodes are
also able to actively down-regulate effector responses
in the gut to maintain this regulatory environment
(reviewed by Maizels and Yazdanbakhsh, 2003).
Both Ascaris spp. and Trichuris spp. infections are
also associated with reduced cellular responsiveness
to both non-specific agonists and parasite-specific
antigens in humans (Figueiredo et al. 2010). The
rebound in N. americanus-specific IFNγ observed
after anti-helminthic treatment to clear infection sug-
gests that Th1 responses may be particularly regu-
lated in chronic hookworm infection (Quinnell et al.
2004).
However, GI nematodes are not homogeneous in
the immune responses that they induce and thus pose
distinct immunopathological risks. T. trichiura in-
fection induces a mixed Th1-Th2 cytokine profile
(Faulkner et al. 2002), whilst Ascaris lumbricoides
infection leads to a highly Th2 environment (Cooper
et al. 2000). It has been postulated that murine
Trichuris spp. are distinct from other GI infections in
specifically up-regulating Th1 cytokines as a means
of evading Th2-mediated clearance (refer to review
by Else, 2005); however, fostering a more mixed
cytokine response may also limit pathology. IL-10
secretion is highly prevalent in T. trichiura endemic
populations with 97% of a Cameroonian cohort
secreting parasite-specific IL-10 and older individ-
uals producing the highest titres of non-specific
IL-10 (Faulkner et al. 2002), suggesting that systemic
immunoregulation coincides with cumulative ex-
posure to infection.
SOURCES OF ACQUIRED IMMUNE
HETEROGENEITY
Helminth life history
Helminths undergo complex life cycles leading to
both physical and molecular variations during the
course of an infection. Table 1 summarizes the key
differences in helminth life histories that can intro-
duce heterogeneity in the development of the host
immune response to infection. Furthermore, the
range of molecules and mechanisms that underlie
helminth-mediated immunomodulation have been
reviewed elsewhere (Maizels and Yazdanbakhsh,
2003; Maizels et al. 2009) and present a potential
source of immune heterogeneity in themselves.
Parasite transmission route
Transmission route impacts upon where and how
infection is initially detected by the immune system.
Immature helminths face site-specific challenges as
they invade their host, for example species that are
transmitted through the skin tend to suffer immune
attrition in this organ (He et al. 2005). Amongst the
schistosome species, which invade by active pene-
tration, S. japonicum cercariae migrate most rapidly
to the dermis and this species also elicits the most
pro-inflammatory response in human skin (He et al.
2002). In contrast S. haematobium and S. mansoni
cercariae promote up-regulation of immunoregu-
latory proteins including IL-10 and IL-1 receptor
antagonist (He et al. 2002), highlighting heterogen-
eity in the effector and regulatory immune mechan-
isms elicited even by closely-related species.
Arthropod-borne larvae are also exposed to im-
mune attrition in human cutaneous tissue when they
enter during blood-feeding by the vector. However,
unlike actively penetrating parasites, antigens, en-
zymes and immunosuppressive molecules in arthro-
pod saliva may skew the host immune response in
favour of vector-transmitted larvae (Demeure et al.
2005). Furthermore, where a single helminth species
(such asW. bancrofti) can be transmitted by multiple
mosquito species of 4 different genera (Aedes,
Anopheles, Culex and Mansonia) (Maizels and
Kurniawan-Atmadja, 2002), there is potential for
the human immune response to be differently shaped
in each instance. The presence of Wolbachia spp.
bacterial endosymbionts in mosquito vectors and
almost all filarial helminth species has also been
suggested to influence host T-cell responsiveness
(Brattig, 2004), but this is yet to be verified.
On a broader scale transmission route can deter-
mine distribution of immune-mediated morbidities
within host populations. One example is the lower
prevalence of Sowda in O. volvulus-infected men
relative towomen inhabiting the same area, which has
been attributed to development of immune tolerance
after repeated exposure to O. volvulus vectors during
agricultural work (Brattig, 2004; Trpis, 2006).
Following initial infection, larval migration may
also contribute to immune heterogeneity between
GI nematodes, particularly with respect to anti-
pathology immunity. Clinical measures of atopic re-
activity suggest that hookworm with lung-migratory
stages effectively suppress asthma and wheeze in
the lung (Scrivener et al. 2001; Leonardi-Bee et al.
2006). TherapeuticN. americanus infection is able to
dampen inflammation both in the lung and in the gut,
where adult worms reside (Falcone and Pritchard,
2005; Croese et al. 2006). On the other hand,
Trichuris spp. which inhabit the lower intestine and
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Table 1. Summary of parasite-factors that may influence the host acquired immune response to helminth infection (Anderson and May, 1992; Maizels et al.
1993; Maizels and Kurniawan-Atmadja, 2002; Gryseels et al. 2006; Hotez et al. 2008).
Gastrointestinal (GI) nematodes Filarial nematodes Schostosoma spp. trematodes




















807 – 576* 30–100** 604 – 37 120 207*** 207*** 207***
Intermediate
host
None None None None None Ano spp. Sim spp. Ano, Cul
Aed spp.















50–80 days 15–43 days 40–50 days − 50–84 days – 365 days – 21–28 days 25–30 days 25–30 days
Adult worm
life-span
1–2 years <1 year 2–3 years – 1–2 years – 8–10 years 3–5 years 3–5 years 3–5 years 6–11 years^
Adult worm
length
15–35 cm 2–13mm 7–11mm – *4 cm 13–55mm 19–50mm 40–100mm 7–20mm 7–20mm 7–20mm
Adult worm
niche




















* All hookworm species.
** Strongyloides stercoralis only.
*** All S. haematobium, S. japonicum and S. mansoni infections.
^ Life-span of S. mansoni estimated using maximum likelihood techniques to assess pre- and post-treatment field data (Fulford et al. 1995).
Abbreviations: A. lum –Ascaris lumbricoides, E. ver –Enterobis vermicularis, N. ame –Necator americanus, Stro spp. –Strongyloides spp., T. tri –Trichuris trichiura, B. mal –Brugia
malayi, O. vol –Onchocerca volvulus, W. ban –Wuchereria bancrofti, S. hae –Schistosoma haematobium, S. jap –Schistosoma japonicum, S. man –Schistosoma mansoni, Af –Africa,
As –Asia, LAm –Latin America, SEAs – South East Asia, SSAf – Sub-Saharan Africa, Ano spp. –Anopheles spp. mosquito, Aed spp. –Aedes spp. mosquito, Cul spp. –Culex spp.









do not migrate through the lung, can dampen inflam-
matory pathologies in the gut (Reddy and Fried,
2007) but are less effective at regulating clinical
allergy elsewhere (Bager et al. 2010). Interestingly
A. lumbricoides infection, which has a lung migratory
phase, does not reduce asthmatic responses and is
associated with elevated atopy (Flohr et al. 2009).
There are many potential reasons for variation in the
effect of GI helminth infection on clinical allergy
(reviewed elsewhere (Flohr et al. 2009)) and conflict-
ing results in existing literature (Leonardi-Bee et al.
2006) and a lack of studies which directly compareGI
nematode infections with distinct migratory path-
ways make it difficult to conclude on the source of
observed variations.
Life-cycle stages
Chronically infected individuals are simultaneously
exposed to 3 helminth life-cycle stages; infective
larvae, adult worms and transmission stage parasites
(eggs, immature larvae or microfilariae). Both pro-
teomic (Moreno and Geary, 2008) and DNA micro-
array studies (Jolly et al. 2007; Fitzpatrick et al. 2009)
have shown that these life-cycle stages are molecu-
larly different and thus elicit stage-specific immune
responses that change over time.
In experimental murine studies where the course
of infection can be tracked from its acute phase, there
is a clear link between the onset of egg production
(week 5–6 post-infection) and a Th1-to-Th2 shift in
the cellular response to schistosomiasis (Pearce and
MacDonald, 2002). Although the Th1-to-Th2 shift
is less clear in human infections, defined egg peptides
can specifically induce Th2 responses in human baso-
phils, DCs and T cells in vitro (Schramm et al. 2003;
Everts et al. 2009). Th2 polarization by schistosome
eggs also induces granuloma formation (ElRidi et al.
1997), which facilitates passage of eggs from venous
blood into the gut/bladder and subsequent trans-
mission to the environment (Karanja et al. 1997;
Pearce and MacDonald, 2002). Carbohydrate anti-
gens on the schistosome egg surface also promote
IgM secretion, which lacks immunological memory
(Mutapi et al. 2003), whilst responses associated with
protective immunity, such as IgE, IgG1 and IgG3,
tend to emerge later in infection in response antigens
released from dying adult worms (Woolhouse and
Hagan, 1999).
There are notable distinctions between the type
and magnitude of the cytokine response to egg-
specific antigens and those directed against adult
worm antigens (Joseph et al. 2004; Silveira et al.
2004). Adult S. mansoni worms tend to elicit a mixed
Th1-Th2 cytokine profile (Williams et al. 1994) and
are less effective at stimulating in vitro granuloma
formation (IVGF) than egg antigens (ElRidi et al.
1997). Cross-sectional data from an S. haematobium
endemic cohort suggests that adult worm-specific
effector Th2 cytokines increase whilst IL-10 titres
decline with age/exposure to infection (Mutapi et al.
2007) and thus effector responses to adult worms are
higher in putatively resistant individuals.
In contrast to the Th2 cytokine responses induced
by schistosome eggs and infective larvae of most
nematodes, schistosome cercariae stimulate Th1/
inflammatory mRNA expression in mice and re-
sistance to larval invasion post-vaccination is depen-
dent on IFNγ (Wynn et al. 1994). Although few
studies have directly compared immune responses
to the three schistosome life-cycle stages in humans,
cercariae-specific IgM, IgG1 and IgG4 titres are
higher than those directed against adult worm anti-
gens (Viana et al. 1995). The distinct immune re-
sponses elicited by different helminth life-cycle
stages underpin the development of so-called con-
comitant immunity, whereby de novo larval infection
is blocked by adult worm-induced immunity but resi-
dent adult parasites are tolerated, a theory originally
formulated for schistosome infections (Smithers and
Terry, 1967). Studies have found evidence for devel-
opment of PBMC-mediated resistance to L3 invasion
in O. volvulus infection in an endemic area of
Cameroon (MacDonald et al. 2002) and development
of peripheral antibody-dependent immunity to
W. bancrofti larvae with age in Papua New Guinea
(Day et al. 1991a,b). There is little evidence for
development of concomitant immunity to GI nema-
tode infections; however, there is a distinct paucity of
data in this area.
In addition to influencing anti-parasite immunity,
helminth life-cycle stage contributes to heterogeneity
in anti-pathology immune responses. Immunomodu-
latory processes can be life cycle stage-specific as
characterized by distinct cytokine and proliferative
responses to their respective antigens (Geiger et al.
2007). In vitro microfilariae are able to impair cyto-
kine expression and maturation of human dendritic
cells (DCs) (Semnani et al. 2001, 2004) and schisto-
some egg antigens can inhibit co-stimulatory mol-
ecule expression and skew APC cytokine secretion
from an inflammatory to regulatory profile (Correale
and Farez, 2009), with potential implications for
the systemic CD4+ T cell phenotype. A variety of
studies have also shown that cercariae excretory/
secretory products actively modulate the host im-
mune response during migration and maturation
independent of egg or adult-worm-mediated pro-
cesses (reviewed by Jenkins et al. 2005). However,
whilst eggs, cercariae and microfilariae can impair
and polarize host responses, the ability of parasites to
evade and modulate immune recognition seems to
increase as they mature (Nutman and Kumaraswami,
2001) and corresponds to large-scale switches in
many suites of genes (Jolly et al. 2007) and active
secretion of immunomodulatory molecules (Geiger
et al. 2007). Thus, despite being exposed to the host
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immune system for the longest of all life-cycle stages,
it is unsurprising that adult worms are so resistant
to immune-mediated clearance (Maizels and
Yazdanbakhsh, 2003), while immature parasites
tend to be immunogenic, more readily killed by ef-
fector immune responses (Viana et al. 1995; Semnani
et al. 2001; Medeiros et al. 2003) and are responsible
for the majority of morbidity in helminth infections
(Maizels and Yazdanbakhsh, 2003).
Parasite life-span
Unlike microbial infections which multiply expo-
nentially in their hosts, helminths have evolved to
invest in immune-evasive mechanisms to prolong
intra-host survival and long-term fecundity (Jackson
et al. 2009). Effective immune evasion and suppres-
sion by adult worms mean that reactivity to the
antigens of live worms is limited (Geiger et al. 2007).
Thus, hosts may only experience an immunogenic
‘threshold’ stimulus of parasite antigens once adult
worms die (Mutapi et al. 2008) and resistance might
be predicted to develop more slowly against long-
lived worms than against shorter-lived species. The
rapid switch to a protective immune profile follow-
ing anti-helminthic drug treatment that kills adult
worms is consistent with this hypothesis (Mutapi
et al. 2003; Watanabe et al. 2007). If adult helminth
life-span does cause a lag in the development of
protective immunity then this may contribute to
the variation in the age at which peak prevalence
(Brooker et al. 2000) and infection intensity (Fig. 2)
occurs in host populations exposed to different
helminths.
Additionally, whilst some helminths have been
known to survive for extremely long periods
(Vermund et al. 1983), most die before reaching
their maximum longevity. It is possible that the
relatively short average helminth life-span in im-
munocompetent individuals reaps the maximal re-
productive success relative to the physiological cost
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Fig. 2. The relationship between age and infection intensity in natural human helminthiases. (A) Mean W. bancrofti
microfilaria (mf) count by age group (n=156, study area: Papua New Guinea, method: microscopy of 2ml
Giemsa-stained blood). Reprinted from the American Journal of Tropical Medicine and Hygiene (Day et al. 1991b), with
permission from the managing editor. (B) Mean hookworm (A. duodenale and N. americanus) egg counts per gram faeces
(EPG) by age group (n=631, study area: China, method: Kato-Katz thick smear). Reprinted from the Journal of
Parasitology (Gandhi et al. 2001), with permission from Allen Press Publishing Services. (C) Mean T. trichiuris eggs per
gram of faeces by age group (n=96, study area: Cameroon, method: Kato-Katz thick smear). Reprinted from the
Journal of Infectious Diseases (Faulkner et al. 2002), with permission from the University of Chicago Press.
(D) Age-infection intensity profiles of S. haematobium egg counts per 10ml of urine from an area of low infection
prevalence (dashed line) and an area of high infection prevalence (solid line) group (n=133 and 147, study area:
Zimbabwe, method: filtration of 10ml of urine) (re-drawn from Mutapi et al. 1997). Reprinted from Parasitology Today
(Woolhouse, 1998), with permission from Elsevier and John Wiley and Sons Ltd.
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immune response. In opposition to this, studies in
hookworm suggest that the immune response has
only a limited impact on parasite longevity (reviewed
by Loukas and Prociv, 2001). Species with indirect
life cycles, such as Schistosoma spp. and vector-borne
helminths, tend to be long-lived (Table 1). Thus,
once adult worms have adapted to their optimal host
niche, they can produce offspring over a long period
and, whilst they are immunogenic, adult worms do
not appear to be the primary targets of the anti-
helminth immune response in humans or in animal
models (Smithers and Terry, 1967). This may be
particularly true of O. volvulus, which has an average
adult life-span of 8–10 years, but can have a
maturation delay in the human host of over a year
(Anderson and May, 1985). For short-lived worms,
such as E. vermicularis, maturation and oviposition
occurs much earlier, with an associated shift in stage-
specific immune responses (Anderson and May,
1985).
GENETIC HETEROGENEITIES IN HELMINTH
INFECTION
Host genetics
The human immune system has evolved in the con-
text of helminth infection and this relationship
has led to significant changes in our immune genes
(Fumagalli et al. 2009; Maizels, 2009). A recent com-
prehensive study of 91 interleukin genes in 52 human
populations found evidence for balancing selection in
the evolution of the human immune response driven
by helminth ‘species richness’, i.e. the greater diver-
sity of helminths to which a population has been
exposed, the greater diversity observed in interleukin
alleles (Fumagalli et al. 2009). These findings are
consistent with helminths differentially affecting
the human acquired immune response at all levels
of the CD4+ T cell axis, including gene families
involved in inflammation in the skin, mucosal immu-
nity, cell proliferation and survival and Th2 cyto-
kines (Fumagalli et al. 2009). This is compounded by
earlier studies indicating that many of the key genetic
loci controlling the balance of effector and regulatory
responses are polymorphic in the human population
(Quinnell, 2003) and that certain human genes are
associatedwith predisposition to infection with speci-
fic helminth parasites (Hoerauf et al. 2002; Peisong
et al. 2004; Kouriba et al. 2005).
Additive genetic effects (heritability) significantly
influence human infections with A. lumbricoides
(Williams-Blangero et al. 2002b), T. trichiura
(Williams-Blangero et al. 2002a), and S. mansoni
(Bethony et al. 2002), whilst other studies have found
host genetics to be less influential relative to exposure
history (King et al. 2004). This conflicting evidence
suggests that helminth distribution, allele frequency
and host behaviour in each localitymay determine the
relative importance of heritable factors in patterns of
infection and immunity (Ellis et al. 2007). Familial
clustering of infection can further confound identi-
fication of genetic factors associated with helminth
infection since in utero sensitization via transfer of
helminth antigens and soluble immune factors from
infected mothers to their offspring is independent of
genotype (Eloi-Santos et al. 1989; Lammie et al.
1991; Novato-Silva et al. 1992) and co-habiting
families often have similar exposure patterns (Smith
et al. 2001). T. trichiura and A. lumbricoides for
example were found to be significantly associated
with shared living conditions; however, when infec-
tion distributionwas investigated inmore depth, only
T. trichiura infection intensity was heritable (Ellis
et al. 2007). In addition, populations in historically
stable endemic areas may exhibit less heritable
variation in host susceptibility if long-term selection
against genotypes less favourable for a specific infec-
tion has occurred (King et al. 2004), particularly
where other species of helminth infection are un-
common (Fumagalli et al. 2009).
Multiple gene loci have now been implicated in
determining the degree of resistance to helminthiases
and while many appear to relate to individual hel-
minth species (reviewed by Quinnell, 2003), there are
also loci controlling multiple susceptibilities, as is the
case for IL-13 polymorphisms associated with pre-
disposition to S. haematobium (Kouriba et al. 2005)
and O. volvulus (Hoerauf et al. 2002).
Parasite genetics
Widespread genetic variation between parasite
species is an equally important source of hetero-
geneity in the development of acquired immune re-
sponses to infection. Since parasitic nematodes have
arisen from several independent evolutionary path-
ways their classificationwithin the PhylumNematoda
belies the huge diversity apparent from their distinct
life-histories, physiology and proteomes (Dorris et al.
1999). Comparisons between nematode worms at
the genomic level have identified multiple species-
specific gene sequences and transcription patterns,
even between phylogenetically close organisms
(Parkinson et al. 2004). Among the 3 major human
Schistosoma spp. differences in immunologically rele-
vant antigens have been found. Notably the leading
anti-schistosome vaccine candidate antigen; gluta-
thione-S-transferase (GST), of S. mansoni differs
from that of S. haematobium (Trottein et al. 1992),
though the impact of this on human immunity is
unknown.
The existence of helminth homologues of human
proteins (Pastrana et al. 1998; Gomez-Escobar et al.
2000) and analyses that indicate more rapid evolution
among parasite secreted proteins are compatible with
the idea that parasitic helminths are diversifying
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fastest among antigens exposed to (and interacting
with) the host immune system (Hoekstra et al. 2000;
Harcus et al. 2004). The relatively recent completion
of the first parasitic nematode (B. malayi; Ghedin
et al. 2007) and trematode genome projects
(S. mansoni; Berriman et al. 2009) and S. japonicum
(Zhou et al. 2009) will inevitably yield greater in-
sights into the evolution of genetic diversity between
different helminth species.
Genetic diversity within helminth species may
partly explain the slow development of protective
immunity in endemic populations. It has been pro-
posed that natural infections consist of several
genetically distinct parasite strains (Galvani, 2005),
evidence for which comes from variations in the non-
coding sequence identified via genome-wide scans
(Hunt et al. 2008; Redman et al. 2008). The effect
of helminth strains on the host immune response
has been investigated in theoretical models based on
field studies of A. lumbricoides, N. americanus,
S. haematobium and T. trichiura infections, which
surmise that challenge with multiple strains delays
development of resistance to infection in human
populations because a different protective response
must be mounted against each parasite genotype
separately (Galvani, 2005).
INDIVIDUAL EXPOSURE HISTORY
The immune environment to which de novo helminth
infections are exposed is not independent of a host’s
infection history (Woolhouse andHagan, 1999). This
was first demonstrated in a study of Sudanese canal
workershyper-exposed toS.mansoni infection,which
showed that those who had been occupationally ex-
posed for over 10 years were more resistant to infec-
tion than newly recruited workers (Satti et al. 1996).
More recently a direct comparison between 2 occu-
pationally exposed male cohorts, found that chroni-
cally exposed individuals develop resistance to
S. mansoni re-infection after significantly fewer
rounds of praziquantel treatment than those with a
shorter exposure history (Black et al. 2010).
It is well known that in endemic populations worm
burdens accumulate with age to a peak intensity and
decline thereafter (Fisher, 1934) but the age at which
peak prevalence occurs (Brooker et al. 2000) and the
relative decline post-peak varies according to hel-
minth species (Fig. 2). For example, intensity of
W. bancrofti (Fig. 2A) and hookworm (Fig. 2B)
infections tends to be highest in adults rather than
children (Day et al. 1991b; Gandhi et al. 2001). In
contrast, T. trichiuria (Fig. 2C) and schistosome
(Fig. 2D) infection intensity peaks in childhood, after
which worm burdens decline (Mutapi et al. 1997;
Faulkner et al. 2002). Host behaviour may partially
explain these differences, for example the risk of
hookworm infection is highest in adults due to occu-
pation-related exposure (Bradley and Chandiwana,
1990), whilst exposure to schistosomiasis is deter-
mined by contact with water from an early age during
washing and domestic activities (Rudge et al. 2008).
Evidence that the host immune response is im-
portant in shaping age-related variation includes the
observation that peak worm burdens occur at a
younger age in regions of high infection intensity
than in regions with low or intermediate intensity, a
phenomenon called the ‘peak shift’ (Woolhouse,
1998) (Fig. 2D). It is clear that, at least for long-
term residents of an area endemic for a particular
species of helminth, age is effectively a proxy of ex-
posure history and cumulative exposure to parasite
antigens over time can trigger changes in the immune
response (Mutapi et al. 2008). The latter assertion is
supported by immuno-epidemiological studies in a
variety of helminthiases indicating that cellular and
humoral changes correlate with development of
resistance to infection with age. For example in an
S. haematobium-infected population, cross-sectional
data showed that cytokine responses switch from a
regulatory IL-10 response in younger individuals
to an effector IL-5 response in older individuals
(Mutapi et al. 2007). Longitudinal studies of
W. bancrofti-infected subjects in Papua New
Guinea showed that adults are relatively resistant to
parasite accrual (Day et al. 1991b) and that this could
be attributed to parallel age-specific acquisition of
anti-larval antibodies (Day et al. 1991a). As discussed
above, development of this form of concomitant
immunity may be one explanation for the lower
prevalence of these species in adults (Day et al.
1991a,b; MacDonald et al. 2002).
In areas of high intensity transmission, people are
exposed to infection from a very early age and these
patterns vary according to parasite species (Sousa-
Figueiredo et al. 2008). A recent study in Zanzibar
found that whilst schistosome infections were rare in
pre-school children, soil-transmitted helminths were
already highly prevalent (Sousa-Figueiredo et al.
2008). Variation in maternal infection status may also
introduce variation in the in utero exposure patterns
and potentially lead to long-lasting effects on the anti-
helminth immune response of their offspring. For
example, Steel and colleagues showed that pre-
natal priming during maternal helminth infection
has far-reaching effects on anti-filarial immunity
including clonal deletion of parasite-specific T cells
(Steel et al. 1994) and life-long susceptibility to
infection (Steel and Nutman, 2003). Cellular studies
in endemic populations have shown that umbilical
cord blood lymphocytes (CBL) from neonates born
of W. bancrofti-infected mothers mount parasite-
specific cytokine responses similar to those of
maternal PBMCs and in contrast to neonates born
of un-infected mothers (Malhotra et al. 1997). An
extension of this study found that schistosome and
B. malayi-specific cytokine responses persisted in
childhood and significantly affected the CD4+ T cell
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polarization of Bacillus Calmette-Guerin (BCG)
vaccine-specific responses in 2 to 10 year olds
(Malhotra et al. 1999). However, an investigation of
CBL responses to N. americanus and O. volvulus
antigens found no evidence for specific polarization
of Th1 and Th2 responses in the offspring of
helminth-infected mothers (Pit et al. 2000). To date
only a very few studies have directly compared the
effect of different helminth species on neonatal
immunity, though researchers hypothesize that
tissue-dwelling helminths may be associated with a
greater trans-placental transfer of antigens (Eloi-
Santos et al. 1989; Novato-Silva et al. 1992;Malhotra
et al. 1997). Since maternal exposure patterns
will inevitably affect neonatal and early post-natal
exposure the contribution of parasite transmission
route and the associated behavioural risk factors for
infection to immune heterogeneity (discussed above)
should not be overlooked in early life.
ANTI-HELMINTHIC TREATMENT
Anti-helminthic treatment can effectively clear in-
fection and thus artificially disrupts host-parasite
immunoepidemiology, for example immune reacti-
vity has been shown to peak shortly after treatment in
many species of helminth infection (Quinnell et al.
2004; Watanabe et al. 2007). Following treatment,
however, endemic populations become re-infected
and the highest re-infection rates are consistently
seen in individuals who carried high worm burdens
before treatment suggesting pre-disposition to infec-
tion in certain hosts (Bundy et al. 1988; Tingley et al.
1988; Chandiwana et al. 1991).
In addition to clearing infection, even a single dose
of chemotherapy can lead to changes in the host
immune response to helminths. Successful treatment
has been shown to enhance the proportion of effector
T cells (Watanabe et al. 2007), increase the range of
parasite proteins recognized by host antibodies and
induce a more rapid switch to protective antibody
isotypes (Mutapi et al. 2003) in schistosomiasis
patients. This post-treatment rebound in immune
responsiveness could be due to heightened DC
activation in an environment of high parasite death
(Watanabe et al. 2007) and/or recovery of normal
immune function following removal of immuno-
suppressive parasite excretory/secretory products
(Maizels and Yazdanbakhsh, 2003).
Furthermore, the large variation in treatment
regimens employed in mass-treatment programmes,
including the drug administered, number of treat-
ments (single or repeated dose), age-ranges targeted
(e.g. school-age children, whole population) and
method of administration (e.g. school-based, hos-
pital/clinic-based), is also a potential source of
variation in host immunity within endemic popu-
lations. Notably, many treatment programmes ex-
clude children under the age of 5 due to a perceived
risk of side-effects, despite evidence that children can
become both infected and a source of transmission
from a very young age (Opara et al. 2007). Most also
employ single-dose regimens, despite evidence that
repeated treatment may be more effective at aug-
menting protective immunity (Black et al. 2010)
potentially by periodically ‘boosting’ development
of immunological memory (Woolhouse and Hagan,
1999). Whilst the long-term effects of anti-
helminthic treatment on the host acquired immune
response remain unclear, the desired reduction
in parasite prevalence and transmission inevitably
impacts upon helminth immunoepidemiology.
CO-INFECTION
Co-infection adds a further level of complexity to
host-pathogen interactions and is highly prevalent
in some communities, particularly in sub-Saharan
Africa (Raso et al. 2004; Brooker et al. 2006). Here
we focus on how co-infections of particular public
health significance contribute to heterogeneity in
the anti-helminth immune response and how these
effects vary depending on the species of helminth
infection.
Helminth-helminth co-infection
Certain combinations of helminth co-infection are
more common in human populations than others,
notably several nematode pairs including: A. lum-
bricoides and T. trichiura (Faulkner et al. 2005; Ellis
et al. 2007), A. lumbricoides and hookworm (Fleming
et al. 2006) andO. volvulus andT. trichiura (Faulkner
et al. 2005). Interactions between schistosomes
and nematodes in co-infection are more variable,
with evidence for co-aggregation with hookworms
(Fleming et al. 2006) and T. trichiura (Ellis et al.
2007), but no significant association with A. lum-
bricoides infection intensity (Tchuem Tchuente et al.
2003; Fleming et al. 2006; Ellis et al. 2007). Co-
infection also tends to be associated with higher
worm burdens than those seen in single species in-
fections (Tchuem Tchuente et al. 2003). A. lumbri-
coides-T. trichiura co-infected individuals were also
found to have higher IgG4:IgE ratios than their
singly-infected counterparts (Figueiredo et al. 2010).
Several explanations for the variable effect of one
helminth species on the likelihood of co-infection
with another have been proposed, although it is
unlikely that these factors act in isolation. Firstly,
similarities in parasite life cycle might mean that
certain species share common behavioural or genetic
risk factors for infection (Ellis et al. 2007; Pullan et al.
2008). Alternatively, since studies in animals and
humans show that patent infection with one helminth
species can depress both the humoral and cellular
responses of the host to challenge by other parasites
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(Brady et al. 1999; Correa-Oliveira et al. 2002) it is
possible that these synergistic interactions result from
non-specific ‘bystander suppression’ (Brady et al.
1999) or immunosuppression directed against cross-
reactive antigens expressed by closely-related species
(Geiger et al. 2002). S. mansoni-exposed but patently
uninfected Brazilian subjects, identified by egg and
adult worm-specific antibodies, were found to have
impaired responses to Ascaris spp. and hookworm
infections (Correa-Oliveira et al. 2002), suggesting
that prior exposure to schistosomiasis may have a
lasting impact on host responses to other helminths.
Experimental studies comparingS. mansoni infection
with antigen (adult worm and egg homogenates)
administration, suggest that immunosuppressive
mechanisms rely on the presence of active infection
(Osada and Kanazawa, 2010). However there is a lack
of data on the effect of exposure to one parasite on
the immunobiology of subsequent infection with a
different species. It is conceivable that, even after
clearance of adult worms, sequestration of eggs in
host tissues, cellular memory responses to cross-
reactive antigens and impaired organ-function result-
ing from cumulative morbidity may all affect the
response to subsequent helminthiases.
Helminth-malaria co-infection
Malaria is a predominantly intracellular protozoan
infection and has a markedly different immuno-
biology to that of helminths. The host response to
malaria is characterized by inflammatory cytokines
causing periodic fevers and immune-mediated patho-
logy and, though protective immunity is yet to be
fully characterized, clearance of blood-stage infection
positively correlates with titres of variant-specific
cytophilic antibodies, particularly IgG3 (Cavanagh
et al. 2004).
Studies of the effect of malaria on immune re-
sponses to helminths are rare and tend to focus on the
anti-malarial, rather than anti-helminth immune re-
sponse. However, work on schistosomiasis-malaria
co-infections indicate distinct effects on humoral and
cellular responses (Mutapi et al. 2000; Wilson et al.
2008). On the one hand, co-infection has been asso-
ciated with elevated titres of schistosome egg-specific
IgE and IgG3 (Mutapi et al. 2000), indicating that
acute inflammatory responses to malaria may reverse
helminth-mediated immune hyporesponsiveness.
Consistent with this hypothesis, skewing of T cell
responses by malaria can exacerbate liver and spleen
pathology due to deficient regulation of schistosome
egg-specific regulatory responses (Wilson et al.
2008). Recent schistosome-malaria co-infection
studies also show that co-infected children do not
differ from singly infected children in their absolute
numbers of circulating Tregs, but do exhibit reduced
proportions of memory Tregs (Muok et al. 2009).
Both elevated malaria-specific IgG3 and high S.
mansoni egg counts are risk factors for splenomegaly
(Booth et al. 2004b), suggesting that both severity of
infection and host immunoreactivity contribute to
the clinical outcome of malaria-schistosome co-
infection (Diallo et al. 2004).
In individuals concurrently infected with GI
nematodes and malaria, the inflammatory response
to Plasmodium spp. might be expected to blunt Th2
effector responses involved in clearance of adult
nematodes (Mountford and Pearlman, 1998). For
example, N. americanus-specific Th2 effector cyto-
kine and total IgE responses were lower in Papua
New Guinean subjects co-infected with malaria, de-
spite no observable effect on hookworm-specific
IFNγ or cell proliferation (Quinnell et al. 2004).
The same study found evidence for malaria and
hookworm-mediated suppression of cell prolifer-
ation, but not effector cytokine secretion, in response
to bacterial antigens (Quinnell et al. 2004). Thus,
malaria co-infection can limit the effector response
to hookworm, but may not significantly affect hook-
worm-mediated immunosuppressive mechanisms.
Conversely, in aMalian study of malaria-W. bancrofti
co-infection, filariasis was significantly associated
with elevated total and malaria-specific IL-10 and
reduced IFNγ (Metenou et al. 2009). As more co-
infection studies are conducted it will become possi-
ble to more directly compare effects of malaria on the
acquired immune responses mounted against differ-
ent helminth species.
Helminth-HIV co-infection
Human Immunodeficiency Virus (HIV) is a lympho-
trophic virus that replicates in CD4+ T cells leading
to incremental abrogation of this cell population
and progression to Acquired Immune Deficiency
Syndrome (AIDS). Both HIV and helminth infec-
tion can be considered as immunocompromising
infections, and it could therefore be predicted that
these effects would synergise to the detriment of
co-infected hosts.
Although co-infection studies tend to focus on
immune responses to HIV, there is some evidence
for heterogeneity in the reciprocal effects of HIV on
helminth immunobiology. For example, HIV infec-
tion is associated with up-regulation of CTLA-4
expression and anergy, which might enhance hel-
minth-mediatedTreg induction and immune evasion
(Steel and Nutman, 2003; Leng et al. 2006). Severe
immunosuppression in advanced HIV/AIDS is also
linked to abnormally high intensity Strongyloides spp.
infections due to increased rates of auto-infection
and, in some regions, strongyloidiasis is considered to
be an AIDS-related opportunistic infection (Meamar
et al. 2007). Furthermore, lowCD4+T cell counts in
HIV seropositive individuals has been associated
12C. D. Bourke and others
with increased tissue sequestration of schistosome
eggs (Karanja et al. 1997), although the relative
impact that this has on host pathology has not been
investigated.
In addition to generalized immunosuppression,
HIV co-infections are negatively correlated with
worm-specific effector cytokine responses (Sentongo
et al. 1998) and may therefore reduce clearance of
both adult and immature worms. HIV-positive
patients co-infected with S. mansoni had lower
measurable agonist-specific IL-4 and parasite and
agonist-specific IL-10 than theirHIV-negative coun-
terparts, but had similar levels of IFNγ (Mwinzi et al.
2001). This finding was linked to an increased Th1:
Th2 effector cytokine ratio in HIV-positive indivi-
duals (Mwinzi et al. 2001), which may result from
preferential infection and abrogation of activatedTh2
cells relative to Th1 and naïve T cells (Maggi et al.
1994).
Disruption of CD4+ T cell polarization and
regulatory mechanisms might be predicted to exacer-
bate helminth-related pathologies (Maggi et al. 1994;
Booth et al. 2004a), particularly in GI infections
which require robust Th2 cytokine responses for
clearance. However, very few studies of nematode-
HIV co-infected populations have been conducted to
date. HIV co-infection with schistosomiasis did not
affect anti-helminthic treatment efficacy in a Kenyan
cohort with high intensity S. mansoni infections
(Karanja et al. 1998). Researchers in the latter study
hypothesized that these findings were partly due to
schistosomiasis preceding HIV infection and that
subsequent co-infection did not affect pre-existing
immune responses to schistosome antigens (Secor
et al. 2004). The latter is of particular interest given
that HIV is most prevalent in sexually-active adults
and thus co-infections tend to arise after initial ex-
posure to helminth infections, which peak in intensity
in childhood. Thus, the stage of HIV infection (and
associated degree of immunosuppression) and popu-
lation-specific age-infection intensity distributions
of different helminthiases are potential sources of
heterogeneity and should be considered when inves-
tigating the immunobiology of co-infections.
CONCLUSIONS
Parasitic helminths present a diverse challenge to
the immune system. Their large proteome and
broad-range of antigens alone may partially explain
the slow development of resistance to helminthiases
(Yazdanbakhsh and Sacks, 2010). Furthermore,
the stage-specific challenges (Day et al. 1991a,b;
MacDonald et al. 2002) and genetic diversity within
single species infections (Galvani, 2005) can lead to
heterogeneity in anti-helminth immune responses in
an individual host.
When comparing different species of helminth it is
clear that immune-heterogeneity can transcend
phylogenetic delineations, particularly with respect
to parasite life-span and intra-host niche. Long-lived
parasites and species inhabiting host tissues can only
exist incognito via sophisticated immunosuppressive
mechanisms that may compromise fecundity and
transmission of infection (Karanja et al. 1997;
Maizels and Yazdanbakhsh, 2003; Brattig, 2004).
Short-lived and GI parasites face different challenges
resulting in characteristic immunobiology. Whilst
immunity to the tissue-dwelling nematodes is associa-
ted with a mixed CD4+ T cell immune response
(Turaga et al. 2000), expulsion of GI nematode
species is more specifically Th2-dependent (Turner
et al. 2003). Few studies have directly compared im-
mune responses to GI nematodes, filarial nematodes
and Schistosoma spp. in single-infections, potentially
due to the high prevalence of co-infection, meaning
that many of the hypothesized sources of inter-
specific immune heterogeneities remain to be em-
pirically tested.
Unlike in experimental animal infections, acquired
immune heterogeneity in natural infections also
arises from host variables. Genetic polymorphism
in the human immune system inevitably translates
into heterogeneous expression of cellular and hu-
moral responses, as is evident in clustering of im-
mune responses within populations and individual
families (Quinnell, 2003; Ellis et al. 2007). The
relatively recent discovery of new CD4+ T cell sub-
classes and identification of further plasticity in
innate effector cells has led to re-evaluation of how
helminths interact with their human host (Diaz
and Allen, 2007; Jenkins and Allen, 2010). Further-
more, the influence that host exposure-history, anti-
helminthic treatment and co-infection have on
anti-helminth responses indicates that immune
heterogeneity arises not from the host and parasite
in isolation, but also from the environment in which
they interact.
Despite the diversity of helminth species and their
host populations identifying the immunological
mechanisms underlying these distinctions has
been a challenge for field studies. Helminth-specific
immune responses become activated and polarized at
a very young age (Eloi-Santos et al. 1989; Lammie
et al. 1991; Novato-Silva et al. 1992; Steel et al. 1994;
King et al. 1998). However, field studies often exclude
individuals under the age of 5, focusing instead on
older individuals in the chronic stage of infection
with a more ambiguous exposure and treatment
history. In addition, whilst co-evolution of humans
and helminths has clearly led to shared features of an
anti-macroparasite response (Jackson et al. 2009), it
is also possible that peripheral sampling methods,
co-infection and long-term systemic disease may
disguise integral differences in human immune
responses (Hayes et al. 2004). The cellular targets
of systemic and highly pleiotropic cytokines and site-
specific immune responses are particularly difficult to
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define in peripheral blood samples. Thus, in addition
to expansion of elegant in vitro cellular assays, a wider
range of immune correlates should be measured in
the field to give a broader characterization of the host
immune ‘phenotype’ in which these cells act.
Anthropophilic helminths are both evolutionarily
ancient and alarmingly prevalent (Hotez et al. 2008),
yet the immune responses mounted against them and
the best means of treating infection remain unclear.
Characterization of risk factors for infection and
morbidity requires immunological measures to be
considered in the context of host and environmental
variables, which can be as influential as those of the
parasite, and in some cases more so (Jackson et al.
2004a; Ellis et al. 2007).
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